
<html lang="en"     class="pb-page"  data-request-id="27b4f5fe-eab4-418a-849b-74d85b043f34"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm300353r;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2012.55.issue-15;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Neuroprotective Methylthiazoles and Modification as NO-Chimeras for Neurodegenerative Therapy" /></meta><meta name="dc.Creator" content="Zhihui  Qin" /></meta><meta name="dc.Creator" content="Jia  Luo" /></meta><meta name="dc.Creator" content="Lawren  VandeVrede" /></meta><meta name="dc.Creator" content="Ehsan  Tavassoli" /></meta><meta name="dc.Creator" content="Mauro  Fa’" /></meta><meta name="dc.Creator" content="Andrew F.  Teich" /></meta><meta name="dc.Creator" content="Ottavio  Arancio" /></meta><meta name="dc.Creator" content="Gregory R. J.  Thatcher" /></meta><meta name="dc.Description" content="Learning and memory deficits in Alzheimer’s disease (AD) result from synaptic failure and neuronal loss, the latter caused in part by excitotoxicity and oxidative stress. A therapeutic approach is ..." /></meta><meta name="Description" content="Learning and memory deficits in Alzheimer’s disease (AD) result from synaptic failure and neuronal loss, the latter caused in part by excitotoxicity and oxidative stress. A therapeutic approach is ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 24, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300353r" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300353r" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300353r" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300353r" /></link>
        
    
    

<title>Design and Synthesis of Neuroprotective Methylthiazoles and Modification as NO-Chimeras for Neurodegenerative Therapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300353r" /></meta><meta property="og:title" content="Design and Synthesis of Neuroprotective Methylthiazoles and Modification as NO-Chimeras for Neurodegenerative Therapy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0011.jpeg" /></meta><meta property="og:description" content="Learning and memory deficits in Alzheimer’s disease (AD) result from synaptic failure and neuronal loss, the latter caused in part by excitotoxicity and oxidative stress. A therapeutic approach is described that uses NO-chimeras directed at restoration of both synaptic function and neuroprotection. 4-Methylthiazole (MZ) derivatives were synthesized, based upon a lead neuroprotective pharmacophore acting in part by GABAA receptor potentiation. MZ derivatives were assayed for protection of primary neurons against oxygen–glucose deprivation and excitotoxicity. Selected neuroprotective derivatives were incorporated into NO-chimera prodrugs, coined nomethiazoles. To provide proof of concept for the nomethiazole drug class, selected examples were assayed for restoration of synaptic function in hippocampal slices from AD-transgenic mice, reversal of cognitive deficits, and brain bioavailability of the prodrug and its neuroprotective MZ metabolite. Taken together, the assay data suggest that these chimeric nomethiazoles may be of use in treatment of multiple components of neurodegenerative disorders, such as AD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300353r"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300353r">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300353r&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300353r&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300353r&amp;href=/doi/10.1021/jm300353r" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6784-6801</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300818k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300385f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Neuroprotective Methylthiazoles and Modification as NO-Chimeras for Neurodegenerative Therapy</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhihui++Qin">Zhihui Qin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jia++Luo">Jia Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawren++VandeVrede">Lawren VandeVrede</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ehsan++Tavassoli">Ehsan Tavassoli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mauro++Fa%E2%80%99">Mauro Fa’</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+F.++Teich">Andrew F. Teich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ottavio++Arancio">Ottavio Arancio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+R.+J.++Thatcher">Gregory R. J. Thatcher</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, University of Illinois at Chicago, 833 S. Wood Street, Chicago, Illinois 60612-7231, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pathology and Cell Biology, The Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University, 630 West 168th Street, New York, New York 10032, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 312-355-5282. Fax: 312-996-7107. E-mail: <a href="/cdn-cgi/l/email-protection#90e4f8f1e4f3f8f5e2d0e5f9f3bef5f4e5"><span class="__cf_email__" data-cfemail="ed99858c998e85889fad98848ec3888998">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300353r&amp;href=/doi/10.1021%2Fjm300353r" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6784–6801</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 10, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 March 2012</li><li><span class="item_label"><b>Published</b> online</span>24 July 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 August 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300353r" title="DOI URL">https://doi.org/10.1021/jm300353r</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6784%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhihui%2BQin%252C%2BJia%2BLuo%252C%2BLawren%2BVandeVrede%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D15%26contentID%3Djm300353r%26title%3DDesign%2Band%2BSynthesis%2Bof%2BNeuroprotective%2BMethylthiazoles%2Band%2BModification%2Bas%2BNO-Chimeras%2Bfor%2BNeurodegenerative%2BTherapy%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6801%26publicationDate%3DAugust%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300353r"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1705</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300353r" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Neuroprotective Methylthiazoles and Modification as NO-Chimeras for Neurodegenerative Therapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhihui&quot;,&quot;last_name&quot;:&quot;Qin&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Lawren&quot;,&quot;last_name&quot;:&quot;VandeVrede&quot;},{&quot;first_name&quot;:&quot;Ehsan&quot;,&quot;last_name&quot;:&quot;Tavassoli&quot;},{&quot;first_name&quot;:&quot;Mauro&quot;,&quot;last_name&quot;:&quot;Fa’&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;F. Teich&quot;},{&quot;first_name&quot;:&quot;Ottavio&quot;,&quot;last_name&quot;:&quot;Arancio&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;R. J. Thatcher&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;6784-6801&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300353r&quot;},&quot;abstract&quot;:&quot;Learning and memory deficits in Alzheimer’s disease (AD) result from synaptic failure and neuronal loss, the latter caused in part by excitotoxicity and oxidative stress. A therapeutic approach is described that uses NO-chimeras directed at restoration of both synaptic function and neuroprotection. 4-Methylthiazole (MZ) derivatives were synthesized, based upon a lead neuroprotective pharmacophore acting in part by GABAA receptor potentiation. MZ derivatives were assayed for protection of primary neurons against oxygen–glucose deprivation and excitotoxicity. Selected neuroprotective derivatives were incorporated into NO-chimera prodrugs, coined nomethiazoles. To provide proof of concept for the nomethiazole drug class, selected examples were assayed for restoration of synaptic function in hippocampal slices from AD-transgenic mice, reversal of cognitive deficits, and brain bioavailability of the prodrug and its neuroprotective MZ metabolite. Taken together, the assay data suggest that these chimeric nomethiazo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300353r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300353r" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300353r&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300353r" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300353r&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300353r" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300353r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300353r&amp;href=/doi/10.1021/jm300353r" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300353r" /></input><a href="/doi/pdf/10.1021/jm300353r" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300353r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300353r%26sid%3Dliteratum%253Aachs%26pmid%3D22779770%26genre%3Darticle%26aulast%3DQin%26date%3D2012%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BNeuroprotective%2BMethylthiazoles%2Band%2BModification%2Bas%2BNO-Chimeras%2Bfor%2BNeurodegenerative%2BTherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D15%26spage%3D6784%26epage%3D6801%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292070" title="Neuroprotection">Neuroprotection</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290792" title="Circuits">Circuits</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jmcmar.2012.55.issue-15/production/jmcmar.2012.55.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Learning and memory deficits in Alzheimer’s disease (AD) result from synaptic failure and neuronal loss, the latter caused in part by excitotoxicity and oxidative stress. A therapeutic approach is described that uses NO-chimeras directed at restoration of both synaptic function and neuroprotection. 4-Methylthiazole (MZ) derivatives were synthesized, based upon a lead neuroprotective pharmacophore acting in part by GABA<sub>A</sub> receptor potentiation. MZ derivatives were assayed for protection of primary neurons against oxygen–glucose deprivation and excitotoxicity. Selected neuroprotective derivatives were incorporated into NO-chimera prodrugs, coined nomethiazoles. To provide proof of concept for the nomethiazole drug class, selected examples were assayed for restoration of synaptic function in hippocampal slices from AD-transgenic mice, reversal of cognitive deficits, and brain bioavailability of the prodrug and its neuroprotective MZ metabolite. Taken together, the assay data suggest that these chimeric nomethiazoles may be of use in treatment of multiple components of neurodegenerative disorders, such as AD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is an age-related neurodegenerative disease manifested by progressive memory loss, decline in language skills, and other cognitive impairments. The disorder is reaching epidemic proportions, with a large human, social, and economic burden.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Currently approved treatments may temporarily reduce the rate of cognitive decline in a limited number of patients, without halting disease progression; however, no treatment is considered disease-modifying.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Diverse factors play a role in the pathogenesis of AD, notably abnormal aggregation of amyloid β (Aβ) and tau protein, glutamate-induced excitotoxicity, oxidative stress, and inflammation.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Accordingly, a variety of therapeutic strategies modulating the progression or prevention of AD are currently being investigated.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> AD represents a major unmet medical need.</div><div class="NLM_p">Excitotoxicity is a mechanism of neuronal dysfunction and cell death characterized by excessive stimulation of glutamate receptors, pathological elevation of intracellular calcium concentration, and mitochondrial damage. The methylthiazole (MZ) containing GABA-mimetic agent clomethiazole (CMZ, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) potentiates the function of the inhibitory neurotransmitter GABA in the brain,<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> attenuating glutamate induced excitotoxicity. CMZ has seen clinical use in a number of indications,<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> and study of compounds related to CMZ has shown that anticonvulsant and hypnotic potency could be dissociated and modulated separately.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17">(12-17)</a> Under the name Zendra, CMZ was explored in clinical trials including phase III trials as a neuroprotective drug for use in spinal cord injury and ischemic stroke,<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25">(18-25)</a> and CMZ continues to be suggested as a potential component of future combination therapies for neuronal injury.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> CMZ has also been demonstrated to counteract inflammation, lowering levels of proinflammatory cytokines, including TNFα,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> and to rescue mitochondrial function in brain tissues.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Recent evidence, from both clinical observations and mouse model studies, supports TNFα as a therapeutic target in AD.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> Likewise, restoration of mictochondrial function is seen as a strategy for AD therapy.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Therefore, MZ derivatives, capable of eliciting neuroprotection and attenuating neuroinflammation, are of potential clinical utility in AD.</div><div class="NLM_p">An early event in AD is synaptic failure.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Restoration of synaptic function via activation of cAMP-responsive element binding factor (CREB) is seen as a new target for treatment of AD and other neurological disorders.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43">(36-43)</a> Activation of CREB is known to enhance or restore long-term potentiation (LTP) and the expression of corresponding gene products to enhance neuronal plasticity and neurogenesis.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44-46)</a> Since activation of CREB in the hippocampus is tightly coupled to NO/cGMP signaling,<a onclick="showRef(event, 'ref44 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref44 ref46 ref47 ref48 ref49">(44, 46-49)</a> restoration of normal NO/cGMP signaling in the aging brain is essential to preserve both synaptic and neuronal survival and function. NO-mimetic agents that enhance CREB activity will likely be of benefit in treatment of AD.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">We have previously reported a chimeric molecule with NO and GABA-mimetic attributes, <b>1</b> (GT-1061), that contains an MZ pharmacophore (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a><b>1</b> significantly improved learning and memory in rats with cognitive deficits in the cholinergic systems of the basal forebrain.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> A key objective of the present study was to determine if <b>1</b> is a prototype of an NO-chimera drug class. A positive observation would allow further optimization and refinement of this drug class for AD and other CNS indications. We report herein (1) the development of a small MZ library, (2) selection of MZ derivatives based upon neuroprotective activity screened in primary neurons, (3) synthesis of novel NO-chimeras, coined nomethiazoles, (4) selection based upon chemical stability, (5) assay for synaptic rescue in brain slices, (6) assay for restoration of learning and memory in vivo, and (7) demonstration of brain bioavailability and measurement of brain/plasma ratios. The drug design approach is depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design Concept for Novel Nomethiazole NO-Chimeras Based upon Neuroprotective MZ Scaffolds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1 Synthesis of MZ Derivatives</h3><div class="NLM_p">Copper(I)-catalyzed Huisgen [3 + 2]-cycloaddition between an azide and a terminal alkyne was used to afford regioselectively 1,4-disubstituted-1<i>H</i>-1,2,3-triazoles, based upon the mild conditions, reliable high yield, and chemoselectivity of this “click” reaction.<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51-53)</a> Azide <b>3</b> was synthesized in two steps and reacted with commercially available alkynes, including alkyl (e.g., 1-hexyne, ethynyltrimethylsilane, propargylbenzene) and aryl (e.g., ethynylbenzene, regioisomers of ethynylpyridine, 3-ethynylthiophene, and 5-ethynyl-1-methyl-1<i>H</i>-imidazole), to generate a small library of 4-methyl-5-(phenyl(1<i>H</i>-1,2,3-triazol-1-yl)methyl)thiazole derivatives (<b>5a</b>–<b>i</b>), and in addition, one fluorinated analogue <b>8</b> was also prepared (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The goal was to increase diversity of MZ derivatives and identify novel neuroprotective scaffolds. Accordingly 5-(2-(1<i>H</i>-1,2,3-triazol-1-yl)ethyl)-4-methylthiazole derivatives (<b>11a</b>–<b>c</b>) and two 5-benzyl-4-methylthiazole derivatives were synthesized (<b>6a</b>,<b>b</b>). Of all the click products, compound <b>5d</b> was identified as an excellent neuroprotectant using in vitro bioassays (discussed below), whereas removal of the 3-pyridyl substitutent (<b>5i</b>), replacement of the pyridine ring with phenyl (<b>5b</b>) or other heterocycles (<b>5g</b>, <b>5h</b>), and changing the position of the nitrogen (<b>5e</b>, <b>5f</b>) led to reduced efficacy. A similar structure–activity pattern was observed for <b>11a</b>–<b>c</b>. Thus, the 3-(1<i>H</i>-1,2,3-triazole-4-yl)pyridine fragment is a potential neuroprotective pharmacophore and was used to develop further MZ derivatives.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Grignard reagent, THF, 0 °C to rt; (b) MsCl, NEt<sub>3</sub> and then NaN<sub>3</sub>, CH<sub>3</sub>CN, rt; (c) alkyne, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <i>t</i>-BuOH/H<sub>2</sub>O (1:1, v/v); (d) LiAlH<sub>4</sub>, THF, reflux; (e) MsCl, NEt<sub>3</sub> and then NaN<sub>3</sub>, CH<sub>3</sub>CN, reflux; (f) MOM-Br, K<sub>2</sub>CO<sub>3</sub>, THF; (g) ethynyltrimethylsilane, CuI, Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, NEt<sub>3</sub>, THF; (h) <b>3</b>, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, K<sub>2</sub>CO<sub>3</sub>, MeOH–H<sub>2</sub>O (2:1); (i) HCl/<i>i</i>-PrOH (1.5 M), 70 °C; (j) 4-nitrooxybutan-1-ol (for <b>18</b>) or 1-acetoxy-4-hydroxybutane (for <b>17</b>), Ph<sub>3</sub>P, DIAD, 0 °C to rt, then K<sub>2</sub>CO<sub>3</sub>, MeOH (for <b>17</b>).</p></p></figure><div class="NLM_p">Synthesis of MZ analogues, retaining the 5-ethyl-4-methylthiazole motif of both CMZ and <b>1</b>, proceeded from 4-methyl-5-vinylthiazole (<b>19</b>) to yield the alcohols <b>22</b> and <b>23</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Epoxide intermediate <b>21</b> was added dropwise to Grignard reagents to give <b>22a</b>–<b>c</b> as major products. Although the ultimate objective was to modify MZ derivatives as NO-chimeras, compounds such as the indole derivative <b>24</b> served to extend and explore the MZ structural space. Compound <b>24</b> also represents an analogue of latrepirdine, a once-promising new AD drug.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Tetrahydrocarboline, the starting material for <b>24</b>, was made according to a published procedure.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> To incorporate the newly discovered 3-(1<i>H</i>-1,2,3-triazole-4-yl)pyridine pharmacophore into NO-chimera scaffolds, azido alcohol <b>25</b> was obtained by treating epoxide <b>21</b> with sodium azide and reacting with 3-ethylnylpyridine under standard click chemistry conditions to give cycloaddition product <b>26</b>. Compound <b>31</b>, a close structural analogue of <b>26</b>, was synthesized from <b>22c</b> using Suzuki coupling to investigate the tolerance of neuroprotection to triazole ring replacement in the novel pharmacophore.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CH<sub>3</sub>CO<sub>2</sub>H, dioxane–H<sub>2</sub>O; (b) K<sub>2</sub>CO<sub>3</sub>, MeOH; (c) Grignard reagent, THF, 0 °C to rt; (d) NaN<sub>3</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O (1:1, v/v), reflux; (e) NaH, DMSO, 90 °C, 5 h; (f) 3-ethynylpyridine, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <i>t</i>-BuOH/H<sub>2</sub>O (1:1, v/v); (g) fuming HNO<sub>3</sub>, Ac<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (h) 3-ethynylpyridine, toluene, reflux, 48 h; (i) 2-mercaptoethanol, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O (2:1); (j) 3-pyridineboronic acid, (2-biphenyl)di-<i>tert</i>-butylphosphine, Pd(OAc)<sub>2</sub>, KF, DMF, 120 °C.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2 CMZ Pharmacology Underlying the Design and Biossay of MZ Derivatives</h3><div class="NLM_p">Many papers have discussed the biological activity of CMZ in clinical settings and in animal models. Thiazole derivatives have long been known to manifest sedative/hypnotic and anticonvulsant effects that are indicative of GABA-mimetic activity.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> The prototype NO-chimera <b>1</b> releases 5-(2-hydroxyethyl)-4-methylthiazole (HMZ) as primary metabolite, which was first reported in 1956 to be an anticonvulsant agent in rabbits.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> CMZ has been shown extensively to be neuroprotective in animal models of transient and global ischemia. CMZ potentiates GABA and muscimol agonism at the GABA<sub>A</sub> receptor without evidence for modulation of levels of GABA itself and opens neuronal Ca-dependent chloride channels enhancing inhibitory neurotransmission. At concentrations 100-fold those required to potentiate GABA function (30 μM), CMZ is a direct GABA<sub>A</sub> receptor agonist.<a onclick="showRef(event, 'ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59">(57-59)</a> CMZ is not a ligand for the GABA<sub>B</sub> or benzodiazepine receptors and potentiates the actions of glycine on inhibitory neurotransmission.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a></div><div class="NLM_p">The mechanism of action of CMZ appears not to be limited to GABA<sub>A</sub> potentiation,<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> since CMZ has been claimed to be a p38-MAPK (mitogen activated protein kinase) pathway inhibitor, although the exact protein target was not defined.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> In Alzheimer’s therapy, inhibition of p38-MAPK is seen as a target, since, for example, Aβ-mediated inhibition of LTP involves stimulation of the p38 MAPK cascade.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> Compound <b>4</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) is the lone analogue of CMZ for which mechanistic data have been reported. In the gerbil model of global ischemia, protection by <i>R</i>-<b>4</b> and <i>S-</i><b>4</b> was equivalent to CMZ;<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> however, <i>R</i>-<b>4</b> was reported to be devoid of anticonvulsant activity, suggested to be compatible with a mechanism involving GABA reuptake inhibition.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">CMZ has a short half-life and is extensively metabolized. Oxidative metabolism at carbon α to the thiazole ring leads to α-hydroxylation and formation of metabolites from further oxidation, including an α-chloro ketone and aldehyde.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a> The replacement of the secondary α-carbon by addition of a group X (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was justified to prevent metabolic oxidation to potentially electrophilic metabolites. The primary α-hydroxyl metabolite of CMZ was also shown to have sedative activity, providing further reason to limit metabolism at this position. The rationale for exploration of the structural space represented by Z (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) using aromatic and heterocyclic groups was based upon the reported biological data on MZ derivative <b>4</b> that clearly show central biological actions including neuroprotection. In the absence of an identified CMZ binding site associated with a GABA<sub>A</sub> subunit, iterative extension of the structural space was carried out by varying the structure and isomerism, represented by <i>n</i>, X, and Z in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><div class="NLM_p">The selection of a bioassay for iterative design and synthesis of MZ derivatives was not immediately apparent. Despite the wealth of reports on CMZ activity in vivo, relatively few publications have described in vitro assays that could be adapted for screening of novel MZ analogues and derivatives for use as neuroprotectants. In SK-N-MC neuroblastoma cells, CMZ was reported to inhibit the glutamate-induced activation of AP-1 mediated by NMDA receptor activation.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> Immortalized cell cultures (e.g., SK-N-MC and the SH-SY5Y human neuroblastoma cell lines) would provide a facile system for cell-based drug screening; however, in SH-SY5Y cell cultures subject to excitotoxic insults including glutamate, NMDA, and oxygen–glucose deprivation (OGD), CMZ did not produce robust and reproducible neuroprotection (data not shown). Therefore, rat primary cortical neurons were studied as a more complete neuronal model. Excitotoxic cell death from treatment with NMDA (100 μM) was inhibited reproducibly by CMZ treatment and by a number of MZ derivatives and analogues (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S1).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Relative Percentage Neuroprotection of Primary Neuronal Cultures in Response to OGD after Treatment with MZ Derivatives<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">% normalized to CMZ after OGD<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">% normalized to CMZ after OGD<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">5-ethyl-4-methylthiazoles</td><td class="colsep0 rowsep0" colspan="2" align="left">4-methyl-5-(phenyl-(1<i>H</i>-1,2,3-triazol-1-yl)methyl)thiazoles</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HMZ</td><td class="colsep0 rowsep0" align="left">14.11 ± 8.5</td><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">26.8 ± 5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CMZ</td><td class="colsep0 rowsep0" align="left">100<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">57.6 ± 6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">ns</td><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">88.3 ± 6.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="left">99.6 ± 1.4</td><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">108 ± 3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22b</b></td><td class="colsep0 rowsep0" align="left">98.9 ± 3.0</td><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">50.9 ± 6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="left">102 ± 1.5</td><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">90.2 ± 2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="left">101 ± 3.9</td><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">62.0 ± 3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">15.4 ± 5.9</td><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="left">93.9 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">ns</td><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="left">58.1 ± 4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">25.0 ± 7.3</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">87.2 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">104 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">(4-methylthiazol-5-yl)(phenyl)methanols</td><td class="colsep0 rowsep0" colspan="2" align="left">5-(2-(1<i>H</i>-1,2,3-triazol-1-yl)ethyl)-4-methylthiazoles</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">94.0 ± 2.9</td><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">51.5 ± 11.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">36.8 ± 6.4</td><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">53.9 ± 6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">25.0 ± 4.6</td><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">99.6 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">110.2 ± 12.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">114.1 ± 4.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">2-(4-methylthiazol-5-yl)-1<i>H</i>-1,2,3-triazol-1-ylethanols</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">107.3 ± 2.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">92.9 ± 7.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">% = (drug – DMSO)/(CMZ – DMSO). ns = not studied. Values are presented as the mean ± SEM (<i>n</i> = 6).</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Readings from MTT assay at 24 h normalized to vehicle (0% survival) and CMZ (100% survival).</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">Comparison, before normalization, with vehicle treated cells demonstrated a mean increase in cell survival of approximately 30% caused by CMZ treatment. </p></div></div></div><div class="NLM_p">NMDA excitotoxicity represents only one aspect of neurotoxicity, whereas OGD provides a much more complete model simulating ischemia followed by reperfusion inducing ATP depletion, glutamate release, NMDA receptor overstimulation, mitochondrial dysfunction, ROS generation, apoptosis, and proinflammatory cytokine release. Given the evidence that multiple pathways underlie the anti-inflammatory and neuroprotective activity of CMZ, OGD in primary neurons was seen as the preferred model to screen and to correlate structure of MZ analogues with activity.</div><div class="NLM_p">The simple 5-ethyl-4-methylthiazole derivatives (<b>22</b>, <b>23</b>) studied in primary neuron OGD retained neuroprotective efficacy comparable to that of CMZ (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In contrast, substitution of the phenyl ring in (4-methylthiazol-5-yl)(phenyl)methanol derivatives (<b>2</b> versus <b>6a</b> and <b>6b</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) significantly reduced efficacy. Further, O-alkylation of <b>2</b> led to improved neuroprotection (<b>2</b> versus <b>38</b> and <b>41</b> in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Compound <b>26</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) incorporated a 3-(1<i>H</i>-1,2,3-triazole-4-yl)pyridine pharmacophore within the MZ scaffold. Both <b>26</b> and its regioisomer <b>30</b> were protective against OGD, whereas replacement of the triazole substitutent in <b>26</b> (<b>26</b> vs <b>31</b>) or substitution of 3-pyridyl in <b>5d</b> with 2-pyridyl (<b>5e</b>) led to significant loss of efficacy. The results indicate that both triazole and 3-pyridyl moieties are critical structural elements to the neuroprotective 3-(1<i>H</i>-1,2,3-triazole-4-yl)pyridine fragment.</div><div class="NLM_p">Mindful of the reports of GABAergic and GABA-independent mechanisms of action for CMZ, the mechanism of neuroprotection of four MZ derivatives was probed using the GABA<sub>A</sub> receptor channel blocker picrotoxin (100 μM) that has been used extensively for selective antagonism of GABA<sub>A</sub> mediated signaling.<a onclick="showRef(event, 'ref68 ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref68 ref69 ref70 ref71">(68-71)</a> Lower concentrations of picrotoxin deliver only partial blockade,<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> and some studies employ higher concentrations.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74, 75)</a> Muscimol, a potent, selective GABA<sub>A</sub> receptor agonist, was studied for comparison. Instead of OGD, the simpler excitotoxic insult delivered by glutamate (100 μM) was used to induce neuronal loss, measured at 24 h (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). As anticipated, muscimol produced effective neuroprotection against glutamate toxicity, which was lost and reversed on blockade of the GABA<sub>A</sub> chloride channel. Neuroprotection produced by <b>22a</b> mirrored that by muscimol, indicating a GABAergic neuroprotective mechanism. In contrast, neuroprotection by <b>11c</b> was significantly attenuated by GABA<sub>A</sub> receptor blockade but was not ablated or reversed, indicating a neuroprotective mechanism only partially dependent on the GABA<sub>A</sub> receptor. MZ derivatives <b>26</b> and <b>41</b> demonstrated intermediate neuroprotective mechanisms. On the basis of these collected data, a neuroprotective pharmacophore was speculated (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Full elucidation of the individual GABA-dependent and GABA-independent pharmacophores requires extended structure–activity studies; however, the objective was achieved: to develop novel MZ derivatives to be functionalized as NO-chimeras.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inhibition by picrotoxin of neuroprotection elicited by MZ derivatives in primary neuronal cultures subject to excitotoxic insult. Primary cortical cultures (10–11 DIV) were subjected to 24 h of glutamate (Glut, 100 μM) toxicity with co-treatment of muscimol (Musc) or MZ derivatives (50 μM). Picrotoxin (Picro, 100 μM) was added, where indicated, 1 h before glutamate treatment to provide blockade of GABA<sub>A</sub> signaling. Survival was measured with the MTT assay and normalized to vehicle treated controls. Data show the mean and SEM from at least six individual experiments analyzed by ANOVA with post hoc Dunnett’s MCT compared to nonglutamate treated vehicle control or compared to the efficacy of picrotoxin in blocking each drug treatment effect with a two-tailed <i>t</i> test: ∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01; ∗∗∗, <i>p</i> < 0.001; ns, not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3 Synthesis of NO-Chimeras</h3><div class="NLM_p">MZ derivatives (e.g., compounds <b>5d</b>, <b>22</b>, <b>23</b>, and <b>26</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were selected for further study based upon efficacy for neuroprotection against OGD-induced cell death and the feasibility of structural modification to give nitrate NO-chimeras. Compound <b>5d</b> is as an excellent neuroprotectant against OGD and NMDA induced cytotoxicity. Compound <b>16</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) is an analogue of <b>5d</b> providing a hydroxyl group on the pyridine ring and allowing modification as an NO-chimera. A TMS protected alkyne was introduced into the pyridine derivative <b>13</b> via a Sonogoshira reaction, yielding <b>14</b>, which underwent direct reaction with azide <b>3</b> in a basic methanolic solution, as adapted from the literature.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The MOM protecting group of <b>15</b> was removed, and NO-chimera <b>18</b> was prepared by coupling of <b>16</b> with 4-nitrooxybutan-1-ol under Mitsunobu conditions. Similarly, <b>17</b>, the denitration product of <b>18</b>, was made by using 4-acetyloxybutan-1-ol as reactant followed by deacetylation. Both <b>16</b> and <b>17</b> are potential metabolites of the NO-chimera <b>18</b>; notably <b>16</b> retained neuroprotective efficacy comparable to that of CMZ (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">Two general strategies were used for synthesis of nitrate NO-chimeras. The first used simple electrophilic or nucleophilic nitration procedures to generate nitrate esters from alcohol or halide intermediates, respectively. For instance, NO-chimeras <b>32a</b>,<b>b</b> and <b>33</b> were prepared from hydroxyl MZ precursors <b>22a</b>,<b>b</b> and <b>23a</b> by the treatment of a mixture of acetic anhydride and fuming nitric acid (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). However, this method failed to directly convert <b>26</b> to NO-chimera <b>28</b>; therefore, nitrate <b>27</b> was prepared from intermediate <b>25</b> and then reacted with 3-ethynylpyridine in the presence of ascorbate and CuSO<sub>4</sub>. The expected instability of the nitrate moiety under these reductive conditions led to a low yield of <b>26</b> as major and <b>28</b> as minor product. However, a mixture of <b>25</b> and alkyne refluxed in toluene successfully gave both regioisomers <b>28</b> and <b>29</b> by thermal cycloaddition. The nitrate group of <b>29</b> was removed using thiol under basic conditions to yield MZ derivative <b>30</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><div class="NLM_p">The second strategy of synthesizing NO-chimeras was to incorporate a labile linker group that would distance the nitrate from the MZ core in an approach more akin to that used in hybrid nitrates such as NO-NSAIDs. Esters of cyclopropane carboxylic acid have been reported to possess substantially increased stability toward both acid- and base-catalyzed hydrolysis.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Inspired by this observation, 1-nitrooxymethylcyclopropanecarboxylic acid (<b>35</b>, Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) was prepared by mononitration and sequential oxidation. Acid <b>35</b> was coupled with <b>2</b> to yield NO-chimera <b>36</b> which was expected to have enhanced stability to esterase hydrolysis and therefore theoretically predicted to have enhanced brain bioavailability. An alternative use of this strategy led to design and synthesis of the carbamate prodrug <b>42</b>, using the isocyanate precursor obtained from <b>4</b> reacting with mononitrate <b>34</b>, again predicted to have further enhanced stability. A similar procedure was used for coupling of 4-nitrooxybutan-1-ol to yield the carbamate <b>43</b>. Preparation of the amide-linked prodrug <b>44</b> and compound <b>37</b> allowed comparison with the ester-linked prodrug <b>36</b>. Aliphatic nitrate <b>40</b> was synthesized from <b>2</b> by O-alkylation with dibromide and subsequent nucleophilic substitution using AgNO<sub>3</sub>. The ethylene glycol linker was incorporated to increase aqueous solubility.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) fuming HNO<sub>3</sub>, Ac<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (b) TEMPO, PhI(OAc)<sub>2</sub>, DCM; (c) NaClO<sub>2</sub>, NaH<sub>2</sub>PO<sub>4</sub>, 2-methyl-2-butene, <i>t</i>-BuOH; (d) <b>35</b> (for <b>36</b>, <b>44</b>) or 1-methylcyclopropane-1-carboxylic acid (for <b>37</b>), EDCI, DIPEA, HOBT, DCM; (e) NaH, CH<sub>3</sub>I, DMF; (f) bis(2-bromomethyl) ether, NaH, DMF; (g) AgNO<sub>3</sub>, CH<sub>3</sub>CN, reflux; (h) LiAlH<sub>4</sub>, THF, reflux; (i) triphosgene, AcOEt, reflux; (j) <b>34</b> (for <b>42</b>) or 4-nitrooxybutan-1-ol (for <b>43</b>), NEt<sub>3</sub>, THF.</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">4 Stability of NO-Chimeras</h3><div class="NLM_p">It was anticipated that future animal studies would require simulation of an extended release formulation, potentially by use of drug in buffered drinking water; therefore, the stability of nitrates was tested in phosphate buffer (100 mM, pH 7.4) using HPLC–UV or LC–MS monitoring. Since the nitrate group itself is stable in acid and mild alkaline solution, the observed stability over 5 days at room temperature of <b>28</b>, <b>29</b>, <b>32a</b>,<b>b</b>, <b>33</b>, and <b>40</b> was expected; the carbamate <b>43</b> and amide <b>44</b> were also stable. However, to our surprise, hydrolysis of <b>36</b> was rapid, rather than being retarded by the hindered α-cyclopropane group, with a half-life of only about 30 min (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The lability of the nitrooxymethylcyclopropanecarboxylate was unexpected, and therefore, comparison was made with the stability of <b>37</b> as an analogue lacking only the nitrate group. The observed half-life of about 380 min for ester hydrolysis confirms that the nitrate group contributes to the instability of <b>36</b>. We have previously reported the phenomenon of accelerated hydrolysis caused by an adjacent nitrate group ascribed to intramolecular Lewis acid catalysis<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> and propose a similar mechanism for <b>36</b> enhanced by a Thorpe–Ingold effect in which the developing negative charge is stabilized by the nitrate moiety through a cyclic transition state (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Although more stable than <b>36</b>, carbamate <b>42</b> also decomposed in phosphate buffer with a half-life of approximately 3000 min to yield at least four UV-detectable products that from LC–MS analysis included two denitrated products (<i>m</i>/<i>z</i> = 333) (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Figure S1).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative kinetic traces for hydrolysis of <b>36</b> and <b>37</b> (10 μM) in phosphate buffer (100 mM, pH 7.4). Incubations were conducted at room temperature and monitored by HPLC with UV detection at 254 nm and fit to a pseudo-first-order rate equation. A putative mechanism is shown for rate acceleration by anchimeric stabilization of the anionic transition state by the nitrate group acting as intramolecular Lewis acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">5 Restoration of Synaptic Function by NO-Chimeras</h3><div class="NLM_p">An early event in AD is synaptic failure leading to deficits in learning and memory.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The importance of synaptic alterations in AD has also been confirmed by studies in transgenic mouse models of AD<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> as well as on LTP, a widely studied cellular model of learning and memory.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Previous work has reported that synaptic transmission and cognition are altered in double transgenic APP/PS1 mice expressing both the human APP mutation (K670M:N671L) and the human PS1 mutation (M146L).<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81, 82)</a> In hippocampal slices obtained from APP/PS1 and WT littermates between 4 and 5 months of age, reproducible LTP responses in the CA1 are observed, with a reduction of LTP in APP/PS1 hippocampal slices, as measured by field excitatory postsynaptic potential (fEPSP). Aβ-induced inhibition of LTP has been observed to be reversed by NO-donors via a mechanism shown to be mediated by the NO/cGMP signaling pathway.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Basal synaptic transmission was determined by measuring the slope of fEPSP at increasing stimulus intensities in slices from 4 to 5 month old APP/PS1 mice for NO-chimeras <b>32a</b> and <b>42</b> (100 μM) perfused for 5 min before inducing LTP through a θ-burst tetanic stimulation of the Schaeffer collateral pathway (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Potentiation was observed for <b>32a</b>, although data for <b>42</b> did not reach significance (<i>P</i> < 0.1). The requirement for reductive bioactivation of nitrates to NO and the instability of <b>42</b> discussed above are likely causes of the observed differences. The potentiation of the actions of the inhibitory neurotransmitter GABA is not expected to enhance LTP, and accordingly, CMZ did not restore LTP (data not shown).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Restoration of CA1-LTP impairment in 3-month-old APP/PS1 mouse hippocampal slices. (A) NO-chimera <b>32a</b> rescued the LTP impairment in APP/PS1 mice (<i>F</i><sub>(1,16)</sub> = 4.129, <i>p</i> = 0.05, compared with vehicle; 50–80 min analysis); (B) NO-chimera <b>42</b> showed a tendency toward reversal of LTP impairment without reaching significance (F<sub>(1,12)</sub> = 2.537, <i>p</i> = 0.13, compared with vehicle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">6 Restoration of Cognition by NO-Chimeras</h3><div class="NLM_p">The step-through passive avoidance (STPA) task was used to measure the reversal of a stimulus-response memory deficit induced by the amnesic agent scopolamine that blocks muscarinic acetylcholine receptor activation. Since muscarinic acetylcholine receptor dysfunction is relevant to AD, scopolamine-induced amnesia remains a useful model for screening of drugs for procognitive actions.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The STPA task tests learned aversion memory, since mice have a natural preference for dark areas over brightly lit and open areas. Following a period of habituation, the animal is placed in the light compartment of the apparatus and inevitably crosses to the dark compartment of the apparatus, at which time an electric shock is delivered. The animals rapidly learn to avoid moving into the dark compartment during the training phase, despite the administration of the amnesic agent. Retention of this newly learned behavior can be tested on subsequent days to assess the strength of the aversive memory by measuring the latency to enter the dark area. In both training and testing phases, the task is halted after 300 s if the animal does not enter the dark side.</div><div class="NLM_p">STPA has a significant advantage for drug screening because the potential locomotor effects of drugs are very unlikely to confound the observations. First, all animals must show a uniform learning response to training regardless of drug treatment, which initially entails movement between the compartments until the task is learned. Second, animals are tested 24 and/or 48 h after a single drug treatment, and since most of the drugs, including all NO-chimeras that we have studied to date, have cleared the system long before memory is tested, the STPA task is primarily a measure of memory consolidation.</div><div class="NLM_p">Scopolamine was administered 30 min and drugs 20 min before training (both ip). Drugs were administered at concentrations equimolar to <b>1</b> (1 mg/kg, i.e., 4.45 μmol/kg) to provide comparison to previous work.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Administration of scopolamine and vehicle resulted in a latency of less than 100 s for mice to enter the dark side of the apparatus when tested 24 h later, demonstrating an inability to consolidate memory. In contrast, treatment with scopolamine and all novel NO-chimeras studied (<b>28</b>, <b>29</b>, <b>32a</b>, <b>32b</b>, <b>40</b>, <b>42</b>, <b>43</b>) significantly restored memory at 24 h (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Procognitive effects of NO-chimeras evaluated in the scopolamine-induced memory deficit model using the STPA task. Scopolamine was administered 30 min and drug was administered 20 min prior to the start of training, and memory was tested 24 h after training and drug treatment. NO-chimeras <b>28</b>, <b>29</b>, <b>32a</b>, <b>32b</b>, <b>42</b>, <b>43</b> (∗∗∗, <i>p</i> < 0.01, compared with vehicle), and <b>40</b> (∗∗, <i>p</i> < 0.05, compared with vehicle) significantly reversed the scopolamine induced memory deficit. Data were obtained from at least five mice per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">7 Brain Bioavailability Assessed by LC–MS/MS</h3><div class="NLM_p">Although the procognitive effects of the NO-chimeras are indicative of brain bioavailability, LC–MS/MS measurements were used to confirm blood–brain barrier penetration. Furthermore, a second objective of these assays was to measure the concentrations of MZ metabolites in the brain after NO-chimera delivery, since the neuroprotective properties of the MZ metabolite are an important aspect of the drug design. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> shows LC–MS/MS chromatograms for multiple reaction monitoring (MRM) after administration of two NO-chimeras and their MZ metabolites, representing two subclasses of NO-chimera with different physicochemical properties. The NO-chimera <b>32a</b> showed good brain bioavailability, and its 5-ethyl-4-methylthiazole metabolite <b>22a</b> was also observed in the brain of mice 20 min after administration. In contrast, the bioavailability of NO-chimera <b>28</b> was low at this time point, whereas the 2-(4-methylthiazol-5-yl)-1<i>H</i>-1,2,3-triazol-1-ylethanol metabolite <b>26</b> was readily detected. Calculated parameters suggest that <b>26</b> (tPSA = 73 Å<sup>2</sup>; ClogP < 0) should not penetrate the blood–brain barrier, whereas <b>22a</b> (tPSA = 33 Å<sup>2</sup>; ClogP = 1.56) has more favorable properties; however, both MZ derivatives were observed in mouse brains after direct ip administration or after administration of the NO-chimera prodrug. The preliminary replicate analyses after administration of <b>26</b> and <b>28</b> suggest that the nitrate chimera prodrug elevates brain levels of <b>26</b>, relative to direct administration of <b>26</b> itself (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These data, obtained after ip administration, are predictive of oral bioavailability by comparison with data for <b>1</b>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Analysis of Selected MZ Derivatives and NO-Chimeras in Mice Brain Tissue</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">injected drug (ip)</th><th class="colsep0 rowsep0" align="center">analyte</th><th class="colsep0 rowsep0" align="center">MRM transition of analytes</th><th class="colsep0 rowsep0" align="center">internal standard and MRM transition</th><th class="colsep0 rowsep0" align="center">brain concn (ng/mL)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">333 → 288</td><td class="colsep0 rowsep0" align="left"><b>8</b>, 352 → 147</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">288 → 147</td><td class="colsep0 rowsep0" align="left"><b>8</b>, 352 → 147</td><td class="colsep0 rowsep0" align="left">76.6 ± 10.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">288 → 147</td><td class="colsep0 rowsep0" align="left"><b>8</b>, 352 → 147</td><td class="colsep0 rowsep0" align="left">56.4 ± 5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32a</b></td><td class="colsep0 rowsep0" align="left"><b>32a</b></td><td class="colsep0 rowsep0" align="left">265 → 220</td><td class="colsep0 rowsep0" align="left"><b>22b</b>, 238 → 207</td><td class="colsep0 rowsep0" align="left">9.5 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32a</b></td><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="left">220 → 189</td><td class="colsep0 rowsep0" align="left"><b>22b</b>, 238 → 207</td><td class="colsep0 rowsep0" align="left">9.5 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="left">220 → 189</td><td class="colsep0 rowsep0" align="left"><b>22b</b>, 238 → 207</td><td class="colsep0 rowsep0" align="left">32.9 ± 3.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Four mice were used for the injection of each drug. Values are presented as the mean ± SEM (<i>n</i> = 4).</p></div></div></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MRM LC–MS/MS chromatograms of extracted mouse brain samples 20 min after ip delivery of each drug at a dosage that was equimolar with <b>1</b> (4.5 μmol/kg): (A) <b>26</b> with <b>8</b> used as internal standard; (B) <b>28</b> with <b>8</b> used as internal standard; (C) <b>22a</b> with <b>22b</b> used as internal standard; (D) <b>32a</b> with <b>22b</b> used as internal standard.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68031" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68031" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synaptic failure is an early event in both AD and mild cognitive impairment (MCI), which causes impaired cognition and memory.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Disease progression involves neurodegeneration of cortical and hippocampal neurons and loss of hippocampal volume. A drug that targets synaptic failure in addition to providing neuroprotection is a rational approach to AD therapy. Abnormally assembled Aβ and tau proteins are associated with both synaptic and neuronal dysfunction and loss.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Aβ has been shown to down-regulate signaling via the NO/cGMP/CREB pathway; therefore, enhancement of NO/cGMP signaling and activation of CREB may provide a novel approach for the treatment of AD.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42 ref47 ref85'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42 ref47 ref85">(39-42, 47, 85)</a> Gene products associated with CREB activation may provide neuroprotection; however, prevention of neuronal loss can also be achieved by selective pharmacological modulation of GABA<sub>A</sub> receptors, a mechanism that has been shown to provide neuroprotection against Aβ mediated toxicity.<a onclick="showRef(event, 'ref86 ref87 ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref86 ref87 ref88 ref89">(86-89)</a></div><div class="NLM_p last">Herein, we have elaborated on the concept of an NO-chimera, incorporating GABA-mimetic and NO-mimetic mechanisms, by developing and derivatizing novel MZ scaffolds. These chimeric agents represent a novel drug class coined nomethiazoles. The milestones for this study were (1) development of the MZ pharmacophore through synthesis of novel derivatives, (2) assay of neuroprotection in primary neurons, (3) synthesis of nomethiazoles by derivatization of novel, neuroprotective MZ scaffolds, possessing (4) satisfactory stability. Proof-of-concept for nomethiazoles was achieved by demonstration of (5) synaptic rescue using LTP measurements ex vivo, (6) restoration of learning and memory in vivo, and (7) brain bioavailability of both NO-chimeras and their MZ metabolites. It was confirmed that <b>1</b> is a prototype of a novel drug class that possesses a combination of GABA-mimetic and NO-mimetic activities, thus providing both neuroprotection and neurorestoration. Since neurodegenerative diseases such as AD are multifactorial, the development of drugs designed to target more than one mechanism of action is likely to be a promising therapeutic approach.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis</h3><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained with Bruker Ultrashield 400 MHz and Advance 300 MHz spectrometers. Chemical shifts are reported as δ values in parts per million (ppm) relative to tetramethylsilane (TMS) for all recorded NMR spectra. All reagents and solvents were obtained commercially from Acros, Aldrich, and Fluka and were used without purification. Low-resolution mass spectrometry (LRMS) was conducted on an Agilent 6300 ion-trap LC–MS instrument. High resolution mass spectral data were collected using a Shimadzu QTOF 6500 instrument. All compounds submitted for biological testing were found to be >95% pure by analytical HPLC. Purity and/or low resolution mass spectral (ESI or APCI) analysis was measured using an Agilent Zorbax Bonus C18, 3.5 μm, 150 mm × 3.0 mm column on either a Shimadzu UFLC or Agilent 1100 series HPLC instrument in tandem with an Agilent 6310 ion trap LC–MS instrument. HPLC parameters were the following: 0.1% FA in 10% CH<sub>3</sub>OH (solvent A); 0.1% FA in CH<sub>3</sub>CN (solvent B); flow rate 0.5 mL/min; gradient, <i>t</i> = 0 min, 10% A; <i>t</i> = 1 min, 10% A; <i>t</i> = 18 min, 80% A; <i>t</i> = 20 min, 80% A; <i>t</i> = 21 min, 95% A.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 1-(4-Methyl-5-thiazolyl)-1-phenylmethanol (<b>2</b>)</h3><div class="NLM_p last">4-Methyl-5-thiazolecarboxaldehyde (1.0 g, 7.8 mmol) was dissolved in THF (40 mL) and cooled in an ice bath, and phenylmagnesium bromide (1 M in THF, 8.5 mL) was added dropwise. The reaction mixture was warmed to room temperature and stirred overnight. The reaction was quenched with aqueous NH<sub>4</sub>Cl, and extraction was with ethyl acetate (2 × 100 mL). Organic solutions were combined and concentrated, and the crude product was purified by column chromatography (hexanes/ethyl acetate, 1:1, 1.4 g, 87%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.81 (s, 1H), 7.45(d, 2H, <i>J</i> = 7.2 Hz) 7.24–7.36 (m, 3H), 6.16 (d, 1H, <i>J</i> = 3.6 Hz), 5.34 (d, 1H, <i>J</i> = 3.6 Hz), 2.38 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 151.57, 148.90, 145.14, 137.96, 129.09, 128.20, 126.92, 69.66, 15.54.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 5-(Azidophenylmethyl)-4-methylthiazole (<b>3</b>)</h3><div class="NLM_p last">MsCl (2.9 mL) was added to a solution of <b>2</b> (6.2 g) and NEt<sub>3</sub> (6.0 mL) in anhydrous acetonitrile (70 mL). Reaction was monitored by TLC until the starting material was consumed. NaN<sub>3</sub> (6.1 g) was added, and the mixture was stirred at room temperature overnight. Most of the acetonitrile was removed under reduced pressure. The residue was diluted with ethyl acetate and washed with water. The organic phase was separated and concentrated, and the crude product was purified by column chromatography (hexane/ethyl acetate, 2:1, 75%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.87 (s, 1H), 7.34–7.47 (m, 5H), 6.41 (s, 1H), 2.45 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 152.86, 151.16, 140.13, 131.97, 129.67, 129.24, 127.62, 61.78, 15.55. HRMS calcd for C<sub>11</sub>H<sub>10</sub>N<sub>4</sub>S [M + H]<sup>+</sup> 231.0704, found 231.0713.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> α-Phenyl-(4-methyl-5-thiazolyl)methanamine (<b>4</b>)</h3><div class="NLM_p last">LiAlH<sub>4</sub> (130 mg, 3.5 mmol) was added to a solution of <b>3</b> (320 mg, 1.39 mmol) in anhydrous THF (10 mL). The mixture was refluxed for 1 h and quenched with 0.1 N NaOH. The residue was diluted with water and extracted using ethyl acetate (2 × 25 mL). Organic solutions were combined and concentrated, and the crude product was purified by column chromatography (DCM/MeOH, 15:1, 230 mg, 82%). <sup>13</sup>C NMR (CD<sub>3</sub>CN, 100 MHz): δ 151.62, 148.35, 145.96, 139.76, 129.52, 128.23, 127.51, 53.69, 15.61. HRMS calcd for C<sub>11</sub>H<sub>12</sub>N<sub>2</sub>S [M + H]<sup>+</sup> 205.0799, found 205.0807.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Compound <b>5</b>. Standard Click Chemistry Procedure</h3><div class="NLM_p last">Azide (1 equiv) and alkyne (1 equiv) were dissolved in <i>t</i>-BuOH and water (1:1). Sodium ascorbate (0.2 equiv) and CuSO<sub>4</sub>·5H<sub>2</sub>O (0.1 equiv) were added. The reaction mixture was stirred overnight, diluted with ethyl acetate, and washed with water. The organic phase was separated and concentrated, and the crude product was purified by column chromatography (DCM/MeOH, 20:1, yield 75–90%). For compounds <b>5i</b> and <b>11a</b>, the solvent was changed to a mixture of MeOH and H<sub>2</sub>O (2:1, v/v). K<sub>2</sub>CO<sub>3</sub> (1 equiv) was also added in addition to other reactants.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 4-Butyl-1-[(4-methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazole (<b>5a</b>)</h3><div class="NLM_p last">1-Hexyne was reacted with <b>3</b> to give <b>5a</b>. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.92 (s,1H), 7.83 (s, 1H), 7.48 (s, 1H), 7.35–7.41(m, 3H), 7.27–7.28 (m, 2H), 2.68 (t, 2H, <i>J</i> = 8.0 Hz), 2.36 (s, 3H), 1.58–1.66 (m, 2H), 1.29–1.38 (m, 2H), 0.88 (t, 3H, <i>J</i> = 7.6 Hz). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 153.50, 152.51, 148.66, 140.45, 131.10, 129.67, 129.34, 127.72, 122.08, 61.08, 32.23, 25.86, 22.79, 15.40, 14.02. HRMS calcd for C<sub>17</sub>H<sub>20</sub>N<sub>4</sub>S [M + H]<sup>+</sup> 313.1481, found 313.1468.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-[(4-Methyl-5-thiazolyl)phenylmethyl]-4-phenyl-1<i>H</i>-1,2,3-triazole (<b>5b</b>)</h3><div class="NLM_p last">Ethynylbenzene was reacted with <b>3</b> to give <b>5b</b>. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 9.02 (s, 1H), 8.48 (s, 1H), 7.92–7.94 (m, 2H), 7.58 (s, 1H), 7.30–7.45 (m, 8H), 2.41 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 147.98, 140.23, 131.82, 129.77, 129.55, 129.48, 128.75, 127.74, 126.29, 121.31, 61.47, 15.47. HRMS calcd for C<sub>19</sub>H<sub>16</sub>N<sub>4</sub>S [M + H]<sup>+</sup> 333.1174, found 333.1186.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-[(4-Methyl-5-thiazolyl)phenylmethyl]-4-(phenylmethyl)-1<i>H</i>-1,2,3-triazole (<b>5c</b>)</h3><div class="NLM_p last">Propargylbenzene was reacted with <b>3</b> to give <b>5c</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.98 (s, 1H), 7.97 (s, 1H), 7.53 (s, 1H), 7.17–7.41 (m, 10H), 4.01 (s, 2H), 2.31 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 153.82, 150.92, 146.33, 139.46, 139.36, 129.81, 128.99, 128.57, 128.52, 126.81, 126.29, 122.78, 59.37, 31.19, 15.05. HRMS calcd for C<sub>20</sub>H<sub>18</sub>N<sub>4</sub>S [M + H]<sup>+</sup> 347.1330, found 347.1344.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-[1-[(4-Methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazol-4-yl]pyridine (<b>5d</b>)</h3><div class="NLM_p last">3-Ethynylpyridine was reacted with <b>3</b> to give <b>5d</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.10 (bs, 1H), 9.03 (s, 1H), 8.83 (s, 1H), 8.54 (bs,1H), 8.25 (d, 1H, <i>J</i> = 8.0 Hz), 7.67 (s, 1H), 7.29–7.49 (m, 6H), 2.45 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): δ 153.98, 151.42, 149.12, 146.58, 143.77, 139.09, 132.71, 129.48, 129.08, 128.76, 126.87, 126.41, 124.08, 122.18, 59.87, 15.12. HRMS calcd for C<sub>18</sub>H<sub>15</sub>N<sub>5</sub>S [M + H]<sup>+</sup> 334.1126, found 334.1118.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-[1-[(4-Methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazol-4-yl]pyridine (<b>5e</b>)</h3><div class="NLM_p last">2-Ethynylpyridine was reacted with <b>3</b> to give <b>5e</b>. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.95 (s, 1H), 8.55 (d, 1H, <i>J</i> = 4.0 Hz), 8.51 (s, 1H), 8.15 (d, 1H, <i>J</i> = 8.0 Hz), 7.85 (triple doublet, 1H, <i>J</i> = 8.0, 1.6 Hz), 7.64 (s, 1H), 7.21–7.45 (m, 6H), 2.43 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 153.73, 152.61, 151.51, 150.42, 148.90, 140.03, 137.59, 130.37, 129.79, 129.51, 127.74, 123.69, 123.32, 120.34, 61.43, 15.43. HRMS calcd for C<sub>18</sub>H<sub>15</sub>N<sub>5</sub>S [M + H]<sup>+</sup> 334.1126, found 334.1129.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-[1-[(4-Methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazol-4-yl]pyridine (<b>5f</b>)</h3><div class="NLM_p last">4-Ethynylpyridine was reacted with <b>3</b> to give <b>5f</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.75 (s, 1H), 8.61 (d, 2H, <i>J</i> = 4.8 Hz), 8.01 (s, 1H), 7.71 (d, 2H, <i>J</i> = 5.6 Hz), 7.34–7.40 (m, 4H), 7.18–7.20 (m, 2H), 2.42 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 152.49, 151.94, 150.09, 145.12, 137.55, 137.39, 129.02, 128.99, 128.81, 126.46, 120.65, 119.73, 60.96, 15.18. HRMS calcd for C<sub>18</sub>H<sub>15</sub>N<sub>5</sub>S [M + H]<sup>+</sup> 334.1126, found 334.1119.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-[(4-Methyl-5-thiazolyl)phenylmethyl]-4-(3-thienyl)-1<i>H</i>-1,2,3-triazole (<b>5g</b>)</h3><div class="NLM_p last">3-Ethynylthiophene was reacted with <b>3</b> to give <b>5g</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.74 (s, 1H), 7.69 (d, 1H, <i>J</i> = 2.0 Hz), 7.60 (s, 1H), 7.36–7.44 (m, 5H), 7.30 (s, 1H), 7.15–7.16 (m, 2H), 2.43 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 152.43, 152.16, 144.17, 138.07, 131.47, 129.34, 129.17, 129.08, 126.70, 126.40, 125.73, 121.42, 118.68, 60.91, 15.42. HRMS calcd for C<sub>17</sub>H<sub>14</sub>N<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> 339.0738, found 339.0754.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-(1-Methyl-1<i>H</i>-imidazol-5-yl)-1-[(4-methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazole (<b>5h</b>)</h3><div class="NLM_p last">5-Ethynyl-1-methyl-1<i>H</i>-imidazole was reacted with <b>3</b> to give <b>5h</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.75 (s, 1H), 7.70(s, 1H), 7.50 (bs, 2H), 7.39–7.40 (m, 3H), 7.31(s, 1H), 7.17–7.19 (m, 2H), 3.93 (s, 3H), 2.44 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 152.50, 151.87, 137.66, 129.04, 128.99, 128.90, 126.52, 120.21, 60.89, 15.22. HRMS calcd for C<sub>17</sub>H<sub>16</sub>N<sub>6</sub>S [M + H]<sup>+</sup> 337.1235, found 337.1235.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-[(4-Methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazole (<b>5i</b>)</h3><div class="NLM_p last">Ethynyltrimethylsilane was reacted with <b>3</b> in the presence of CuSO<sub>4</sub>, sodium ascorbate, and K<sub>2</sub>CO<sub>3</sub> to give <b>5i</b>. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.90 (s, 1H), 8.06 (d, 1H, <i>J</i> = 0.8 Hz), 7.75 (s, 1H, <i>J</i> = 0.8 Hz), 7.57 (s, 1H), 7.26–7.43 (m, 5H), 2.37 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 153.57, 152.41, 140.39, 134.11, 130.73, 129.73, 129.42, 127.71, 125.00, 61.00, 15.35. HRMS calcd for C<sub>13</sub>H<sub>12</sub>N<sub>4</sub>S [M + H]<sup>+</sup> 257.0861, found 257.0873.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-(4-Methyl-5-thiazolyl)-1-(4-fluorophenyl)methanol (<b>6a</b>)</h3><div class="NLM_p last">4-Fluorophenylmagnesium bromide was reacted with <b>1</b> to give <b>6a</b> according to the method described for compound <b>2</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.49 (s, 1H), 7.33–7.37 (m, 2H), 7.03 (t, 2H, <i>J</i> = 8.4 Hz), 6.04 (s, 1H), 2.32 (s, 3H). HRMS calcd for C<sub>11</sub>H<sub>10</sub>FNOS [M + H]<sup>+</sup> 224.0545, found 224.0544.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(4-Methyl-5-thiazolyl)-1-(4-chlorophenyl)methanol (<b>6b</b>)</h3><div class="NLM_p last">4-Chlorophenylmagnesium bromide was reacted with <b>1</b> to give <b>6b</b> according to the method described for compound <b>2</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.56 (s, 3H), 7.33 (bs, 4H), 6.07 (s, 1H), 2.38 (s, 3H). HRMS calcd for C<sub>11</sub>H<sub>10</sub>ClNOS [M + H]<sup>+</sup> 240.0250, found 240.0245.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5-[Azido(4-fluorophenyl)methyl]-4-methylthiazole (<b>7</b>)</h3><div class="NLM_p last"><b>6a</b> was used to prepare <b>7</b> according to the method described for compound <b>3</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.69 (s, 1H), 7.27–7.34 (m, 2H), 7.07 (t, 2H, <i>J</i> = 8.4 Hz), 5.98 (s, 1H), 2.43 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 163.82, 161.35, 151.85, 150.28, 134.43, 134.40, 130.92, 128.60, 128.52, 115.98, 115.77, 60.74, 15.49.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-[1-[(4-Fluorophenyl)(4-methyl-5-thiazolyl)methyl]-1<i>H</i>-1,2,3-triazol-4-yl]pyridine (<b>8</b>)</h3><div class="NLM_p last">3-Ethylnylpyridine was reacted with <b>7</b> to give <b>8</b> using a method described for compound <b>5</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.99 (s, 1H), 8.77 (s, 1H), 8.56 (d, 1H, <i>J</i> = 3.6 Hz), 8.18–8.21 (m, 1H), 7.88 (s, 1H), 7.34–7.37 (m, 2H), 7.17–7.20 (m, 2H), 7.06–7.11 (m, 2H), 2.44 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 163.97, 161.49, 152.59, 152.09, 149.33, 146.89, 144.89, 113.71, 113.68, 132.89, 128.79, 128.61, 128.53,126.16, 123.60, 119.27, 116.26, 116.04, 60.42, 15.30. . HRMS calcd for C<sub>18</sub>H<sub>14</sub>FN<sub>5</sub>S [M + H]<sup>+</sup> 352.1032, found 352.1040.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-(2-Azidoethyl)-4-methylthiazole (<b>10</b>)</h3><div class="NLM_p last">MsCl (2.1 g, 18.1 mmol) was added to a solution of <b>9</b> and DIPEA (3.7 mL, 22.3 mmol) in anhydrous acetonitrile (100 mL). Reaction was monitored by TLC until the starting material was consumed. NaN<sub>3</sub> (2.7 g, 41.9 mmol) was added, and the mixture was refluxed for 3 h. Most of the acetonitrile was removed under reduced pressure. The residue was diluted with ethyl acetate and washed with water. The organic phase was separated and concentrated, and the crude product was purified by column chromatography. Product was obtained as a slightly yellow oil. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.74 (s, 1H), 3.59 (t, 2H, <i>J</i> = 6.8 Hz), 3.09 (t, 2H, <i>J</i> = 6.8 Hz), 2.38 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 150.75, 128.19, 52.72, 26.54, 14.96.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Compound <b>11</b></h3><div class="NLM_p last"><b>11a</b>–<b>c</b> were synthesized using the method described for compound <b>5.</b></div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-[2-(4-Methyl-5-thiazolyl)ethyl]-1<i>H</i>-1,2,3-triazole (<b>11a</b>)</h3><div class="NLM_p last">Ethynyltrimethylsilane was reacted with <b>10</b> in the presence of CuSO<sub>4</sub>, sodium ascorbate, and K<sub>2</sub>CO<sub>3</sub> to give <b>11a</b>. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.70 (s, 1H), 7.83 (s, 1H), 7.62 (s, 1H), 4.68 (t, 2H, <i>J</i> = 6.8 Hz), 3.45 (t, 2H, <i>J</i> = 6.8 Hz), 2.18 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 151.12, 150.93, 133.81, 127.25, 125.13, 51.14, 27.68, 14.59. HRMS calcd for C<sub>8</sub>H<sub>10</sub>N<sub>4</sub>S [M + H]<sup>+</sup> 195.0704, found 195.0711.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-[2-(4-Methyl-5-thiazolyl)ethyl]-4-phenyl-1<i>H</i>-1,2,3-triazole (<b>11b</b>)</h3><div class="NLM_p last">Ethynylbenzene was reacted with <b>10</b> to give <b>11b</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.60 (s, 1H), 7.76–7.78 (m, 2H), 7.51 (s, 1H), 7.39–7.43 (m, 2H), 7.31–7.35 (m, 1H), 4.60 (t, 2H, <i>J</i> = 6.8 Hz), 3.44 (t, 2H, <i>J</i> = 6.8 Hz), 2.25 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 150.73, 150.32, 147.78, 130.32, 128.80, 128.20, 125.84, 125.69, 119.94, 51.06, 27.34, 14.58. HRMS calcd for C<sub>14</sub>H<sub>14</sub>N<sub>4</sub>S [M + H]<sup>+</sup> 271.1017, found 271.1015.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-[1-[2-(4-Methyl-5-thiazolyl)ethyl]-1<i>H</i>-1,2,3-triazol-4-yl]pyridine (<b>11c</b>)</h3><div class="NLM_p last">3-Ethynylpyridine was reacted with <b>10</b> to give <b>11c</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.95 (s, 1H), 8.61 (s, 1H), 8.56 (d, 1H, <i>J</i> = 3.6 Hz), 8.13–8.15 (m, 1H), 7.70 (s, 1H), 7.34–7.37 (m, 1H), 4.64 (t, 2H, <i>J</i> = 6.8 Hz), 3.47 (t, 2H, <i>J</i> = 6.8 Hz), 2.26 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 150.82, 150.40, 149.33, 147.01, 144.73, 132.98, 126.49, 125.66, 123.74, 120.35, 51.23, 27.31, 14.61. HRMS calcd for C<sub>13</sub>H<sub>13</sub>N<sub>5</sub>S [M + H]<sup>+</sup> 272.0970, found 272.0965.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 3-Bromo-5-(methoxymethoxy)pyridine (<b>13</b>)</h3><div class="NLM_p last">3-Bromo-5-hydroxypyridine (1.0 g, 5.7 mmol) and MOM-Br (0.64 mL, 6.9 mmol) were dissolved in THF(10 mL). Anhydrous K<sub>2</sub>CO<sub>3</sub> (1.5 g, 10.9 mmol) was added, and the reaction mixture was stirred overnight. After filtration and concentration, the product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 3:1, 1.1 g, 88%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.34 (s, 1H), 8.33 (s, 1H), 7.56 (t, 1H, <i>J</i> = 2.4 Hz), 5.19 (s, 2H), 3.49 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 153.70, 143.96, 137.81, 125.72, 120.18, 94.66, 56.27.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 3-(Methoxymethoxy)-5-[2-(trimethylsilyl)ethynyl]pyridine (<b>14</b>)</h3><div class="NLM_p last">Compound <b>13</b> (1.0 g, 4.6 mmol), CuI (44 mg, 0.23 mmol), and Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub> (162 mg, 0.23 mmol) were placed in a flask and filled with argon. THF (10 mL) was added using a syringe followed by NEt<sub>3</sub> (3.0 mL, 21 mmol) and ethynyltrimethylsilane (0.7 mL, 5.1 mmol). The reaction mixture was stirred overnight at room temperature. Most of the solvent was removed, and the residue was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 5:1, 0.85 g, 81%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.32–8.35 (m, 2H), 7.43–7.44 (m, 2H), 5.19 (s, 2H), 3.48 (s, 3H), 0.26 (s, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 152.65, 145.97, 139.21, 125.18, 120.38, 101.15, 98.03, 94.53, 56.17.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 3-(Methoxymethoxy)-5-[1-[(4-methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazol-4-yl]pyridine (<b>15</b>)</h3><div class="NLM_p last">Azide <b>3</b> (783 mg, 3.4 mmol) and alkyne <b>14</b> (0.8 g, 3.4 mmol) were dissolved in a mixture of MeOH and water (2:1, 5 mL). K<sub>2</sub>CO<sub>3</sub> (484 mg, 3.5 mmol), CuSO<sub>4</sub>·5H<sub>2</sub>O (170 mg, 0.68 mmol), and sodium ascorbate (272 mg, 0.68 mmol) were added, and the reaction mixture was stirred at room temperature overnight. Most of the solvent was removed under reduced pressure. The residue was dissolved in DCM and washed with water. The organic phase was separated and concentrated, and the crude product was purified by column chromatography (DCM/MeOH, 20:1, 1.15 g, 86%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.75 (s, 1H), 8.65 (s, 1H), 8.37 (s, 1H), 7.92 (s, 1H), 7.90 (s, 1H), 7.35–7.39 (m, 4H), 7.18–7.20 (m, 2H), 5.24 (s, 2H), 3.48 (s, 3H), 2.43 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 153.40, 152.50, 151.92, 144.42, 140.07, 139.05, 137.69, 129.01, 128.96, 128.92, 126.79, 126.51, 119.70, 119.48, 94.31, 60.93, 56.03, 15.20.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-[1-[(4-Methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazol-4-yl]-3-pyridinol (<b>16</b>)</h3><div class="NLM_p last">Click product <b>15</b> (230 mg, 0.58 mmol) was dissolved in HCl/<i>i</i>-PrOH solution (1.5M, 5.0 mL) and heated at 70 °C for 1 h. The solvent was removed. The residue was dissolved in AcOEt and washed with aqueous NaHCO<sub>3</sub>. The organic phase was separated and concentrated, and the crude product was purified by column chromatography (DCM/MeOH, 15:1, 170 mg, 83%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 9.11 (bs, 1H), 8.93 (s, 1H), 8.61 (s, 1H), 8.59 (s, 1H), 8.17 (d, 1H, <i>J</i> = 2.8 Hz), 7.76 (t, 1H, <i>J</i> = 2.4 Hz), 7.60 (s, 1H), 7.35–7.46 (m, 5H), 2.41 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ154.63, 153.77, 152.72, 145.09, 140.14, 139.11, 138.41, 130.41, 129.83, 129.56, 128.41, 127.78, 122.09, 119.22, 61.50, 15.43. HRMS calcd for C<sub>18</sub>H<sub>15</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> 350.1076, found 350.1068.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-[5-[1-[(4-Methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazol-4-yl]-3-pyridinyl]oxy-1-butanol (<b>17</b>)</h3><div class="NLM_p last">1-Acetoxy-4-hydroxybutane (150 mg, 1.2 mmol), <b>16</b> (200 mg, 0.57 mmol), and PPh<sub>3</sub> (227 mg) were dissolved in THF (5 mL), and the flask was filled with argon. The solution was cooled in an ice bath, and DIAD (230 μL, 1.1 mmol) was added using a syringe. The mixture was stirred overnight and quenched with water. After workup, the crude product was dissolved in methanol (10 mL) and treated with K<sub>2</sub>CO<sub>3</sub> (140 mg). Solvent was removed, and the residue was dissolved in ethyl acetate and washed with water. The crude product was purified by column chromatography (DCM/MeOH, 15:1, 67 mg, 28%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.76 (s,1H), 8.50 (d, 1H, <i>J</i> = 0.8 Hz), 8.24 (d, 1H, <i>J</i> = 2.4 Hz), 7.84 (s,1H), 7.77 (t, 1H, <i>J</i> = 1.6 Hz), 7.39–7.41 (m, 3H), 7.33 (s,1H), 7.17–7.19 (m, 2H), 4.10 (t, 2H, <i>J</i> = 6.4 Hz), 3.73 (t, 2H, <i>J</i> = 6.4 Hz), 2.44 (s, 3H), 1.89–1.94 (m, 2H), 1.74–1.79 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 155.30, 152.60, 152.09, 144.66, 138.82, 138.13, 137.74, 129.19, 129.16, 129.06, 126.84, 126.64, 119.58, 117.38, 68.19, 62.01, 61.11, 29.07, 25.55, 15.35. HRMS calcd for C<sub>22</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 422.1645, found 422.1657.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-[[5-[1-[(4-Methyl-5-thiazolyl)phenylmethyl]-1<i>H</i>-1,2,3-triazol-4-yl]-3-pyridinyl]oxybutane]-1-nitrate (<b>18</b>)</h3><div class="NLM_p last">1-Nitrooxy-4-hydroxybutane (25 mg, 0.19 mmol), <b>16</b> (25 mg, 0.07 mmol), and PPh<sub>3</sub> (37 mg, 0.14 mmol) were dissolved in THF (2 mL), and the flask was filled with argon. The solution was cooled in an ice bath, and DIAD (40 μL) was added using a syringe. The mixture was stirred overnight and quenched with water. Solvent was removed, and crude product was purified by purified by column chromatography (DCM/MeOH, 20:1, 67%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.77 (s, 1H), 8.53 (s, 1H), 8.26 (s, 1H), 7.81 (s, 1H), 7.80–7.79 (m, 1H), 7.40–7.42 (m, 3H), 7.33 (s, 1H), 7.17–7.19 (m, 2H), 4.55 (t, 2H, <i>J</i> = 6.0 Hz), 4.12 (t, 2H, <i>J</i> = 6.0 Hz), 2.45 (t, 3H), 1.95–1.97 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ155.14, 152.65, 152.24, 144.67, 139.20, 138.14, 137.81, 129.29, 129.26, 129.09, 126.98, 126.72, 119.54, 117.39, 72.70, 67.47, 61.21, 25.47, 23.71, 15.45. HRMS calcd for C<sub>22</sub>H<sub>22</sub>N<sub>6</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 467.1501, found 467.1488.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> α-(Bromomethyl)-4-methyl-5-thiazolemethanol (<b>20</b>)</h3><div class="NLM_p last">4-Methyl-5-vinylthiazole (900 mg, 7.2 mmol) was dissolved in a mixture of dioxane (2.5 mL), H<sub>2</sub>O (5 mL) and acetic acid (430 mg). NBS (1.4 g, 7.9 mmol) was added in three portions. The reaction mixture was stirred at room temperature for 1 h and then diluted with ethyl acetate (50 mL). The organic phase was separated and concentrated, and the product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 1.5:1, 900 mg, 52%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.64 (s, 1H), 5.22 (t, 1H, <i>J</i> = 6.8 Hz), 3.57 (d, 2H, <i>J</i> = 6.8 Hz), 2.42 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 151.53, 149.48, 132.10, 67.63, 38.44, 15.39.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4-Methyl-5-(2-oxiranyl)thiazole (<b>21</b>)</h3><div class="NLM_p last">Bromohydrin <b>20</b> (650 mg, 2.94 mmol) was dissolved in MeOH (10 mL). K<sub>2</sub>CO<sub>3</sub> (1.2 g, 8.8 mmol) was added, and the reaction mixture was stirred at room temperature for 1 h. Solvent was removed under reduced pressure, and the residue was diluted with hexane and ethyl acetate (50 mL, 2:1 v/v). After filtration and concentration, the product was obtained with enough purity for the next step reaction. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.63 (s, 1H), 4.10 (t, 1H, <i>J</i> = 3.6 Hz), 3.22–3.24 (m, 1H), 2.91–2.93 (m, 1H), 2.53 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 151.90, 150.69, 128.97, 51.25, 46.80, 14.95.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> β-Phenyl-4-methyl-5-thiazoleethanol (<b>22a</b>) and α-(Phenylmethyl)-4-methyl-5-thiazolemethanol (<b>23a</b>)</h3><div class="NLM_p last">Crude epoxide <b>21</b> (1.0 g, 7.1 mmol) was dissolved in anhydrous THF (10 mL) and added dropwise to a phenylmagnisum bromide solution (1 M in THF, 10 mL) at 4 °C. The reaction mixture was stirred overnight at room temperature, quenched with aqueous NH<sub>4</sub>Cl, and extracted with ethyl acetate (2 × 50 mL). The organic phase was separated and concentrated. <b>22a</b> and <b>23a</b> were separated and purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate 1:1). <b>22a</b> (major product, 1.0 g, 65%), <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.43 (s, 1H), 7.25–7.29 (m, 2H), 7.17–7.21 (m, 3H), 4.38 (t, 1H, <i>J</i> = 6.4 Hz), 3.95–4.05 (m, 2H), 3.87 (s, 1H, OH), 2.28 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 150.11, 149.87, 140.13, 131.48, 128.92, 127.91, 127.33, 67.13, 46.27, 15.34. HRMS calcd for C<sub>12</sub>H<sub>13</sub>NOS [M + H]<sup>+</sup> 220.0796, found 220.0795. <b>23a</b> (minor product, 0.2 g, 13%), <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.43 (s, 1H), 7.28–7.33 (m, 5H), 4.83 (t, 1H, <i>J</i> = 6.4 Hz), 3.29 (s, 1H), 3.10–3.19 (m, 2H), 2.17 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 150.07, 149.89, 143.23, 128.42, 127.82, 126.95, 125.77, 74.36, 36.08, 14.63. HRMS calcd for C<sub>12</sub>H<sub>13</sub>NOS [M + H]<sup>+</sup> 220.0796, found 220.0796.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> β-(4-Fluorophenyl)-4-methyl-5-thiazoleethanol (<b>22b</b>) and α-[(4-Fluorophenyl)methyl]-4-methyl-5-thiazolemethanol (<b>23b</b>)</h3><div class="NLM_p last"><b>22b</b> and <b>23b</b> were synthesized using the procedure described above for <b>22a</b> from epoxide <b>21</b> and 4-fluorophenylmagnisum bromide. Products were separated and purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 1:1). <b>22b</b> (major product, 60%), <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.45 (s, 1H), 7.16–7.19 (m, 2H), 6.30–6.97 (m, 2H), 4.37 (t, 1H, <i>J</i> = 6.4 Hz), 3.94–4.03 (m, 2H), 2.26 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 162.66, 160.22, 150.07, 148.95, 136.24, 136.21, 131.98, 129.26, 129.18, 115.36, 115.14, 66.22, 45.16, 14.82. HRMS calcd for C<sub>12</sub>H<sub>12</sub>FNOS [M + H]<sup>+</sup> 238.0702, found 238.0699. <b>23b</b> (minor product, 14%), <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.39 (s, 1H), 7.21–7.24 (m, 2H), 6.96–6.99 (m, 2H), 4.81 (t, 1H, <i>J</i> = 6.4 Hz), 3.04–3.16 (m, 2H), 2.12 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 163.50, 161.06, 150.25, 149.84, 139.14, 139.11, 127.51, 127.43, 126.89, 115.35, 115.14, 73.62, 36.19, 14.61. HRMS calcd for C<sub>12</sub>H<sub>12</sub>FNOS [M + H]<sup>+</sup> 238.0702, found 238.0709.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> β-(4-Chlorophenyl)-4-methyl-5-thiazoleethanol (<b>22c</b>)</h3><div class="NLM_p last">Compound <b>22c</b> was synthesized using the procedure described above for <b>22a</b> from epoxide <b>21</b> and 4-chlorophenylmagnisum bromide (1 M in diethyl ether). Product was separated and purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 1:1, 79%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.61 (s, 1H), 7.29 (d, 2H, <i>J</i> = 8.4 Hz), 7.18 (d, 2H, <i>J</i> = 8.4 Hz), 4.42 (t, 1H, <i>J</i> = 6.4 Hz), 4.03–4.07 (m, 2H), 2.35 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 150.29, 149.95, 138.78, 133.13, 131.02, 129.26, 129.00, 66.86, 45.57, 15.32.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2,3,4,5-Tetrahydro-2,8-dimethyl-5-[2-(4-methyl-5-thiazolyl)ethyl]-1<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>24</b>)</h3><div class="NLM_p last">Caboline (500 mg, 2.5 mmol) was dissolved in DMSO (5 mL). NaH (120 mg, 60%, 3 mmol) was added, and the mixture was stirred for 5 min. 4-Methyl-5-vinylthiazole (2.86 mL, 25 mmol) was added, and the reaction mixture was heated at 90 °C for 5 h. Reaction was quenched with MeOH (0.5 mL), and the solvent was evaporated under high vacuum. The residue was dissolved in DCM (20 mL) and washed with water. The organic phase was separated and concentrated, and the product was purified by column chromatography (SiO<sub>2</sub>, DCM/MeOH, 25:1, 0.1% HOAc, 350 mg, yellow solid, 36%). Compound <b>24</b> was obtained as an AcOH salt. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.67 (s, 1H), 7.18–7.22 (m, 2H), 6.93 (d, 1H,<i>J</i> = 8.4 Hz), 4.28 (t, 2H, <i>J</i> = 6.4 Hz), 3.82 (s, 2H), 3.23 (t, 2H, <i>J</i> = 6.4 Hz), 2.92 (t, 2H, <i>J</i> = 6.0 Hz), 2.56–2.62 (m, 5H), 2.38 (s, 3H), 1.96 (s, 3H), 1.91 (s, 3H) . <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): δ 172.71, 150.34,150.75, 135.69, 133.51, 128.69, 128.35, 126.83, 123.21, 118.16, 109.16, 106.11, 52.23, 51.42, 44.69, 44.22, 27.10, 21.84, 21.48, 20.89, 14.43. HRMS calcd for C<sub>19</sub>H<sub>23</sub>N<sub>3</sub>S·CH<sub>3</sub>CO<sub>2</sub>H [M + H]<sup>+</sup> 326.1691, found 326.1687.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> β-Azido-4-methyl-5-thiazoleethanol (<b>25</b>)</h3><div class="NLM_p last">Epoxide <b>21</b> (400 mg, 2.8 mmol) was dissolved in acetonitrile and water (1:1, 10 mL). NaN<sub>3</sub> (553 mg, 8.4 mmol) was added. The reaction mixture was refluxed for 1 h. Most of the solvent was removed under reduced pressure. The residue was dissolved in DCM (20 mL) and washed with water. The organic phase was separated and concentrated, and the crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 1:1, 410 mg, 61%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.71 (s, 1H), 4.98–5.00 (m, 1H), 4.80 (bs, 1H), 3.76–3.87 (m, 2H), 2.49 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 152.35, 150.67, 126.97, 65.28, 59.85, 15.01. HRMS calcd for C<sub>6</sub>H<sub>8</sub>N<sub>4</sub>OS [M + H]<sup>+</sup> 185.0497, found 185.0508.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> [1-[β-(4-Methyl-5-thiazolyl)ethanol]-4-(3-pyridinyl)]-1<i>H</i>-1,2,3-triazole (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was prepared according to the standard click chemistry procedure described above from <b>25</b> and 3-ethynylpyridine. The crude product was purified by column chromatography (SiO<sub>2</sub>, DCM/MeOH, 20:1, 95%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 9.05 (s, 1H), 9.01 (s, 1H), 8.80 (s, 1H), 8.52 (d, 1H, <i>J</i> = 3.6 Hz), 8.21 (d, 1H, <i>J</i> = 8.0 Hz), 7.45 (dd, 1H, <i>J</i> = 5.2 Hz, 7.6 Hz), 6.22–6.25 (m, 1H), 4.15–4.20 (m, 1H), 4.04–4.08 (m, 1H), 2.44 (m, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 153.49, 151.44, 148.90, 146.37, 143.36, 132.42, 126.56, 126.36, 123.96, 121.73, 63.87, 58.99, 15.07. HRMS calcd for C<sub>13</sub>H<sub>13</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> 288.0919, found 288.0918.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-Nitrooxy-β-azido-(4-methyl-5-thiazoyl)ethane (<b>27</b>)</h3><div class="NLM_p last"><b>25</b> (400 mg, 2.17 mmol) was dissolved in DCM (10 mL) and cooled in an ice bath. Fuming nitric acid (130 μL) and acetic anhydride (245 μL) were added. The reaction mixture was stirred at 0–4 °C for 4 h. After dilution with ethyl acetate (20 mL), the reaction mixture was neutralized by saturated aqueous NaHCO<sub>3</sub>. The organic phase was separated and concentrated, and the crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 2.5:1, 350 mg, 71%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.79 (s, 1H), 5.24 (t, 1H, <i>J</i> = 2.4 Hz), 4.58 (d, 2H, <i>J</i> = 6.0 Hz), 2.53 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 152.61, 151.93, 125.14, 73.29, 55.79, 15.33.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> β-(4-Methyl-5-thiazolyl)-[4-(3-pyridinyl)-1<i>H</i>-1,2,3-triazole-1-ethane]-1-nitrate (<b>28</b>) and β-(4-Methyl-5-thiazolyl)-[5-(3-pyridinyl)-1<i>H</i>-1,2,3-triazole-1-ethane]-1-nitrate (<b>29</b>)</h3><div class="NLM_p last">Compound <b>27</b> (260 mg, 1.1 mmol) and 3-ethynylpyridine (234 mg, 2.2 mmol) were dissolved in toluene (5 mL). The reaction mixture was refluxed for 48 h. Toluene was removed under reduced pressure, and the residue was purified by column chromatography (SiO<sub>2</sub>, DCM/MeOH, 20:1). <b>28</b> (165 mg, 44%), <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.98 (s, 1H), 8.82 (s, 1H), 8.59 (d, 1H, <i>J</i> = 3.2 Hz), 8.18 (d, 1H, <i>J</i> = 8.0 Hz), 7.91 (s, 1H), 7.37 (dd, 1H, <i>J</i> = 4.8 Hz, 8.0 Hz), 6.35–6.38 (m, 1H), 5.31–5.36 (m, 1H), 5.09–5.13 (m, 1H), 2.56 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ153.33, 153.10, 149.63, 147.04, 145.27, 133.11, 126.01, 123.77, 123.58, 119.70, 72.32, 55.41, 15.40. HRMS calcd for C<sub>13</sub>H<sub>12</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 333.0764, found 333.0751. <b>29</b> (120 mg, 32%), <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.80 (dd, 1H, <i>J</i> = 4.8 Hz, 1.6 Hz), 8.78 (s, 1H), 8.59 (d, 1H, <i>J</i> = 1.6 Hz), 7.80 (s, 1H), 7.64–7.67 (m, 1H), 7.49–7.52 (m, 1H), 5.97–6.01 (m, 1H), 5.44–5.50 (m, 1H), 4.98–5.02 (m, 1H), 2.24 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 153.83, 151.55, 151.34, 149.41, 136.44, 135.22, 133.71, 124.74, 123.80, 122.30, 72.76, 52.95, 14.93. HRMS calcd for C<sub>13</sub>H<sub>12</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 333.0764, found 333.0776.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> β-(4-Methyl-5-thiazolyl)-5-(3-pyridinyl)-1<i>H</i>-1,2,3-triazole-1-ethanol (<b>30</b>)</h3><div class="NLM_p last">Nitrate <b>29</b> (100 mg, 0.3 mmol) was dissolved in CH<sub>3</sub>CN/H<sub>2</sub>O (2:1, 5 mL). Na<sub>2</sub>CO<sub>3</sub> (300 mg, 3 mmol) and 2-mercaptoethanol (70 μL, 1 mmol) were added. The reaction mixture was stirred at room temperature until most of the starting material was consumed. After dilution with DCM (20 mL), the solution was washed with H<sub>2</sub>O and concentrated. The crude product was purified with column chromatography (DCM/MeOH, 20:1, 81%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.73 (d, 1H, <i>J</i> = 4.0 Hz), 8.66 (bs, 2H), 7.76–7.77 (m, 1H), 7.72 (s, 1H), 7.45–7.49 (m, 1H), 5.85–5.88 (m, 1H), 4.65–4.71 (m, 1H), 4.18–4.22 (m, 1H), 2.14 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 152.97, 150.91, 150.65, 149.63, 136.91, 135.65, 133.38, 126.45, 123.79, 122.96, 65.62, 58.02, 14.96. HRMS calcd for C<sub>13</sub>H<sub>13</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> 288.0919, found 288.0916.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> β-[4-(3-Pyridyl)phenyl]-4-methyl-5-thiazoleethanol (<b>31</b>)</h3><div class="NLM_p last"><b>22c</b> (350 mg, 1.4 mmol), 3-pyridineboronic acid (270 mg, 2.2 mmol), Pd(OAc)<sub>2</sub> (15 mg), (2-biphenyl)di-<i>tert</i>-butylphosphine (41 mg), and KF (240 mg, 4.1 mmol) were placed in a flask filled with argon. DMF (10 mL) was added using a syringe. The mixture was heated at 120 °C for 1 h. DMF was removed under vacuum, and the residue was diluted with DCM (50 mL) and washed with water. The crude product was purified with column chromatography (DCM/MeOH, 20:1, 58%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.57–8.60 (m, 2H), 8.47 (d, 1H, <i>J</i> = 3.6 Hz), 7.80 (d, 1H, <i>J</i> = 7.6 Hz), 7.47 (d, 2H, <i>J</i> = 8.0 Hz), 7.31–7.37 (d, 3H), 4.50 (t, 1H, <i>J</i> = 6.0 Hz), 4.09–4.18 (m, 2H), 2.38 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 150.18, 149.57, 147.96, 147.61, 140.81, 136.27, 136.03, 134.38, 131.51, 128.74, 127.30, 123.57, 66.62, 45.98, 15.26. HRMS calcd for C<sub>17</sub>H<sub>16</sub>N<sub>2</sub>OS [M + H]<sup>+</sup> 297.1062, found 297.1071.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> β-Phenyl-(4-methyl-5-thiazolyl)ethane-1-nitrate (<b>32a</b>)</h3><div class="NLM_p last"><b>22a</b> (150 mg, 0.68 mmol) was dissolved in DCM (3 mL) and cooled in an ice bath. Fuming nitric acid (120 μL) and acetic anhydride (280 μL) were added. The reaction mixture was stirred at 0–4 °C for 4 h. After dilution with ethyl acetate (20 mL), the reaction mixture was neutralized by saturated aqueous NaHCO<sub>3</sub>. The organic phase was separated and concentrated, and the crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 3:1, 110 mg, 61%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.64 (s, 1H), 7.25–7.37 (m, 5H), 4.89–4.94 (m, 1H), 4.80–4.85 (m, 1H), 4.68 (t, 1H, <i>J</i> = 7.2 Hz), 2.40 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 150.35, 150.21, 138.33, 130.04, 129.06, 127.86, 127.49, 75.02, 41.34, 15.21. HRMS calcd for C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 265.0647, found 265.0657.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> β-(4-Fluorophenyl)-(4-methyl-5-thiazolyl)ethane-1-nitrate (<b>32b</b>)</h3><div class="NLM_p last">Compound <b>32b</b> was prepared from <b>22b</b> as described for <b>32a</b>. Product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 3:1, 69%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.68 (s, 1H), 7.21–7.27 (m, 2H), 7.03–7.07 (m, 2H), 4.86–4.91 (m, 1H), 4.79–4.84 (m, 1H), 4.68 (t, 1H, <i>J</i> = 7.2 Hz), 2.40 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 163.39, 160.93, 150.56, 150.27, 134.18, 134.14, 129.83, 129.25, 129.17, 116.17, 115.95, 74.85, 40.69, 15.22. HRMS calcd for C<sub>12</sub>H<sub>11</sub>FN<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 283.0553, found 283.0565.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> α-(Phenylmethyl)-(4-methyl-5-thiazolyl)methanenitrate (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared from <b>23a</b> as described for <b>32a</b> (86%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.55 (s, 1H), 7.32–7.34 (m, 3H), 7.26–7.28 (m, 2H), 5.88 (t, 1H, <i>J</i> = 7.2 Hz), 3.38–3.44 (m, 1H), 3.24–3.29 (m, 1H), 2.22 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 150.90, 150.41, 136.15, 129.12, 128.66, 126.22, 124.04, 84.51, 31.27, 14.51. HRMS calcd for C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 265.0647, found 265.0657.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-[(Nitrooxy)methyl]cyclopropanemethanol (<b>34</b>)</h3><div class="NLM_p last">1,1-Bis(hydroxymethyl)cyclopropane (5.0 g, 48.9 mmol) was dissolved in DCM (100 mL) and cooled in an ice bath. Fuming nitric acid (2.5 mL) followed by acetic anhydride (5 mL) was added slowly. The mixture was stirred at 4 °C for 4 h and quenched by aqueous NaHCO<sub>3</sub>. The organic phase was separated and washed with water. The crude product was purified by column chromatography (hexanes/ethyl acetate, 4:1, 1.2 g, 17%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 4.53 (s, 2H), 3.44 (s, 2H), 0.59–0.66 (m, 4H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): 78.35, 65.36, 21.35, 8.92.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1-[(Nitrooxy)methyl]cyclopropanecarboxylic Acid (<b>35</b>)</h3><div class="NLM_p last">Compound <b>34</b> (1.9 g, 12.9 mmol) was dissolved in DCM (100 mL). TEMPO (0.4 g, 2.6 mmol) and PhI(OAc)<sub>2</sub> (4.5 g, 14.2 mmol) were added successively. The reaction mixture was stirred until the alcohol was no longer detectable by TLC. The reaction mixture was washed with aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>, NaHCO<sub>3</sub>, and H<sub>2</sub>O. The organic phase was separated and concentrated. The residue was purified by column chromatography (hexanes/ethyl acetate, 2:1). The starting material was oxidized to an aldehyde as a white solid (1.3 g, 70%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.84 (s, 1H), 4.78 (s, 2H), 1.36–1.47 (m, 4H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): 199.35, 74.15, 30.35, 12.56. The aldehyde (1.1 g, 7.6 mmol) and 2-methyl-2-butene (8.8 mL) were dissolved in <i>t</i>-BuOH (50 mL). NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O (10.0 g) and NaClO<sub>2</sub> (9.0 g) were mixed with H<sub>2</sub>O (25 mL), and then the mixture was added to the <i>t</i>-BuOH solution. The reaction mixture was stirred overnight. Solvent was removed under reduced pressure, and the residue was diluted with ethyl acetate (200 mL) and washed with aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (25 mL), NaHCO<sub>3</sub> (25 mL), and H<sub>2</sub>O (2 × 40 mL). The organic phase was separated, dried over anhydrous MgSO<sub>4</sub>, and concentrated. Product was obtained as a white solid (1.1 g, 90%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 10.3 (bs, 1H), 4.73 (s, 2H), 1.36–1.40 (m, 2H), 1.16–1.20 (m, 2H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>, 100 MHz): 174.21, 76.96, 21.58, 14.48.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> [1-[(Nitrooxy)methyl]cyclopropanecarboxyl]-[(4-methyl-5-thiazolyl)phenylmethyl] Ester (<b>36</b>)</h3><div class="NLM_p last">Compounds <b>2</b> (236 mg, 1.15 mmol) and <b>35</b> (222 mg, 1.38 mmol) were dissolved in a mixture of DCM (5 mL) and DIPEA (570 μL). EDCI (330 mg, 1.7 mmol), HOBt (233 mg, 1.7 mmol), and DMAP (15 mg, 0.13 mmol) were added. The reaction mixture was stirred overnight and then diluted with ethyl acetate (50 mL) and washed with water. The organic phase was separated and concentrated, and the crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 2:1, 160 mg, 40%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.66 (s, 1H), 7.29–7.39 (m, 5H), 7.15 (s, 1H), 4.62–4.68 (m, 2H), 2.48 (s, 3H), 1.45–1.52 (m, 2H), 1.06–1.10 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 170.67, 151.94, 150.66, 138.77, 130.72, 128.76, 128.50, 126.06, 75.06, 71.18, 21.54, 15.39, 14.85, 14.78. HRMS calcd for C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 349.0858, found 349.0854.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> [1-Methylcyclopropanecarboxyl]-[(4-methyl-5-thiazolyl)phenylmethyl] Ester (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was prepared from <b>2</b> and 1-methylcyclopropane-1-carboxylic acid as described for <b>36</b> (85%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.65 (s, 1H), 7.31–7.38 (m, 5H), 7.12 (s, 1H), 2.49 (s, 3H), 1.35 (s, 3H), 1.28–1.32 (m, 2H), 0.72–0.76 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 174.50, 151.68, 150.40, 139.54, 131.62, 128.70, 128.29, 126.19, 70.16, 19.28, 18.70, 17.03, 17.00, 15.50. HRMS calcd for C<sub>16</sub>H<sub>17</sub>NO<sub>2</sub>S [M + H]<sup>+</sup> 288.1058, found 288.1070.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 5-(Methoxyphenylmethyl)-4-methylthiazole (<b>38</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (200 mg, 0.87 mmol) in DMF (4 mL) was added NaH (52 mg, 60%, 0.87 mmol). The reaction mixture was stirred at room temperature for 15 min. CH<sub>3</sub>I (65 μL, 1 mmol) was added, and the reaction mixture was stirred for another 3 h. The reaction was quenched with MeOH (1 mL), and then most of the solvent was removed under vacuum. The residue was dissolved in ethyl acetate (50 mL) and washed with water. The organic phase was separated and concentrated. The crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 2:1, 150 mg, 70%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ 8.80 (s, 1H), 7.42–7.44 (m, 2H), 7.35–7.39 (m, 2H), 7.27–7.31 (m, 1H), 5.68 (s, 1H), 3.34 (s, 3H), 2.43 (s, 3H). HRMS calcd for C<sub>12</sub>H<sub>13</sub>NOS [M + H]<sup>+</sup> 220.0796, found 220.0792.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 5-[[2-(2-Bromoethoxy)ethoxy]phenylmethyl]-4-methylthiazole (<b>39</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (500 mg, 2.4 mmol) in DMF (5 mL) was added NaH (117 mg, 2.92 mmol). The reaction mixture was stirred at room temperature for 15 min. Bis(2-bromomethyl) ether (2.2 g, 9.6 mmol) was added, and the reaction mixture was stirred for another 3 h. The reaction was quenched with MeOH (1 mL), and then most of the solvent was removed. The residue was dissolved in ethyl acetate (50 mL) and washed with water. The organic phase was separated and concentrated. The crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 2:1, 740 mg, 86%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 8.65 (s, 1H), 7.26–7.39 (m, 5H), 5.75 (s, 1H), 3.81(t, 2H, <i>J</i> = 6.1 Hz), 3.62–3.73 (m, 4H), 3.46 (t, 2H, <i>J</i> = 6.1 Hz), 2.45 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 151.50, 149.60, 140.83, 133.74, 128.60, 128.09, 126.58, 77.31, 71.25, 70.65, 68.36, 30.45, 15.57.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-Nitrooxy-2-[2-[(4-methyl-5-thiazolyl)phenylmethoxy]ethoxy]ethane (<b>40</b>)</h3><div class="NLM_p last">Silver nitrate (2.0 g, 11.8 mmol) was added to a solution of <b>39</b> (1.1 g, 3.1 mmol) in CH<sub>3</sub>CN (15 mL). The reaction was refluxed for 2 h and then diluted with ethyl acetate (50 mL). After filtration and concentration, the crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 1.5:1, 720 mg, 69%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.62 (s, 1H), 7.26–7.38 (m, 5H), 4.59 (t, 2H, <i>J</i> = 4.4 Hz), 3.77 (t, 2H, <i>J</i> = 4.4 Hz), 3.67–3.69 (m, 2H), 3.62–3.64 (m, 2H), 2.45 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 151.40, 149.46, 140.63, 133.55, 128.49, 127.99, 126.39, 77.22, 72.03, 70.69, 68.26, 67.15, 15.36. HRMS calcd for C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 339.1014, found 339.1014.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> [2-[(4-Methyl-5-thiazolyl)phenylmethoxy]ethoxy]ethanol (<b>41</b>)</h3><div class="NLM_p last">To a solution of <b>40</b> (70 mg, 0.21 mmol) in THF (5 mL) was added LiAlH<sub>4</sub> (35 mg, 0.85 mmol). The mixture was refluxed for 1 h and then quenched with methanol. Solvent was removed under reduced pressure, and the residue was diluted with ethyl acetate and washed with water. The crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/acetone, 2:1, 25 mg, 41%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.64 (s, 1H), 7.29–7.38 (m, 5H), 5.70 (s, 1H), 3.71–3.74 (m, 4H), 3.60–3.66 (m, 4H), 2.45 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 151.60, 149.56, 140.71, 133.66, 128.65, 128.16, 126.52, 72.38, 70.37, 68.49, 61.80, 15.52. HRMS calcd for C<sub>15</sub>H<sub>19</sub>NO<sub>3</sub>S [M + H]<sup>+</sup> 294.1164, found 294.1169.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-[(4-Methyl-5-thiazolyl)phenylmethyl]-[1-[(nitrooxy)methyl]cyclopropyl]methyl Carbamate (<b>42</b>)</h3><div class="NLM_p last">Compound <b>4</b> (160 mg, 0.78 mmol) and triphosgene (297 mg, 1.0 mmol) were dissolved in ethyl acetate (10 mL) and refluxed for 2 h. Solvent was removed. The residue was redissolved in a mixture of THF (5 mL) and NEt<sub>3</sub> (0.25 mL, 1.8 mmol), and <b>34</b> (147 mg, 1 mmol) was added. The reaction mixture was stirred at 40 °C for 1 h. Solvent was removed, and the product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 2:1, 150 mg, 51%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.55 (s, 1H), 7.27–7.36 (m, 5H), 6.19 (s, 1H), 5.98 (s, 1H), 4.35 (s, 2H), 3.98 (s, 2H), 2.39 (s, 3H), 0.67–0.71 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 155.21, 150.51, 149.68, 140.32, 133.53, 128.69, 127.93, 126.39, 77.06, 68.31, 51.97, 30.68, 18.33, 15.08, 9.41. HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 378.1124, found 378.1114.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-[(4-Methyl-5-thiazolyl)phenylmethyl]-[4-(nitrooxy)butyl] Carbamate (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> was prepared from <b>4</b> and 4-nitrooxybutan-1-ol<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> using the same procedure described for <b>42</b>. Product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 2:1, 65%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.60 (s, 1H), 7.27–7.38 (m, 5H), 6.19 (bs, 1H), 5.45 (bs, 1H), 4.45 (bs, 2H), 4.13 (t, 2H, <i>J</i> = 5.6 Hz), 2.41 (s, 3H), 1.60–1.80 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 155.35, 150.46, 149.51, 140.31, 133.60, 128.60, 127.83, 126.35, 72.40, 64.10, 51.81, 25.01, 23.18, 14.98. HRMS calcd for C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 366.1124, found 366.1117.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-[(4-Methyl-5-thiazolyl)phenylmethyl]-1-[(nitrooxy)methyl]cyclopropanecarboxamide (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> was prepared from <b>4</b> and <b>35</b> as described for <b>36</b>. The crude product was purified by column chromatography (SiO<sub>2</sub>, hexane/ethyl acetate, 1:1, 49%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 8.59 (s, 1H), 7.23–7.38 (m, 5H), 6.61 (d, 1H, <i>J</i> = 7.2 Hz), 6.45 (d, 1H, <i>J</i> = 7.3 Hz), 4.58 (s, 2H), 2.39 (s, 3H), 1.35–1.39 (m, 2H), 0.94–0.97 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 169.97, 150.58, 150.04, 139.98, 133.04, 128.97, 128.18, 126.50, 76.03, 50.59, 22.68, 15.26, 13.74, 13.66. HRMS calcd for C<sub>16</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 348.1018, found 348.1008.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Stability of NO-Chimera in Neutral Phosphate Buffer</h3><div class="NLM_p">Stock solutions of <b>36</b>, <b>37</b>, and <b>42</b> were made in DMSO. <b>36</b> or <b>37</b> (10 μM) and <b>5i</b> (internal standard, 10 μM) were dissolved in phosphate buffer (100 mM, pH 7.4), and the final concentration of DMSO was 2% (v/v). The solution was kept in the autosampler of the HPLC instrument at room temperature, and an aliquot (50 μL) was injected into HPLC column. Injection occurred about every 7 min for <b>36</b> and 67 min for <b>37</b> because of the different stability of the two compounds. HPLC analysis was performed using a Shimadzu UFLC instrument with UV absorbance detection at 254 nm. Separation of parent compound, hydrolysis product (compound <b>2</b>), and internal standard (IS) was achieved using a Hypersil BDS C18 column (2.1 mm × 30 mm, 3 μm). The composition of the HPLC mobile phase was a mixture of water with 10% methanol, 0.1% formic acid (solution A), and acetonitrile with 0.1% formic acid (solution B). The mobile phase was initially composed of solvent A/solvent B (90:10), held for 1 min, and then a linear gradient of solution B from 10% to 95% over the next 3 min. The solvent was held at 95% of solution B over 1 min, and the column was finally balanced using 10% solvent B for 1.5 min. Flow rate was 0.5 mL/min. Peak area ratio of parent compound vs internal standard was calculated at each time point and divided by the time zero value to give the percentage of compound remaining.</div><div class="NLM_p last">To detect the decomposition products of <b>42</b>, the compound (100 μM) was dissolved in phosphate buffer (100 mM, pH 7.4). The final concentration of DMSO was 2% (v/v). The sample was placed in the dark at room temperature for 48 h. An aliquot (10 μL) of the sample was analyzed using an Agilent 6310 ion trap mass spectrometer (Agilent Technologies, Santa Clara, CA) equipped with Agilent 1100 HPLC system and electrospray ionization (ESI) source operated in positive mode. HPLC was performed using an Agilent Zorbax Bonus reverse phase C18 column (3.0 mm × 150 mm, 3.5 μm) with UV absorbance detection at 254 nm. The composition of the HPLC mobile phase was a mixture of water with 10% methanol, 0.1% formic acid (solution A), and acetonitrile with 0.1% formic acid (solution B). The mobile phase was initially composed of solvent A/solvent B (90:10), held for 1 min, and then a linear gradient of solution B from 10% to 80% over 17 min, 0.5 min gradient of solution B from 80% to 95% and held for 5 min. Flow rate was set at 0.5 mL/min.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Animals</h3><div class="NLM_p">Male C57BL/6 mice aged 8–10 weeks (20–25 g, Charles River Laboratories, IL) were used for step-through passive avoidance (STPA) task and brain bioavailability assay. Sprague–Dawley rat (gestational days 17–18, Charles River Laboratories, IL) were used for the primary neuronal cultures. Animals were housed at the BRL (biological resources laboratories) animal facility at the University of Illinois at Chicago (UIC). The animals were kept under standard laboratory conditions with free access to dry food and water but no nesting materials (Nestlets) supplied (not enriched environment). Regular light–dark cycle with at least 12 h of light was maintained throughout the housing in the facility. Animals were acclimated for at least 1 week in BRL before running any experiment. Also, 1–2 h prior to each testing, mice were habituated to the animal study room in the facility. All protocols using live animals were reviewed and approved by Institutional Animal Care and Use Committee (IACUC) at UIC (Animal Care Committee). Injection volumes were adjusted based on the animal weight (0.1 mL/25 g mouse).</div><div class="NLM_p last">Double transgenic APP/PS1 mice expressing both the human APP (K670M:N671L) and PS1 (M146L) (line 6.2) mutations were used for the LTP study. They were obtained by crossing APP with PS1 animals.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The animals were maintained on a 12 h light/dark cycle (with light onset at 6:00 a.m.) in temperature- and humidity-controlled rooms of the Columbia University Animal Facility. Food and water were available ad libitum.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Primary Neuronal Cultures</h3><div class="NLM_p last">Primary cultures of rat cortical neurons were prepared as described.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Briefly, brains were removed from embryonic day 17 Sprague–Dawley rat embryos, cortices were dissected, and meninges were removed. Neurons were mechanically dissociated in basal medium Eagle 1× containing glucose (33 mM), glutamine (2 mM), 10% horse serum, and 10% FBS and then plated at 3 × 10<sup>5</sup> cells/cm<sup>2</sup> in poly-<span class="smallcaps smallerCapital">l</span>-lysine-precoated plates. The medium was replaced 24 h later with serum-free neurobasal medium (NBM) supplemented with 0.5 mmol/<span class="smallcaps smallerCapital">l</span>-glutamine and 2% complete B27 supplement. Four days later, 50% of the medium was replaced with fresh NBM. Neurons were used for OGD or NMDA cytotoxicity experiments after being grown for 8–10 days in NBM.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Primary Neurons Subject to Transient OGD Followed by Reoxygenation</h3><div class="NLM_p last">Primary cortical cultured neurons were subjected to a transient OGD as described.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> On days 8–10 of culture, cultured neurons were placed in a humidified 37 °C incubator (95% N<sub>2</sub>, 5% CO<sub>2</sub>) and the culture medium was replaced with deoxygenated, glucose-free balanced salt solution, pH 7.4, containing the following (in mM): NaCl 116, CaCl<sub>2</sub> 1.8, MgSO<sub>4</sub> 0.8, KCl 5.4, NaH<sub>2</sub>PO<sub>4</sub> 1, NaHCO<sub>3</sub> 14.7, and HEPES 10. Following 2 h of OGD incubation, OGD was ended by replacing OGD medium with testing compound conditioned fresh NBM (supplemented with 0.5 mmol/<span class="smallcaps smallerCapital">l</span>-glutamine and B27 without antioxidants). Cultures were returned to the normoxic 37 °C incubator (5% CO<sub>2</sub>) for 24 h prior to evaluation of cell viability and neuronal death by MTT and LDH assays. The test compounds (50 μM) were present during the 2 h OGD and 24 h reoxygenation.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> NMDA and Glutamate Induced Cytotoxicity in Primary Neurons</h3><div class="NLM_p">Primary cortical cultured neurons were subjected to NMDA induced cytotoxicity as described.<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93, 94)</a> On day 11 of culture, primary neurons were preincubated with testing compounds (50 μM) for 30 min in neurobasal culture mudium and were exposed to NMDA (100 μM) in HEPES-buffered salt solution containing the following (in mM): NaCl 20, KCl 5.4, MgCl<sub>2</sub> 0.8, CaCl<sub>2</sub> 1.8, glucose 15, and HEPES 20 (pH 7.4). Twenty-four hours later, cell viability and neuronal death were evaluated by MTT and LDH assays. The testing compounds (50 μM) were presented during the preincubation and 24 h chronic NMDA cytotoxicity. MTT assay for cell viability and LDH assay of cell death were performed as described previously.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p last">To probe the mechanism of neuroprotection elicited by MZ derivatives, after 10–11 DIV (days in vitro), picrotoxin (100 μM) was added to primary neuronal cultures 1 h before glutamate (100 μM) insult. One hour after glutamate addition, MZ derivatives or muscimol were supplied at a final concentration of 50 μM. After incubation for 24 h, final cell survival was assayed using MTT. For comparison, picrotoxin treatment was omitted in another experiment.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> LTP Measurement</h3><div class="NLM_p last">Hippocampal slice preparation was performed as described.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Briefly, APP/PS1 trangenic mice were decapitated and their hippocampi were quickly removed. Transverse hippocampal slices (400 μm) were cut and transferred to an interface chamber, where they were maintained at 29 °C. They were perfused (1–3 mL/min) with saline solution (124.0 mM NaCl/4.4 mM KCl/1.0 mM Na<sub>2</sub>HPO<sub>4</sub>/25.0 mM NaHCO<sub>3</sub>/2.0 mM CaCl<sub>2</sub>/2.0 mM MgSO<sub>4</sub>/10 mM glucose) continuously bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. Slices were maintained at 29 °C for 90 min before recording. The CA1 region of the hippocampus field excitatory postsynaptic potentials (fEPSPs) were recorded by placing both the stimulating and the recording electrodes in CA1 stratum radiatum. A 15 min baseline was recorded every minute at an intensity that evokes a response of approximately 35% of the maximum evoked response. LTP was induced using θ-burst stimulation at 20 min. Responses were recorded for 1 h after tetanization.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Step-Through Passive Avoidance (STPA) Task</h3><div class="NLM_p last">The STPA apparatus consists of a two-compartment acrylic box with an illuminated side (15 cm × 12 cm × 12 cm) connected to a dark side (15 cm × 12 cm × 12 cm) by a vertical door. The dark side is equipped with an electric grid floor. Animals was habituated to translocating to the dark from the light side until latency of entering the dark side for each animal is <30 s. During training, animals received an aversive electrical shock (0.5 mA, 2 s), triggered by entry to the dark compartment, until the latency of entering the dark side reaches 300 s. To test procognitive activity of NO-chimeras, scopolamine (1.0 mg/kg, ip) was given 30 min before training and drug (4.5 μmol/kg, ip) was administered 20 min before training. At 24 h after training, the animals were again individually placed in the light compartment and the latency to enter the dark comparment, without shock stimulus, was recorded. Statistical analysis of the latency data was performed with one-way ANOVA followed by Bonferroni multiple comparison test.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Brain Bioavailability of NO-Chimeras</h3><div class="NLM_p">Mice were injected (ip) with drug at a dosage that was equimolar with <b>1</b> (4.5 μmol/kg, ip). Four mice were used for the injection of each drug. Brain tissues were collected 20 min after ip injection. Analytes were extracted as follows: to a mixture of blank brain tissue (100 mg) and cold acetonitrile/MeOH (1:1, 600 μL), internal standard (400 ng/mL, 10 μL) in acetonitrile/MeOH (1:1) was added. Brain tissue was homogenized manually using a disposable pestle, vortexed, and then centrifuged at 4 °C, 13 000 rpm for 15 min. The supernatant was transferred to another vial. The remaining pellet was washed and extracted with cold acetonitrile/MeOH (300 μL,1:1 v/v) and centrifuged as described above. Supernatants were combined and stored at −20 °C for 1 h, allowing further protein precipitation. The clear supernatant from centrifugation was collected and concentrated using a flow of N<sub>2</sub>. The residue was reconstituted with solvent (200 μL, H<sub>2</sub>O/MeOH/acetonitrile, 50/25/25, v/v), vortexed, centrifuged, and analyzed using LC–MS/MS. To construct standard curves, working solutions in MeOH/acetonitrile/H<sub>2</sub>O (0.5:0.5:1) containing NO-chimera and corresponding hydroxyl compound at different concentrations were prepared. Concentrations of working solutions were 2000, 1000, 500, 200, 80, 40, 20 ng/mL. To a mixture of blank brain tissue (100 mg) and cold acetonitrile/MeOH (1:1, 600 μL) were added each analyte working solution (10 μL) and internal standard (400 ng/mL, 10 μL). Calibration samples were extracted as described above, and the final concentrations of analytes after reconstitution were 100, 50, 25, 10, 4, 2, 1 ng/mL. The final concentration of IS was 20 ng/mL.</div><div class="NLM_p last">All LC–MS/MS measurements were carried out using the positive mode electrospray ionization method on an API 3000 (Applied Biosystem, Foster City, CA) triple quadrupole mass spectrometer attached to an Agilent 1200 HPLC (Agilent Technologies) instrument. MRM transitions for the detection of analytes and internal standards are described in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. HPLC was performed with a Waters XBridge C18 column (3.5 μm, 3 mm × 100 mm). Flow rate was set at 0.35 mL/min. The composition of the HPLC mobile phase was a mixture of water with 10% methanol, 0.1% formic acid (solution A), and acetonitrile with 0.1% formic acid (solution B). To analyze <b>32a</b> and <b>22a</b>, the mobile phase was initially composed of solvent A/solvent B (90:10), held for 1 min, and a linear gradient of solution B from 10% to 60% over the next 1 min. The composition of B was then increased to 99% in 13 min. The solvent was held at 99% of solution B over 5 min, and the column was finally balanced using 10% solvent B for 5 min. To analyze <b>26</b> and <b>28</b>, the mobile phase was initially composed of solvent A/solvent B (95:5), held for 1 min, and a linear gradient of solution B from 10% to 60% over next 1 min. Composition of B was then increased to 99% in 11 min. The solvent was held at 99% of solution B over 5 min, and the column was finally balanced using 5% solvent B for 5 min.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Statistical Analyses</h3><div class="NLM_p last">For all experiments, data were expressed as the mean ± SEM. LTP results were analyzed with two-way ANOVA. STPA results were analyzed with one-way ANOVA followed by Bonferroni multiple comparison test. The level of significance was set for <i>p</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/jm300353r">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">HPLC chromatogram of the incubation of <b>42</b> in phosphate buffer (100 mM, pH 7.4) at room temperature for 48 h and the proposed mechanism of decomposition (Figure S1); inhibition of excitotoxic cell death from treatment with NMDA (100 μM) by CMZ and by a number of MZ derivatives (Table S1). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300353r/suppl_file/jm300353r_si_001.pdf">jm300353r_si_001.pdf (147.3 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300353r" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory R. J. Thatcher</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry
and Pharmacognosy, University of Illinois College of Pharmacy, University of Illinois at Chicago, 833 S. Wood Street,
Chicago, Illinois 60612-7231, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#45312d2431262d203705302c266b202130"><span class="__cf_email__" data-cfemail="3c48545d485f54594e7c49555f12595849">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihui Qin</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry
and Pharmacognosy, University of Illinois College of Pharmacy, University of Illinois at Chicago, 833 S. Wood Street,
Chicago, Illinois 60612-7231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Luo</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry
and Pharmacognosy, University of Illinois College of Pharmacy, University of Illinois at Chicago, 833 S. Wood Street,
Chicago, Illinois 60612-7231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawren VandeVrede</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry
and Pharmacognosy, University of Illinois College of Pharmacy, University of Illinois at Chicago, 833 S. Wood Street,
Chicago, Illinois 60612-7231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ehsan Tavassoli</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry
and Pharmacognosy, University of Illinois College of Pharmacy, University of Illinois at Chicago, 833 S. Wood Street,
Chicago, Illinois 60612-7231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mauro Fa’</span> - <span class="hlFld-Affiliation affiliation">Department of Pathology and
Cell Biology, The Taub Institute for Research on Alzheimer’s
Disease and the Aging Brain, Columbia University, 630 West 168th Street, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew F. Teich</span> - <span class="hlFld-Affiliation affiliation">Department of Pathology and
Cell Biology, The Taub Institute for Research on Alzheimer’s
Disease and the Aging Brain, Columbia University, 630 West 168th Street, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ottavio Arancio</span> - <span class="hlFld-Affiliation affiliation">Department of Pathology and
Cell Biology, The Taub Institute for Research on Alzheimer’s
Disease and the Aging Brain, Columbia University, 630 West 168th Street, New York, New York 10032, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): G.R.J.T. has a consulting relationship with sGC Pharma, an entity that currently licenses intellectual property associated with nomethiazoles from the University of Illinois.<br /></br></div></li></ul></div><div class="ack" id="ACK-d834e4847-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The work was supported by NIH Grant U01 AG031294. Hong Zhang and Ian J. Orozco are thanked for technical assistance.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> Abbreviations Used</h2><tr><td class="NLM_term">NO-GC</td><td class="NLM_def"><p class="first last">NO-sensitive or soluble guanylyl cyclase</p></td></tr><tr><td class="NLM_term">cGK</td><td class="NLM_def"><p class="first last">cGMP-dependent protein kinase</p></td></tr><tr><td class="NLM_term">CREB</td><td class="NLM_def"><p class="first last">cyclic adenosine 5′-monophosphate response element binding protein</p></td></tr><tr><td class="NLM_term">LTP</td><td class="NLM_def"><p class="first last">long-term potentiation</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">BDNF</td><td class="NLM_def"><p class="first last">brain derived neurotropic growth factor</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen activated protein kinase</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">MZ</td><td class="NLM_def"><p class="first last">4-methylthiazole</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">OGD</td><td class="NLM_def"><p class="first last">oxygen glucose deprivation</p></td></tr><tr><td class="NLM_term">DIV</td><td class="NLM_def"><p class="first last">day in vitro</p></td></tr><tr><td class="NLM_term">NO<sub><i>x</i></sub></td><td class="NLM_def"><p class="first last">a nitrogen oxide (including NO, NO<sub>2</sub><sup>–</sup>, and NO<sub>3</sub><sup>–</sup>)</p></td></tr><tr><td class="NLM_term">STPA</td><td class="NLM_def"><p class="first last">step-through passive avoidance</p></td></tr><tr><td class="NLM_term">MRM</td><td class="NLM_def"><p class="first last">multiple reaction monitoring</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 95 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wimo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, L.</span><span> </span><span class="NLM_article-title">The worldwide societal costs of dementia: estimates for 2009</span> <span class="citation_source-journal">Alzheimer's Dement</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.jalz.2010.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20298969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BC3c3gsVyruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=98-103&author=A.+Wimoauthor=B.+Winbladauthor=L.+Jonsson&title=The+worldwide+societal+costs+of+dementia%3A+estimates+for+2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The worldwide societal costs of dementia: Estimates for 2009</span></div><div class="casAuthors">Wimo Anders; Winblad Bengt; Jonsson Linus</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">98-103</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The purpose of this study was to update the previous estimate of the worldwide cost of dementia in 2005 to 2009.  METHODS:  The cost model is based on prevalence estimates, country and region-specific data on Gross Domestic Product per person and average wage, with results from previously published cost-of-illness studies in different countries.  Prevalence figures are updated to 2009 and costs were adjusted to 2009 constant US dollars ($).  RESULTS:  The total worldwide societal cost of dementia, based on a dementia population of 34.4 million demented persons, was estimated to $422 billion in 2009, including $142 billion for informal care (34%).  CONCLUSIONS:  The worldwide cost of dementia has increased by 34% (18% in fixed prices) between 2005 and 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxtJbIshR0Vo3yKPtYViAGfW6udTcc2eaUOnVT4defZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3gsVyruw%253D%253D&md5=1ca735469abfe70ba933a725aef54a26</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DWimo%26aufirst%3DA.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DJonsson%26aufirst%3DL.%26atitle%3DThe%2520worldwide%2520societal%2520costs%2520of%2520dementia%253A%2520estimates%2520for%25202009%26jtitle%3DAlzheimer%2527s%2520Dement%26date%3D2010%26volume%3D6%26spage%3D98%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1056%2FNEJMra040223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15229308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlOjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=56-67&author=J.+L.+Cummings&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-67</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6JT2vPzAVrVg90H21EOLACvtfcHk0lj7rXGHPSfvTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlOjsb8%253D&md5=ec3a7d85cdfbeb7ea5cfaeeefc3a94ad</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra040223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra040223%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D56%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Resolving controversies on the path to Alzheimer’s therapeutics</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1060</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1038%2Fnm.2460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=21900936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1060-1065&author=D.+J.+Selkoe&title=Resolving+controversies+on+the+path+to+Alzheimer%E2%80%99s+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Resolving controversies on the path to Alzheimer's therapeutics</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1060-1065</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease constitutes a personal and societal tragedy of immense proportions.  Since 1960, research in labs. and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents.  However, some of these agents have already failed.  Gnawing controversies and important gaps in our knowledge seem to cast addnl. doubt on the ability of the field to move forward effectively.  Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future.  Rigorous preclin. validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their assocd. biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9e3VIkcVvWrVg90H21EOLACvtfcHk0lj7rXGHPSfvTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E&md5=501720027a4b1e4fd2a838f94aecd667</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm.2460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2460%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DResolving%2520controversies%2520on%2520the%2520path%2520to%2520Alzheimer%25E2%2580%2599s%2520therapeutics%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1060%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mangialasche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mecocci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: clinical trials and drug development</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2FS1474-4422%2810%2970119-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20610346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFajur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=702-716&author=F.+Mangialascheauthor=A.+Solomonauthor=B.+Winbladauthor=P.+Mecocciauthor=M.+Kivipelto&title=Alzheimer%E2%80%99s+disease%3A+clinical+trials+and+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: clinical trials and drug development</span></div><div class="casAuthors">Mangialasche, Francesca; Solomon, Alina; Winblad, Bengt; Mecocci, Patrizia; Kivipelto, Miia</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-716</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most common cause of dementia in elderly people.  Research into Alzheimer's disease therapy has been at least partly successful in terms of developing symptomatic treatments, but has also had several failures in terms of developing disease-modifying therapies.  These successes and failures have led to debate about the potential deficiencies in our understanding of the pathogenesis of Alzheimer's disease and potential pitfalls in diagnosis, choice of therapeutic targets, development of drug candidates, and design of clin. trials.  Many clin. and exptl. studies are ongoing, but we need to acknowledge that a single cure for Alzheimer's disease is unlikely to be found and that the approach to drug development for this disorder needs to be reconsidered.  Preclin. research is constantly providing us with new information on pieces of the complex Alzheimer's disease puzzle, and an anal. of this information might reveal patterns of pharmacol. interactions instead of single potential drug targets.  Several promising randomized controlled trials are ongoing, and the increased collaboration between pharmaceutical companies, basic researchers, and clin. researchers has the potential to bring us closer to developing an optimum pharmaceutical approach for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIaQ4TlzK_v7Vg90H21EOLACvtfcHk0lj7rXGHPSfvTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFajur8%253D&md5=8641c7a6fdb89aa80a2e35fbd2f369a1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2810%2970119-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252810%252970119-8%26sid%3Dliteratum%253Aachs%26aulast%3DMangialasche%26aufirst%3DF.%26aulast%3DSolomon%26aufirst%3DA.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520clinical%2520trials%2520and%2520drug%2520development%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D702%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nelson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=159-166&author=R.+M.+Nelsonauthor=A.+H.+Hainsworthauthor=D.+G.+Lambertauthor=J.+A.+Jonesauthor=T.+K.+Murrayauthor=D.+A.+Richardsauthor=J.+Gabrielssonauthor=A.+J.+Crossauthor=A.+R.+Green&title=Neuroprotective+efficacy+of+AR-A008055%2C+a+clomethiazole+analogue%2C+in+a+global+model+of+acute+ischaemic+stroke+and+its+effect+on+ischaemia-induced+glutamate+and+GABA+efflux+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DR.%2BM.%26aulast%3DHainsworth%26aufirst%3DA.%2BH.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DRichards%26aufirst%3DD.%2BA.%26aulast%3DGabrielsson%26aufirst%3DJ.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DNeuroprotective%2520efficacy%2520of%2520AR-A008055%252C%2520a%2520clomethiazole%2520analogue%252C%2520in%2520a%2520global%2520model%2520of%2520acute%2520ischaemic%2520stroke%2520and%2520its%2520effect%2520on%2520ischaemia-induced%2520glutamate%2520and%2520GABA%2520efflux%2520in%2520vitro%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D159%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debens, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span> </span><span class="NLM_article-title">The interaction of AR-A008055 and its enantiomers with the GABA(A) receptor complex and their sedative, muscle relaxant and anticonvulsant activity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=167-174&author=A.+R.+Greenauthor=A.+H.+Hainsworthauthor=A.+Misraauthor=T.+A.+Debensauthor=D.+M.+Jacksonauthor=T.+K.+Murrayauthor=R.+M.+Nelsonauthor=A.+J.+Cross&title=The+interaction+of+AR-A008055+and+its+enantiomers+with+the+GABA%28A%29+receptor+complex+and+their+sedative%2C+muscle+relaxant+and+anticonvulsant+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DHainsworth%26aufirst%3DA.%2BH.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DDebens%26aufirst%3DT.%2BA.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DNelson%26aufirst%3DR.%2BM.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520interaction%2520of%2520AR-A008055%2520and%2520its%2520enantiomers%2520with%2520the%2520GABA%2528A%2529%2520receptor%2520complex%2520and%2520their%2520sedative%252C%2520muscle%2520relaxant%2520and%2520anticonvulsant%2520activity%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D167%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Colado, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA (“ecstasy”)-induced neurodegeneration in rat brain</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2001&pages=82-88&author=M.+I.+Coladoauthor=E.+O%E2%80%99Sheaauthor=B.+Estebanauthor=A.+R.+Green&title=Studies+on+the+neuroprotective+effect+of+the+enantiomers+of+AR-A008055%2C+a+compound+structurally+related+to+clomethiazole%2C+on+MDMA+%28%E2%80%9Cecstasy%E2%80%9D%29-induced+neurodegeneration+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColado%26aufirst%3DM.%2BI.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DE.%26aulast%3DEsteban%26aufirst%3DB.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DStudies%2520on%2520the%2520neuroprotective%2520effect%2520of%2520the%2520enantiomers%2520of%2520AR-A008055%252C%2520a%2520compound%2520structurally%2520related%2520to%2520clomethiazole%252C%2520on%2520MDMA%2520%2528%25E2%2580%259Cecstasy%25E2%2580%259D%2529-induced%2520neurodegeneration%2520in%2520rat%2520brain%26jtitle%3DPsychopharmacology%26date%3D2001%26volume%3D157%26spage%3D82%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Lechat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streichenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boime, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemeignan, M.</span><span> </span><span class="NLM_article-title">Relation between chemical structure and physiological activity of certain thiazole derivatives. I. 4-Methyl-5-(β-hydroxyethyl)thiazole</span> <span class="citation_source-journal">Ann. Pharm. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=14334022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaF2MXksVWltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1965&pages=179-186&author=P.+Lechatauthor=G.+Streichenbergerauthor=A.+Boimeauthor=M.+Lemeignan&title=Relation+between+chemical+structure+and+physiological+activity+of+certain+thiazole+derivatives.+I.+4-Methyl-5-%28%CE%B2-hydroxyethyl%29thiazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between chemical structure and physiological activity of certain thiazole derivatives. I. 4-Methyl-5-(β-hydroxyethyl)thiazole</span></div><div class="casAuthors">Lechat, P.; Streichenberger, G.; Boime, A.; Lemeignan, M.</div><div class="citationInfo"><span class="NLM_cas:title">Annales Pharmaceutiques Francaises</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">179-86</span>CODEN:
                <span class="NLM_cas:coden">APFRAD</span>;
        ISSN:<span class="NLM_cas:issn">0003-4509</span>.
    </div><div class="casAbstract">A study of the action on the mouse central nervous system of injection of 6 derivs. of 4-methyl-5-(βhydroxyethyl)thiazole shows the thiol to be less active than the corresponding alc.  The halogenoethyl derivs. have more anticonvulsant activity than the original alc.  The HCl ester is particularly effective, but the carbamic and acetic esters are inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5yBAIi5CMtrVg90H21EOLACvtfcHk0lg7H4ReWZ66yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXksVWltLo%253D&md5=4f4b5804715d3b7d542e264305b7b80c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLechat%26aufirst%3DP.%26aulast%3DStreichenberger%26aufirst%3DG.%26aulast%3DBoime%26aufirst%3DA.%26aulast%3DLemeignan%26aufirst%3DM.%26atitle%3DRelation%2520between%2520chemical%2520structure%2520and%2520physiological%2520activity%2520of%2520certain%2520thiazole%2520derivatives.%2520I.%25204-Methyl-5-%2528%25CE%25B2-hydroxyethyl%2529thiazole%26jtitle%3DAnn.%2520Pharm.%2520Fr.%26date%3D1965%26volume%3D23%26spage%3D179%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lechat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streichenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boime, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemeignan, M.</span><span> </span><span class="NLM_article-title">Relations between the chemical structure and physiological activity of certain thiazole derivatives. II. Effect of the length of the alkyl chain in 4-methyl-5-(ω-chloroalkyl)thiazoles</span> <span class="citation_source-journal">Ann. Pharm. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5846544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADyaF28%252Fks1Glsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1965&pages=369-576&author=P.+Lechatauthor=G.+Streichenbergerauthor=A.+Boimeauthor=M.+Lemeignan&title=Relations+between+the+chemical+structure+and+physiological+activity+of+certain+thiazole+derivatives.+II.+Effect+of+the+length+of+the+alkyl+chain+in+4-methyl-5-%28%CF%89-chloroalkyl%29thiazoles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Relations between chemical structure and physiological action of some thiazole derivatives. II. Influence of the length of the carbon chain attached at position 5 in 4-methyl-5-(omega-chloroalkyl)-thiazoles</span></div><div class="casAuthors">Lechat P; Streichenberger G; Boime A; Lemeignan M</div><div class="citationInfo"><span class="NLM_cas:title">Annales pharmaceutiques francaises</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">369-76</span>
        ISSN:<span class="NLM_cas:issn">0003-4509</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3VJxoeYEclqcY7HFp97qMfW6udTcc2eaZ0q2ifgmsFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF28%252Fks1Glsw%253D%253D&md5=9064144d704fbb050231fe04471ca561</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLechat%26aufirst%3DP.%26aulast%3DStreichenberger%26aufirst%3DG.%26aulast%3DBoime%26aufirst%3DA.%26aulast%3DLemeignan%26aufirst%3DM.%26atitle%3DRelations%2520between%2520the%2520chemical%2520structure%2520and%2520physiological%2520activity%2520of%2520certain%2520thiazole%2520derivatives.%2520II.%2520Effect%2520of%2520the%2520length%2520of%2520the%2520alkyl%2520chain%2520in%25204-methyl-5-%2528%25CF%2589-chloroalkyl%2529thiazoles%26jtitle%3DAnn.%2520Pharm.%2520Fr.%26date%3D1965%26volume%3D23%26spage%3D369%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lechat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Driessche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemeignan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleau, D.</span><span> </span><span class="NLM_article-title">Pharmacological investigation of a quaternary ammonium compound with ganglion-exciting properties</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5841183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaF2MXkslGisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1965&pages=262-272&author=P.+Lechatauthor=J.+van+den+Driesscheauthor=M.+Lemeignanauthor=D.+Deleau&title=Pharmacological+investigation+of+a+quaternary+ammonium+compound+with+ganglion-exciting+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological investigation of a quaternary ammonium compound with ganglion-exciting properties</span></div><div class="casAuthors">Lechat, P.; van den Driessche, J.; Lemeignan, M.; Deleau, D.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-72</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">The pharmacol. activity of 4-methyl-5-(β-chloroethyl)thiazole-MeI (I) was investigated.  Intravenous injections of 1 mg. I/kg. into dogs induced hypertension, often preceded by hypotension, and increased the amplitude of the respiration.  I had no potentiating effect on adrenaline- or acetylcholine-induced hypotension.  Injections of I (1-5 mg./kg.) contracted the nictitating membrane in the cat.  I had no effect on the rabbit heart in situ or in vitro or on the guinea pig intestine in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmbcdoqt545rVg90H21EOLACvtfcHk0liOgTEXmXPlxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXkslGisL4%253D&md5=87cf9e7a7cd9c354032d7bb540777e31</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLechat%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BDriessche%26aufirst%3DJ.%26aulast%3DLemeignan%26aufirst%3DM.%26aulast%3DDeleau%26aufirst%3DD.%26atitle%3DPharmacological%2520investigation%2520of%2520a%2520quaternary%2520ammonium%2520compound%2520with%2520ganglion-exciting%2520properties%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1965%26volume%3D155%26spage%3D262%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bengtsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, U. H.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. VI. Synthesis of some reference compounds in connection with biotransformation studies</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaL38XhvVWiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1982&pages=37-42&author=S.+Bengtssonauthor=U.+H.+Lindberg&title=Compounds+related+to+clomethiazole.+VI.+Synthesis+of+some+reference+compounds+in+connection+with+biotransformation+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole.  VI.  Synthesis of some reference compounds in connection with biotransformation studies</span></div><div class="casAuthors">Bengtsson, Stefan; Lindberg, Ulf Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">The thiazoles I (R = CO2Et, CO2H, CH2Cl, CH2OH, R1 = HO; R = CONHCH2CO2Et, CONHCH2CO2H, R1 = H, HO) were prepd.  Thus, MeCOCHBrCH2CO2H was cyclized with H3N+COS- to give I (R = CO2Et, R1 = H).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiQkj_JFns4LVg90H21EOLACvtfcHk0liOgTEXmXPlxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhvVWiurk%253D&md5=c7556e61242dbd4f6a7248bd81fd8914</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBengtsson%26aufirst%3DS.%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520VI.%2520Synthesis%2520of%2520some%2520reference%2520compounds%2520in%2520connection%2520with%2520biotransformation%2520studies%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1982%26volume%3D19%26spage%3D37%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. I. Oxazole and pyridine isosteres of clomethiazole</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5967303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaF28XksFSrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1966&pages=161-166&author=U.+H.+Lindberg&title=Compounds+related+to+clomethiazole.+I.+Oxazole+and+pyridine+isosteres+of+clomethiazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole. I. Oxazole and pyridine isosteres of clomethiazole</span></div><div class="casAuthors">Lindberg, Ulf Henrik</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Bis[5-(2-chloroethyl)-4-methyloxazolium]ethane-1,2-disulfonate (I), the oxazole isostere of 5-(2-chloroethyl)-4-methylthiazole (clomethiazole), was synthesized and found to be ∼1.5 times as potent hypnotically as clomethiazole in mice intraperitoneally, and ∼3 times as potent orally.  The sedative effect of this deriv. was ∼1.5 times greater than that of the parent compd.  The anticonvulsant activity of the 2 drugs was about equal.  I was ∼50% as toxic as the parent compd. intravenously, though more than twice as toxic orally. 3-(2-Chloroethyl)-2-methylpyridine-HCl, the pyridine isostere, was synthesized, but it did not produce hypnosis in sublethal doses and was almost twice as toxic as the parent compd. intraperitoneally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvZEtHGePRArVg90H21EOLACvtfcHk0liOgTEXmXPlxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XksFSrur4%253D&md5=e2cf44c8c004c05963c42bf80b9667bc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520I.%2520Oxazole%2520and%2520pyridine%2520isosteres%2520of%2520clomethiazole%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1966%26volume%3D3%26spage%3D161%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulff, B.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. II. Haloalkyl and aminoalkyl analogs of clomethiazole</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=6081464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaF1cXhtVGjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1967&pages=269-280&author=U.+H.+Lindbergauthor=J.+Pedersenauthor=B.+Ulff&title=Compounds+related+to+clomethiazole.+II.+Haloalkyl+and+aminoalkyl+analogs+of+clomethiazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole.  II.  Haloalkyl and aminoalkyl analogs of clomethiazole</span></div><div class="casAuthors">Lindberg, Ulf H.; Pedersen, Jorgen; Ulff, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-80</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">I, where X is O and S, and II are prepd.  Thus, a mixt. of 0.6 mole thiourea, 0.6 mole AcCHClCH2CH2OH, and 600 ml. H2O is refluxed to give 77% 2-amino-5-(2-hydroxyethyl)-4-methylthiazole-HCl (III), m. 156-7° (Me2CO-EtOH).  Similarly prepd. are the following I (X, R, R1, R2, b.p./mm., nD, and % yield given): S, H, Me, CH2CHMeOH, 120-2°/3, 1.5382 (20°), 40; S, H, Me, CH2OH, 105-6-/1, -, 78; S, H, H, CH2OH, 133-40-/10, 15562 (24°), 36; S, H, H, CH2CH2OH, 138-41°/10, 1.5544 (22°), 65; O, Me, Me, CH2CH2OH, 82°/0.08, 1.4802 (20°), 38; O, Ph, Me, CH2CH2OH, 140-50°/0.07, 1.5874 (20°), 33.  A mixt. of 19.5 g. III in 150 ml. CHCl3 is treated 2 hrs. with HCl gas, 15.5 g. SOCl2 is added in 30 min. at ≤30°, and the mixt. is refluxed 2 hrs. to give 90% 2-amino-5-(2-chloroethyl)-4-methylthiazole-HCl, m. 170-1° (Me2CO).  Similarly prepd. are the following I (X, R, R1, R2, b.p./mm., nD and % yield given): S, H, Me, CH2CHClMe, 100-4°/2, 1.5330 (21°), 75; S, H, Me, CH2Cl, 62-4°/1.5, -, 36 (m. 32-3°); S, H, H, CH2Cl, -, -, 58; S, H, H, CH2CH2Cl, 99-101°/10, 1.5525 (20°), 58; O, H, Me, CH2Cl, 65-7°/12, 1.4883 (20°), 49; O, Me, Me, CH2CH2Cl, 82-3°/10, 1.4782 (20°), 84; O, Ph, Me, CH2CH2Cl, 140°/0.1, -, 19; S, H, Me, CH2CH2Br, 71-4°/0.07, -, 50: O, H, Me, CH2CH2Br, 87-8°/10, 1.5072 (20°), 60.  I (X = S, R = H, R1 = Me, R2 = CH2CH2Cl) (32.3 g.) is treated with NH3 7 hrs. at 125-50° and 30-40 kg./cm.2 to give 26% 5-(2-aminoethyl)-4-methylthiazole-HCl (IV.HCl), m. 191-2°; IV.2HCl m. 246°.  Similarly prepd. are the following I (X = S) (R, R1, R2, b.p./mm., salt m.p., and % yield given): H, Me, CH2CH2NEt2, -, 2HCl 187-9°, 20; H, Me, CH2CH2NH(CH2)3NEt2, -, 3HCl 135-40°, 17; H, Me, 2-(4-methylpiperazino)ethyl, 135-8°/0.1, 3HCl 250° (decompn.), 60.  2-(3-Chloropropyl)pyridine-HCl, m. 95-60°, and the following II (R, R1, R2, R3, and m.p. HCl salt given): H, H, (CH2)3Cl, H, 129-30°; H, H, H, (CH2)3Cl, 135-6°; H, CH2CH2Cl, H, H, 118-19°; H, H, CH2CH2Cl, H, 156°; Me, CH2CH2Cl, H, H, 86-8°; Me, CH2Cl, H, H, 149-51; are prepd. according to U.H. Lindberg (1966).  The following I ethanedisulfonates are prepd. (X, R, R1, R2, and m.p. given): S, H, Me, CH2CHClMe, 169-70°; S, H, Me, CH2CH2Br, 131-2°; O, H, Me, CH2CH2Br, 125-60°; O, Me, Me, CH2CH2Cl, 137-8°.  Also prepd. are the following I ethanedisulfonates (X, R, R1, R2, and m.p. given): S, H, Me, CH2Cl, 193-4°; S, H, H, CH2CH2Cl, 172-4°; S, H, H, CH2CH2Cl, 148-9°; O, H, Me, CH2Cl, 141-2°; O, Ph, Me, CH2CH2Cl, 154-6°.  Some of the prepd. compds. showed hypnotic and anticonvulsant activity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrREvjnV7e6-7Vg90H21EOLACvtfcHk0liOgTEXmXPlxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXhtVGjtLc%253D&md5=9d5997a5185ab37d5aa216487c472c08</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26aulast%3DPedersen%26aufirst%3DJ.%26aulast%3DUlff%26aufirst%3DB.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520II.%2520Haloalkyl%2520and%2520aminoalkyl%2520analogs%2520of%2520clomethiazole%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1967%26volume%3D4%26spage%3D269%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span> </span><span class="NLM_article-title">Hypnotic and anticonvulsant agents related to the thiazole part of thiamine</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5139739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaE38XhsVyksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1971&pages=647-660&author=U.+H.+Lindberg&title=Hypnotic+and+anticonvulsant+agents+related+to+the+thiazole+part+of+thiamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hypnotic and anticonvulsant agents related to the thiazole part of thiamine</span></div><div class="casAuthors">Lindberg, Ulf H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-60</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">The i.v. administration of nontoxic doses of active thiazole and oxazole derivs. into mice induced hypnosis, while pyridine derivs. did not.  In the 5-alkyl-4-methylazole drugs, the anticonvulsant activity decreased with increasing the length of the alkyl chain.  Among the drugs used and prepd. were Hemineurine (clomethiazole ethanedisulfonate) (I) [137-00-8], 5-methyl-4-methyloxazole [20662-83-3], and 3-ethyl-2-methylpyridine [14159-59-2].  The hypnotic potency of these drugs was related to basic strength and soly., and to the position and type of substituents.  5-(2-Chloroethyl)-4-methyloxazole [823-51-8] was active as an oral hypnotic, an i.v. anesthetic, and an agent against spasticity and rigidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkdxexLbi_urVg90H21EOLACvtfcHk0lhQtxnftu26hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XhsVyksb0%253D&md5=f8e231a26fc10796fd4467062bf71258</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26atitle%3DHypnotic%2520and%2520anticonvulsant%2520agents%2520related%2520to%2520the%2520thiazole%2520part%2520of%2520thiamine%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1971%26volume%3D8%26spage%3D647%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. IV. 4-Methylthiazoles and oxazoles with polar side-chains and some other analogs of clomethiazole</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5575873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaE3MXhsVWls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1971&pages=39-48&author=U.+H.+Lindberg&title=Compounds+related+to+clomethiazole.+IV.+4-Methylthiazoles+and+oxazoles+with+polar+side-chains+and+some+other+analogs+of+clomethiazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole.  IV.  4-Methylthiazoles and oxazoles with polar side-chains and some other analogs of clomethiazole</span></div><div class="casAuthors">Lindberg, Ulf H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-48</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">Twenty-four analogs of clomethiazole (5-(2-chloroethyl)-4-methylthiazole) (I) were synthesized and tested for their atoxic and hypnotic effects in mice.  Most of the compds. were prepd. by conventional methods; dehydration of 5-(1-hydroxyethyl)-4-methylthiazole with PCl3 gave 4-methyl-5-vinylthiazole.  Chlorination of II with SOCl2 afforded 4,4'-dimethyl-5,5'-bis(2-chloroethyl)-2,2'-dithiazolyl (III).  5-(2-Hydroxyethyl)-4-methylthiazole trihydrogen phosphate, 5-(2-acetoxyethyl)-4-methylthiazole, 5-(2-benzoyloxyethyl)-4-methylthiazole, 5-(2-hydroxymethyl)-4-methyloxazole, and 5-(2-acetoxyethyl)-4-methyloxazole (IV) were atoxic, whereas 5-methoxymethyl-4-methyloxazole 5-isopropoxymethyl-4-methylthiazole, 5-methoxymethyl-4-methyloxazole, and 5-isoproxymethyl-4-methyloxazole were hypnotic.  Structure-activity correlations showed the importance of the polarity of the side-chain substituents, while an unpolar, lipophilic substituent is necessary for the hypnotic activity, this does not seem to be a strict requirement for the anticonvulsant effect of these types of compds.  Hypnotic potency (HD50) and anticonvulsant effects (AD50) values are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogZP-nwaVKRrVg90H21EOLACvtfcHk0lhQtxnftu26hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhsVWls7k%253D&md5=c67dbc47034003d7989efb4615c03de4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520IV.%25204-Methylthiazoles%2520and%2520oxazoles%2520with%2520polar%2520side-chains%2520and%2520some%2520other%2520analogs%2520of%2520clomethiazole%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1971%26volume%3D8%26spage%3D39%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bexell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulff, B.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. V. 4-(Alkyl or aryl) thiazoles and oxazoles with various substituents in the 2- and 5-positions</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5575874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaE3MXhsVWls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1971&pages=49-58&author=U.+H.+Lindbergauthor=G.+Bexellauthor=B.+Ulff&title=Compounds+related+to+clomethiazole.+V.+4-%28Alkyl+or+aryl%29+thiazoles+and+oxazoles+with+various+substituents+in+the+2-+and+5-positions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole.  V.  4-(Alkyl or aryl) thiazoles and oxazoles with various substituents in the 2- and 5-positions</span></div><div class="casAuthors">Lindberg, Ulf H.; Bexell, Gunilla; Ulff, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-58</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">Seventeen thiazole and five oxazole derivs. of clomethiazole (5-(2-chloroethyl)-4-methylthiazole) (I) were prepared and tested for their hypnotic and anticonvulsant effects in mice.  Condensation of RC(X)NH2 (R = H or H2N, X = S or O) with α-halo ketones giving, e.g., 2-aminothiazoles, followed by the Sandmeyer reaction gave 2-chlorothiazoles which could be extd. leaving the more basic 2-unsubstituted thiazole protonated in an acid phase; thus the 2 thiazoles could be sepd. by chromatog.  Several of the compds., esp. those with amino substituents in the 2-position such as 2-benzylamino-5-(2-chloroethyl)-4-methylthiazole (Ia), 2-amino-4-methyl-5-propylthiazole, 2-amino-4,5-tetramethylene-thiazole, 2-amino-5-methyl-4-phenylthiazole, and 2-diethylamino-5-ethyl-4-phenyloxazole showed marked hypnotic activity, whereas most of the agents were devoid of anticonvulsant properties.  In contrast to the 2-amino derivs., the 2-methyl, 2-phenyl, and 2-chloro substituted compds. were either inactive or less active as hypnotics than I or 5-(2-chloroethyl)-4-methyloxazole (II).  Hypnotic potency (HD50) and anticonvulsant effect (AD50) values are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkArDTpYgzsrVg90H21EOLACvtfcHk0lhQtxnftu26hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhsVWls7Y%253D&md5=87df8c6698fffc80c975e226b289a0f5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26aulast%3DBexell%26aufirst%3DG.%26aulast%3DUlff%26aufirst%3DB.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520V.%25204-%2528Alkyl%2520or%2520aryl%2529%2520thiazoles%2520and%2520oxazoles%2520with%2520various%2520substituents%2520in%2520the%25202-%2520and%25205-positions%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1971%26volume%3D8%26spage%3D49%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2FS0163-7258%2898%2900024-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=9839769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1cXmslyrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1998&pages=123-147&author=A.+R.+Green&title=Clomethiazole+%28Zendra%29+in+acute+ischemic+stroke%3A+basic+pharmacology+and+biochemistry+and+clinical+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy</span></div><div class="casAuthors">Green, A. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-147</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">This review discusses the efficacy of clomethiazole (CMZ) in models of global and focal ischemia.  The fact that neuroprotection is demonstrable by using histol., biochem., and functional measures is emphasized.  The importance of the neuroprotection obsd. when the drug is given after the ischemic insult and at doses that are safely tolerated by humans is discussed, with ref. to requirements necessary for an exptl. neuroprotective agent to be considered as a therapeutic drug for stroke.  The biochem. pharmacol. of CMZ is reviewed and also evaluated with ref. to the possible mechanism(s) by which CMZ exerts its neuroprotective action.  Finally, the clin. evidence that CMZ protects against the neurol. consequences of a major stroke is outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojAvTY7B0m3LVg90H21EOLACvtfcHk0lhQtxnftu26hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslyrsrg%253D&md5=f5684337fc341c160c8762cd03e4538b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900024-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900024-2%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DClomethiazole%2520%2528Zendra%2529%2520in%2520acute%2520ischemic%2520stroke%253A%2520basic%2520pharmacology%2520and%2520biochemistry%2520and%2520clinical%2520efficacy%26jtitle%3DPharmacol.%2520Ther.%26date%3D1998%26volume%3D80%26spage%3D123%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Marshall, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, R. M.</span><span> </span><span class="NLM_article-title">Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1006%2Fexnr.1998.6994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10192783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1MXis1Cjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1999&pages=121-129&author=J.+W.+Marshallauthor=A.+J.+Crossauthor=R.+M.+Ridley&title=Functional+benefit+from+clomethiazole+treatment+after+focal+cerebral+ischemia+in+a+nonhuman+primate+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species</span></div><div class="casAuthors">Marshall, J. W. B.; Cross, A. J.; Ridley, R. M.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Clomethiazole (CMZ) (Zendra) is neuroprotective in rodents following focal and global ischemia.  However, its neuroprotective effects in other species, particularly on functional outcome, have not been reported.  We have therefore examd. the ability of CMZ to ameliorate the functional deficits produced by a focal cerebral ischemic lesion in the marmoset, a New World primate.  Six monkeys received permanent middle cerebral artery occlusion (pMCAO); six further monkeys received pMCAO with administration of CMZ, 5 min after the arterial occlusion, by i.p. bolus injection and by s.c. implantation of an osmotic minipump, which released CMZ for 24 h.  The monkeys were trained and tested preoperatively on a no. of behavioral tasks which were repeated 3 and 9 wk after surgery.  CMZ-treated monkeys were better than non-drug-treated monkeys at using the disabled arm contralateral to the lesion and also showed a redn. in contralateral spatial hemineglect.  Postmortem histopathol. anal. at several stereotaxic levels showed a significant redn. in the area of ischemic damage in CMZ-treated monkeys compared to that in untreated animals.  CMZ treatment reduced the overall vol. of damage by 31.8% (MCA group, 370.8 ± 37.4 mm3 of damage; CMZ group, 253.0 ± 38.0 mm3 of damage).  This study demonstrates that CMZ is neuroprotective in a nonhuman primate species and is able to ameliorate the level of functional disability and reduce the size of infarct produced by focal cerebral ischemia.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqergIwe9iNZ7Vg90H21EOLACvtfcHk0lhCaWvDbcmOyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXis1Cjtrw%253D&md5=41b00f33b2f2798531cdcc666ea745f8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1006%2Fexnr.1998.6994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.1998.6994%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DJ.%2BW.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26aulast%3DRidley%26aufirst%3DR.%2BM.%26atitle%3DFunctional%2520benefit%2520from%2520clomethiazole%2520treatment%2520after%2520focal%2520cerebral%2520ischemia%2520in%2520a%2520nonhuman%2520primate%2520species%26jtitle%3DExp.%2520Neurol.%26date%3D1999%26volume%3D156%26spage%3D121%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Farooque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaksson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, Y.</span><span> </span><span class="NLM_article-title">Clomethiazole (ZENDRA, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rat</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1007%2Fs004010051047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10412797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1MXjtleksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=22-30&author=M.+Farooqueauthor=J.+Isakssonauthor=D.+M.+Jacksonauthor=Y.+Olsson&title=Clomethiazole+%28ZENDRA%2C+CMZ%29+improves+hind+limb+motor+function+and+reduces+neuronal+damage+after+severe+spinal+cord+injury+in+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Clomethiazole (ZENDRA, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rats</span></div><div class="casAuthors">Farooque, M.; Isaksson, J.; Jackson, D. M.; Olsson, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-30</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The effect of pretreatment with CMZ on motor function recovery and nerve cell damage after spinal cord injury (SCI) was studied in rats.  Thirty min before SCI the rats received a single i.p. dose of CMZ (150 mg/kg) or saline.  The spinal cord was injured with a 50-g load, applied over the exposed dura, for 5 min at T8-9.  The animals became paraplegic 1 day after injury.  They were evaluated for recovery of hind limb motor function.  All the animals recovered to some extent over the observation period of 12 wk.  However, hind limb motor function was better in the animals pretreated with CMZ.  After 12 wk the rats were killed and perfused/fixed for morphol. investigations.  Microtubule-assocd. protein 2 (MAP2) immunostaining was used to stain neurons and dendrites and Luxol-fast blue to stain myelinated tracts of the white matter.  The injured segment of the spinal cord showed severe atrophy, distortion, cavitation and necrosis of gray and white matter.  Compared to uninjured controls the transverse sectional area was reduced to 32.7% in untreated animals but only to 38.5% in CMZ-treated animals.  MAP2 staining showed that, compared to uninjured controls, gray matter was reduced to 7.4% in saline-treated injured animals and to 22.7% in CMZ-treated rats.  The results thus show that in this model CMZ improves hind limb motor function and attenuates the morphol. damage to the spinal cord.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE_j1zSf_1-LVg90H21EOLACvtfcHk0lhCaWvDbcmOyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtleksbc%253D&md5=30df21e84e28fc66aa3717a635ff4ef2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs004010051047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004010051047%26sid%3Dliteratum%253Aachs%26aulast%3DFarooque%26aufirst%3DM.%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DOlsson%26aufirst%3DY.%26atitle%3DClomethiazole%2520%2528ZENDRA%252C%2520CMZ%2529%2520improves%2520hind%2520limb%2520motor%2520function%2520and%2520reduces%2520neuronal%2520damage%2520after%2520severe%2520spinal%2520cord%2520injury%2520in%2520rat%26jtitle%3DActa%2520Neuropathol.%26date%3D1999%26volume%3D98%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wahlgren, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez-Tejedor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arboix, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, E.</span><span> </span><span class="NLM_article-title">Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2000&pages=82-85&author=N.+G.+Wahlgrenauthor=E.+Diez-Tejedorauthor=J.+Teitelbaumauthor=A.+Arboixauthor=D.+Leysauthor=T.+Ashwoodauthor=E.+Grossman&title=Results+in+95+hemorrhagic+stroke+patients+included+in+CLASS%2C+a+controlled+trial+of+clomethiazole+versus+placebo+in+acute+stroke+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWahlgren%26aufirst%3DN.%2BG.%26aulast%3DDiez-Tejedor%26aufirst%3DE.%26aulast%3DTeitelbaum%26aufirst%3DJ.%26aulast%3DArboix%26aufirst%3DA.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DGrossman%26aufirst%3DE.%26atitle%3DResults%2520in%252095%2520hemorrhagic%2520stroke%2520patients%2520included%2520in%2520CLASS%252C%2520a%2520controlled%2520trial%2520of%2520clomethiazole%2520versus%2520placebo%2520in%2520acute%2520stroke%2520patients%26jtitle%3DStroke%26date%3D2000%26volume%3D31%26spage%3D82%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wahlgren, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranasinha, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosolacci, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Erven, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson, L.</span><span> </span><span class="NLM_article-title">Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1999&pages=21-28&author=N.+G.+Wahlgrenauthor=K.+W.+Ranasinhaauthor=T.+Rosolacciauthor=C.+L.+Frankeauthor=P.+M.+van+Ervenauthor=T.+Ashwoodauthor=L.+Claesson&title=Clomethiazole+acute+stroke+study+%28CLASS%29%3A+results+of+a+randomized%2C+controlled+trial+of+clomethiazole+versus+placebo+in+1360+acute+stroke+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWahlgren%26aufirst%3DN.%2BG.%26aulast%3DRanasinha%26aufirst%3DK.%2BW.%26aulast%3DRosolacci%26aufirst%3DT.%26aulast%3DFranke%26aufirst%3DC.%2BL.%26aulast%3Dvan%2BErven%26aufirst%3DP.%2BM.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DClaesson%26aufirst%3DL.%26atitle%3DClomethiazole%2520acute%2520stroke%2520study%2520%2528CLASS%2529%253A%2520results%2520of%2520a%2520randomized%252C%2520controlled%2520trial%2520of%2520clomethiazole%2520versus%2520placebo%2520in%25201360%2520acute%2520stroke%2520patients%26jtitle%3DStroke%26date%3D1999%26volume%3D30%26spage%3D21%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mucke, H.</span><span> </span><span class="NLM_article-title">Clomethiazole (Astra Arcus AB)</span> <span class="citation_source-journal">IDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16160952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlCgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1999&pages=184-193&author=H.+Mucke&title=Clomethiazole+%28Astra+Arcus+AB%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Clomethiazole Astra Arcus AB</span></div><div class="casAuthors">Mucke, Herman</div><div class="citationInfo"><span class="NLM_cas:title">IDrugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-193</span>CODEN:
                <span class="NLM_cas:coden">IDRUFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-7056</span>.
    
            (<span class="NLM_cas:orgname">Current Drugs Ltd.</span>)
        </div><div class="casAbstract">Clomethiazole has been marketed for several years as a sedative/antiepileptic.  Astra is now developing it for the potential treatment of stroke.  An NDA is expected to be filed in 1999/2000 [275465].  A North American phase III trial for large stroke has commenced.  This will include 1200 patients.  Two other smaller scale phase III studies with clomethiazole have also commenced in North America for intracerebral hemorrhage (n=200) and safety in combination with TPA (n=100 to 200) (Genentech) [275465].  A large-scale phase III trial has been completed in which clomethiazole was evaluated for its ability to reduce nerve damage in acute cerebrovascular ischemia.  The multicenter, international trial, called CLASS (Clomethiazole Acute Stroke Study), analyzed 1360 patients and found no significant treatment effect.  However, a subgroup of patients who presented with large stroke, experienced a significant benefit.  Of these (n=545), 41% treated patients were functionally independent after 90 days, compared to 30% patients on placebo [275465].  Clomethiazole reduced functional disability and brain damage in the marmoset permanent MCAO model [306981].  Clomethiazole is thought to act through a GABAergic pathway, whereby it augments GABA's depressive effect on the CNS, giving the drug both hypnotic and neuroprotectant properties [216474] [306978].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKiecutOAVCLVg90H21EOLACvtfcHk0lhCaWvDbcmOyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlCgsLc%253D&md5=000e5e93799764a3f3b8f0013b87784b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMucke%26aufirst%3DH.%26atitle%3DClomethiazole%2520%2528Astra%2520Arcus%2520AB%2529%26jtitle%3DIDrugs%26date%3D1999%26volume%3D2%26spage%3D184%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lyden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacoby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzeo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordlund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odergren, T.</span><span> </span><span class="NLM_article-title">The clomethiazole acute stroke study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=1199-1205&author=P.+Lydenauthor=M.+Jacobyauthor=J.+Schimauthor=G.+Albersauthor=P.+Mazzeoauthor=T.+Ashwoodauthor=A.+Nordlundauthor=T.+Odergren&title=The+clomethiazole+acute+stroke+study+in+tissue-type+plasminogen+activator-treated+stroke+%28CLASS-T%29%3A+final+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DJacoby%26aufirst%3DM.%26aulast%3DSchim%26aufirst%3DJ.%26aulast%3DAlbers%26aufirst%3DG.%26aulast%3DMazzeo%26aufirst%3DP.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DNordlund%26aufirst%3DA.%26aulast%3DOdergren%26aufirst%3DT.%26atitle%3DThe%2520clomethiazole%2520acute%2520stroke%2520study%2520in%2520tissue-type%2520plasminogen%2520activator-treated%2520stroke%2520%2528CLASS-T%2529%253A%2520final%2520results%26jtitle%3DNeurology%26date%3D2001%26volume%3D57%26spage%3D1199%26epage%3D1205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lyden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuaib, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajput, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wechsler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odergren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar-Grueso, E.</span><span> </span><span class="NLM_article-title">Clomethiazole acute stroke study in ischemic stroke (CLASS-I): final results</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2002&pages=122-128&author=P.+Lydenauthor=A.+Shuaibauthor=K.+Ngauthor=K.+Levinauthor=R.+P.+Atkinsonauthor=A.+Rajputauthor=L.+Wechslerauthor=T.+Ashwoodauthor=L.+Claessonauthor=T.+Odergrenauthor=E.+Salazar-Grueso&title=Clomethiazole+acute+stroke+study+in+ischemic+stroke+%28CLASS-I%29%3A+final+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DShuaib%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DLevin%26aufirst%3DK.%26aulast%3DAtkinson%26aufirst%3DR.%2BP.%26aulast%3DRajput%26aufirst%3DA.%26aulast%3DWechsler%26aufirst%3DL.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DClaesson%26aufirst%3DL.%26aulast%3DOdergren%26aufirst%3DT.%26aulast%3DSalazar-Grueso%26aufirst%3DE.%26atitle%3DClomethiazole%2520acute%2520stroke%2520study%2520in%2520ischemic%2520stroke%2520%2528CLASS-I%2529%253A%2520final%2520results%26jtitle%3DStroke%26date%3D2002%26volume%3D33%26spage%3D122%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wilby, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, P. J.</span><span> </span><span class="NLM_article-title">The pharmacology of chlormethiazole: a potential neuroprotective agent?</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=281-294&author=M.+J.+Wilbyauthor=P.+J.+Hutchinson&title=The+pharmacology+of+chlormethiazole%3A+a+potential+neuroprotective+agent%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilby%26aufirst%3DM.%2BJ.%26aulast%3DHutchinson%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520pharmacology%2520of%2520chlormethiazole%253A%2520a%2520potential%2520neuroprotective%2520agent%253F%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2004%26volume%3D10%26spage%3D281%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Harmon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorten, G.</span><span> </span><span class="NLM_article-title">The effect of clomethiazole on plasma concentrations of interleukin-6, -8, -1beta, tumor necrosis factor-alpha, and neutrophil adhesion molecule expression during experimental extracorporeal circulation</span> <span class="citation_source-journal">Anesth. Analg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1213%2F01.ANE.0000063821.60233.7D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=12818935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVKnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2003&pages=13-18&author=D.+Harmonauthor=E.+Colemanauthor=C.+Marshallauthor=W.+Lanauthor=G.+Shorten&title=The+effect+of+clomethiazole+on+plasma+concentrations+of+interleukin-6%2C+-8%2C+-1beta%2C+tumor+necrosis+factor-alpha%2C+and+neutrophil+adhesion+molecule+expression+during+experimental+extracorporeal+circulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of clomethiazole on plasma concentrations of interleukin-6, -8, -1β, tumor necrosis factor-α, and neutrophil adhesion molecule expression during experimental extracorporeal circulation</span></div><div class="casAuthors">Harmon, D.; Coleman, E.; Marshall, C.; Lan, W.; Shorten, G.</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia & Analgesia (Baltimore, MD, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-18</span>CODEN:
                <span class="NLM_cas:coden">AACRAT</span>;
        ISSN:<span class="NLM_cas:issn">0003-2999</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Clomethiazole (CMZ), a neuroprotective drug, has antiinflammatory actions.  We investigated the effects of CMZ administration on plasma concns. of interleukin (IL)-6, IL-8, IL-1β, tumor necrosis factor-α, and neutrophil adhesion mol. expression during exptl. extracorporeal circulation.  Five healthy volunteers each donated 500 mL of blood, which was subsequently divided into equal portions.  Identical extracorporeal circuits were simultaneously primed with donated blood (250 mL) and circulated for 2 h at 37°C.  CMZ was added to 1 of the circuits of each pair to achieve a total plasma concn. of 40 μmol/L.  Blood samples were withdrawn at (i) donation, (ii) immediately after addn. of CMZ, and at (iii) 30, 60, 90, and 120 min after commencing circulation.  Plasma concns. of IL-6, IL-8, and tumor necrosis factor-α were less in the CMZ group compared with control after 60 min of circulation (2.2 [0.3] vs. 3.2 [0.4], 14.9 [4.8] vs. 21.9 [18.4], 63.3 [43.5] vs. 132.2 [118.9] pg/mL, resp., P < 0.05).  After 120 min of circulation, neutrophils from CMZ-treated circuits showed significantly less CD18 expression compared with control (237.5 [97.4] vs. 280.5 [111.5], P = 0.03).  The addn. of CMZ to exptl. extracorporeal circuits decreases the inflammatory response.  This effect may be of clin. benefit by decreasing inflammatory-mediated neurol. injury during cardiopulmonary bypass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogFOHtqDsbTrVg90H21EOLACvtfcHk0lizUmKRRR4WGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVKnsbw%253D&md5=8554c50817e41920b615315914dfe070</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1213%2F01.ANE.0000063821.60233.7D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252F01.ANE.0000063821.60233.7D%26sid%3Dliteratum%253Aachs%26aulast%3DHarmon%26aufirst%3DD.%26aulast%3DColeman%26aufirst%3DE.%26aulast%3DMarshall%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DW.%26aulast%3DShorten%26aufirst%3DG.%26atitle%3DThe%2520effect%2520of%2520clomethiazole%2520on%2520plasma%2520concentrations%2520of%2520interleukin-6%252C%2520-8%252C%2520-1beta%252C%2520tumor%2520necrosis%2520factor-alpha%252C%2520and%2520neutrophil%2520adhesion%2520molecule%2520expression%2520during%2520experimental%2520extracorporeal%2520circulation%26jtitle%3DAnesth.%2520Analg.%26date%3D2003%26volume%3D97%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Clarkson, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, D. S.</span><span> </span><span class="NLM_article-title">Clomethiazole: mechanisms underlying lasting neuroprotection following hypoxia-ischemia</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1036</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1036-1038&author=A.+N.+Clarksonauthor=H.+Liuauthor=R.+Rahmanauthor=D.+M.+Jacksonauthor=I.+Appletonauthor=D.+S.+Kerr&title=Clomethiazole%3A+mechanisms+underlying+lasting+neuroprotection+following+hypoxia-ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarkson%26aufirst%3DA.%2BN.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DRahman%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DAppleton%26aufirst%3DI.%26aulast%3DKerr%26aufirst%3DD.%2BS.%26atitle%3DClomethiazole%253A%2520mechanisms%2520underlying%2520lasting%2520neuroprotection%2520following%2520hypoxia-ischemia%26jtitle%3DFASEB%2520J.%26date%3D2005%26volume%3D19%26spage%3D1036%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Clarkson, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammut, I. A.</span><span> </span><span class="NLM_article-title">Mitochondrial involvement in transhemispheric diaschisis following hypoxia-ischemia: clomethiazole-mediated amelioration</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2007&pages=547-561&author=A.+N.+Clarksonauthor=J.+Clarksonauthor=D.+M.+Jacksonauthor=I.+A.+Sammut&title=Mitochondrial+involvement+in+transhemispheric+diaschisis+following+hypoxia-ischemia%3A+clomethiazole-mediated+amelioration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarkson%26aufirst%3DA.%2BN.%26aulast%3DClarkson%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DSammut%26aufirst%3DI.%2BA.%26atitle%3DMitochondrial%2520involvement%2520in%2520transhemispheric%2520diaschisis%2520following%2520hypoxia-ischemia%253A%2520clomethiazole-mediated%2520amelioration%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D144%26spage%3D547%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Shi, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span> </span><span class="NLM_article-title">Anti-TNF-alpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1368</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.brainres.2010.10.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20971085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1368&publication_year=2011&pages=239-247&author=J.+Q.+Shiauthor=W.+Shenauthor=J.+Chenauthor=B.+R.+Wangauthor=L.+L.+Zhongauthor=Y.+W.+Zhuauthor=H.+Q.+Zhuauthor=Q.+Q.+Zhangauthor=Y.+D.+Zhangauthor=J.+Xu&title=Anti-TNF-alpha+reduces+amyloid+plaques+and+tau+phosphorylation+and+induces+CD11c-positive+dendritic-like+cell+in+the+APP%2FPS1+transgenic+mouse+brains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains</span></div><div class="casAuthors">Shi, Jian-Quan; Shen, Wei; Chen, Jun; Wang, Bian-Rong; Zhong, Ling-Ling; Zhu, Yin-Wei; Zhu, Hai-Qing; Zhang, Qiao-Quan; Zhang, Ying-Dong; Xu, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1368</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239-247</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inflammation plays an important role in the pathogenesis of Alzheimer's disease (AD).  Overexpression of tumor necrosis factor-α (TNF-α) occurs in the AD brain.  Recent clin. studies have shown that the anti-TNF-α therapy improves cognition function of AD patients rapidly.  However, the underlying mechanism remains elusive.  The present study investigates the effects of intracerebroventricular injection of the monoclonal TNF-α antibody, Infliximab, on the pathol. features of AD in the APP/PS1 double transgenic mice.  We found that Infliximab administration reduced the levels of TNF-α, amyloid plaques, and tau phosphorylation as early as three days after daily injection of 150 μg Infliximab for three days.  The no. of CD11c-pos. dendritic-like cells and the expression of CD11c were found to be increased concurrently after Infliximab injection.  These data suggested that the CD11c-pos. dendritic-like cells might contribute to the Infliximab-induced redn. of AD-like pathol.  Furthermore, our results support the use of anti-TNF-α for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj2nCqmPbXQLVg90H21EOLACvtfcHk0lhfIjuTfBC6Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWktw%253D%253D&md5=88dd0b7905ec4ce6c13b6cc18c22255c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2010.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2010.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%2BQ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%2BR.%26aulast%3DZhong%26aufirst%3DL.%2BL.%26aulast%3DZhu%26aufirst%3DY.%2BW.%26aulast%3DZhu%26aufirst%3DH.%2BQ.%26aulast%3DZhang%26aufirst%3DQ.%2BQ.%26aulast%3DZhang%26aufirst%3DY.%2BD.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DAnti-TNF-alpha%2520reduces%2520amyloid%2520plaques%2520and%2520tau%2520phosphorylation%2520and%2520induces%2520CD11c-positive%2520dendritic-like%2520cell%2520in%2520the%2520APP%252FPS1%2520transgenic%2520mouse%2520brains%26jtitle%3DBrain%2520Res.%26date%3D2011%26volume%3D1368%26spage%3D239%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacabelos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanpedro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Fantini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleixandre, M.</span><span> </span><span class="NLM_article-title">Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.neurobiolaging.2006.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16569464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFyksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=533-536&author=A.+Alvarezauthor=R.+Cacabelosauthor=C.+Sanpedroauthor=M.+Garcia-Fantiniauthor=M.+Aleixandre&title=Serum+TNF-alpha+levels+are+increased+and+correlate+negatively+with+free+IGF-I+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease</span></div><div class="casAuthors">Alvarez, Anton; Cacabelos, Ramon; Sanpedro, Carolina; Garcia-Fantini, Manuel; Aleixandre, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-536</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Tumor necrosis factor-alpha (TNF-alpha) and insulin-like growth factor-I (IGF-I) have been involved in the pathogenesis of Alzheimer's disease (AD) as neurotoxic and survival factors, resp.  Recent exptl. studies suggest that the signalling pathways of TNF-alpha and IGF-I are functionally interrelated.  In order to investigate the possible interaction of TNF-alpha and IGF-I in AD and mild cognitive impairment (MCI), the serum levels of total IGF-I, free IGF-I and TNF-alpha were detd. in 141 AD patients, 56 MCI cases and 30 controls.  As compared with controls, AD patients showed increased TNF-alpha and decreased IGF-I levels in serum, as well as a significant neg. correlation between TNF-alpha and free IGF-I values.  MCI patients also exhibited significantly higher TNF-alpha levels than controls.  The present results suggest that increased TNF-alpha levels are involved in the pathogenesis of AD and MCI, and might antagonize the neurotrophic activity of IGF-I in these medical conditions.  In addn., the combined detn. of TNF-alpha and IGF-I might be useful to monitor anti-inflammatory and/or neurotrophic drug effects in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGRYdwTv6zF7Vg90H21EOLACvtfcHk0lhfIjuTfBC6Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFyksrc%253D&md5=b5a50a78b96beb6731fc899e20877225</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2006.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2006.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DCacabelos%26aufirst%3DR.%26aulast%3DSanpedro%26aufirst%3DC.%26aulast%3DGarcia-Fantini%26aufirst%3DM.%26aulast%3DAleixandre%26aufirst%3DM.%26atitle%3DSerum%2520TNF-alpha%2520levels%2520are%2520increased%2520and%2520correlate%2520negatively%2520with%2520free%2520IGF-I%2520in%2520Alzheimer%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2007%26volume%3D28%26spage%3D533%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">McAlpine, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhn, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blurton-Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tansey, M. G.</span><span> </span><span class="NLM_article-title">Inhibition of soluble TNF signaling in a mouse model of Alzheimer’s disease prevents pre-plaque amyloid-associated neuropathology</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.nbd.2009.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=19320056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVOgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=163-177&author=F.+E.+McAlpineauthor=J.+K.+Leeauthor=A.+S.+Harmsauthor=K.+A.+Ruhnauthor=M.+Blurton-Jonesauthor=J.+Hongauthor=P.+Dasauthor=T.+E.+Goldeauthor=F.+M.+LaFerlaauthor=S.+Oddoauthor=A.+Bleschauthor=M.+G.+Tansey&title=Inhibition+of+soluble+TNF+signaling+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease+prevents+pre-plaque+amyloid-associated+neuropathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology</span></div><div class="casAuthors">McAlpine, Fiona E.; Lee, Jae-Kyung; Harms, Ashley S.; Ruhn, Kelly A.; Blurton-Jones, Mathew; Hong, John; Das, Pritam; Golde, Todd E.; LaFerla, Frank M.; Oddo, Salvatore; Blesch, Armin; Tansey, Malu G.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163-177</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Microglial activation and overprodn. of inflammatory mediators in the central nervous system (CNS) have been implicated in Alzheimer's disease (AD).  Elevated levels of the pro-inflammatory cytokine tumor necrosis factor (TNF) have been reported in serum and post-mortem brains of patients with AD, but its role in progression of AD is unclear.  Using novel engineered dominant neg. TNF inhibitors (DN-TNFs) selective for sol. TNF (solTNF), we investigated whether blocking TNF signaling with chronic infusion of the recombinant DN-TNF XENP345 or a single injection of a lentivirus encoding DN-TNF prevented the acceleration of AD-like pathol. induced by chronic systemic inflammation in 3xTgAD mice.  We found that chronic inhibition of solTNF signaling with either approach decreased the LPS-induced accumulation of 6E10-immunoreactive protein in hippocampus, cortex, and amygdala.  Immunohistol. and biochem. approaches using a C-terminal APP antibody indicated that a major fraction of the accumulated protein was likely to be C-terminal APP fragments (β-CTF) while a minor fraction consisted of Aβ40 and 42.  Genetic inactivation of TNFR1-mediated TNF signaling in 3xTgAD mice yielded similar results.  Taken together, our studies indicate that sol. TNF is a crit. mediator of the effects of neuroinflammation on early (pre-plaque) pathol. in 3xTgAD mice.  Targeted inhibition of solTNF in the CNS may slow the appearance of amyloid-assocd. pathol., cognitive deficits, and potentially the progressive loss of neurons in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKWtPLgHkfW7Vg90H21EOLACvtfcHk0lhfIjuTfBC6Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVOgu7o%253D&md5=aeec1eea06c3c035408b37070eb4966b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DMcAlpine%26aufirst%3DF.%2BE.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DHarms%26aufirst%3DA.%2BS.%26aulast%3DRuhn%26aufirst%3DK.%2BA.%26aulast%3DBlurton-Jones%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26aulast%3DOddo%26aufirst%3DS.%26aulast%3DBlesch%26aufirst%3DA.%26aulast%3DTansey%26aufirst%3DM.%2BG.%26atitle%3DInhibition%2520of%2520soluble%2520TNF%2520signaling%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520prevents%2520pre-plaque%2520amyloid-associated%2520neuropathology%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D34%26spage%3D163%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Strum, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shehee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roses, A.</span><span> </span><span class="NLM_article-title">Rosiglitazone induces mitochondrial biogenesis in mouse brain</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=17361034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVGju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=45-51&author=J.+C.+Strumauthor=R.+Sheheeauthor=D.+Virleyauthor=J.+Richardsonauthor=M.+Mattieauthor=P.+Selleyauthor=S.+Ghoshauthor=C.+Nockauthor=A.+Saundersauthor=A.+Roses&title=Rosiglitazone+induces+mitochondrial+biogenesis+in+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Rosiglitazone induces mitochondrial biogenesis in mouse brain</span></div><div class="casAuthors">Strum, Jay C.; Shehee, Ron; Virley, David; Richardson, Jill; Mattie, Michael; Selley, Paula; Ghosh, Sujoy; Nock, Christina; Saunders, Ann; Roses, Allen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Rosiglitazone was found to simulate mitochondrial biogenesis in mouse brain in an apolipoprotein (Apo) E isoenzyme-independent manner.  Rosiglitazone induced both mitochondrial DNA (mtDNA) and estrogen-stimulated related receptor alpha (ESRRA) mRNA, a key regulator of mitochondrial biogenesis.  Transcriptomics and proteomics anal. suggested the mitochondria produced in the presence of human ApoE3 and E4 were not as metabolically efficient as those in the wild type or ApoE knockout mice.  Thus, we propose that PPARγ agonism induces neuronal mitochondrial biogenesis and improves glucose utilization leading to improved cellular function and provides mechanistic support for the improvement in cognition obsd. in treatment of Alzheimer's patients with rosiglitazone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_DQHQzEezirVg90H21EOLACvtfcHk0lgFGg-8Ny2m7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVGju70%253D&md5=1179690e759268ad73edf039cc1ef11b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrum%26aufirst%3DJ.%2BC.%26aulast%3DShehee%26aufirst%3DR.%26aulast%3DVirley%26aufirst%3DD.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DMattie%26aufirst%3DM.%26aulast%3DSelley%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DNock%26aufirst%3DC.%26aulast%3DSaunders%26aufirst%3DA.%26aulast%3DRoses%26aufirst%3DA.%26atitle%3DRosiglitazone%2520induces%2520mitochondrial%2520biogenesis%2520in%2520mouse%2520brain%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2007%26volume%3D11%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Santos, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreira, P. I.</span><span> </span><span class="NLM_article-title">Mitophagy in neurodegeneration: an opportunity for therapy?</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.2174%2F138945011795528813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=21269269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlOgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=790-799&author=R.+X.+Santosauthor=S.+C.+Correiaauthor=C.+Carvalhoauthor=S.+Cardosoauthor=M.+S.+Santosauthor=P.+I.+Moreira&title=Mitophagy+in+neurodegeneration%3A+an+opportunity+for+therapy%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mitophagy in neurodegeneration: an opportunity for therapy?</span></div><div class="casAuthors">Santos, R. X.; Correia, S. C.; Carvalho, C.; Cardoso, S.; Santos, M. S.; Moreira, P. I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">790-799</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases are characterized by distinct clin. manifestations and neuropathol. hallmarks, but they also share common features like mitochondrial dysfunction.  As strategic organelles in several cellular pathways, including life/death decision, it is crucial to maintain a healthy mitochondrial pool to ensure cellular homeostasis.  Macroautophagy is a pathway of lysosomal-dependent degrdn. of cytosolic portions, such as misfolded proteins or damaged organelles.  In the last decade this process has gained new frontiers and is currently seen as a specific, rather than a random process.  In this regard the term mitophagy came to describe the selective degrdn. of mitochondria by autophagy.  This review is intended to discuss mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.  The recent developments on the mol. basis of mitophagy will be also argued.  Finally, we will discuss mitophagy as a potential therapeutic target for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYKZLdFzkV7Vg90H21EOLACvtfcHk0lgFGg-8Ny2m7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlOgtLw%253D&md5=bc44dc68b98c650b170b542df1cd94f9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F138945011795528813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945011795528813%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DR.%2BX.%26aulast%3DCorreia%26aufirst%3DS.%2BC.%26aulast%3DCarvalho%26aufirst%3DC.%26aulast%3DCardoso%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26atitle%3DMitophagy%2520in%2520neurodegeneration%253A%2520an%2520opportunity%2520for%2520therapy%253F%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2011%26volume%3D12%26spage%3D790%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease is a synaptic failure</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=789-91&author=D.+J.+Selkoe&title=Alzheimer%E2%80%99s+disease+is+a+synaptic+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520is%2520a%2520synaptic%2520failure%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D789%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, J. N.</span><span> </span><span class="NLM_article-title">NO chimeras as therapeutic agents in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.2174%2F156720506777632925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16842101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFGlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=237-245&author=G.+R.+J.+Thatcherauthor=B.+M.+Bennettauthor=J.+N.+Reynolds&title=NO+chimeras+as+therapeutic+agents+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">NO chimeras as therapeutic agents in Alzheimer's disease</span></div><div class="casAuthors">Thatcher, Gregory R. J.; Bennett, Brian M.; Reynolds, James N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-245</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  NO is an important messenger mol. in the brain, playing an important role in learning and memory, in particular via the ERK/CREB signaling pathway.  NO is also a neuroprotective agent; multiple mechanisms having been demonstrated that can contribute to cell survival as levels of antioxidants and trophic factors are reduced with aging.  Small mols. that mimic the biol. activity of NO, including NO donors, may thus ameliorate cognition and provide neuroprotection.  Several lines of evidence have linked the neurodegeneration and dementia characteristic of Alzheimer's disease with the action of β-amyloid protein at the α7-nicotinic acetylcholine receptor.  The interplay of Aβ with α7-nicotinic ACh receptors operating via the ERK signaling cascade links the amyloid cascade and the cholinergic hypothesis in pathways that impact synaptic plasticity and memory.  This interplay also provides linkages to disruption of NO/cGMP signaling in AD, and in addn., recent direct evidence has been found demonstrating that Aβ downregulates the NO/cGMP/CREB pathway.  Activation of sol. guanylyl cyclase elevating cGMP in the brain represents the central element of a therapeutic approach to the treatment of AD and other neurodegenerative diseases, furthermore, evidence suggests that NO may display cGMP-independent activity and may operate via multiple biochem. signaling pathways to ensure the survival of neurons subjected to stress.  GT 1061 is an NO chimera, an NO mimetic compd. that contains an ancillary, synergistic pharmacophore, currently in clin. trials for Alzheimer's.  NO chimeras and hybrid nitrates hold promise as therapeutics for AD with multiple sites of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0SSQZjqhUKLVg90H21EOLACvtfcHk0lgFGg-8Ny2m7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFGlsbk%253D&md5=e6754a624169c087d960b481e8194bbd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156720506777632925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506777632925%26sid%3Dliteratum%253Aachs%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BN.%26atitle%3DNO%2520chimeras%2520as%2520therapeutic%2520agents%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D237%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusky, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=505-513&author=B.+M.+Bennettauthor=J.+N.+Reynoldsauthor=G.+T.+Pruskyauthor=R.+M.+Douglasauthor=R.+J.+Sutherlandauthor=G.+R.+J.+Thatcher&title=Cognitive+deficits+in+rats+after+forebrain+cholinergic+depletion+are+reversed+by+a+novel+NO+mimetic+nitrate+ester"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BN.%26aulast%3DPrusky%26aufirst%3DG.%2BT.%26aulast%3DDouglas%26aufirst%3DR.%2BM.%26aulast%3DSutherland%26aufirst%3DR.%2BJ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DCognitive%2520deficits%2520in%2520rats%2520after%2520forebrain%2520cholinergic%2520depletion%2520are%2520reversed%2520by%2520a%2520novel%2520NO%2520mimetic%2520nitrate%2520ester%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D505%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniszewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Privitera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leznik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer’s disease mouse model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">8075</span><span class="NLM_x">–</span> <span class="NLM_lpage">8086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.0864-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=19553447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=8075-8086&author=D.+Puzzoauthor=A.+Staniszewskiauthor=S.+X.+Dengauthor=L.+Priviteraauthor=E.+Leznikauthor=S.+Liuauthor=H.+Zhangauthor=Y.+Fengauthor=A.+Palmeriauthor=D.+W.+Landryauthor=O.+Arancio&title=Phosphodiesterase+5+inhibition+improves+synaptic+function%2C+memory%2C+and+amyloid-beta+load+in+an+Alzheimer%E2%80%99s+disease+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model</span></div><div class="casAuthors">Puzzo, Daniela; Staniszewski, Agnieszka; Deng, Shi Xian; Privitera, Lucia; Leznik, Elena; Liu, Shumin; Zhang, Hong; Feng, Yan; Palmeri, Agostino; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8075-8086</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss, synaptic dysfunction, and accumulation of amyloid β-peptides (Aβ) are major hallmarks of Alzheimer's disease (AD).  Downregulation of the nitric oxide/cGMP/cGMP-dependent protein kinase/c-AMP responsive element-binding protein (CREB) cascade has been linked to the synaptic deficits after Aβ elevation.  Here, we report that the phosphodiesterase 5 inhibitor (PDE5) sildenafil (Viagra), a mol. that enhances phosphorylation of CREB, a mol. involved in memory, through elevation of cGMP levels, is beneficial against the AD phenotype in a mouse model of amyloid deposition.  We demonstrate that the inhibitor produces an immediate and long-lasting amelioration of synaptic function, CREB phosphorylation, and memory.  This effect is also assocd. with a long-lasting redn. of Aβ levels.  Given that side effects of PDE5 inhibitors are widely known and do not preclude their administration to a senile population, these drugs have potential for the treatment of AD and other diseases assocd. with elevated Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69pOrzfjxY7Vg90H21EOLACvtfcHk0ljnNcmFeqIdBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D&md5=5aead1f7c92b6166b8591c3e7951f78d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0864-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0864-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DLeznik%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPhosphodiesterase%25205%2520inhibition%2520improves%2520synaptic%2520function%252C%2520memory%252C%2520and%2520amyloid-beta%2520load%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D8075%26epage%3D8086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Saura, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, J.</span><span> </span><span class="NLM_article-title">The role of CREB signaling in Alzheimer’s disease and other cognitive disorders</span> <span class="citation_source-journal">Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1515%2Frns.2011.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=21476939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvit1CltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=153-169&author=C.+A.+Sauraauthor=J.+Valero&title=The+role+of+CREB+signaling+in+Alzheimer%E2%80%99s+disease+and+other+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The role of CREB signaling in Alzheimer's disease and other cognitive disorders</span></div><div class="casAuthors">Saura Carlos A; Valero Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the neurosciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-69</span>
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    </div><div class="casAbstract">Gene expression changes in the brain affect cognition during normal and pathological aging.  Progress in understanding the cellular processes regulating gene expression networks in cognition is relevant to develop therapeutic interventions for age-related cognitive disorders.  Synaptic efficacy mediating memory storage requires the activation of specific gene expression programs regulated, among others, by the transcription factor cAMP-response element binding protein (CREB).  CREB signaling is essential for long-lasting changes in synaptic plasticity that mediates the conversion of short-term memory to long-term memory.  CREB signaling has been recently involved in several brain pathological conditions including cognitive and neurodegenerative disorders.  The β-amyloid (Aβ) peptide, which plays a crucial role in the pathogenesis of Alzheimer's disease, alters hippocampal-dependent synaptic plasticity and memory and mediates synapse loss through the CREB signaling pathway.  The fact that altered CREB signaling has been implicated in other cognitive disorders including Huntington's disease and Rubinstein-Taybi and Coffin-Lowry syndromes suggests a crucial role of CREB signaling in cognitive dysfunction.  In this review paper, we summarize recent findings indicating a role of CREB and its coactivators CREB binding protein and CREB-regulated transcription coactivator in cognition during normal and pathological aging.  We also discuss the development of novel therapeutic strategies based on CREB targeting to ameliorate cognitive decline in aging and cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNqWMEv046oHl8icjszYl0fW6udTcc2eYzJW_FYqLJG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvit1CltA%253D%253D&md5=ebba8bee0b273f8deed9602b4d62036d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1515%2Frns.2011.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Frns.2011.018%26sid%3Dliteratum%253Aachs%26aulast%3DSaura%26aufirst%3DC.%2BA.%26aulast%3DValero%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520CREB%2520signaling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520cognitive%2520disorders%26jtitle%3DRev.%2520Neurosci.%26date%3D2011%26volume%3D22%26spage%3D153%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Espana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minano-Molina, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masgrau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Llort, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Alvarez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saura, C. A.</span><span> </span><span class="NLM_article-title">beta-Amyloid disrupts activity-dependent gene transcription required for memory through the CREB coactivator CRTC1</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">9402</span><span class="NLM_x">–</span> <span class="NLM_lpage">9410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.2154-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20631169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslSju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=9402-9410&author=J.+Espanaauthor=J.+Valeroauthor=A.+J.+Minano-Molinaauthor=R.+Masgrauauthor=E.+Martinauthor=C.+Guardia-Laguartaauthor=A.+Lleoauthor=L.+Gimenez-Llortauthor=J.+Rodriguez-Alvarezauthor=C.+A.+Saura&title=beta-Amyloid+disrupts+activity-dependent+gene+transcription+required+for+memory+through+the+CREB+coactivator+CRTC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">β-amyloid disrupts activity-dependent gene transcription required for memory through the CREB coactivator CRTC1</span></div><div class="casAuthors">Espana, Judit; Valero, Jorge; Minano-Molina, Alfredo J.; Masgrau, Roser; Martin, Elsa; Guardia-Laguarta, Cristina; Lleo, Alberto; Gimenez-Llort, Lydia; Rodriguez-Alvarez, Jose; Saura, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9402-9410</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Activity-dependent gene expression mediating changes of synaptic efficacy is important for memory storage, but the mechanisms underlying gene transcriptional changes in age-related memory disorders are poorly understood.  In this study, we report that gene transcription mediated by the cAMP-response element binding protein (CREB)-regulated transcription coactivator CRTC1 is impaired in neurons and brain from an Alzheimer's disease (AD) transgenic mouse expressing the human β-amyloid precursor protein (APPSw,Ind).  Suppression of CRTC1-dependent gene transcription by β-amyloid (Aβ) in response to cAMP and Ca2+ signals is mediated by reduced calcium influx and disruption of PP2B/calcineurin-dependent CRTC1 dephosphorylation at Ser151.  Consistently, expression of CRTC1 or active CRTC1 S151A and calcineurin mutants reverse the deficits on CRTC1 transcriptional activity in APPSw,Ind neurons.  Inhibition of calcium influx by pharmacol. blockade of L-type voltage-gated calcium channels (VGCCs), but not by blocking NMDA or AMPA receptors, mimics the decrease on CRTC1 transcriptional activity obsd. in APPSw,Ind neurons, whereas agonists of L-type VGCCs reverse efficiently these deficits.  Consistent with a role of CRTC1 on Aβ-induced synaptic and memory dysfunction, we demonstrate a selective redn. of CRTC1-dependent genes related to memory (Bdnf, c-fos, and Nr4a2) coinciding with hippocampal-dependent spatial memory deficits in APPSw,Ind mice.  These findings suggest that CRTC1 plays a key role in coupling synaptic activity to gene transcription required for hippocampal-dependent memory, and that Aβ could disrupt cognition by affecting CRTC1 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRX6uaShWwlbVg90H21EOLACvtfcHk0ljnNcmFeqIdBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslSju7g%253D&md5=837c57a6b8df850a57e34d83112cad50</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2154-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2154-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DEspana%26aufirst%3DJ.%26aulast%3DValero%26aufirst%3DJ.%26aulast%3DMinano-Molina%26aufirst%3DA.%2BJ.%26aulast%3DMasgrau%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DGimenez-Llort%26aufirst%3DL.%26aulast%3DRodriguez-Alvarez%26aufirst%3DJ.%26aulast%3DSaura%26aufirst%3DC.%2BA.%26atitle%3Dbeta-Amyloid%2520disrupts%2520activity-dependent%2520gene%2520transcription%2520required%2520for%2520memory%2520through%2520the%2520CREB%2520coactivator%2520CRTC1%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D9402%26epage%3D9410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibb, J. A.</span><span> </span><span class="NLM_article-title">Is CREB the angry bird that releases memory in alzheimer’s?</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2153</span><span class="NLM_x">–</span> <span class="NLM_lpage">2154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=2153-2154&author=A.+Wangauthor=J.+A.+Bibb&title=Is+CREB+the+angry+bird+that+releases+memory+in+alzheimer%E2%80%99s%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DA.%26aulast%3DBibb%26aufirst%3DJ.%2BA.%26atitle%3DIs%2520CREB%2520the%2520angry%2520bird%2520that%2520releases%2520memory%2520in%2520alzheimer%25E2%2580%2599s%253F%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D2153%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Pugazhenthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sze, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C. B.</span><span> </span><span class="NLM_article-title">Downregulation of CREB expression in Alzheimer’s brain and in Abeta-treated rat hippocampal neurons</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1186%2F1750-1326-6-60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=21854604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SqtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=60&author=S.+Pugazhenthiauthor=M.+Wangauthor=S.+Phamauthor=C.+I.+Szeauthor=C.+B.+Eckman&title=Downregulation+of+CREB+expression+in+Alzheimer%E2%80%99s+brain+and+in+Abeta-treated+rat+hippocampal+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons</span></div><div class="casAuthors">Pugazhenthi, Subbiah; Wang, Maorong; Pham, Serena; Sze, Chun-I.; Eckman, Christopher B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Oxidative stress plays an important role in neuronal dysfunction and neuron loss in Alzheimer's brain.  Previous studies have reported downregulation of CREB-mediated transcription by oxidative stress and Aβ.  The promoter for CREB itself contains cAMP response elements.  Therefore, we examd. the expression of CREB in the hippocampal neurons of Tg2576 mice, AD post-mortem brain and in cultured rat hippocampal neurons exposed to Aβ aggregates.  Results: Laser Capture Microdissection of hippocampal neurons from Tg2576 mouse brain revealed decreases in the mRNA levels of CREB and its target, BDNF.  Immunohistochem. anal. of Tg2576 mouse brain showed decreases in CREB levels in hippocampus and cortex.  Markers of oxidative stress were detected in transgenic mouse brain and decreased CREB staining was obsd. in regions showing abundance of astrocytes.  There was also an inverse correlation between SDS-extd. Aβ and CREB protein levels in Alzheimer's post-mortem hippocampal samples.  The levels of CREB-regulated BDNF and BIRC3, a caspase inhibitor, decreased and the active cleaved form of caspase-9, a marker for the intrinsic pathway of apoptosis, was elevated in these samples.  Exposure of rat primary hippocampal neurons to Aβ fibrils decreased CREB promoter activity.  Decrease in CREB mRNA levels in Aβ-treated neurons was reversed by the antioxidant, N-acetyl cysteine.  Overexpression of CREB by adenoviral transduction led to significant protection against Aβ-induced neuronal apoptosis.  Conclusions: Our findings suggest that chronic downregulation of CREB-mediated transcription results in decrease of CREB content in the hippocampal neurons of AD brain which may contribute to exacerbation of disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Jy8qMsXYa7Vg90H21EOLACvtfcHk0lgXYVat7yIrlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SqtLrM&md5=d844676fb6b7ce36eca53a5438528665</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-6-60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-6-60%26sid%3Dliteratum%253Aachs%26aulast%3DPugazhenthi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPham%26aufirst%3DS.%26aulast%3DSze%26aufirst%3DC.%2BI.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26atitle%3DDownregulation%2520of%2520CREB%2520expression%2520in%2520Alzheimer%25E2%2580%2599s%2520brain%2520and%2520in%2520Abeta-treated%2520rat%2520hippocampal%2520neurons%26jtitle%3DMol.%2520Neurodegener.%26date%3D2011%26volume%3D6%26spage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Yiu, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rashid, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josselyn, S. A.</span><span> </span><span class="NLM_article-title">Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2169</span><span class="NLM_x">–</span> <span class="NLM_lpage">2186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=2169-2186&author=A.+P.+Yiuauthor=A.+J.+Rashidauthor=S.+A.+Josselyn&title=Increasing+CREB+function+in+the+CA1+region+of+dorsal+hippocampus+rescues+the+spatial+memory+deficits+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYiu%26aufirst%3DA.%2BP.%26aulast%3DRashid%26aufirst%3DA.%2BJ.%26aulast%3DJosselyn%26aufirst%3DS.%2BA.%26atitle%3DIncreasing%2520CREB%2520function%2520in%2520the%2520CA1%2520region%2520of%2520dorsal%2520hippocampus%2520rescues%2520the%2520spatial%2520memory%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D2169%26epage%3D2186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Lu, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, R. D.</span><span> </span><span class="NLM_article-title">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">10250</span><span class="NLM_x">–</span> <span class="NLM_lpage">10261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.19-23-10250.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10575022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=10250-10261&author=Y.+F.+Luauthor=E.+R.+Kandelauthor=R.+D.+Hawkins&title=Nitric+oxide+signaling+contributes+to+late-phase+LTP+and+CREB+phosphorylation+in+the+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Kandel, Eric R.; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10250-10261</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term potentiation (LTP) in the hippocampus has an early phase (E-LTP) that can be induced by 1- or 2-train tetanization, lasts ∼1 h, and is cAMP-dependent protein kinase A (PKA)- and protein synthesis-independent and a late phase (L-LTP) that can be induced by 3- or 4-train tetanization, lasts >3 h, and is reduced by inhibitors of PKA and of protein or RNA synthesis.  NO is thought to be involved in E-LTP, but until now there has been no information about the role of the NO-signaling pathway in L-LTP.  Here, the authors examd. this question at the Schaffer collateral-CA1 synapses in slices of mouse hippocampus.  An inhibitor of nitric oxide synthase blocked L-LTP induced by 3-train tetanization and reduced L-LTP induced by 4-train tetanization, whereas an inhibitor of PKA was more effective in blocking 4-train L-LTP than 3-train L-LTP.  Three-train L-LTP was also blocked by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G (PKG).  Conversely, either NO or cGMP analogs paired with 1-train tetanization produced late-phase potentiation, and the cGMP-induced potentiation was blocked by inhibitors of protein or RNA synthesis and an inhibitor of PKG, but not by an inhibitor of PKA.  To test a possible downstream target of PKG, the authors examd. changes in phospho-CRE-binding protein (phospho-CREB) immunofluorescence in the CA1 cell body area and obtained results similar to those of the electrophysiol. expts.  The results suggested that NO contributes to L-LTP by stimulating guanylyl cyclase and PKG, which acts in parallel with PKA to increase phosphorylation of transcription factor CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0i0LYOPf7LVg90H21EOLACvtfcHk0lgXYVat7yIrlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D&md5=6d09b68560c09b81e38354826f7c21b6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-23-10250.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-23-10250.1999%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%2BF.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DNitric%2520oxide%2520signaling%2520contributes%2520to%2520late-phase%2520LTP%2520and%2520CREB%2520phosphorylation%2520in%2520the%2520hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D10250%26epage%3D10261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Riccio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonze, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginty, D. D.</span><span> </span><span class="NLM_article-title">A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=283-294&author=A.+Riccioauthor=R.+S.+Alvaniaauthor=B.+E.+Lonzeauthor=N.+Ramananauthor=T.+Kimauthor=Y.+Huangauthor=T.+M.+Dawsonauthor=S.+H.+Snyderauthor=D.+D.+Ginty&title=A+nitric+oxide+signaling+pathway+controls+CREB-mediated+gene+expression+in+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiccio%26aufirst%3DA.%26aulast%3DAlvania%26aufirst%3DR.%2BS.%26aulast%3DLonze%26aufirst%3DB.%2BE.%26aulast%3DRamanan%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26aulast%3DGinty%26aufirst%3DD.%2BD.%26atitle%3DA%2520nitric%2520oxide%2520signaling%2520pathway%2520controls%2520CREB-mediated%2520gene%2520expression%2520in%2520neurons%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D21%26spage%3D283%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Zhuo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, R. D.</span><span> </span><span class="NLM_article-title">Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1994&pages=635-639&author=M.+Zhuoauthor=Y.+Huauthor=C.+Schultzauthor=E.+R.+Kandelauthor=R.+D.+Hawkins&title=Role+of+guanylyl+cyclase+and+cGMP-dependent+protein+kinase+in+long-term+potentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSchultz%26aufirst%3DC.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DRole%2520of%2520guanylyl%2520cyclase%2520and%2520cGMP-dependent%2520protein%2520kinase%2520in%2520long-term%2520potentiation%26jtitle%3DNature%26date%3D1994%26volume%3D368%26spage%3D635%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.5291-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16033898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6887-6897&author=D.+Puzzoauthor=O.+Vitoloauthor=F.+Trincheseauthor=J.+P.+Jacobauthor=A.+Palmeriauthor=O.+Arancio&title=Amyloid-beta+peptide+inhibits+activation+of+the+nitric+oxide%2FcGMP%2FcAMP-responsive+element-binding+protein+pathway+during+hippocampal+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span></div><div class="casAuthors">Puzzo, Daniela; Vitolo, Ottavio; Trinchese, Fabrizio; Jacob, Joel P.; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6887-6897</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different 2nd-messenger cascades.  Interestingly, Aβ was found to markedly impair hippocampal long-term potentiation (LTP).  To identify a new pathway that might be responsible for such impairment, the authors analyzed the role of the NO/sol. guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP.  The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Aβ-induced impairment of CA1-LTP through cGK activation.  Furthermore, these compds. reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Aβ.  We also found that Aβ blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Aβ.  These results strongly suggest that, when modulating hippocampal synaptic plasticity, Aβ downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated prodn. of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_M3WUlYelLVg90H21EOLACvtfcHk0lg2IYSHq3QmdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D&md5=448717d56147ceb9665d8c1ce8136c98</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5291-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5291-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DVitolo%26aufirst%3DO.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DJacob%26aufirst%3DJ.%2BP.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520peptide%2520inhibits%2520activation%2520of%2520the%2520nitric%2520oxide%252FcGMP%252FcAMP-responsive%2520element-binding%2520protein%2520pathway%2520during%2520hippocampal%2520synaptic%2520plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6887%26epage%3D6897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer’s disease</span> <span class="citation_source-journal">Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1515%2FREVNEURO.2006.17.5.497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=17180876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=497-523&author=D.+Puzzoauthor=A.+Palmeriauthor=O.+Arancio&title=Involvement+of+the+nitric+oxide+pathway+in+synaptic+dysfunction+following+amyloid+elevation+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease</span></div><div class="casAuthors">Puzzo, Daniela; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-523</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Freund & Pettman</span>)
        </div><div class="casAbstract">A review.  Amyloid-beta (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has attracted scientific interest with the aim of characterizing the mechanisms by which it is involved in AD pathogenesis.  Aβ has been found to markedly impair hippocampal long-term potentiation (LTP), a widely studied cellular model of synaptic plasticity that is thought to underlie learning and memory.  The overall purpose of this review is to define the role of the nitric oxide (NO)/cGMP/cAMP-regulatory element binding (CREB) pathway in beta-amyloid-induced changes of basal neurotransmission and synaptic plasticity in the hippocampus, a structure within the temporal lobe of the brain crit. for memory storage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzLKNBiiakNLVg90H21EOLACvtfcHk0lg2IYSHq3QmdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ&md5=faa3271286d20c9cd431f9b001476089</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2006.17.5.497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2006.17.5.497%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DInvolvement%2520of%2520the%2520nitric%2520oxide%2520pathway%2520in%2520synaptic%2520dysfunction%2520following%2520amyloid%2520elevation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRev.%2520Neurosci.%26date%3D2006%26volume%3D17%26spage%3D497%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Paul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleppisch, T.</span><span> </span><span class="NLM_article-title">cGMP-dependent protein kinase type I promotes CREB/CRE-mediated gene expression in neurons of the lateral amygdala</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">473</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2010&pages=82-86&author=C.+Paulauthor=C.+Stratilauthor=F.+Hofmannauthor=T.+Kleppisch&title=cGMP-dependent+protein+kinase+type+I+promotes+CREB%2FCRE-mediated+gene+expression+in+neurons+of+the+lateral+amygdala"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DC.%26aulast%3DStratil%26aufirst%3DC.%26aulast%3DHofmann%26aufirst%3DF.%26aulast%3DKleppisch%26aufirst%3DT.%26atitle%3DcGMP-dependent%2520protein%2520kinase%2520type%2520I%2520promotes%2520CREB%252FCRE-mediated%2520gene%2520expression%2520in%2520neurons%2520of%2520the%2520lateral%2520amygdala%26jtitle%3DNeurosci.%2520Lett.%26date%3D2010%26volume%3D473%26spage%3D82%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, J. N.</span><span> </span><span class="NLM_article-title">Nitric oxide mimetic molecules as therapeutic agents in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.2174%2F1567205053585945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15974915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVantrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=171-182&author=G.+R.+J.+Thatcherauthor=B.+M.+Bennettauthor=J.+N.+Reynolds&title=Nitric+oxide+mimetic+molecules+as+therapeutic+agents+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide mimetic molecules as therapeutic agents in Alzheimer's disease</span></div><div class="casAuthors">Thatcher, Gregory R. J.; Bennett, Brian M.; Reynolds, James N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-182</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide is multifunctional messenger mol. in the brain, playing important roles including in learning and memory and in regulating the expression of trophic factors that may be reduced with aging.  Small mols. that mimic the biol. activity of NO, NO mimetics, will bypass cholinergic receptor activation and are anticipated to provide multiple pathways of treating and circumventing dementia in Alzheimer's disease.  Activation of sol. guanylyl cyclase and cGMP formation in the brain represents one element of effective neuroprotective pathways mediated by NO.  Substantial evidence suggests that NO mimetics may display cGMP-dependent and cGMP-independent activity and may operate via multiple biochem. signaling pathways, both to ensure the survival of neurons subjected to stress and also to provide cognition-enabling pathways to circumvent dementia.  GT 1061 is an NO mimetic compd. currently in clin. trials for Alzheimer's disease.  A survey of current research indicates that NO mimetics will provide a combined neuroprotective and cognition-enabling approach to anti-neurodegenerative therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE3z7OoRg7wbVg90H21EOLACvtfcHk0lg2IYSHq3QmdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVantrY%253D&md5=cb19bafe437fac666c7b72e982479743</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2174%2F1567205053585945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205053585945%26sid%3Dliteratum%253Aachs%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BN.%26atitle%3DNitric%2520oxide%2520mimetic%2520molecules%2520as%2520therapeutic%2520agents%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2005%26volume%3D2%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Rostovtsev, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2596</span><span class="NLM_x">–</span> <span class="NLM_lpage">2599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=12203546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Ohsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2596-2599&author=V.+V.+Rostovtsevauthor=L.+G.+Greenauthor=V.+V.+Fokinauthor=K.+B.+Sharpless&title=A+stepwise+Huisgen+cycloaddition+process%3A+copper%28I%29-catalyzed+regioselective+%E2%80%9Cligation%E2%80%9D+of+azides+and+terminal+alkynes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes</span></div><div class="casAuthors">Rostovtsev, Vsevolod V.; Green, Luke G.; Fokin, Valery V.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2596-2599</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">1,4-Disubstituted 1,2,3-triazoles I (R1 = PhCH2, PhCH2OCH2, 1-adamantyl, etc.; R2 = HO2C, Ph, PhOCH2, Et2NCH2, etc.) were readily and cleanly prepd. via highly efficient and regioselective copper(I)-catalyzed cycloaddn. of azides R1N3 with terminal alkynes R2C≡CH in 82-93% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptcW2JUNM1r7Vg90H21EOLACvtfcHk0lg2IYSHq3QmdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Ohsr4%253D&md5=4603664be6639353b5e70f19b9f8d59f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820020715%252941%253A14%253C2596%253A%253AAID-ANIE2596%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DRostovtsev%26aufirst%3DV.%2BV.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520stepwise%2520Huisgen%2520cycloaddition%2520process%253A%2520copper%2528I%2529-catalyzed%2520regioselective%2520%25E2%2580%259Cligation%25E2%2580%259D%2520of%2520azides%2520and%2520terminal%2520alkynes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D2596%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Tornoe, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meldal, M.</span><span> </span><span class="NLM_article-title">Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">3057</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo011148j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVeks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=3057-3064&author=C.+W.+Tornoeauthor=C.+Christensenauthor=M.+Meldal&title=Peptidotriazoles+on+solid+phase%3A+%5B1%2C2%2C3%5D-triazoles+by+regiospecific+copper%28I%29-catalyzed+1%2C3-dipolar+cycloadditions+of+terminal+alkynes+to+azides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidotriazoles on Solid Phase: [1,2,3]-Triazoles by Regiospecific Copper(I)-Catalyzed 1,3-Dipolar Cycloadditions of Terminal Alkynes to Azides</span></div><div class="casAuthors">Tornoe, Christian W.; Christensen, Caspar; Meldal, Morten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3057-3064</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cycloaddn. of azides to alkynes is one of the most important synthetic routes to 1H-[1,2,3]-triazoles.  This work reports a novel regiospecific copper(I)-catalyzed 1,3-dipolar cycloaddn. of terminal alkynes to azides on solid-phase.  Primary, secondary, and tertiary alkyl azides, aryl azides, and an azido sugar were used successfully in the copper(I)-catalyzed cycloaddn. producing diversely 1,4-substituted [1,2,3]-triazoles in peptide backbones or side chains.  The reaction conditions were fully compatible with solid-phase peptide synthesis on polar supports.  The copper(I) catalysis is mild and efficient (>95% conversion and purity in most cases) and furthermore, the x-ray structure of 2-azido-2-methylpropanoic acid has been solved, to yield structural information on the 1,3-dipoles entering the reaction.  Novel Fmoc-protected amino azides were prepd. from Fmoc-amino alcs. by Mitsunobu reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJXSF5l0g_lrVg90H21EOLACvtfcHk0lhhilEm5GucUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVeks7w%253D&md5=6b3b805572783873952871f1b69f46dd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo011148j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo011148j%26sid%3Dliteratum%253Aachs%26aulast%3DTornoe%26aufirst%3DC.%2BW.%26aulast%3DChristensen%26aufirst%3DC.%26aulast%3DMeldal%26aufirst%3DM.%26atitle%3DPeptidotriazoles%2520on%2520solid%2520phase%253A%2520%255B1%252C2%252C3%255D-triazoles%2520by%2520regiospecific%2520copper%2528I%2529-catalyzed%25201%252C3-dipolar%2520cycloadditions%2520of%2520terminal%2520alkynes%2520to%2520azides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D3057%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Moorhouse, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, J. E.</span><span> </span><span class="NLM_article-title">Click chemistry and medicinal chemistry: a case of “cyclo-addiction”</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=715-723&author=A.+D.+Moorhouseauthor=J.+E.+Moses&title=Click+chemistry+and+medicinal+chemistry%3A+a+case+of+%E2%80%9Ccyclo-addiction%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoorhouse%26aufirst%3DA.%2BD.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26atitle%3DClick%2520chemistry%2520and%2520medicinal%2520chemistry%253A%2520a%2520case%2520of%2520%25E2%2580%259Ccyclo-addiction%25E2%2580%259D%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D715%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Jones, R. W.</span><span> </span><span class="NLM_article-title">Dimebon disappointment</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1186%2Falzrt49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20836898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BC3cbnsVKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=25&author=R.+W.+Jones&title=Dimebon+disappointment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Dimebon disappointment</span></div><div class="casAuthors">Jones Roy W</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dimebon (latrepirdine) has received widespread publicity as a potential therapy for Alzheimer's disease following a very positive phase 2 study carried out in Russia and published in the Lancet in 2008.  In this study there were improvements over 6 months in all endpoints (cognitive, global, daily function and behaviour), with continuing improvement at 12 months in cognition and daily function.  A more recent multinational phase 3 study, however, showed no improvements whatsoever and no difference between the two drug-treated groups and the placebo group.  Of note, there was little deterioration in any of the groups after 6 months in contrast to the placebo group in the phase 2 study.  The potential reasons for these disappointing results are discussed, as well as the implication for dimebon and drug treatment in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF38Y8DmqCPX6oPH0mYWL1fW6udTcc2eZdXpHMJsm5B7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbnsVKksw%253D%253D&md5=d6b4e50451bbdb83da41e90e4d030a21</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2Falzrt49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt49%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BW.%26atitle%3DDimebon%2520disappointment%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2010%26volume%3D2%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Lizarzaburu, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">1,2,3,4-Tetrahydro-<i>c</i>-carbolinium salts: novel reactions with thiols, mediated by polymer-supported reagents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4781</span><span class="NLM_x">–</span> <span class="NLM_lpage">4783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=4781-4783&author=M.+E.+Lizarzaburuauthor=S.+J.+Shuttleworth&title=1%2C2%2C3%2C4-Tetrahydro-c-carbolinium+salts%3A+novel+reactions+with+thiols%2C+mediated+by+polymer-supported+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLizarzaburu%26aufirst%3DM.%2BE.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3D1%252C2%252C3%252C4-Tetrahydro-c-carbolinium%2520salts%253A%2520novel%2520reactions%2520with%2520thiols%252C%2520mediated%2520by%2520polymer-supported%2520reagents%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D4781%26epage%3D4783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Charonnat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chareton, J.</span><span> </span><span class="NLM_article-title">From a convulsive to an anticonvulsive product in the thiamine series</span> <span class="citation_source-journal">Therapie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1956&pages=261-264&author=R.+Charonnatauthor=P.+Lechatauthor=J.+Chareton&title=From+a+convulsive+to+an+anticonvulsive+product+in+the+thiamine+series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharonnat%26aufirst%3DR.%26aulast%3DLechat%26aufirst%3DP.%26aulast%3DChareton%26aufirst%3DJ.%26atitle%3DFrom%2520a%2520convulsive%2520to%2520an%2520anticonvulsive%2520product%2520in%2520the%2520thiamine%2520series%26jtitle%3DTherapie%26date%3D1956%26volume%3D11%26spage%3D261%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Ogren, S. O.</span><span> </span><span class="NLM_article-title">Chlormethiazole—mode of action</span> <span class="citation_source-journal">Acta Psychiatr. Scand., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1111%2Fj.1600-0447.1986.tb10530.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=2875615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADyaL28zhvFequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1986&pages=13-27&author=S.+O.+Ogren&title=Chlormethiazole%E2%80%94mode+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Chlormethiazole--mode of action</span></div><div class="casAuthors">Ogren S O</div><div class="citationInfo"><span class="NLM_cas:title">Acta psychiatrica Scandinavica. Supplementum</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-27</span>
        ISSN:<span class="NLM_cas:issn">0065-1591</span>.
    </div><div class="casAbstract">Studies in mice demonstrated that the anticonvulsant profile of chlormethiazole differs from that of diazepam and the barbiturates.  Chlormethiazole protects animals from convulsions induced by a wide variety of chemoconvulsants known to block the action of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), such as bicuculline, picrotoxin, isoniazid and pentetrazol, thus confirming and extending earlier studies on its broad anticonvulsant characteristics.  Chlormethiazole is particularly potent against isoniazid-induced convulsions, which are probably induced by reductions of GABA levels in the brain.  Chlormethiazole was found to have a weak action on benzodiazepine receptor binding, GABA receptor binding and kainic acid receptor binding.  Chlormethiazole inhibited picrotoxin binding at very high concentrations, but lowered the functional effects of picrotoxin at much lower concentrations than those affecting picrotoxin binding.  Moreover, chlormethiazole failed to change GABA or glutamate levels in the brain and did not affect glutamic acid decarboxylase (GAD) activities in the rat brain.  Muscimol (a GABAA agonist) enhanced the anticonvulsant activity of chlormethiazole against picrotoxin but not against bicuculline-induced convulsions.  Muscimol enhanced the anticonvulsant potency of diazepam against both chemoconvulsants.  These data suggest that the anticonvulsant activity of chlormethiazole is not mediated directly through changes in GABA or glutamate levels or by a direct (agonist) action at the GABA or benzodiazepine receptor complex.  These findings suggest that chlormethiazole may enhance GABA transmission beyond the GABA receptors, hypothetically at the level of the GABA receptor coupled ionophore (e.g. the chloride ion channel).  Applied micro-iontophoretically, chlormethiazole was found to potentiate the inhibitory responses to GABA, muscimol and glycine, but not to acetylcholine.  The potentiation of glycine-mediated inhibition is unique for chlormethiazole and does not occur with any other known anticonvulsant (barbiturates, benzodiazepine, phenytoin or sodium valproate).  Studies in primary cultures, derived from spinal cord neurones, showed that chlormethiazole produces hyperpolarization together with an increase in the threshold for action potential generation.  Further in vitro studies indicated that chlormethiazole acts on some types of Ca2+-dependent chloride ion channels.(ABSTRACT TRUNCATED AT 400 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4x0VSMbsbGUwlCcfExbvbfW6udTcc2eZVAA6GlMW_67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL28zhvFequg%253D%253D&md5=861da22e1915e4a3cb2a810fd71563e6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0447.1986.tb10530.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0447.1986.tb10530.x%26sid%3Dliteratum%253Aachs%26aulast%3DOgren%26aufirst%3DS.%2BO.%26atitle%3DChlormethiazole%25E2%2580%2594mode%2520of%2520action%26jtitle%3DActa%2520Psychiatr.%2520Scand.%252C%2520Suppl.%26date%3D1986%26volume%3D329%26spage%3D13%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Hedlund, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogren, S. O.</span><span> </span><span class="NLM_article-title">Chlormethiazole acts on chloride channels in cultured spinal cord neurons</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1987&pages=217-221&author=B.+Hedlundauthor=S.+O.+Ogren&title=Chlormethiazole+acts+on+chloride+channels+in+cultured+spinal+cord+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHedlund%26aufirst%3DB.%26aulast%3DOgren%26aufirst%3DS.%2BO.%26atitle%3DChlormethiazole%2520acts%2520on%2520chloride%2520channels%2520in%2520cultured%2520spinal%2520cord%2520neurons%26jtitle%3DNeurosci.%2520Lett.%26date%3D1987%26volume%3D78%26spage%3D217%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Nelson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, A. H.</span><span> </span><span class="NLM_article-title">Electrophysiological actions of γ-aminobutyric acid and clomethiazole on recombinant GABAA receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">452</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2FS0014-2999%2802%2902233-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=12359265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVagtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2002&pages=255-262&author=R.+M.+Nelsonauthor=A.+R.+Greenauthor=A.+H.+Hainsworth&title=Electrophysiological+actions+of+%CE%B3-aminobutyric+acid+and+clomethiazole+on+recombinant+GABAA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Electrophysiological actions of γ-aminobutyric acid and clomethiazole on recombinant GABAA receptors</span></div><div class="casAuthors">Nelson, Rachael M.; Green, A. Richard; Hainsworth, Atticus H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-262</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Clomethiazole is a γ-aminobutyric acid (GABA)-mimetic agent with anticonvulsant, sedative and neuroprotective properties.  The pharmacol. actions of clomethiazole that underlie its functional profile have not been fully explored, but are known to result from an interaction with the GABAA receptor.  Here, the authors present a quant. electrophysiol. study of clomethiazole action at human recombinant GABAA receptors.  Whole-cell currents were recorded from murine L(tk-) cells stably transfected with either α1, β1 and γ2 or α1, β2 and γ2 GABAA receptor subunits.  Clomethiazole directly activated GABAA currents in α1/β1/γ2- and α1/β2/γ2-contg. cells, with EC50 values of 0.3 and 1.5 mM, resp.  A low concn. of clomethiazole (30 μM) also potentiated the action of GABA in both cell types, equiv. to a 3-fold increase in potency and up to 1.8-fold increase in maximal current.  Both direct activation and gamma-aminobutyric acid potentiation are likely to contribute to the in vivo profile of clomethiazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6QNADF3WTorVg90H21EOLACvtfcHk0lgSMwZcZ2plVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVagtrc%253D&md5=ff387c765d1a507b8b1ee27e5bb91547</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902233-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902233-1%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DR.%2BM.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DHainsworth%26aufirst%3DA.%2BH.%26atitle%3DElectrophysiological%2520actions%2520of%2520%25CE%25B3-aminobutyric%2520acid%2520and%2520clomethiazole%2520on%2520recombinant%2520GABAA%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D452%26spage%3D255%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Marshall, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, R. M.</span><span> </span><span class="NLM_article-title">Clomethiazole protects against hemineglect in a primate model of stroke</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2FS0361-9230%2899%2900275-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10779698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFGqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2000&pages=21-29&author=J.+W.+Marshallauthor=A.+J.+Crossauthor=D.+M.+Jacksonauthor=A.+R.+Greenauthor=H.+F.+Bakerauthor=R.+M.+Ridley&title=Clomethiazole+protects+against+hemineglect+in+a+primate+model+of+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Clomethiazole protects against hemineglect in a primate model of stroke</span></div><div class="casAuthors">Marshall, J. W. B.; Cross, A. J.; Jackson, D. M.; Green, A. R.; Baker, H. F.; Ridley, R. M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Permanent occlusion of the M1 segment of the middle cerebral artery (pMCAO) in the marmoset, a New World species of monkey, produces unilateral functional deficits, including motor neglect with the contralesional arm and contralesional spatial hemineglect.  This study examd. whether clomethiazole, a drug which modulates the GABAA receptor, would reduce the severity of the hemineglect and other deficits in this primate model of stroke.  Monkeys received pMCAO; 1 h later some were administered clomethiazole by i.p. injection and s.c. implantation of osmotic minipumps, which released clomethiazole for 48 h.  The monkeys had been trained and tested on a no. of behavioral tasks prior to surgery and were retested 3 and 10 wk later.  Three weeks after pMCAO, the monkeys treated with clomethiazole had a reduced degree of spatial neglect compared to untreated controls.  Clomethiazole was not effective against the severe contralesional motor impairment, although it had ameliorated a somewhat less severe motor deficit in a previous study in which the more distal, M2 segment of the middle cerebral artery had been occluded.  Postmortem anal. of the brains showed that clomethiazole treatment had reduced the area of damage in part of the parietal cortex.  Clomethiazole may reduce the neglect that can be a debilitating consequence of right-sided stroke in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJzqnYFto78rVg90H21EOLACvtfcHk0lgSMwZcZ2plVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFGqsbg%253D&md5=6be6ef6d5328c5f07a0f400ca74de036</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2899%2900275-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252899%252900275-0%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DJ.%2BW.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DBaker%26aufirst%3DH.%2BF.%26aulast%3DRidley%26aufirst%3DR.%2BM.%26atitle%3DClomethiazole%2520protects%2520against%2520hemineglect%2520in%2520a%2520primate%2520model%2520of%2520stroke%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2000%26volume%3D52%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Gilby, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydserff, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, H. A.</span><span> </span><span class="NLM_article-title">Differential neuroprotective effects for three GABA-potentiating compounds in a model of hypoxia-ischemia</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1035</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.brainres.2004.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15722059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslWktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1035&publication_year=2005&pages=196-205&author=K.+L.+Gilbyauthor=S.+G.+Sydserffauthor=H.+A.+Robertson&title=Differential+neuroprotective+effects+for+three+GABA-potentiating+compounds+in+a+model+of+hypoxia-ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Differential neuroprotective effects for three GABA-potentiating compounds in a model of hypoxia-ischemia</span></div><div class="casAuthors">Gilby, K. L.; Sydserff, S. G.; Robertson, H. A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1035</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-205</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Clomethiazole (CMZ) is a GABAA-potentiating compd.; however, it is unclear whether this mode of action is responsible for its neuroprotective effects in animal models of ischemia.  This study compared the neuroprotective efficacies of muscimol and midazolam, two potent GABAA-potentiating compds., to that of CMZ in a model of hypoxia-ischemia (H-I).  To establish a neuroprotective profile for CMZ, CMZ (60, 95, or 125 mg kg-1, i.p.) was administered to post-natal day 25 male rats at numerous post-hypoxic time points and the rats were sacrificed 1 or 4 wk later.  Varying degrees of histol. protection were evident when CMZ was administered 1, 2, or 3 h post-hypoxia with the 125 mg kg-1 dose producing complete histol. protection if administered 3 h post-hypoxia.  To det. whether midazolam or muscimol could match the protection provided by CMZ administered 3 h post-hypoxia, H-I rats received varying doses of these compds. 3 h post-hypoxia and were sacrificed 1 wk later.  Under identical conditions, no dose of muscimol or midazolam provided equiv. neuroprotection to that provided by CMZ.  In fact, muscimol showed no neuroprotective ability whatsoever.  Thus, CMZ, administered as late as 3 h post-hypoxia, was able to completely prevent H-I-induced cell death while a full dose range of other GABA-potentiating agents did not.  Such direct comparison of these compds. in this model suggests the mechanism underlying the protective effects of CMZ may not rely solely on GABAA-potentiating properties.  Elucidation of a novel mechanism of action for CMZ may expose new therapeutic targets in stroke treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb3jTbqIFigbVg90H21EOLACvtfcHk0lh9RLDq3FO4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslWktb4%253D&md5=b65eca56e9a4f562fc6abf2d98c118df</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2004.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2004.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DGilby%26aufirst%3DK.%2BL.%26aulast%3DSydserff%26aufirst%3DS.%2BG.%26aulast%3DRobertson%26aufirst%3DH.%2BA.%26atitle%3DDifferential%2520neuroprotective%2520effects%2520for%2520three%2520GABA-potentiating%2520compounds%2520in%2520a%2520model%2520of%2520hypoxia-ischemia%26jtitle%3DBrain%2520Res.%26date%3D2005%26volume%3D1035%26spage%3D196%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwyl, R.</span><span> </span><span class="NLM_article-title">Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3370</span><span class="NLM_x">–</span> <span class="NLM_lpage">3378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.1633-03.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15056716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1yhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=3370-3378&author=Q.+Wangauthor=D.+M.+Walshauthor=M.+J.+Rowanauthor=D.+J.+Selkoeauthor=R.+Anwyl&title=Block+of+long-term+potentiation+by+naturally+secreted+and+synthetic+amyloid+beta-peptide+in+hippocampal+slices+is+mediated+via+activation+of+the+kinases+c-Jun+N-terminal+kinase%2C+cyclin-dependent+kinase+5%2C+and+p38+mitogen-activated+protein+kinase+as+well+as+metabotropic+glutamate+receptor+type+5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5</span></div><div class="casAuthors">Wang, Qinwen; Walsh, Dominic M.; Rowan, Michael J.; Selkoe, Dennis J.; Anwyl, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3370-3378</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The mechanisms of action of human synthetic and naturally secreted cell-derived amyloid β-peptide (Aβ)1-42 on the induction of long-term potentiation (LTP) were investigated in the medial perforant path to dentate granule cell synapses in hippocampal slices.  Synthetic and cell-derived Aβ strongly inhibited high-frequency stimulation (HFS)-induced LTP at peak HFS and 1 h after HFS.  Cell-derived Aβ was much more potent than synthetic Aβ at inhibiting LTP induction, with threshold concns. of ∼1 and 100-200 nM, resp.  The involvement of various kinases in Aβ-mediated inhibition of LTP induction was investigated by applying Aβ in the presence of inhibitors of these kinases.  The c-Jun N-terminal kinase (JNK) inhibitor JNKI prevented the block of LTP induction by both synthetic and cell-derived Aβ.  The block of LTP induced by synthetic Aβ was also prevented by the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one, the cyclin-dependent kinase 5 (Cdk5) inhibitors butyrolactone and roscovitine, and the p38 MAP kinase (MAPK) inhibitor 4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1H-imidazole but not by the p42-p44 MAP kinase inhibitor 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene.  The group I-group II metabotropic glutamate receptor (mGluR) antagonist 2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid and the mGluR5 antagonist methyl-6-(phenylethynyl)pyridine prevented the block of LTP induction by Aβ.  However, the α7 nicotinic ACh receptor antagonist methylcaconatine did not prevent the inhibition of LTP induction by Aβ.  These studies provide evidence that the Aβ-mediated inhibition of LTP induction involves stimulation of the kinases JNK, Cdk5, and p38 MAPK after the activation of both the Aβ receptor(s) and mGluR5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM3Y0ZEhug9bVg90H21EOLACvtfcHk0lh9RLDq3FO4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1yhsL0%253D&md5=59877a2758587038672a2ad3662827e2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1633-03.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1633-03.2004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DRowan%26aufirst%3DM.%2BJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DAnwyl%26aufirst%3DR.%26atitle%3DBlock%2520of%2520long-term%2520potentiation%2520by%2520naturally%2520secreted%2520and%2520synthetic%2520amyloid%2520beta-peptide%2520in%2520hippocampal%2520slices%2520is%2520mediated%2520via%2520activation%2520of%2520the%2520kinases%2520c-Jun%2520N-terminal%2520kinase%252C%2520cyclin-dependent%2520kinase%25205%252C%2520and%2520p38%2520mitogen-activated%2520protein%2520kinase%2520as%2520well%2520as%2520metabotropic%2520glutamate%2520receptor%2520type%25205%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D3370%26epage%3D3378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Rowan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyubin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwyl, R.</span><span> </span><span class="NLM_article-title">Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity</span> <span class="citation_source-journal">Exp. Gerontol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.exger.2004.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15582282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCltLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2004&pages=1661-1667&author=M.+J.+Rowanauthor=I.+Klyubinauthor=Q.+Wangauthor=R.+Anwyl&title=Mechanisms+of+the+inhibitory+effects+of+amyloid+beta-protein+on+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of the inhibitory effects of amyloid β-protein on synaptic plasticity</span></div><div class="casAuthors">Rowan, Michael J.; Klyubin, Igor; Wang, Qinwen; Anwyl, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1661-1667</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease can be considered a protein misfolding disease.  In particular, inappropriate processing of a proteolytic fragment of amyloid precursor protein, amyloid β-protein (Aβ), in early stages of Alzheimer's disease may lead to stabilization of small oligomers that are highly mobile and have a potential to be extremely toxic assemblies.  Recently, the importance of such sol. species of Aβ in triggering synaptic dysfunction, long before neuronal loss occurs, has become apparent.  Animal models have revealed that plasticity of hippocampal excitatory synaptic transmission is relatively selectively vulnerable to Aβ both in vitro and in vivo.  This review focuses on the mechanisms of Aβ inhibition of long-term potentiation at synapses in the rodent hippocampus from two complementary perspectives.  Firstly, the authors examine evidence that the synaptic activity of this peptide resides primarily in oligomeric rather than monomeric or fibrillar Aβ species.  Secondly, the importance of different oxidative/nitrosative stress-linked cascades including JNK, p38 MAPK and NADPH oxidase/iNOS-generated reactive oxygen/nitrogen free radicals in mediating the inhibition of LTP by Aβ is emphasized.  These mechanistic studies provide a plausible explanation for the sensitivity of hippocampus-dependent memory to impairment in the early preclin. stages of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGHLfBfxTn8bVg90H21EOLACvtfcHk0lh9RLDq3FO4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCltLbL&md5=b73b5843a0da754004121bf62d2941ac</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2004.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2004.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DM.%2BJ.%26aulast%3DKlyubin%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAnwyl%26aufirst%3DR.%26atitle%3DMechanisms%2520of%2520the%2520inhibitory%2520effects%2520of%2520amyloid%2520beta-protein%2520on%2520synaptic%2520plasticity%26jtitle%3DExp.%2520Gerontol.%26date%3D2004%26volume%3D39%26spage%3D1661%26epage%3D1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snape, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span> </span><span class="NLM_article-title">The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolites</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1038%2Fsj.bjp.0703042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10694207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVart7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=95-100&author=A.+R.+Greenauthor=T.+K.+Murrayauthor=A.+Misraauthor=M.+F.+Snapeauthor=J.+A.+Jonesauthor=A.+J.+Cross&title=The+metabolism+of+clomethiazole+in+gerbils+and+the+neuroprotective+and+sedative+activity+of+the+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolites</span></div><div class="casAuthors">Green, A. R.; Murray, T. K.; Misra, A.; Snape, M. F.; Jones, J. A.; Cross, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-100</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A single dose of clomethiazole (600 μmol kg-1 i.p.) has previously been shown to be neuroprotective in the gerbil model of global ischemia.  In gerbils, clomethiazole (600 μmol kg-1) injection produced a rapid appearance (peak within 5 min) of drug in plasma and brain and similar clearance (plasma t1/2: 40 min) from both tissues.  The peak brain concn. (226±56 nmol g-1) was 40% higher than plasma.  One major metabolite, 5-(1-hydroxyethyl-2-chloro)-4-methylthiazole (NLA-715) and 2 minor metabolites 5-(1-hydroxyethyl)-4-methylthiazole (NLA-272) and 5-acetyl-4-methylthiazole (NLA-511) were detected in plasma and brain.  Evidence suggested that clomethiazole is metabolized directly to both NLA-715 and NLA-272.  Injection of NLA-715, NLA-272 or NLA-511 (each at 600 μmol kg-1) produced brain concns. resp. 2.2, 38 and 92 times greater than seen after clomethiazole (600 μmol kg-1).  Clomethiazole (600 μmol kg-1) injected 60 min after a 5 min bilateral carotid artery occlusion in gerbils attenuated the ischemia-induced degeneration of the hippocampus by approx. 70%.  The metabolites were not neuroprotective at this dose.  In mice, clomethiazole (600 μmol kg-1) produced peak plasma and brain concns. approx. 100% higher than in gerbils, drug concns. in several brain regions were similar but 35% higher than plasma.  Clomethiazole (ED50: 180 μmol kg-1) and NLA-715 (ED50: 240 μmol kg-1) inhibited spontaneous locomotor activity.  The other metabolites were not sedative (ED50 >600 μmol kg-1).  Thus, the neuroprotective action of clomethiazole results from an action of the parent compd. and that NLA-715 contributes to the sedative activity of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS1-NIwBMzabVg90H21EOLACvtfcHk0lh9RLDq3FO4BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVart7c%253D&md5=7156dc247caefae479ee8669e07af1b5</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703042%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DSnape%26aufirst%3DM.%2BF.%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520metabolism%2520of%2520clomethiazole%2520in%2520gerbils%2520and%2520the%2520neuroprotective%2520and%2520sedative%2520activity%2520of%2520the%2520metabolites%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D129%26spage%3D95%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Ende, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiteller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heipertz, R.</span><span> </span><span class="NLM_article-title">Urinary metabolites of clomethiazole. Detection and structural analysis by gas chromatography–mass spectrometry</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=543872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaL3cXmvFamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1979&pages=1655-8&author=M.+Endeauthor=G.+Spitellerauthor=G.+Rembergauthor=R.+Heipertz&title=Urinary+metabolites+of+clomethiazole.+Detection+and+structural+analysis+by+gas+chromatography%E2%80%93mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary metabolites of clomethiazole.  Detection and structural analysis by gas chromatography-mass spectrometry</span></div><div class="casAuthors">Ende, M.; Spiteller, G.; Remberg, G.; Heipertz, R.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1655-8</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">Five previously unknown metabolites of clomethiazole (I)  [533-45-9] were isolated from human urine, and their structures were elucidated by gas chromatog.-mass spectrometry.  Metabolic studies of I demonstrated changes only at the Et group, however, the newly isolated metabolites demonstrated changes at the Me group, also.  The newly isolated compds., 5-(1-hydroxy-2-chloroethyl)-4-methylthiazole  [72579-01-2] and 5-(2-hydroxyethyl)-4-thiazole carboxylic acid lactone  [72579-00-1] were more abundant in human urine than 4-methyl-5-thiazole acetic acid  [5255-33-4], previously considered as the main metabolite of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsORu3eG4kcbVg90H21EOLACvtfcHk0ljka5KcbrKhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXmvFamsQ%253D%253D&md5=2bc31dd1bd54869272aa2845c57aefc2</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEnde%26aufirst%3DM.%26aulast%3DSpiteller%26aufirst%3DG.%26aulast%3DRemberg%26aufirst%3DG.%26aulast%3DHeipertz%26aufirst%3DR.%26atitle%3DUrinary%2520metabolites%2520of%2520clomethiazole.%2520Detection%2520and%2520structural%2520analysis%2520by%2520gas%2520chromatography%25E2%2580%2593mass%2520spectrometry%26jtitle%3DArzneim.%2520Forsch.%26date%3D1979%26volume%3D29%26spage%3D1655%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Simi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingelman-Sundberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tindberg, N.</span><span> </span><span class="NLM_article-title">Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">–</span> <span class="NLM_lpage">1088</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1097%2F00004647-200007000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10908041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFOmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1077-1088&author=A.+Simiauthor=M.+Ingelman-Sundbergauthor=N.+Tindberg&title=Neuroprotective+agent+chlomethiazole+attenuates+c-fos%2C+c-jun%2C+and+AP-1+activation+through+inhibition+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective agent clomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase</span></div><div class="casAuthors">Simi, Anastasia; Ingelman-Sundberg, Magnus; Tindberg, Niclas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1077-1088</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Recent evidence suggests that stress-activated protein kinases expressed in glial cells have very important roles during cerebral ischemia.  The neuroprotective agent clomethiazole, which is known to enhance the conductance at the GABAA receptor complex, is presently in clin. trials for the treatment of severe stroke.  Here the authors suggested that clomethiazole has anti-inflammatory properties because it potently and selectively inhibited p38 mitogen-activated protein (MAP) kinase in primary cortical glial cultures.  The inhibition of p38 MAP kinase resulted in the attenuation of the induction of c-fos and c-jun mRNA and AP-1 DNA binding by lipopolysaccharide (LPS).  In addn., clomethiazole inhibited the activation of an AP-1-dependent luciferase reporter plasmid in SK-N-MC human neuroblastoma cells in response to glutamate.  Clomethiazole inhibited the p38 MAP kinase activity as revealed by the decrease in the LPS-induced phosphorylation of the substrates ATF-2 and hsp27, whereas the phosphorylation status of the p38 MAP kinase itself was unaffected.  Interestingly, clomethiazole exhibited an IC50 of ∼ 2 μmol/L for inhibition of c-fos mRNA expression, indicating 25 to 75 times higher potency than reported EC50 values for enhancing GABAA chloride currents.  The results indicated a novel mechanism of action of clomethiazole, and provided support for a distinctive role of p38 MAP kinase in cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyPrW4adbmIrVg90H21EOLACvtfcHk0ljka5KcbrKhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFOmurk%253D&md5=2acd66a47a5058bd2424d06a1af3de08</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1097%2F00004647-200007000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-200007000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DSimi%26aufirst%3DA.%26aulast%3DIngelman-Sundberg%26aufirst%3DM.%26aulast%3DTindberg%26aufirst%3DN.%26atitle%3DNeuroprotective%2520agent%2520chlomethiazole%2520attenuates%2520c-fos%252C%2520c-jun%252C%2520and%2520AP-1%2520activation%2520through%2520inhibition%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab%26date%3D2000%26volume%3D20%26spage%3D1077%26epage%3D1088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Impey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, R. H.</span><span> </span><span class="NLM_article-title">CREB signaling—timing is everything</span> <span class="citation_source-journal">Sci. STKE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">PE1</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2001&publication_year=2001&pages=PE1&author=S.+Impeyauthor=R.+H.+Goodman&title=CREB+signaling%E2%80%94timing+is+everything"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImpey%26aufirst%3DS.%26aulast%3DGoodman%26aufirst%3DR.%2BH.%26atitle%3DCREB%2520signaling%25E2%2580%2594timing%2520is%2520everything%26jtitle%3DSci.%2520STKE%26date%3D2001%26volume%3D2001%26spage%3DPE1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Radley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, C. L.</span><span> </span><span class="NLM_article-title">Investigation of the mechanisms of progesterone protection following oxygen–glucose deprivation in organotypic hippocampal slice cultures</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">506</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=506&publication_year=2012&pages=131-135&author=E.+Radleyauthor=A.+Akramauthor=B.+D.+Grubbauthor=C.+L.+Gibson&title=Investigation+of+the+mechanisms+of+progesterone+protection+following+oxygen%E2%80%93glucose+deprivation+in+organotypic+hippocampal+slice+cultures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRadley%26aufirst%3DE.%26aulast%3DAkram%26aufirst%3DA.%26aulast%3DGrubb%26aufirst%3DB.%2BD.%26aulast%3DGibson%26aufirst%3DC.%2BL.%26atitle%3DInvestigation%2520of%2520the%2520mechanisms%2520of%2520progesterone%2520protection%2520following%2520oxygen%25E2%2580%2593glucose%2520deprivation%2520in%2520organotypic%2520hippocampal%2520slice%2520cultures%26jtitle%3DNeurosci.%2520Lett.%26date%3D2012%26volume%3D506%26spage%3D131%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Whalley, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constanti, A.</span><span> </span><span class="NLM_article-title">Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1111%2Fj.1476-5381.2008.00110.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=19226287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=994-1008&author=B.+J.+Whalleyauthor=G.+J.+Stephensauthor=A.+Constanti&title=Investigation+of+the+effects+of+the+novel+anticonvulsant+compound+carisbamate+%28RWJ-333369%29+on+rat+piriform+cortical+neurones+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro</span></div><div class="casAuthors">Whalley, B. J.; Stephens, G. J.; Constanti, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">994-1008</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Carisbamate is being developed for adjuvant treatment of partial onset epilepsy.  Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizure models, and exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models.  Phase IIb clin. trials of carisbamate demonstrated efficacy against partial onset seizures; however, its mechanisms of action remain unknown.  Here, we report the effects of carisbamate on membrane properties, evoked and spontaneous synaptic transmission and induced epileptiform discharges in layer II-III neurons in piriform cortical brain slices.  Effects of carisbamate were investigated in rat piriform cortical neurons by using intracellular electrophysiol. recordings.  Carisbamate (50-400 μmol/L-1) reversibly decreased amplitude, duration and rise-time of evoked action potentials and inhibited repetitive firing, consistent with use-dependent Na+ channel block; 150-400 μmol/L-1 carisbamate reduced neuronal input resistance, without altering membrane potential.  After microelectrode intracellular Cl- loading, carisbamate depolarized cells, an effect reversed by picrotoxin.  Carisbamate (100-400 μmol/L-1) also selectively depressed lateral olfactory tract-afferent evoked excitatory synaptic transmission (opposed by picrotoxin), consistent with activation of a presynpatic Cl- conductance.  Lidocaine (40-320 μmol/L-1) mimicked carisbamate, implying similar modes of action.  Carisbamate (300-600 μmol/L-1) had no effect on spontaneous GABAA miniature inhibitory postsynaptic currents and at lower concns. (50-200 μmol/L-1) inhibited Mg2+-free or 4-aminopyridine-induced seizure-like discharges.  Carisbamate blocked evoked action potentials use-dependently, consistent with a primary action on Na+ channels and increased Cl- conductances presynaptically and, under certain conditions, postsynaptically to selectively depress excitatory neurotransmission in piriform cortical layer la-afferent terminals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtZBWJAUuBrVg90H21EOLACvtfcHk0ljka5KcbrKhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7k%253D&md5=81ecb1a4d724b88bf616660055c4de93</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00110.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00110.x%26sid%3Dliteratum%253Aachs%26aulast%3DWhalley%26aufirst%3DB.%2BJ.%26aulast%3DStephens%26aufirst%3DG.%2BJ.%26aulast%3DConstanti%26aufirst%3DA.%26atitle%3DInvestigation%2520of%2520the%2520effects%2520of%2520the%2520novel%2520anticonvulsant%2520compound%2520carisbamate%2520%2528RWJ-333369%2529%2520on%2520rat%2520piriform%2520cortical%2520neurones%2520in%2520vitro%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26spage%3D994%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Pond, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustine, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz-Bloom, R. D.</span><span> </span><span class="NLM_article-title">The chloride transporter Na(+)-K(+)-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1396</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.1421-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16452663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFait74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=1396-406&author=B.+B.+Pondauthor=K.+Berglundauthor=T.+Kunerauthor=G.+Fengauthor=G.+J.+Augustineauthor=R.+D.+Schwartz-Bloom&title=The+chloride+transporter+Na%28%2B%29-K%28%2B%29-Cl-+cotransporter+isoform-1+contributes+to+intracellular+chloride+increases+after+in+vitro+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">The chloride transporter Na+-K+-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia</span></div><div class="casAuthors">Pond, Brooks B.; Berglund, Ken; Kuner, Thomas; Feng, Guoping; Augustine, George J.; Schwartz-Bloom, Rochelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1396-1406</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Ischemic episodes in the CNS cause significant disturbances in neuronal ionic homeostasis.  To directly measure changes in intracellular Cl- concn. ([Cl-]i) during and after ischemia, we used Clomeleon, a novel ratiometric optical indicator for Cl-.  Hippocampal slices from adult transgenic mice expressing Clomeleon in hippocampal neurons were subjected to 8 min of oxygen-glucose deprivation (OGD) (an in vitro model for ischemia) and reoxygenated in the presence of glucose.  This produced mild neuronal damage 3 h later that was prevented when the extracellular [Cl-] was maintained at 10 mM during reoxygenation.  OGD induced a transient decrease in fluorescence resonance energy transfer within Clomeleon, indicating an increase in [Cl-]i.  During reoxygenation, there was a partial recovery in [Cl-]i, but [Cl-]i rose again 45 min later.  To investigate sources of Cl- accumulation, we examd. the effects of Cl- transport inhibitors on the rises in [Cl-]i during and after OGD.  Bumetanide and furosemide, which inhibit Cl- influx through the Na+-K+-Cl- cotransporter isoform-1 (NKCC-1) and efflux through the K+-Cl- cotransporter isoform-2, were unable to inhibit the first rise in [Cl-]i, yet entirely prevented the secondary rise in [Cl-]i during reoxygenation.  In contrast, picrotoxin, which blocks the GABA-gated Cl- channel, did not inhibit the secondary rise in [Cl-]i after OGD.  [Cl-]i increases during reoxygenation were accompanied by an increase in phosphorylation of NKCC-1, an indication of increased NKCC-1 activity after OGD.  We conclude that NKCC-1 plays an important role in OGD-induced Cl- accumulation and subsequent neuronal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqUf8nabtWD7Vg90H21EOLACvtfcHk0lgQ5C4jVGS_iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFait74%253D&md5=ebea2486d8f669b3221fc9cdf404f854</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1421-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1421-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DPond%26aufirst%3DB.%2BB.%26aulast%3DBerglund%26aufirst%3DK.%26aulast%3DKuner%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DAugustine%26aufirst%3DG.%2BJ.%26aulast%3DSchwartz-Bloom%26aufirst%3DR.%2BD.%26atitle%3DThe%2520chloride%2520transporter%2520Na%2528%252B%2529-K%2528%252B%2529-Cl-%2520cotransporter%2520isoform-1%2520contributes%2520to%2520intracellular%2520chloride%2520increases%2520after%2520in%2520vitro%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D1396%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Gravielle, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russek, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farb, D. H.</span><span> </span><span class="NLM_article-title">GABA induces activity dependent delayed-onset uncoupling of GABA/benzodiazepine site interactions in neocortical neurons</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">20954</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=20954-60&author=M.+C.+Gravielleauthor=R.+Farisauthor=S.+J.+Russekauthor=D.+H.+Farb&title=GABA+induces+activity+dependent+delayed-onset+uncoupling+of+GABA%2Fbenzodiazepine+site+interactions+in+neocortical+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGravielle%26aufirst%3DM.%2BC.%26aulast%3DFaris%26aufirst%3DR.%26aulast%3DRussek%26aufirst%3DS.%2BJ.%26aulast%3DFarb%26aufirst%3DD.%2BH.%26atitle%3DGABA%2520induces%2520activity%2520dependent%2520delayed-onset%2520uncoupling%2520of%2520GABA%252Fbenzodiazepine%2520site%2520interactions%2520in%2520neocortical%2520neurons%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D20954%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Sedelnikova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erkkila, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakharkin, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, D. S.</span><span> </span><span class="NLM_article-title">Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">577</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1113%2Fjphysiol.2006.120287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16990398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12r" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=577&publication_year=2006&pages=569-577&author=A.+Sedelnikovaauthor=B.+E.+Erkkilaauthor=H.+Harrisauthor=S.+O.+Zakharkinauthor=D.+S.+Weiss&title=Stoichiometry+of+a+pore+mutation+that+abolishes+picrotoxin-mediated+antagonism+of+the+GABAA+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor</span></div><div class="casAuthors">Sedelnikova, Anna; Erkkila, Brian E.; Harris, Holly; Zakharkin, Stanislav O.; Weiss, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">577</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">569-577</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Picrotoxin, a potent antagonist of the inhibitory central nervous system GABAA and glycine receptors, is believed to interact with residues that line the central ion pore.  These pore-lining residues are in the second transmembrane domain (TM2) of each of the five constituent subunits.  One of these amino acids, a threonine at the 6' location, when mutated to phenylalanine, abolishes picrotoxin sensitivity.  It has been suggested that this threonine, via hydrogen bonding, directly interacts with the picrotoxin mol.  We previously demonstrated that this mutation, in the α, β or γ subunit, can impart picrotoxin resistance to the GABA receptor.  Since the functional pentameric GABA receptor contains two α subunits, two β subunits and one γ subunit, it is not clear how many α and β subunits must carry this mutation to impart the resistant phenotype.  In this study, by coexpression of mutant α or β subunits with their wild-type counterparts in various defined ratios, we demonstrate that any single subunit carrying the 6' mutation imparts picrotoxin resistance.  Implications of this finding in terms of the mechanism of antagonism are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXHzn5xmq8O7Vg90H21EOLACvtfcHk0lgQ5C4jVGS_iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12r&md5=97a1388bc68aca250186213cd6d0727b</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2006.120287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2006.120287%26sid%3Dliteratum%253Aachs%26aulast%3DSedelnikova%26aufirst%3DA.%26aulast%3DErkkila%26aufirst%3DB.%2BE.%26aulast%3DHarris%26aufirst%3DH.%26aulast%3DZakharkin%26aufirst%3DS.%2BO.%26aulast%3DWeiss%26aufirst%3DD.%2BS.%26atitle%3DStoichiometry%2520of%2520a%2520pore%2520mutation%2520that%2520abolishes%2520picrotoxin-mediated%2520antagonism%2520of%2520the%2520GABAA%2520receptor%26jtitle%3DJ.%2520Physiol.%26date%3D2006%26volume%3D577%26spage%3D569%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Korshoej, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. D.</span><span> </span><span class="NLM_article-title">Kinetic analysis of evoked IPSCs discloses mechanism of antagonism of synaptic GABAA receptors by picrotoxin</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1111%2Fj.1476-5381.2009.00542.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20105180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlCiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2010&pages=636-649&author=A.+R.+Korshoejauthor=M.+M.+Holmauthor=K.+Jensenauthor=J.+D.+Lambert&title=Kinetic+analysis+of+evoked+IPSCs+discloses+mechanism+of+antagonism+of+synaptic+GABAA+receptors+by+picrotoxin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic analysis of evoked IPSCs discloses mechanism of antagonism of synaptic GABAA receptors by picrotoxin</span></div><div class="casAuthors">Korshoej, A. R.; Holm, M. M.; Jensen, K.; Lambert, J. D. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-649</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: Although picrotoxin is a well-established antagonist of GABAA receptors, detailed studies of its action on inhibitory synaptic transmission have not previously been made.  Exptl. approach: Electrophysiol. techniques were used to study the action of picrotoxin on inhibitory postsynaptic currents (IPSCs) evoked in hippocampal neurons, in culture and slice prepns. prepd. from Wistar rat embryos and juveniles, resp.  Key results: Picrotoxin gradually reduced the amplitude of GABAA receptor-mediated eIPSCs in a concn.-dependent manner.  This was accompanied by a marked acceleration of the eIPSC decay kinetics, which, in contrast to the effect on amplitude, developed immediately and was completely reversed on washing.  The decaying phase of the IPSC could be resolved into two components; 30 μM picrotoxin reduced τfast by 34% and increased its relative amplitude, while τslow was reduced by 38%, and its relative amplitude decreased.  The area under the decaying phase of the normalized eIPSC showed an immediate redn. by 36% in 30 μM picrotoxin.  With increasing concns. of picrotoxin, this normalized area converged towards 55% of the control, indicating that the rate of relaxation and block has a finite max.  This implies that picrotoxin does not act by a pore-occluding mechanism (open-channel blocking), and suggests allosteric stabilization of desensitized receptor states as a more likely alternative.  This was corroborated by modeling, based on two established microscopic GABAA receptor transition schemes.  Conclusions and implications: Although the identity of the stabilized state has not been detd. unequivocally, picrotoxin effectively traps synaptic GABAA receptors in a desensitized state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYbcwdX2gW67Vg90H21EOLACvtfcHk0lgQ5C4jVGS_iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlCiu7g%253D&md5=ed734b3f9364ceb42df81091128e0c60</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00542.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00542.x%26sid%3Dliteratum%253Aachs%26aulast%3DKorshoej%26aufirst%3DA.%2BR.%26aulast%3DHolm%26aufirst%3DM.%2BM.%26aulast%3DJensen%26aufirst%3DK.%26aulast%3DLambert%26aufirst%3DJ.%2BD.%26atitle%3DKinetic%2520analysis%2520of%2520evoked%2520IPSCs%2520discloses%2520mechanism%2520of%2520antagonism%2520of%2520synaptic%2520GABAA%2520receptors%2520by%2520picrotoxin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D159%26spage%3D636%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Sceniak, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciver, M. B.</span><span> </span><span class="NLM_article-title">Slow GABA(A) mediated synaptic transmission in rat visual cortex</span> <span class="citation_source-journal">BMC Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1186%2F1471-2202-9-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=18199338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BD1c7itFSjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=8&author=M.+P.+Sceniakauthor=M.+B.+Maciver&title=Slow+GABA%28A%29+mediated+synaptic+transmission+in+rat+visual+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Slow GABA(A) mediated synaptic transmission in rat visual cortex</span></div><div class="casAuthors">Sceniak Michael P; Maciver M Bruce</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Previous reports of inhibition in the neocortex suggest that inhibition is mediated predominantly through GABA(A) receptors exhibiting fast kinetics.  Within the hippocampus, it has been shown that GABA(A) responses can take the form of either fast or slow response kinetics.  Our findings indicate, for the first time, that the neocortex displays synaptic responses with slow GABA(A) receptor mediated inhibitory postsynaptic currents (IPSCs).  These IPSCs are kinetically and pharmacologically similar to responses found in the hippocampus, although the anatomical specificity of evoked responses is unique from hippocampus.  Spontaneous slow GABA(A) IPSCs were recorded from both pyramidal and inhibitory neurons in rat visual cortex.  RESULTS:  GABA(A) slow IPSCs were significantly different from fast responses with respect to rise times and decay time constants, but not amplitudes.  Spontaneously occurring GABA(A) slow IPSCs were nearly 100 times less frequent than fast sIPSCs and both were completely abolished by the chloride channel blocker, picrotoxin.  The GABA(A) subunit-specific antagonist, furosemide, depressed spontaneous and evoked GABA(A) fast IPSCs, but not slow GABA(A)-mediated IPSCs.  Anatomical specificity was evident using minimal stimulation: IPSCs with slow kinetics were evoked predominantly through stimulation of layer 1/2 apical dendritic zones of layer 4 pyramidal neurons and across their basal dendrites, while GABA(A) fast IPSCs were evoked through stimulation throughout the dendritic arborization.  Many evoked IPSCs were also composed of a combination of fast and slow IPSC components.  CONCLUSION:  GABA(A) slow IPSCs displayed durations that were approximately 4 fold longer than typical GABA(A)fast IPSCs, but shorter than GABA(B)-mediated inhibition.  The anatomical and pharmacological specificity of evoked slow IPSCs suggests a unique origin of synaptic input.  Incorporating GABA(A) slow IPSCs into computational models of cortical function will help improve our understanding of cortical information processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnxydL3b1fDSCEBeYuoi7AfW6udTcc2ealuLwBApLAW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7itFSjtw%253D%253D&md5=57679bf2fdfbe69f4215ffaf1b3beadb</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-9-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-9-8%26sid%3Dliteratum%253Aachs%26aulast%3DSceniak%26aufirst%3DM.%2BP.%26aulast%3DMaciver%26aufirst%3DM.%2BB.%26atitle%3DSlow%2520GABA%2528A%2529%2520mediated%2520synaptic%2520transmission%2520in%2520rat%2520visual%2520cortex%26jtitle%3DBMC%2520Neurosci.%26date%3D2008%26volume%3D9%26spage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Han, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youn, D. H.</span><span> </span><span class="NLM_article-title">GABAA receptor-mediated tonic currents in substantia gelatinosa neurons of rat spinal trigeminal nucleus pars caudalis</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2008&pages=296-301&author=S.+M.+Hanauthor=D.+H.+Youn&title=GABAA+receptor-mediated+tonic+currents+in+substantia+gelatinosa+neurons+of+rat+spinal+trigeminal+nucleus+pars+caudalis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%2BM.%26aulast%3DYoun%26aufirst%3DD.%2BH.%26atitle%3DGABAA%2520receptor-mediated%2520tonic%2520currents%2520in%2520substantia%2520gelatinosa%2520neurons%2520of%2520rat%2520spinal%2520trigeminal%2520nucleus%2520pars%2520caudalis%26jtitle%3DNeurosci.%2520Lett.%26date%3D2008%26volume%3D441%26spage%3D296%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Fletcher, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeney, M. E.</span><span> </span><span class="NLM_article-title">Monosubstituted 1,2,3-triazoles from two-step one-pot deprotection/click additions of trimethylsilylacetylene</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7030</span><span class="NLM_x">–</span> <span class="NLM_lpage">7032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=7030-7032&author=J.+T.+Fletcherauthor=S.+E.+Walzauthor=M.+E.+Keeney&title=Monosubstituted+1%2C2%2C3-triazoles+from+two-step+one-pot+deprotection%2Fclick+additions+of+trimethylsilylacetylene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DJ.%2BT.%26aulast%3DWalz%26aufirst%3DS.%2BE.%26aulast%3DKeeney%26aufirst%3DM.%2BE.%26atitle%3DMonosubstituted%25201%252C2%252C3-triazoles%2520from%2520two-step%2520one-pot%2520deprotection%252Fclick%2520additions%2520of%2520trimethylsilylacetylene%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D7030%26epage%3D7032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Bender, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol702892e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=509-511&author=D.+M.+Benderauthor=J.+A.+Petersonauthor=J.+R.+McCarthyauthor=H.+Gunaydinauthor=Y.+Takanoauthor=K.+N.+Houk&title=Cyclopropanecarboxylic+acid+esters+as+potential+prodrugs+with+enhanced+hydrolytic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fol702892e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol702892e%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DD.%2BM.%26aulast%3DPeterson%26aufirst%3DJ.%2BA.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DCyclopropanecarboxylic%2520acid%2520esters%2520as%2520potential%2520prodrugs%2520with%2520enhanced%2520hydrolytic%2520stability%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D509%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Buckell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartry, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajalingam, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Hydrolysis of nitrite esters: putative intermediates in the biotransformation of organic nitrates</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 2</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1039%2Fp29940000401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK2cXisVekt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=401-403&author=F.+Buckellauthor=J.+D.+Hartryauthor=U.+Rajalingamauthor=B.+M.+Bennettauthor=R.+A.+Whitneyauthor=G.+R.+J.+Thatcher&title=Hydrolysis+of+nitrite+esters%3A+putative+intermediates+in+the+biotransformation+of+organic+nitrates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolysis of nitrite esters: putative intermediates in the biotransformation of organic nitrates</span></div><div class="casAuthors">Buckell, Felicity; Hartry, Jeffrey D.; Rajalingam, Umarani; Bennett, Brian M.; Whitney, Ralph A.; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Perkin Transactions 2:  Physical Organic Chemistry (1972-1999)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-3</span>CODEN:
                <span class="NLM_cas:coden">JCPKBH</span>;
        ISSN:<span class="NLM_cas:issn">0300-9580</span>.
    </div><div class="casAbstract">Study and comparison of the pH-independent hydrolysis of eight alkyl nitrites shows 3-nitroso-1,2-glyceryl dinitrate, a putative intermediate in the biotransformation of glyceryl trinitrate, to be unexpectedly reactive and too labile to be detected as a biotransformation intermediate in aq. soln., suggesting a role for neighboring group participation by the β-nitrate group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA8x9pPNJUgLVg90H21EOLACvtfcHk0ljw8MM--KZT0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXisVekt70%253D&md5=526f3f99ad87780c7232c5dfcab11ccc</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1039%2Fp29940000401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp29940000401%26sid%3Dliteratum%253Aachs%26aulast%3DBuckell%26aufirst%3DF.%26aulast%3DHartry%26aufirst%3DJ.%2BD.%26aulast%3DRajalingam%26aufirst%3DU.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DWhitney%26aufirst%3DR.%2BA.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DHydrolysis%2520of%2520nitrite%2520esters%253A%2520putative%2520intermediates%2520in%2520the%2520biotransformation%2520of%2520organic%2520nitrates%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25202%26date%3D1994%26spage%3D401%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Sant’Angelo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Usefulness of behavioral and electrophysiological studies in transgenic models of Alzheimer’s disease</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1023%2FA%3A1023251005197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=12737525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=1009-1015&author=A.+Sant%E2%80%99Angeloauthor=F.+Trincheseauthor=O.+Arancio&title=Usefulness+of+behavioral+and+electrophysiological+studies+in+transgenic+models+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Usefulness of behavioral and electrophysiological studies in transgenic models of Alzheimer's disease</span></div><div class="casAuthors">Sant'Angelo, Antonino; Trinchese, Fabrizio; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1009-1015</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Over the past several years researchers have engineered many transgenic models of Alzheimer's disease.  Since loss of memory is one of the major hallmarks of the disorder, the phenotypic characterization of these animals has included both behavioral tests which aim to evaluate learning abilities, and electrophysiol. studies to analyze synaptic transmission and long-term potentiation, a widely studied cellular model of learning and memory.  These studies are fundamental for the design of novel therapies for the treatment and/or prevention of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQE0yx9BvJ_LVg90H21EOLACvtfcHk0ljNiALtpHvcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislyisro%253D&md5=33386492cbaa336643330ec425e8be0e</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023251005197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023251005197%26sid%3Dliteratum%253Aachs%26aulast%3DSant%25E2%2580%2599Angelo%26aufirst%3DA.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DUsefulness%2520of%2520behavioral%2520and%2520electrophysiological%2520studies%2520in%2520transgenic%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Res.%26date%3D2003%26volume%3D28%26spage%3D1009%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Bliss, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collingridge, G. L.</span><span> </span><span class="NLM_article-title">A synaptic model of memory: long-term potentiation in the hippocampus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1038%2F361031a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=8421494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK3sXntlOntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=1993&pages=31-39&author=T.+V.+Blissauthor=G.+L.+Collingridge&title=A+synaptic+model+of+memory%3A+long-term+potentiation+in+the+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A synaptic model of memory:  long-term potentiation in the hippocampus</span></div><div class="casAuthors">Bliss, T. V. P.; Collingridge, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">6407</span>),
    <span class="NLM_cas:pages">31-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A review, with 174 refs., of long-term potentiation (LTP) of synaptic transmission in the hippocampus as the primary exptl. model for investigating the synaptic basis of learning and memory in vertebrates.  Topics discussed were: properties of hippocampal LTP; induction of LTP; and expression of LTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1tHZif2aP7Vg90H21EOLACvtfcHk0ljNiALtpHvcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXntlOntw%253D%253D&md5=285f5a175da5a77f4f57a3f5236e3e0a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2F361031a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F361031a0%26sid%3Dliteratum%253Aachs%26aulast%3DBliss%26aufirst%3DT.%2BV.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26atitle%3DA%2520synaptic%2520model%2520of%2520memory%253A%2520long-term%2520potentiation%2520in%2520the%2520hippocampus%26jtitle%3DNature%26date%3D1993%26volume%3D361%26spage%3D31%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battaglia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">814</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1002%2Fana.20101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15174014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=801-814&author=F.+Trincheseauthor=S.+Liuauthor=F.+Battagliaauthor=S.+Walterauthor=P.+M.+Mathewsauthor=O.+Arancio&title=Progressive+age-related+development+of+Alzheimer-like+pathology+in+APP%2FPS1+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span></div><div class="casAuthors">Trinchese, Fabrizio; Liu, Shumin; Battaglia, Fortunato; Walter, Sean; Mathews, Paul M.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">801-814</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasing evidence points to synaptic plasticity impairment as one of the first events in Alzheimer's disease (AD).  However, studies on synaptic dysfunction in different transgenic AD models that overexpress familial AD mutant forms of amyloid precursor protein (APP) and/or presenilin (PS) have provided conflicting results.  Both long-term potentiation (LTP) and basal synaptic transmission (BST) have been found to be both unchanged and altered in different models and under differing exptl. conditions.  Because of their more robust amyloid-β (Aβ) deposition, double transgenic mice currently are used by several labs. as an AD model.  Here, we report that mice overexpressing APP (K670N: M671L) together with PS1 (M146L) have abnormal LTP as early as 3 mo of age.  Interestingly, reduced LTP paralleled plaque appearance and increased Aβ levels and abnormal short-term memory (working memory).  BST and long-term memory (ref. memory) are impaired only later (approx. 6 mo) as amyloid burden increases.  Aβ pathol. across different ages did not correlate with synaptic and cognitive deficits, suggesting that Aβ levels are not a marker of memory decline.  In contrast, progression of LTP impairment correlated with the deterioration of working memory, suggesting that percentage of potentiation might be an indicator of the cognitive decline and disease progression in the APP/PS1 mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-0Sep8mnVgLVg90H21EOLACvtfcHk0ljNiALtpHvcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D&md5=87f7a6dea17b0d35a775712088213641</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1002%2Fana.20101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20101%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBattaglia%26aufirst%3DF.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DProgressive%2520age-related%2520development%2520of%2520Alzheimer-like%2520pathology%2520in%2520APP%252FPS1%2520mice%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D801%26epage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Gong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1624</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1172%2FJCI22831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15578094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2004&pages=1624-1634&author=B.+Gongauthor=O.+V.+Vitoloauthor=F.+Trincheseauthor=S.+Liuauthor=M.+Shelanskiauthor=O.+Arancio&title=Persistent+improvement+in+synaptic+and+cognitive+functions+in+an+Alzheimer+mouse+model+after+rolipram+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span></div><div class="casAuthors">Gong, Bing; Vitolo, Ottavio V.; Trinchese, Fabrizio; Liu, Shumin; Shelanski, Michael; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1624-1634</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Evidence suggests that Alzheimer disease (AD) begins as a disorder of synaptic function, caused in part by increased levels of amyloid β-peptide 1-42 (Aβ42).  Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution K670N,M671L) and presenilin-1 (AA substitution M146V).  Here the authors demonstrate that brief treatment with the phosphodiesterase 4 inhibitor rolipram ameliorates deficits in both long-term potentiation (LTP) and contextual learning in the double-transgenic mice.  Most importantly, this beneficial effect can be extended beyond the duration of the administration.  One course of long-term systemic treatment with rolipram improves LTP and basal synaptic transmission as well as working, ref., and associative memory deficits for at least 2 mo after the end of the treatment.  This protective effect is possibly due to stabilization of synaptic circuitry via alterations in gene expression by activation of the cAMP-dependent protein kinase (PKA)/cAMP regulatory element-binding protein (CREB) signaling pathway that make the synapses more resistant to the insult inflicted by Aβ.  Thus, agents that enhance the cAMP/PKA/CREB pathway have potential for the treatment of AD and other diseases assocd. with elevated Aβ42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI79h3DC1rU7Vg90H21EOLACvtfcHk0ljNiALtpHvcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I&md5=72e43d10754678b58a452160fe7142e2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1172%2FJCI22831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI22831%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DVitolo%26aufirst%3DO.%2BV.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DShelanski%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPersistent%2520improvement%2520in%2520synaptic%2520and%2520cognitive%2520functions%2520in%2520an%2520Alzheimer%2520mouse%2520model%2520after%2520rolipram%2520treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D114%26spage%3D1624%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Schindler, U.</span><span> </span><span class="NLM_article-title">Pre-clinical evaluation of cognition enhancing drugs</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S99</span><span class="NLM_x">–</span> <span class="NLM_lpage">S115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1989&pages=S99-S115&issue=Suppl.&author=U.+Schindler&title=Pre-clinical+evaluation+of+cognition+enhancing+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DU.%26atitle%3DPre-clinical%2520evaluation%2520of%2520cognition%2520enhancing%2520drugs%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D1989%26volume%3D13%26issue%3DSuppl%26spage%3DS99%26epage%3DS115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Abdul-Hay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiefer, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelhamid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavassoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asghodom, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R.</span><span> </span><span class="NLM_article-title">NO-SSRIs: nitric oxide chimera drugs incorporating a selective serotonin reuptake inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=656-661&author=S.+Abdul-Hayauthor=I.+T.+Schieferauthor=R.+E.+Chandrasenaauthor=M.+Liauthor=R.+Abdelhamidauthor=Y.+T.+Wangauthor=E.+Tavassoliauthor=B.+Michalsenauthor=R.+T.+Asghodomauthor=J.+Luoauthor=G.+R.+Thatcher&title=NO-SSRIs%3A+nitric+oxide+chimera+drugs+incorporating+a+selective+serotonin+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fml2000033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000033%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Hay%26aufirst%3DS.%26aulast%3DSchiefer%26aufirst%3DI.%2BT.%26aulast%3DChandrasena%26aufirst%3DR.%2BE.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DAbdelhamid%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DTavassoli%26aufirst%3DE.%26aulast%3DMichalsen%26aufirst%3DB.%26aulast%3DAsghodom%26aufirst%3DR.%2BT.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DNO-SSRIs%253A%2520nitric%2520oxide%2520chimera%2520drugs%2520incorporating%2520a%2520selective%2520serotonin%2520reuptake%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D656%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Satoh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabunoki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arima, K.</span><span> </span><span class="NLM_article-title">Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus</span> <span class="citation_source-journal">Dis. Markers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1155%2F2009%2F618619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20037212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SmsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=239-252&author=J.+Satohauthor=H.+Tabunokiauthor=K.+Arima&title=Molecular+network+analysis+suggests+aberrant+CREB-mediated+gene+regulation+in+the+Alzheimer+disease+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus</span></div><div class="casAuthors">Satoh, Jun-Ichi; Tabunoki, Hiroko; Arima, Kunimasa</div><div class="citationInfo"><span class="NLM_cas:title">Disease Markers</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">239-252</span>CODEN:
                <span class="NLM_cas:coden">DMARD3</span>;
        ISSN:<span class="NLM_cas:issn">0278-0240</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The pathogenesis of Alzheimer disease (AD) involves the complex interaction between genetic and environmental factors affecting multiple cellular pathways. Recent advances in systems biol. provide a system-level understanding of AD by elucidating the genome-wide mol. interactions.  By using KeyMolnet, a bioinformatics tool for analyzing mol. interactions on the curated knowledgebase, we characterized mol. network of 2,883 all stages of AD-related genes (ADGs) and 559 incipient AD-related genes (IADGs) identified by global gene expression profiling of the hippocampal CA1 region of AD brains in terms of significant clin. and pathol. correlations (Blalock et al., Proc Natl Acad Sci USA 101: 2173-2178, 2004).  By the common upstream search, KeyMolnet identified cAMP-response element-binding protein (CREB) as the principal transcription factor exhibiting the most significant relevance to mol. networks of both ADGs and IADGs.  The CREB-regulated transcriptional network included upregulated and downregulated sets of ADGs and IADGs, suggesting an involvement of generalized deregulation of the CREB signaling pathway in the pathophysiol. of AD, beginning at the early stage of the disease.  To verify the in silico observations in vivo, we conducted immunohistochem. studies of 11 AD and 13 age-matched control brains by using anti-phoshorylated CREB (pCREB) antibody.  An abnormal accumulation of pCREB imunoreactivity was identified in granules of granulovacuolar degeneration (GVD) in the hippocampal neurons of AD brains.  These observations suggest that aberrant CREB-mediated gene regulation serves as a mol. biomarker of AD-related pathol. processes, and support the hypothesis that sequestration of pCREB in GVD granules is in part responsible for deregulation of CREB-mediated gene expression in AD hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrkQ-abEnjnrVg90H21EOLACvtfcHk0lj7jk61E-YIRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SmsbrI&md5=74a61093c3ca828b41437136046819cd</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1155%2F2009%2F618619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2009%252F618619%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DJ.%26aulast%3DTabunoki%26aufirst%3DH.%26aulast%3DArima%26aufirst%3DK.%26atitle%3DMolecular%2520network%2520analysis%2520suggests%2520aberrant%2520CREB-mediated%2520gene%2520regulation%2520in%2520the%2520Alzheimer%2520disease%2520hippocampus%26jtitle%3DDis.%2520Markers%26date%3D2009%26volume%3D27%26spage%3D239%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Louzada, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paula Lima, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca-Silva, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mello, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, S. T.</span><span> </span><span class="NLM_article-title">Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer’s disease and other neurological disorders</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=511-518&author=P.+R.+Louzadaauthor=A.+C.+Paula+Limaauthor=D.+L.+Mendonca-Silvaauthor=F.+Noelauthor=F.+G.+De+Melloauthor=S.+T.+Ferreira&title=Taurine+prevents+the+neurotoxicity+of+beta-amyloid+and+glutamate+receptor+agonists%3A+activation+of+GABA+receptors+and+possible+implications+for+Alzheimer%E2%80%99s+disease+and+other+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouzada%26aufirst%3DP.%2BR.%26aulast%3DPaula%2BLima%26aufirst%3DA.%2BC.%26aulast%3DMendonca-Silva%26aufirst%3DD.%2BL.%26aulast%3DNoel%26aufirst%3DF.%26aulast%3DDe%2BMello%26aufirst%3DF.%2BG.%26aulast%3DFerreira%26aufirst%3DS.%2BT.%26atitle%3DTaurine%2520prevents%2520the%2520neurotoxicity%2520of%2520beta-amyloid%2520and%2520glutamate%2520receptor%2520agonists%253A%2520activation%2520of%2520GABA%2520receptors%2520and%2520possible%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520neurological%2520disorders%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D511%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun-Tian, Z.</span><span> </span><span class="NLM_article-title">Neuroprotection by <span class="smallcaps smallerCapital">d</span>-securinine against neurotoxicity induced by beta-amyloid (25–35)</span> <span class="citation_source-journal">Neurol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1179%2F016164104225014148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15494124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BD2crisVCmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=792-796&author=X.+Linauthor=Z.+Jun-Tian&title=Neuroprotection+by+d-securinine+against+neurotoxicity+induced+by+beta-amyloid+%2825%E2%80%9335%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by D-securinine against neurotoxicity induced by beta-amyloid (25-35)</span></div><div class="casAuthors">Lin Xu; Jun-Tian Zhang</div><div class="citationInfo"><span class="NLM_cas:title">Neurological research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">792-6</span>
        ISSN:<span class="NLM_cas:issn">0161-6412</span>.
    </div><div class="casAbstract">The effects of (+) securinine on behavior and morphological changes after intracerebral ventricle injection of beta-amyloid (25-35) (Abeta(25-35)) in rats were investigated.  A single high dose of Abeta(25-35) could impair the spatial cognitive function.  The latency of locating the platform was longer in the model group than in the sham-operated group.  While chronic administration of D-securinine (40 mg kg(-1)) could significantly shorten the latency.  After Morris water maze, the activity of choline acetyltransferase (ChAT) and acetylcholinesterase (AchE) were detected.  The results showed that D-securinine could decrease the AchE activity significantly and have no effect on ChAT.  Meanwhile, immunohistochemistry analysis revealed that D-securinine could reduce the glial inflammatory responses induced by beta-amyloid protein.  These results suggest that the effect of D-securinine in improving the cognitive deficits and neurodegeneration in betaAP(25-35)-treated rats may involve direct and indirect actions on targets.  The GABA receptor plays a key role in these therapeutic effects and may be helpful in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJMikAQ3UnnYUSrryheKE6fW6udTcc2ebIlG08jKzz4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crisVCmtg%253D%253D&md5=9cd653fa6e1526612775cf3cea6186ab</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1179%2F016164104225014148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F016164104225014148%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DJun-Tian%26aufirst%3DZ.%26atitle%3DNeuroprotection%2520by%2520d-securinine%2520against%2520neurotoxicity%2520induced%2520by%2520beta-amyloid%2520%252825%25E2%2580%259335%2529%26jtitle%3DNeurol.%2520Res.%26date%3D2004%26volume%3D26%26spage%3D792%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Lee, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seong, Y. H.</span><span> </span><span class="NLM_article-title">Chronic stimulation of GABAA receptor with muscimol reduces amyloid beta protein (25–35)-induced neurotoxicity in cultured rat cortical cells</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.neures.2005.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15896866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFanurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=347-356&author=B.+Y.+Leeauthor=J.+Y.+Banauthor=Y.+H.+Seong&title=Chronic+stimulation+of+GABAA+receptor+with+muscimol+reduces+amyloid+beta+protein+%2825%E2%80%9335%29-induced+neurotoxicity+in+cultured+rat+cortical+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic stimulation of GABAA receptor with muscimol reduces amyloid β protein (25-35)-induced neurotoxicity in cultured rat cortical cells</span></div><div class="casAuthors">Lee, Bo Young; Ban, Ju Yeon; Seong, Yeon Hee</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-356</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study was performed to examine how the stimulation of γ-aminobutyric acid (GABA) receptor affects amyloid β protein (25-35) (Aβ (25-35)), a synthetic 25-35 amyloid peptide, -induced neurotoxicity using cultured rat cortical neurons.  Aβ (25-35) produced a concn.-dependent redn. of cell viability, which was significantly reduced by (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (MK-801), an N-methyl-D-aspartate (NMDA) receptor antagonist, verapamil, an L-type Ca2+ channel blocker, and NG-nitro-L-arginine Me ester (L-NAME), a nitric oxide synthase inhibitor.  Pretreatment with muscimol, a GABAA receptor agonist, over a concn. range of 0.1-10 μM 24 h before the treatment with 10 μM Aβ (25-35) showed concn.-dependent inhibition on the Aβ (25-35)-induced neuronal apoptotic death.  However, baclofen (1 and 10 μM), a GABAB receptor agonist, failed to inhibit the Aβ (25-35)-induced neuronal death.  In addn., pretreatment with muscimol (1 μM) for 24 h inhibited the Aβ (25-35) (10 μM)-induced elevation of cytosolic Ca2+ concn. ([Ca2+]c) and glutamate release, generation of reactive oxygen species (ROS), and caspase-3 activity in cultured neurons.  These neuroprotective effects of muscimol (1 μM) were completely blocked by the simultaneous treatment with 10 μM bicuculline, a GABAA receptor antagonist, indicating that the protective effects of muscimol were due to GABAA receptor stimulation.  When, however, treated just 15 min before the treatment with Aβ (25-35), muscimol (1 μM) did not show any protective effect against Aβ (25-35) (10 μM)-induced neurotoxicity in cultured neurons.  These results suggest that the chronic activation of GABAA receptor may ameliorate Aβ-induced neurotoxicity by interfering with the increase of [Ca2+]c, and then by inhibiting glutamate release, generation of ROS and caspase-3 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog0nPnnM_Lf7Vg90H21EOLACvtfcHk0ljHc9cTY_oYNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFanurk%253D&md5=c180d58b267ec76b7740f7b59089bfd4</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2005.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2005.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BY.%26aulast%3DBan%26aufirst%3DJ.%2BY.%26aulast%3DSeong%26aufirst%3DY.%2BH.%26atitle%3DChronic%2520stimulation%2520of%2520GABAA%2520receptor%2520with%2520muscimol%2520reduces%2520amyloid%2520beta%2520protein%2520%252825%25E2%2580%259335%2529-induced%2520neurotoxicity%2520in%2520cultured%2520rat%2520cortical%2520cells%26jtitle%3DNeurosci.%2520Res.%26date%3D2005%26volume%3D52%26spage%3D347%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Marcade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peillon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desire, L.</span><span> </span><span class="NLM_article-title">Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1111%2Fj.1471-4159.2008.05396.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=18397369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Ogtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=392-404&author=M.+Marcadeauthor=J.+Bourdinauthor=N.+Loiseauauthor=H.+Peillonauthor=A.+Rayerauthor=D.+Drouinauthor=F.+Schweighofferauthor=L.+Desire&title=Etazolate%2C+a+neuroprotective+drug+linking+GABA%28A%29+receptor+pharmacology+to+amyloid+precursor+protein+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing</span></div><div class="casAuthors">Marcade, Maryline; Bourdin, Jerome; Loiseau, Nadia; Peillon, Helene; Rayer, Aurelie; Drouin, Dominique; Schweighoffer, Fabien; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">392-404</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Pharmacol. modulation of the GABAA receptor has gained increasing attention as a potential treatment for central processes affected in Alzheimer disease (AD), including neuronal survival and cognition.  The proteolytic cleavage of the amyloid precursor protein (APP) through the α-secretase pathway decreases in AD, concurrent with cognitive impairment.  This APP cleavage occurs within the β-amyloid peptide (Aβ) sequence, precluding formation of amyloidogenic peptides and leading to the release of the sol. N-terminal APP fragment (sAPPα) which is neurotrophic and procognitive.  In this study, we show that at nanomolar-low micromolar concns., etazolate, a selective GABAA receptor modulator, stimulates sAPPα prodn. in rat cortical neurons and in guinea pig brains.  Etazolate (20 nM-2 μM) dose-dependently protected rat cortical neurons against Aβ-induced toxicity.  The neuroprotective effects of etazolate were fully blocked by GABAA receptor antagonists indicating that this neuroprotection was due to GABAA receptor signaling.  Baclofen, a GABAB receptor agonist failed to inhibit the Aβ-induced neuronal death.  Furthermore, both pharmacol. α-secretase pathway inhibition and sAPPα immunoneutralization approaches prevented etazolate neuroprotection against Aβ, indicating that etazolate exerts its neuroprotective effect via sAPPα induction.  Our findings therefore indicate a relation between GABAA receptor signaling, the α-secretase pathway and neuroprotection, documenting a new therapeutic approach for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrztjL6EyMUk7Vg90H21EOLACvtfcHk0ljHc9cTY_oYNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Ogtrc%253D&md5=7cc211782d7167d22844102b4a920603</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05396.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05396.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarcade%26aufirst%3DM.%26aulast%3DBourdin%26aufirst%3DJ.%26aulast%3DLoiseau%26aufirst%3DN.%26aulast%3DPeillon%26aufirst%3DH.%26aulast%3DRayer%26aufirst%3DA.%26aulast%3DDrouin%26aufirst%3DD.%26aulast%3DSchweighoffer%26aufirst%3DF.%26aulast%3DDesire%26aufirst%3DL.%26atitle%3DEtazolate%252C%2520a%2520neuroprotective%2520drug%2520linking%2520GABA%2528A%2529%2520receptor%2520pharmacology%2520to%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D392%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Ziakas, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rekka, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavalas, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleftheriou, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiakitzis, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourounakis, P. N.</span><span> </span><span class="NLM_article-title">Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">6485</span><span class="NLM_x">–</span> <span class="NLM_lpage">6492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.bmc.2005.07.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16185877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=6485-6492&author=G.+N.+Ziakasauthor=E.+A.+Rekkaauthor=A.+M.+Gavalasauthor=P.+T.+Eleftheriouauthor=K.+C.+Tsiakitzisauthor=P.+N.+Kourounakis&title=Nitric+oxide+releasing+derivatives+of+tolfenamic+acid+with+anti-inflammatory+activity+and+safe+gastrointestinal+profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile</span></div><div class="casAuthors">Ziakas, George N.; Rekka, Eleni A.; Gavalas, Antonios M.; Eleftheriou, Phaedra T.; Tsiakitzis, Karyofillis C.; Kourounakis, Panos N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6485-6492</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tolfenamic acid esters with nitrooxyalcs. are synthesized.  They are anti-inflammatory agents reducing carrageenan rat paw edema, with low gastrointestinal and general toxicity.  In vitro, they are nitric oxide donors, inhibitors of lipoxygenase and cyclooxygenases.  A two to three carbon chain between carboxylic and nitric ester groups seems optimal for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFG3Vrt6Akb7Vg90H21EOLACvtfcHk0ljHc9cTY_oYNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsLbN&md5=fd4363233e709ce62fb73e94eaebf443</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.07.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.07.049%26sid%3Dliteratum%253Aachs%26aulast%3DZiakas%26aufirst%3DG.%2BN.%26aulast%3DRekka%26aufirst%3DE.%2BA.%26aulast%3DGavalas%26aufirst%3DA.%2BM.%26aulast%3DEleftheriou%26aufirst%3DP.%2BT.%26aulast%3DTsiakitzis%26aufirst%3DK.%2BC.%26aulast%3DKourounakis%26aufirst%3DP.%2BN.%26atitle%3DNitric%2520oxide%2520releasing%2520derivatives%2520of%2520tolfenamic%2520acid%2520with%2520anti-inflammatory%2520activity%2520and%2520safe%2520gastrointestinal%2520profile%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D6485%26epage%3D6492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Madrigal, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dello Russo, C.</span><span> </span><span class="NLM_article-title">Norepinephrine protects cortical neurons against microglial-induced cell death</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1002%2Fjnr.20481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15948176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnsVeltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2005&pages=390-396&author=J.+L.+Madrigalauthor=D.+L.+Feinsteinauthor=C.+Dello+Russo&title=Norepinephrine+protects+cortical+neurons+against+microglial-induced+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Norepinephrine protects cortical neurons against microglial-induced cell death</span></div><div class="casAuthors">Madrigal, Jose L. M.; Feinstein, Douglas L.; Russo, Cinzia Dello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-396</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Interleukin-1 beta (IL-1β) is one of the main cytokines involved in the inflammatory response; it has multiple effects that can contribute to cell damage, one of which is the upregulation of the inducible form of nitric oxide (NO) synthase (NOS2) in certain cell types.  The authors demonstrated previously that in vivo, cortical microglial inflammatory responses were increased when noradrenaline (NE) levels were depleted, suggesting that NE can reduce microglial activation.  In the present report, the authors examd. the role of IL-1β in neurotoxicity induced by microglial-conditioned media, and possible neuroprotective effects of NE.  Incubation of cortical neurons with conditioned media (CM) obtained from lipopolysaccharide (LPS)-treated microglia induced neuronal NOS2 expression and increased neuronal cell death, and these responses were reduced if the neurons were coincubated with interleukin-1 receptor antagonist.  Cotreatment of microglial cells with LPS plus NE potently blocked IL-1β prodn. and reduced the ability of the CM to induce neuronal NOS2 and cell death.  These results suggest that microglial release of IL-1β is an important activator of neuronal inflammatory responses, and that protective effects of NE upon neurons involve a redn. of microglial-derived IL-1β.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_m4emv_nBLrVg90H21EOLACvtfcHk0lhEoYnULz3J3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnsVeltLs%253D&md5=891a9e3b4659e918118c0a9e62d57315</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20481%26sid%3Dliteratum%253Aachs%26aulast%3DMadrigal%26aufirst%3DJ.%2BL.%26aulast%3DFeinstein%26aufirst%3DD.%2BL.%26aulast%3DDello%2BRusso%26aufirst%3DC.%26atitle%3DNorepinephrine%2520protects%2520cortical%2520neurons%2520against%2520microglial-induced%2520cell%2520death%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2005%26volume%3D81%26spage%3D390%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Canas, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velly, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrande, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillet, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautou-Miranda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masmejean, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieoullon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruder, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, P. S.</span><span> </span><span class="NLM_article-title">Sevoflurane protects rat mixed cerebrocortical neuronal-glial cell cultures against transient oxygen–glucose deprivation: involvement of glutamate uptake and reactive oxygen species</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2006&pages=990-998&author=P.+T.+Canasauthor=L.+J.+Vellyauthor=C.+N.+Labrandeauthor=B.+A.+Guilletauthor=V.+Sautou-Mirandaauthor=F.+M.+Masmejeanauthor=A.+L.+Nieoullonauthor=F.+M.+Gouinauthor=N.+J.+Bruderauthor=P.+S.+Pisano&title=Sevoflurane+protects+rat+mixed+cerebrocortical+neuronal-glial+cell+cultures+against+transient+oxygen%E2%80%93glucose+deprivation%3A+involvement+of+glutamate+uptake+and+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCanas%26aufirst%3DP.%2BT.%26aulast%3DVelly%26aufirst%3DL.%2BJ.%26aulast%3DLabrande%26aufirst%3DC.%2BN.%26aulast%3DGuillet%26aufirst%3DB.%2BA.%26aulast%3DSautou-Miranda%26aufirst%3DV.%26aulast%3DMasmejean%26aufirst%3DF.%2BM.%26aulast%3DNieoullon%26aufirst%3DA.%2BL.%26aulast%3DGouin%26aufirst%3DF.%2BM.%26aulast%3DBruder%26aufirst%3DN.%2BJ.%26aulast%3DPisano%26aufirst%3DP.%2BS.%26atitle%3DSevoflurane%2520protects%2520rat%2520mixed%2520cerebrocortical%2520neuronal-glial%2520cell%2520cultures%2520against%2520transient%2520oxygen%25E2%2580%2593glucose%2520deprivation%253A%2520involvement%2520of%2520glutamate%2520uptake%2520and%2520reactive%2520oxygen%2520species%26jtitle%3DAnesthesiology%26date%3D2006%26volume%3D105%26spage%3D990%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Schubert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piasecki, D.</span><span> </span><span class="NLM_article-title">Oxidative glutamate toxicity can be a component of the excitotoxicity cascade</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7455</span><span class="NLM_x">–</span> <span class="NLM_lpage">7462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=11567035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFCksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=7455-7462&author=D.+Schubertauthor=D.+Piasecki&title=Oxidative+glutamate+toxicity+can+be+a+component+of+the+excitotoxicity+cascade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative glutamate toxicity can be a component of the excitotoxicity cascade</span></div><div class="casAuthors">Schubert, David; Piasecki, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7455-7462</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Along with ionotropic and metabotropic glutamate receptors, the cystine/glutamate antiporter xc- may play a crit. role in CNS pathol.  High levels of extracellular glutamate inhibit the import of cystine, resulting in the depletion of glutathione and a form of cell injury called oxidative glutamate toxicity.  Here the authors show that a portion of the cell death assocd. with NMDA receptor-initiated excitotoxicity can be caused by oxidative glutamate toxicity.  In primary mouse cortical neurons the cell death resulting from the short-term application of 10 μM glutamate can be divided into NMDA and NMDA receptor-independent phases.  The NMDA receptor-independent component is assocd. with high extracellular glutamate and is inhibited by a variety of reagents that block oxidative glutamate toxicity.  These results suggest that oxidative glutamate toxicity toward neurons lacking functional NMDA receptors can be a component of the excitotoxicity-initiated cell death pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7e-C8fPwJ67Vg90H21EOLACvtfcHk0lhEoYnULz3J3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFCksrY%253D&md5=3085eb710b5808260bad255440a9aa84</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchubert%26aufirst%3DD.%26aulast%3DPiasecki%26aufirst%3DD.%26atitle%3DOxidative%2520glutamate%2520toxicity%2520can%2520be%2520a%2520component%2520of%2520the%2520excitotoxicity%2520cascade%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3D7455%26epage%3D7462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Ha, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeng, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. S.</span><span> </span><span class="NLM_article-title">Chronic glutamate toxicity in mouse cortical neuron culture</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1273</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.brainres.2009.03.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=19344697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlKisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1273&publication_year=2009&pages=138-143&author=J.+S.+Haauthor=C.+S.+Leeauthor=J.+S.+Maengauthor=K.+S.+Kwonauthor=S.+S.+Park&title=Chronic+glutamate+toxicity+in+mouse+cortical+neuron+culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic glutamate toxicity in mouse cortical neuron culture</span></div><div class="casAuthors">Ha, Jong Seong; Lee, Chul-Sang; Maeng, Jin-Soo; Kwon, Ki-Sun; Park, Sung Sup</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1273</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-143</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two pathways for glutamate toxicity have been described, receptor-mediated excitotoxicity and non-receptor mediated oxidative glutamate toxicity.  Here, we show that two distinct forms of receptor-mediated primary cortical neuronal death exist, chronic and acute glutamate toxicity, and that these depend on exposure time.  In vitro, neuronal sensitivity to chronic glutamate exposure increased as neurons matured and the initial plating medium contributed as well.  In immature neurons, high concns. of glutamate induced neuronal death.  The chronic glutamate toxicity was independent of neuronal d., whereas increased d. potentiated acute glutamate toxicity.  Activation of ionotropic glutamate receptors (iGluRs) contributed to induction of chronic and acute glutamate toxicity at similar rates at DIV14.  Inactivation of the metabotropic glutamate receptors (mGluRs) by AIDA increased neuronal sensitivity to chronic glutamate exposure but not to acute exposure.  Neuronal death by acute toxicity was much faster than by chronic toxicity in which activation of mGluRs was involved.  These results suggest that acute glutamate toxicity is quite different from chronic toxicity, in which activation of mGluRs is assocd. with resistance to glutamate toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTLWeIYQO1dbVg90H21EOLACvtfcHk0lhEoYnULz3J3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlKisLw%253D&md5=5d9f68620c43dd811a062f03aa7dd41a</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.03.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.03.050%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DMaeng%26aufirst%3DJ.%2BS.%26aulast%3DKwon%26aufirst%3DK.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BS.%26atitle%3DChronic%2520glutamate%2520toxicity%2520in%2520mouse%2520cortical%2520neuron%2520culture%26jtitle%3DBrain%2520Res.%26date%3D2009%26volume%3D1273%26spage%3D138%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Abdelhamid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandevrede, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litosh, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiefer, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherezghiher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R.</span><span> </span><span class="NLM_article-title">Benzothiophene selective estrogen receptor modulators provide neuroprotection by a novel GPR30-dependent mechanism</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100106a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFektLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=256-268&author=R.+Abdelhamidauthor=J.+Luoauthor=L.+Vandevredeauthor=I.+Kunduauthor=B.+Michalsenauthor=V.+A.+Litoshauthor=I.+T.+Schieferauthor=T.+Gherezghiherauthor=P.+Yaoauthor=Z.+Qinauthor=G.+R.+Thatcher&title=Benzothiophene+selective+estrogen+receptor+modulators+provide+neuroprotection+by+a+novel+GPR30-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a Novel GPR30-Dependent Mechanism</span></div><div class="casAuthors">Abdelhamid, Ramy; Luo, Jia; Vande Vrede, Lawren; Kundu, Indraneel; Michalsen, Bradley; Litosh, Vladislav A.; Schiefer, Isaac T.; Gherezghiher, Teshome; Yao, Ping; Qin, Zhihui; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">256-268</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The clin. benzothiophene SERM (BT-SERM) raloxifene was compared with estrogens in protection of primary rat neurons against oxygen-glucose deprivation (OGD).  Structure-activity relationships for neuroprotection were detd. for a family of BT-SERMs displaying a spectrum of ERα and ERβ binding affinity and agonist/antagonist activity, leading to discovery of a neuroprotective pharmacophore, present in the clin. relevant SERMS, raloxifene, and desmethylarzoxifene (DMA), for which submicromolar potency was obsd. for neuroprotection.  BT-SERM neuroprotection did not correlate with binding to ER or classical ER activity; however, both the neuroprotective SERMs and estrogens were shown, using pharmacol. probes, to activate the same kinase signaling cascades.  The antiestrogen ICI 182,780 inhibited the actions of estrogens but not those of BT-SERMs, whereas antagonism of the G-protein coupled receptor, GPR30, was effective for both SERMs and estrogens.  Since SERMs have antioxidant activity, ER-independent mechanisms were studied using the classical phenolic antioxidants, BHT and Trolox, and the Nrf2-dependent cytoprotective electrophile, sulforaphane.  However, neuroprotection by these agents was not sensitive to GPR30 antagonism.  Collectively, these data indicate that the activity of neuroprotective BT-SERMs is GPR30-dependent and ER-independent and not mediated by antioxidant effects.  Comparison of novel BT-SERM derivs. and analogs identified a neuroprotective pharmacophore of potential use in design of novel neuroprotective agents with a spectrum of ER activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvBt-wQmRmLrVg90H21EOLACvtfcHk0liG_0sWIFqGmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFektLg%253D&md5=c1d5a55aee4f2271ec666b42f62b50c1</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fcn100106a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100106a%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelhamid%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DVandevrede%26aufirst%3DL.%26aulast%3DKundu%26aufirst%3DI.%26aulast%3DMichalsen%26aufirst%3DB.%26aulast%3DLitosh%26aufirst%3DV.%2BA.%26aulast%3DSchiefer%26aufirst%3DI.%2BT.%26aulast%3DGherezghiher%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DP.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DBenzothiophene%2520selective%2520estrogen%2520receptor%2520modulators%2520provide%2520neuroprotection%2520by%2520a%2520novel%2520GPR30-dependent%2520mechanism%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D256%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Samuel Thurow, Alessandra A. G. Fernandes, Yovanny Quevedo-Acosta, Matheus F. de Oliveira, Marcelo G. de Oliveira, <span class="NLM_string-name hlFld-ContribAuthor">Igor D. Jurberg</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of Organic Nitrates from Aryldiazoacetates and Fe(NO3)3·9H2O. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (17)
                                     , 6909-6913. <a href="https://doi.org/10.1021/acs.orglett.9b02522" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02522%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPreparation%252Bof%252BOrganic%252BNitrates%252Bfrom%252BAryldiazoacetates%252Band%252BFe%252528NO3%2525293%2525C2%2525B79H2O%26aulast%3DThurow%26aufirst%3DSamuel%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19072019%26date%3D21082019%26volume%3D21%26issue%3D17%26spage%3D6909%26epage%3D6913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cauê Benito  Scarim</span>, <span class="hlFld-ContribAuthor ">Fernando Rogério  Pavan</span>. </span><span class="cited-content_cbyCitation_article-title">Thiazole, triazole, thio- and semicarbazone derivatives - Promising moieties for drug development for the treatment of tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry Reports</span><span> <strong>2021,</strong> <em>1 </em>, 100002. <a href="https://doi.org/10.1016/j.ejmcr.2021.100002" title="DOI URL">https://doi.org/10.1016/j.ejmcr.2021.100002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmcr.2021.100002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmcr.2021.100002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%2520Reports%26atitle%3DThiazole%25252C%252Btriazole%25252C%252Bthio-%252Band%252Bsemicarbazone%252Bderivatives%252B-%252BPromising%252Bmoieties%252Bfor%252Bdrug%252Bdevelopment%252Bfor%252Bthe%252Btreatment%252Bof%252Btuberculosis%26aulast%3DScarim%26aufirst%3DCau%25C3%25AA%2BBenito%26date%3D2021%26volume%3D1%26spage%3D100002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roxan  Calvo</span>, <span class="hlFld-ContribAuthor ">Antoine  Le Tellier</span>, <span class="hlFld-ContribAuthor ">Thomas  Nauser</span>, <span class="hlFld-ContribAuthor ">David  Rombach</span>, <span class="hlFld-ContribAuthor ">Darryl  Nater</span>, <span class="hlFld-ContribAuthor ">Dmitry  Katayev</span>. </span><span class="cited-content_cbyCitation_article-title">Synthese, Charakterisierung und Reaktivität eines Nitrooxylierungsreagenzes basierend auf einer hypervalenten Iodverbindung. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (39)
                                     , 17312-17319. <a href="https://doi.org/10.1002/ange.202005720" title="DOI URL">https://doi.org/10.1002/ange.202005720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202005720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202005720%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSynthese%25252C%252BCharakterisierung%252Bund%252BReaktivit%2525C3%2525A4t%252Beines%252BNitrooxylierungsreagenzes%252Bbasierend%252Bauf%252Beiner%252Bhypervalenten%252BIodverbindung%26aulast%3DCalvo%26aufirst%3DRoxan%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D39%26spage%3D17312%26epage%3D17319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roxan  Calvo</span>, <span class="hlFld-ContribAuthor ">Antoine  Le Tellier</span>, <span class="hlFld-ContribAuthor ">Thomas  Nauser</span>, <span class="hlFld-ContribAuthor ">David  Rombach</span>, <span class="hlFld-ContribAuthor ">Darryl  Nater</span>, <span class="hlFld-ContribAuthor ">Dmitry  Katayev</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, and Reactivity of a Hypervalent‐Iodine‐Based Nitrooxylating Reagent. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (39)
                                     , 17162-17168. <a href="https://doi.org/10.1002/anie.202005720" title="DOI URL">https://doi.org/10.1002/anie.202005720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202005720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202005720%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252Band%252BReactivity%252Bof%252Ba%252BHypervalent%2525E2%252580%252590Iodine%2525E2%252580%252590Based%252BNitrooxylating%252BReagent%26aulast%3DCalvo%26aufirst%3DRoxan%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D39%26spage%3D17162%26epage%3D17168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mattéa J.  Finelli</span>. </span><span class="cited-content_cbyCitation_article-title">Redox Post-translational Modifications of Protein Thiols in Brain Aging and Neurodegenerative Conditions—Focus on S-Nitrosation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2020,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnagi.2020.00254" title="DOI URL">https://doi.org/10.3389/fnagi.2020.00254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2020.00254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2020.00254%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DRedox%252BPost-translational%252BModifications%252Bof%252BProtein%252BThiols%252Bin%252BBrain%252BAging%252Band%252BNeurodegenerative%252BConditions%2525E2%252580%252594Focus%252Bon%252BS-Nitrosation%26aulast%3DFinelli%26aufirst%3DMatt%25C3%25A9a%2BJ.%26date%3D2020%26date%3D2020%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yilan  Xu</span>, <span class="hlFld-ContribAuthor ">Manna  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuying  Han</span>, <span class="hlFld-ContribAuthor ">Heng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2020,</strong> <em>14 </em><a href="https://doi.org/10.3389/fnins.2020.00660" title="DOI URL">https://doi.org/10.3389/fnins.2020.00660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2020.00660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2020.00660%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DGABAergic%252BInhibitory%252BInterneuron%252BDeficits%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BImplications%252Bfor%252BTreatment%26aulast%3DXu%26aufirst%3DYilan%26date%3D2020%26date%3D2020%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Austin  Horton</span>, <span class="hlFld-ContribAuthor ">Isaac T.  Schiefer</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents. </span><span class="cited-content_cbyCitation_journal-name">Nitric Oxide</span><span> <strong>2019,</strong> <em>84 </em>, 69-78. <a href="https://doi.org/10.1016/j.niox.2019.01.001" title="DOI URL">https://doi.org/10.1016/j.niox.2019.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.niox.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.niox.2019.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DNitric%2520Oxide%26atitle%3DPharmacokinetics%252Band%252Bpharmacodynamics%252Bof%252Bnitric%252Boxide%252Bmimetic%252Bagents%26aulast%3DHorton%26aufirst%3DAustin%26date%3D2019%26volume%3D84%26spage%3D69%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Hollas</span>, <span class="hlFld-ContribAuthor ">Manel  Ben Aissa</span>, <span class="hlFld-ContribAuthor ">Sue H.  Lee</span>, <span class="hlFld-ContribAuthor ">Jesse M.  Gordon-Blake</span>, <span class="hlFld-ContribAuthor ">Gregory R.J.  Thatcher</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nitric Oxide</span><span> <strong>2019,</strong> <em>82 </em>, 59-74. <a href="https://doi.org/10.1016/j.niox.2018.10.006" title="DOI URL">https://doi.org/10.1016/j.niox.2018.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.niox.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.niox.2018.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNitric%2520Oxide%26atitle%3DPharmacological%252Bmanipulation%252Bof%252BcGMP%252Band%252BNO%25252FcGMP%252Bin%252BCNS%252Bdrug%252Bdiscovery%26aulast%3DHollas%26aufirst%3DMichael%2BA.%26date%3D2019%26volume%3D82%26spage%3D59%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao‐Mei  Jiang</span>, <span class="hlFld-ContribAuthor ">Wei‐Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi‐Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Hua‐Jing  Yin</span>, <span class="hlFld-ContribAuthor ">Hao  Ma</span>, <span class="hlFld-ContribAuthor ">Nan  Feng</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Hai‐Hong  Huang</span>, <span class="hlFld-ContribAuthor ">Xiao‐Liang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">2‐(4‐methyl‐thiazol‐5‐yl) ethyl nitrate maleate‐potentiated GABA
              A
              receptor response in hippocampal neurons. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2018,</strong> <em>24 </em>
                                    (12)
                                     , 1231-1240. <a href="https://doi.org/10.1111/cns.13033" title="DOI URL">https://doi.org/10.1111/cns.13033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cns.13033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcns.13033%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3D2%2525E2%252580%252590%2525284%2525E2%252580%252590methyl%2525E2%252580%252590thiazol%2525E2%252580%2525905%2525E2%252580%252590yl%252529%252Bethyl%252Bnitrate%252Bmaleate%2525E2%252580%252590potentiated%252BGABA%252BA%252Breceptor%252Bresponse%252Bin%252Bhippocampal%252Bneurons%26aulast%3DJiang%26aufirst%3DXiao%25E2%2580%2590Mei%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D12%26spage%3D1231%26epage%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Monticelli</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bellemin-Laponnaz</span>, <span class="hlFld-ContribAuthor ">Cristina  Tubaro</span>, <span class="hlFld-ContribAuthor ">Marzio  Rancan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Structure and Antitumoural Activity of Triazole-Functionalised NHC-Metal Complexes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Inorganic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (18)
                                     , 2488-2495. <a href="https://doi.org/10.1002/ejic.201700142" title="DOI URL">https://doi.org/10.1002/ejic.201700142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejic.201700142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejic.201700142%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Inorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252BStructure%252Band%252BAntitumoural%252BActivity%252Bof%252BTriazole-Functionalised%252BNHC-Metal%252BComplexes%26aulast%3DMonticelli%26aufirst%3DMarco%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D18%26spage%3D2488%26epage%3D2495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Luo</span>, <span class="hlFld-ContribAuthor ">Sue H.  Lee</span>, <span class="hlFld-ContribAuthor ">Lawren  VandeVrede</span>, <span class="hlFld-ContribAuthor ">Zhihui  Qin</span>, <span class="hlFld-ContribAuthor ">Manel  Ben Aissa</span>, <span class="hlFld-ContribAuthor ">John  Larson</span>, <span class="hlFld-ContribAuthor ">Andrew F.  Teich</span>, <span class="hlFld-ContribAuthor ">Ottavio  Arancio</span>, <span class="hlFld-ContribAuthor ">Yohan  D’Souza</span>, <span class="hlFld-ContribAuthor ">Ahmed  Elharram</span>, <span class="hlFld-ContribAuthor ">Kevin  Koster</span>, <span class="hlFld-ContribAuthor ">Leon M.  Tai</span>, <span class="hlFld-ContribAuthor ">Mary Jo  LaDu</span>, <span class="hlFld-ContribAuthor ">Brian M.  Bennett</span>, <span class="hlFld-ContribAuthor ">Gregory R. J.  Thatcher</span>. </span><span class="cited-content_cbyCitation_article-title">A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurodegeneration</span><span> <strong>2016,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13024-016-0103-6" title="DOI URL">https://doi.org/10.1186/s13024-016-0103-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13024-016-0103-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13024-016-0103-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurodegeneration%26atitle%3DA%252Bmultifunctional%252Btherapeutic%252Bapproach%252Bto%252Bdisease%252Bmodification%252Bin%252Bmultiple%252Bfamilial%252Bmouse%252Bmodels%252Band%252Ba%252Bnovel%252Bsporadic%252Bmodel%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLuo%26aufirst%3DJia%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lidia  Bakota</span>, <span class="hlFld-ContribAuthor ">Roland  Brandt</span>. </span><span class="cited-content_cbyCitation_article-title">Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2016,</strong> <em>76 </em>
                                    (3)
                                     , 301-313. <a href="https://doi.org/10.1007/s40265-015-0529-0" title="DOI URL">https://doi.org/10.1007/s40265-015-0529-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-015-0529-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-015-0529-0%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DTau%252BBiology%252Band%252BTau-Directed%252BTherapies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBakota%26aufirst%3DLidia%26date%3D2016%26date%3D2016%26volume%3D76%26issue%3D3%26spage%3D301%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yana A.  Naumovich</span>, <span class="hlFld-ContribAuthor ">Victoria Emily  Buckland</span>, <span class="hlFld-ContribAuthor ">Dmitry A.  Sen'ko</span>, <span class="hlFld-ContribAuthor ">Yulia V.  Nelyubina</span>, <span class="hlFld-ContribAuthor ">Yulia A.  Khoroshutina</span>, <span class="hlFld-ContribAuthor ">Alexey Yu.  Sukhorukov</span>, <span class="hlFld-ContribAuthor ">Sema L.  Ioffe</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-assisted addition of a nitrate anion to bis(oxy)enamines. A general approach to the synthesis of α-nitroxy-oxime derivatives from nitronates. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (16)
                                     , 3963-3974. <a href="https://doi.org/10.1039/C6OB00388E" title="DOI URL">https://doi.org/10.1039/C6OB00388E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00388E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00388E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMetal-assisted%252Baddition%252Bof%252Ba%252Bnitrate%252Banion%252Bto%252Bbis%252528oxy%252529enamines.%252BA%252Bgeneral%252Bapproach%252Bto%252Bthe%252Bsynthesis%252Bof%252B%2525CE%2525B1-nitroxy-oxime%252Bderivatives%252Bfrom%252Bnitronates%26aulast%3DNaumovich%26aufirst%3DYana%2BA.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D16%26spage%3D3963%26epage%3D3974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Luo</span>, <span class="hlFld-ContribAuthor ">Sue H.  Lee</span>, <span class="hlFld-ContribAuthor ">Lawren  VandeVrede</span>, <span class="hlFld-ContribAuthor ">Zhihui  Qin</span>, <span class="hlFld-ContribAuthor ">Sujeewa  Piyankarage</span>, <span class="hlFld-ContribAuthor ">Ehsan  Tavassoli</span>, <span class="hlFld-ContribAuthor ">Rezene T.  Asghodom</span>, <span class="hlFld-ContribAuthor ">Manel Ben  Aissa</span>, <span class="hlFld-ContribAuthor ">Mauro  Fà</span>, <span class="hlFld-ContribAuthor ">Ottavio  Arancio</span>, <span class="hlFld-ContribAuthor ">Lan  Yue</span>, <span class="hlFld-ContribAuthor ">David R.  Pepperberg</span>, <span class="hlFld-ContribAuthor ">Gregory R. J.  Thatcher</span>. </span><span class="cited-content_cbyCitation_article-title">Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia. </span><span class="cited-content_cbyCitation_journal-name">BMC Neuroscience</span><span> <strong>2015,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12868-015-0208-9" title="DOI URL">https://doi.org/10.1186/s12868-015-0208-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12868-015-0208-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12868-015-0208-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Neuroscience%26atitle%3DRe-engineering%252Ba%252Bneuroprotective%25252C%252Bclinical%252Bdrug%252Bas%252Ba%252Bprocognitive%252Bagent%252Bwith%252Bhigh%252Bin%252Bvivo%252Bpotency%252Band%252Bwith%252BGABAA%252Bpotentiating%252Bactivity%252Bfor%252Buse%252Bin%252Bdementia%26aulast%3DLuo%26aufirst%3DJia%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Konstantin  Chegaev</span>, <span class="hlFld-ContribAuthor ">Antonella  Federico</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Marini</span>, <span class="hlFld-ContribAuthor ">Barbara  Rolando</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>, <span class="hlFld-ContribAuthor ">Michela  Morbin</span>, <span class="hlFld-ContribAuthor ">Giacomina  Rossi</span>, <span class="hlFld-ContribAuthor ">Valeria  Fugnanesi</span>, <span class="hlFld-ContribAuthor ">Antonio  Bastone</span>, <span class="hlFld-ContribAuthor ">Mario  Salmona</span>, <span class="hlFld-ContribAuthor ">Nahuai B.  Badiola</span>, <span class="hlFld-ContribAuthor ">Laura  Gasparini</span>, <span class="hlFld-ContribAuthor ">Sara  Cocco</span>, <span class="hlFld-ContribAuthor ">Cristian  Ripoli</span>, <span class="hlFld-ContribAuthor ">Claudio  Grassi</span>, <span class="hlFld-ContribAuthor ">Alberto  Gasco</span>. </span><span class="cited-content_cbyCitation_article-title">NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4688-4698. <a href="https://doi.org/10.1016/j.bmc.2015.05.050" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNO-donor%252Bthiacarbocyanines%252Bas%252Bmultifunctional%252Bagents%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DChegaev%26aufirst%3DKonstantin%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4688%26epage%3D4698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rubén  Tejero</span>, <span class="hlFld-ContribAuthor ">Daniel  López</span>, <span class="hlFld-ContribAuthor ">Fátima  López-Fabal</span>, <span class="hlFld-ContribAuthor ">José L.  Gómez-Garcés</span>, <span class="hlFld-ContribAuthor ">Marta  Fernández-García</span>. </span><span class="cited-content_cbyCitation_article-title">Antimicrobial polymethacrylates based on quaternized 1,3-thiazole and 1,2,3-triazole side-chain groups. </span><span class="cited-content_cbyCitation_journal-name">Polymer Chemistry</span><span> <strong>2015,</strong> <em>6 </em>
                                    (18)
                                     , 3449-3459. <a href="https://doi.org/10.1039/C5PY00288E" title="DOI URL">https://doi.org/10.1039/C5PY00288E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5PY00288E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5PY00288E%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymer%2520Chemistry%26atitle%3DAntimicrobial%252Bpolymethacrylates%252Bbased%252Bon%252Bquaternized%252B1%25252C3-thiazole%252Band%252B1%25252C2%25252C3-triazole%252Bside-chain%252Bgroups%26aulast%3DTejero%26aufirst%3DRub%25C3%25A9n%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D18%26spage%3D3449%26epage%3D3459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lawren  VandeVrede</span>, <span class="hlFld-ContribAuthor ">Ehsan  Tavassoli</span>, <span class="hlFld-ContribAuthor ">Jia  Luo</span>, <span class="hlFld-ContribAuthor ">Zhihui  Qin</span>, <span class="hlFld-ContribAuthor ">Lan  Yue</span>, <span class="hlFld-ContribAuthor ">David R  Pepperberg</span>, <span class="hlFld-ContribAuthor ">Gregory R  Thatcher</span>. </span><span class="cited-content_cbyCitation_article-title">Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA
              A
              receptor potentiation. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2014,</strong> <em>171 </em>
                                    (2)
                                     , 389-402. <a href="https://doi.org/10.1111/bph.12454" title="DOI URL">https://doi.org/10.1111/bph.12454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12454%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DNovel%252Banalogues%252Bof%252Bchlormethiazole%252Bare%252Bneuroprotective%252Bin%252Bfour%252Bcellular%252Bmodels%252Bof%252Bneurodegeneration%252Bby%252Ba%252Bmechanism%252Bwith%252Bvariable%252Bdependence%252Bon%252BGABA%252BA%252Breceptor%252Bpotentiation%26aulast%3DVandeVrede%26aufirst%3DLawren%26date%3D2014%26date%3D2013%26volume%3D171%26issue%3D2%26spage%3D389%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lawren  VandeVrede</span>, <span class="hlFld-ContribAuthor ">Ramy  Abdelhamid</span>, <span class="hlFld-ContribAuthor ">Zhihui  Qin</span>, <span class="hlFld-ContribAuthor ">Jaewoo  Choi</span>, <span class="hlFld-ContribAuthor ">Sujeewa  Piyankarage</span>, <span class="hlFld-ContribAuthor ">Jia  Luo</span>, <span class="hlFld-ContribAuthor ">John  Larson</span>, <span class="hlFld-ContribAuthor ">Brian M.  Bennett</span>, <span class="hlFld-ContribAuthor ">Gregory R. J.  Thatcher</span>, . </span><span class="cited-content_cbyCitation_article-title">An NO Donor Approach to Neuroprotective and Procognitive Estrogen Therapy Overcomes Loss of NO Synthase Function and Potentially Thrombotic Risk. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , e70740. <a href="https://doi.org/10.1371/journal.pone.0070740" title="DOI URL">https://doi.org/10.1371/journal.pone.0070740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0070740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0070740%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DAn%252BNO%252BDonor%252BApproach%252Bto%252BNeuroprotective%252Band%252BProcognitive%252BEstrogen%252BTherapy%252BOvercomes%252BLoss%252Bof%252BNO%252BSynthase%252BFunction%252Band%252BPotentially%252BThrombotic%252BRisk%26aulast%3DVandeVrede%26aufirst%3DLawren%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3De70740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qin  Zhihui</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating nitric oxide signaling in the CNS for Alzheimer’s disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (12)
                                     , 1451-1468. <a href="https://doi.org/10.4155/fmc.13.111" title="DOI URL">https://doi.org/10.4155/fmc.13.111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.111%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DModulating%252Bnitric%252Boxide%252Bsignaling%252Bin%252Bthe%252BCNS%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Btherapy%26aulast%3DZhihui%26aufirst%3DQin%26date%3D2013%26volume%3D5%26issue%3D12%26spage%3D1451%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design Concept for Novel Nomethiazole NO-Chimeras Based upon Neuroprotective MZ Scaffolds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Grignard reagent, THF, 0 °C to rt; (b) MsCl, NEt<sub>3</sub> and then NaN<sub>3</sub>, CH<sub>3</sub>CN, rt; (c) alkyne, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <i>t</i>-BuOH/H<sub>2</sub>O (1:1, v/v); (d) LiAlH<sub>4</sub>, THF, reflux; (e) MsCl, NEt<sub>3</sub> and then NaN<sub>3</sub>, CH<sub>3</sub>CN, reflux; (f) MOM-Br, K<sub>2</sub>CO<sub>3</sub>, THF; (g) ethynyltrimethylsilane, CuI, Pd(Ph<sub>3</sub>P)<sub>2</sub>Cl<sub>2</sub>, NEt<sub>3</sub>, THF; (h) <b>3</b>, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, K<sub>2</sub>CO<sub>3</sub>, MeOH–H<sub>2</sub>O (2:1); (i) HCl/<i>i</i>-PrOH (1.5 M), 70 °C; (j) 4-nitrooxybutan-1-ol (for <b>18</b>) or 1-acetoxy-4-hydroxybutane (for <b>17</b>), Ph<sub>3</sub>P, DIAD, 0 °C to rt, then K<sub>2</sub>CO<sub>3</sub>, MeOH (for <b>17</b>).</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CH<sub>3</sub>CO<sub>2</sub>H, dioxane–H<sub>2</sub>O; (b) K<sub>2</sub>CO<sub>3</sub>, MeOH; (c) Grignard reagent, THF, 0 °C to rt; (d) NaN<sub>3</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O (1:1, v/v), reflux; (e) NaH, DMSO, 90 °C, 5 h; (f) 3-ethynylpyridine, CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, <i>t</i>-BuOH/H<sub>2</sub>O (1:1, v/v); (g) fuming HNO<sub>3</sub>, Ac<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (h) 3-ethynylpyridine, toluene, reflux, 48 h; (i) 2-mercaptoethanol, Na<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O (2:1); (j) 3-pyridineboronic acid, (2-biphenyl)di-<i>tert</i>-butylphosphine, Pd(OAc)<sub>2</sub>, KF, DMF, 120 °C.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inhibition by picrotoxin of neuroprotection elicited by MZ derivatives in primary neuronal cultures subject to excitotoxic insult. Primary cortical cultures (10–11 DIV) were subjected to 24 h of glutamate (Glut, 100 μM) toxicity with co-treatment of muscimol (Musc) or MZ derivatives (50 μM). Picrotoxin (Picro, 100 μM) was added, where indicated, 1 h before glutamate treatment to provide blockade of GABA<sub>A</sub> signaling. Survival was measured with the MTT assay and normalized to vehicle treated controls. Data show the mean and SEM from at least six individual experiments analyzed by ANOVA with post hoc Dunnett’s MCT compared to nonglutamate treated vehicle control or compared to the efficacy of picrotoxin in blocking each drug treatment effect with a two-tailed <i>t</i> test: ∗, <i>p</i> < 0.05; ∗∗, <i>p</i> < 0.01; ∗∗∗, <i>p</i> < 0.001; ns, not significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) fuming HNO<sub>3</sub>, Ac<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (b) TEMPO, PhI(OAc)<sub>2</sub>, DCM; (c) NaClO<sub>2</sub>, NaH<sub>2</sub>PO<sub>4</sub>, 2-methyl-2-butene, <i>t</i>-BuOH; (d) <b>35</b> (for <b>36</b>, <b>44</b>) or 1-methylcyclopropane-1-carboxylic acid (for <b>37</b>), EDCI, DIPEA, HOBT, DCM; (e) NaH, CH<sub>3</sub>I, DMF; (f) bis(2-bromomethyl) ether, NaH, DMF; (g) AgNO<sub>3</sub>, CH<sub>3</sub>CN, reflux; (h) LiAlH<sub>4</sub>, THF, reflux; (i) triphosgene, AcOEt, reflux; (j) <b>34</b> (for <b>42</b>) or 4-nitrooxybutan-1-ol (for <b>43</b>), NEt<sub>3</sub>, THF.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative kinetic traces for hydrolysis of <b>36</b> and <b>37</b> (10 μM) in phosphate buffer (100 mM, pH 7.4). Incubations were conducted at room temperature and monitored by HPLC with UV detection at 254 nm and fit to a pseudo-first-order rate equation. A putative mechanism is shown for rate acceleration by anchimeric stabilization of the anionic transition state by the nitrate group acting as intramolecular Lewis acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Restoration of CA1-LTP impairment in 3-month-old APP/PS1 mouse hippocampal slices. (A) NO-chimera <b>32a</b> rescued the LTP impairment in APP/PS1 mice (<i>F</i><sub>(1,16)</sub> = 4.129, <i>p</i> = 0.05, compared with vehicle; 50–80 min analysis); (B) NO-chimera <b>42</b> showed a tendency toward reversal of LTP impairment without reaching significance (F<sub>(1,12)</sub> = 2.537, <i>p</i> = 0.13, compared with vehicle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Procognitive effects of NO-chimeras evaluated in the scopolamine-induced memory deficit model using the STPA task. Scopolamine was administered 30 min and drug was administered 20 min prior to the start of training, and memory was tested 24 h after training and drug treatment. NO-chimeras <b>28</b>, <b>29</b>, <b>32a</b>, <b>32b</b>, <b>42</b>, <b>43</b> (∗∗∗, <i>p</i> < 0.01, compared with vehicle), and <b>40</b> (∗∗, <i>p</i> < 0.05, compared with vehicle) significantly reversed the scopolamine induced memory deficit. Data were obtained from at least five mice per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/medium/jm-2012-00353r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MRM LC–MS/MS chromatograms of extracted mouse brain samples 20 min after ip delivery of each drug at a dosage that was equimolar with <b>1</b> (4.5 μmol/kg): (A) <b>26</b> with <b>8</b> used as internal standard; (B) <b>28</b> with <b>8</b> used as internal standard; (C) <b>22a</b> with <b>22b</b> used as internal standard; (D) <b>32a</b> with <b>22b</b> used as internal standard.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300353r/production/images/large/jm-2012-00353r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300353r&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 95 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wimo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, L.</span><span> </span><span class="NLM_article-title">The worldwide societal costs of dementia: estimates for 2009</span> <span class="citation_source-journal">Alzheimer's Dement</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.jalz.2010.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20298969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BC3c3gsVyruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=98-103&author=A.+Wimoauthor=B.+Winbladauthor=L.+Jonsson&title=The+worldwide+societal+costs+of+dementia%3A+estimates+for+2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The worldwide societal costs of dementia: Estimates for 2009</span></div><div class="casAuthors">Wimo Anders; Winblad Bengt; Jonsson Linus</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">98-103</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The purpose of this study was to update the previous estimate of the worldwide cost of dementia in 2005 to 2009.  METHODS:  The cost model is based on prevalence estimates, country and region-specific data on Gross Domestic Product per person and average wage, with results from previously published cost-of-illness studies in different countries.  Prevalence figures are updated to 2009 and costs were adjusted to 2009 constant US dollars ($).  RESULTS:  The total worldwide societal cost of dementia, based on a dementia population of 34.4 million demented persons, was estimated to $422 billion in 2009, including $142 billion for informal care (34%).  CONCLUSIONS:  The worldwide cost of dementia has increased by 34% (18% in fixed prices) between 2005 and 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxtJbIshR0Vo3yKPtYViAGfW6udTcc2eboI25NxbNzvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3gsVyruw%253D%253D&md5=1ca735469abfe70ba933a725aef54a26</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DWimo%26aufirst%3DA.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DJonsson%26aufirst%3DL.%26atitle%3DThe%2520worldwide%2520societal%2520costs%2520of%2520dementia%253A%2520estimates%2520for%25202009%26jtitle%3DAlzheimer%2527s%2520Dement%26date%3D2010%26volume%3D6%26spage%3D98%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1056%2FNEJMra040223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15229308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlOjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=56-67&author=J.+L.+Cummings&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-67</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6JT2vPzAVrVg90H21EOLACvtfcHk0liIBw_Cu4j6Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlOjsb8%253D&md5=ec3a7d85cdfbeb7ea5cfaeeefc3a94ad</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra040223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra040223%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D56%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Resolving controversies on the path to Alzheimer’s therapeutics</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1060</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1038%2Fnm.2460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=21900936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1060-1065&author=D.+J.+Selkoe&title=Resolving+controversies+on+the+path+to+Alzheimer%E2%80%99s+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Resolving controversies on the path to Alzheimer's therapeutics</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1060-1065</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease constitutes a personal and societal tragedy of immense proportions.  Since 1960, research in labs. and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents.  However, some of these agents have already failed.  Gnawing controversies and important gaps in our knowledge seem to cast addnl. doubt on the ability of the field to move forward effectively.  Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future.  Rigorous preclin. validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their assocd. biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9e3VIkcVvWrVg90H21EOLACvtfcHk0ljBTm7aT3ck7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCntL7E&md5=501720027a4b1e4fd2a838f94aecd667</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm.2460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2460%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DResolving%2520controversies%2520on%2520the%2520path%2520to%2520Alzheimer%25E2%2580%2599s%2520therapeutics%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1060%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mangialasche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mecocci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: clinical trials and drug development</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2FS1474-4422%2810%2970119-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20610346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFajur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=702-716&author=F.+Mangialascheauthor=A.+Solomonauthor=B.+Winbladauthor=P.+Mecocciauthor=M.+Kivipelto&title=Alzheimer%E2%80%99s+disease%3A+clinical+trials+and+drug+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: clinical trials and drug development</span></div><div class="casAuthors">Mangialasche, Francesca; Solomon, Alina; Winblad, Bengt; Mecocci, Patrizia; Kivipelto, Miia</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">702-716</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most common cause of dementia in elderly people.  Research into Alzheimer's disease therapy has been at least partly successful in terms of developing symptomatic treatments, but has also had several failures in terms of developing disease-modifying therapies.  These successes and failures have led to debate about the potential deficiencies in our understanding of the pathogenesis of Alzheimer's disease and potential pitfalls in diagnosis, choice of therapeutic targets, development of drug candidates, and design of clin. trials.  Many clin. and exptl. studies are ongoing, but we need to acknowledge that a single cure for Alzheimer's disease is unlikely to be found and that the approach to drug development for this disorder needs to be reconsidered.  Preclin. research is constantly providing us with new information on pieces of the complex Alzheimer's disease puzzle, and an anal. of this information might reveal patterns of pharmacol. interactions instead of single potential drug targets.  Several promising randomized controlled trials are ongoing, and the increased collaboration between pharmaceutical companies, basic researchers, and clin. researchers has the potential to bring us closer to developing an optimum pharmaceutical approach for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIaQ4TlzK_v7Vg90H21EOLACvtfcHk0ljBTm7aT3ck7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFajur8%253D&md5=8641c7a6fdb89aa80a2e35fbd2f369a1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2810%2970119-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252810%252970119-8%26sid%3Dliteratum%253Aachs%26aulast%3DMangialasche%26aufirst%3DF.%26aulast%3DSolomon%26aufirst%3DA.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520clinical%2520trials%2520and%2520drug%2520development%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D702%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nelson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=159-166&author=R.+M.+Nelsonauthor=A.+H.+Hainsworthauthor=D.+G.+Lambertauthor=J.+A.+Jonesauthor=T.+K.+Murrayauthor=D.+A.+Richardsauthor=J.+Gabrielssonauthor=A.+J.+Crossauthor=A.+R.+Green&title=Neuroprotective+efficacy+of+AR-A008055%2C+a+clomethiazole+analogue%2C+in+a+global+model+of+acute+ischaemic+stroke+and+its+effect+on+ischaemia-induced+glutamate+and+GABA+efflux+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DR.%2BM.%26aulast%3DHainsworth%26aufirst%3DA.%2BH.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DRichards%26aufirst%3DD.%2BA.%26aulast%3DGabrielsson%26aufirst%3DJ.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DNeuroprotective%2520efficacy%2520of%2520AR-A008055%252C%2520a%2520clomethiazole%2520analogue%252C%2520in%2520a%2520global%2520model%2520of%2520acute%2520ischaemic%2520stroke%2520and%2520its%2520effect%2520on%2520ischaemia-induced%2520glutamate%2520and%2520GABA%2520efflux%2520in%2520vitro%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D159%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debens, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span> </span><span class="NLM_article-title">The interaction of AR-A008055 and its enantiomers with the GABA(A) receptor complex and their sedative, muscle relaxant and anticonvulsant activity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=167-174&author=A.+R.+Greenauthor=A.+H.+Hainsworthauthor=A.+Misraauthor=T.+A.+Debensauthor=D.+M.+Jacksonauthor=T.+K.+Murrayauthor=R.+M.+Nelsonauthor=A.+J.+Cross&title=The+interaction+of+AR-A008055+and+its+enantiomers+with+the+GABA%28A%29+receptor+complex+and+their+sedative%2C+muscle+relaxant+and+anticonvulsant+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DHainsworth%26aufirst%3DA.%2BH.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DDebens%26aufirst%3DT.%2BA.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DNelson%26aufirst%3DR.%2BM.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520interaction%2520of%2520AR-A008055%2520and%2520its%2520enantiomers%2520with%2520the%2520GABA%2528A%2529%2520receptor%2520complex%2520and%2520their%2520sedative%252C%2520muscle%2520relaxant%2520and%2520anticonvulsant%2520activity%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D167%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Colado, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA (“ecstasy”)-induced neurodegeneration in rat brain</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2001&pages=82-88&author=M.+I.+Coladoauthor=E.+O%E2%80%99Sheaauthor=B.+Estebanauthor=A.+R.+Green&title=Studies+on+the+neuroprotective+effect+of+the+enantiomers+of+AR-A008055%2C+a+compound+structurally+related+to+clomethiazole%2C+on+MDMA+%28%E2%80%9Cecstasy%E2%80%9D%29-induced+neurodegeneration+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColado%26aufirst%3DM.%2BI.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DE.%26aulast%3DEsteban%26aufirst%3DB.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DStudies%2520on%2520the%2520neuroprotective%2520effect%2520of%2520the%2520enantiomers%2520of%2520AR-A008055%252C%2520a%2520compound%2520structurally%2520related%2520to%2520clomethiazole%252C%2520on%2520MDMA%2520%2528%25E2%2580%259Cecstasy%25E2%2580%259D%2529-induced%2520neurodegeneration%2520in%2520rat%2520brain%26jtitle%3DPsychopharmacology%26date%3D2001%26volume%3D157%26spage%3D82%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Lechat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streichenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boime, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemeignan, M.</span><span> </span><span class="NLM_article-title">Relation between chemical structure and physiological activity of certain thiazole derivatives. I. 4-Methyl-5-(β-hydroxyethyl)thiazole</span> <span class="citation_source-journal">Ann. Pharm. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=14334022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaF2MXksVWltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1965&pages=179-186&author=P.+Lechatauthor=G.+Streichenbergerauthor=A.+Boimeauthor=M.+Lemeignan&title=Relation+between+chemical+structure+and+physiological+activity+of+certain+thiazole+derivatives.+I.+4-Methyl-5-%28%CE%B2-hydroxyethyl%29thiazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between chemical structure and physiological activity of certain thiazole derivatives. I. 4-Methyl-5-(β-hydroxyethyl)thiazole</span></div><div class="casAuthors">Lechat, P.; Streichenberger, G.; Boime, A.; Lemeignan, M.</div><div class="citationInfo"><span class="NLM_cas:title">Annales Pharmaceutiques Francaises</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">179-86</span>CODEN:
                <span class="NLM_cas:coden">APFRAD</span>;
        ISSN:<span class="NLM_cas:issn">0003-4509</span>.
    </div><div class="casAbstract">A study of the action on the mouse central nervous system of injection of 6 derivs. of 4-methyl-5-(βhydroxyethyl)thiazole shows the thiol to be less active than the corresponding alc.  The halogenoethyl derivs. have more anticonvulsant activity than the original alc.  The HCl ester is particularly effective, but the carbamic and acetic esters are inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5yBAIi5CMtrVg90H21EOLACvtfcHk0lgCx3EON7T--g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXksVWltLo%253D&md5=4f4b5804715d3b7d542e264305b7b80c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLechat%26aufirst%3DP.%26aulast%3DStreichenberger%26aufirst%3DG.%26aulast%3DBoime%26aufirst%3DA.%26aulast%3DLemeignan%26aufirst%3DM.%26atitle%3DRelation%2520between%2520chemical%2520structure%2520and%2520physiological%2520activity%2520of%2520certain%2520thiazole%2520derivatives.%2520I.%25204-Methyl-5-%2528%25CE%25B2-hydroxyethyl%2529thiazole%26jtitle%3DAnn.%2520Pharm.%2520Fr.%26date%3D1965%26volume%3D23%26spage%3D179%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lechat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streichenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boime, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemeignan, M.</span><span> </span><span class="NLM_article-title">Relations between the chemical structure and physiological activity of certain thiazole derivatives. II. Effect of the length of the alkyl chain in 4-methyl-5-(ω-chloroalkyl)thiazoles</span> <span class="citation_source-journal">Ann. Pharm. Fr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5846544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADyaF28%252Fks1Glsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1965&pages=369-576&author=P.+Lechatauthor=G.+Streichenbergerauthor=A.+Boimeauthor=M.+Lemeignan&title=Relations+between+the+chemical+structure+and+physiological+activity+of+certain+thiazole+derivatives.+II.+Effect+of+the+length+of+the+alkyl+chain+in+4-methyl-5-%28%CF%89-chloroalkyl%29thiazoles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Relations between chemical structure and physiological action of some thiazole derivatives. II. Influence of the length of the carbon chain attached at position 5 in 4-methyl-5-(omega-chloroalkyl)-thiazoles</span></div><div class="casAuthors">Lechat P; Streichenberger G; Boime A; Lemeignan M</div><div class="citationInfo"><span class="NLM_cas:title">Annales pharmaceutiques francaises</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">369-76</span>
        ISSN:<span class="NLM_cas:issn">0003-4509</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3VJxoeYEclqcY7HFp97qMfW6udTcc2eZGQTVj8kIPRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF28%252Fks1Glsw%253D%253D&md5=9064144d704fbb050231fe04471ca561</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLechat%26aufirst%3DP.%26aulast%3DStreichenberger%26aufirst%3DG.%26aulast%3DBoime%26aufirst%3DA.%26aulast%3DLemeignan%26aufirst%3DM.%26atitle%3DRelations%2520between%2520the%2520chemical%2520structure%2520and%2520physiological%2520activity%2520of%2520certain%2520thiazole%2520derivatives.%2520II.%2520Effect%2520of%2520the%2520length%2520of%2520the%2520alkyl%2520chain%2520in%25204-methyl-5-%2528%25CF%2589-chloroalkyl%2529thiazoles%26jtitle%3DAnn.%2520Pharm.%2520Fr.%26date%3D1965%26volume%3D23%26spage%3D369%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lechat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Driessche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemeignan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleau, D.</span><span> </span><span class="NLM_article-title">Pharmacological investigation of a quaternary ammonium compound with ganglion-exciting properties</span> <span class="citation_source-journal">Arch. Int. Pharmacodyn. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5841183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaF2MXkslGisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1965&pages=262-272&author=P.+Lechatauthor=J.+van+den+Driesscheauthor=M.+Lemeignanauthor=D.+Deleau&title=Pharmacological+investigation+of+a+quaternary+ammonium+compound+with+ganglion-exciting+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological investigation of a quaternary ammonium compound with ganglion-exciting properties</span></div><div class="casAuthors">Lechat, P.; van den Driessche, J.; Lemeignan, M.; Deleau, D.</div><div class="citationInfo"><span class="NLM_cas:title">Archives Internationales de Pharmacodynamie et de Therapie</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-72</span>CODEN:
                <span class="NLM_cas:coden">AIPTAK</span>;
        ISSN:<span class="NLM_cas:issn">0003-9780</span>.
    </div><div class="casAbstract">The pharmacol. activity of 4-methyl-5-(β-chloroethyl)thiazole-MeI (I) was investigated.  Intravenous injections of 1 mg. I/kg. into dogs induced hypertension, often preceded by hypotension, and increased the amplitude of the respiration.  I had no potentiating effect on adrenaline- or acetylcholine-induced hypotension.  Injections of I (1-5 mg./kg.) contracted the nictitating membrane in the cat.  I had no effect on the rabbit heart in situ or in vitro or on the guinea pig intestine in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmbcdoqt545rVg90H21EOLACvtfcHk0lgCx3EON7T--g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXkslGisL4%253D&md5=87cf9e7a7cd9c354032d7bb540777e31</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLechat%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BDriessche%26aufirst%3DJ.%26aulast%3DLemeignan%26aufirst%3DM.%26aulast%3DDeleau%26aufirst%3DD.%26atitle%3DPharmacological%2520investigation%2520of%2520a%2520quaternary%2520ammonium%2520compound%2520with%2520ganglion-exciting%2520properties%26jtitle%3DArch.%2520Int.%2520Pharmacodyn.%2520Ther.%26date%3D1965%26volume%3D155%26spage%3D262%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bengtsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, U. H.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. VI. Synthesis of some reference compounds in connection with biotransformation studies</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaL38XhvVWiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1982&pages=37-42&author=S.+Bengtssonauthor=U.+H.+Lindberg&title=Compounds+related+to+clomethiazole.+VI.+Synthesis+of+some+reference+compounds+in+connection+with+biotransformation+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole.  VI.  Synthesis of some reference compounds in connection with biotransformation studies</span></div><div class="casAuthors">Bengtsson, Stefan; Lindberg, Ulf Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">The thiazoles I (R = CO2Et, CO2H, CH2Cl, CH2OH, R1 = HO; R = CONHCH2CO2Et, CONHCH2CO2H, R1 = H, HO) were prepd.  Thus, MeCOCHBrCH2CO2H was cyclized with H3N+COS- to give I (R = CO2Et, R1 = H).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiQkj_JFns4LVg90H21EOLACvtfcHk0liQltUQjLLUVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhvVWiurk%253D&md5=c7556e61242dbd4f6a7248bd81fd8914</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBengtsson%26aufirst%3DS.%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520VI.%2520Synthesis%2520of%2520some%2520reference%2520compounds%2520in%2520connection%2520with%2520biotransformation%2520studies%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1982%26volume%3D19%26spage%3D37%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. I. Oxazole and pyridine isosteres of clomethiazole</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5967303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaF28XksFSrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1966&pages=161-166&author=U.+H.+Lindberg&title=Compounds+related+to+clomethiazole.+I.+Oxazole+and+pyridine+isosteres+of+clomethiazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole. I. Oxazole and pyridine isosteres of clomethiazole</span></div><div class="casAuthors">Lindberg, Ulf Henrik</div><div class="citationInfo"><span class="NLM_cas:title"></span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Bis[5-(2-chloroethyl)-4-methyloxazolium]ethane-1,2-disulfonate (I), the oxazole isostere of 5-(2-chloroethyl)-4-methylthiazole (clomethiazole), was synthesized and found to be ∼1.5 times as potent hypnotically as clomethiazole in mice intraperitoneally, and ∼3 times as potent orally.  The sedative effect of this deriv. was ∼1.5 times greater than that of the parent compd.  The anticonvulsant activity of the 2 drugs was about equal.  I was ∼50% as toxic as the parent compd. intravenously, though more than twice as toxic orally. 3-(2-Chloroethyl)-2-methylpyridine-HCl, the pyridine isostere, was synthesized, but it did not produce hypnosis in sublethal doses and was almost twice as toxic as the parent compd. intraperitoneally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvZEtHGePRArVg90H21EOLACvtfcHk0liQltUQjLLUVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XksFSrur4%253D&md5=e2cf44c8c004c05963c42bf80b9667bc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520I.%2520Oxazole%2520and%2520pyridine%2520isosteres%2520of%2520clomethiazole%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1966%26volume%3D3%26spage%3D161%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulff, B.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. II. Haloalkyl and aminoalkyl analogs of clomethiazole</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=6081464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaF1cXhtVGjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1967&pages=269-280&author=U.+H.+Lindbergauthor=J.+Pedersenauthor=B.+Ulff&title=Compounds+related+to+clomethiazole.+II.+Haloalkyl+and+aminoalkyl+analogs+of+clomethiazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole.  II.  Haloalkyl and aminoalkyl analogs of clomethiazole</span></div><div class="casAuthors">Lindberg, Ulf H.; Pedersen, Jorgen; Ulff, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-80</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">I, where X is O and S, and II are prepd.  Thus, a mixt. of 0.6 mole thiourea, 0.6 mole AcCHClCH2CH2OH, and 600 ml. H2O is refluxed to give 77% 2-amino-5-(2-hydroxyethyl)-4-methylthiazole-HCl (III), m. 156-7° (Me2CO-EtOH).  Similarly prepd. are the following I (X, R, R1, R2, b.p./mm., nD, and % yield given): S, H, Me, CH2CHMeOH, 120-2°/3, 1.5382 (20°), 40; S, H, Me, CH2OH, 105-6-/1, -, 78; S, H, H, CH2OH, 133-40-/10, 15562 (24°), 36; S, H, H, CH2CH2OH, 138-41°/10, 1.5544 (22°), 65; O, Me, Me, CH2CH2OH, 82°/0.08, 1.4802 (20°), 38; O, Ph, Me, CH2CH2OH, 140-50°/0.07, 1.5874 (20°), 33.  A mixt. of 19.5 g. III in 150 ml. CHCl3 is treated 2 hrs. with HCl gas, 15.5 g. SOCl2 is added in 30 min. at ≤30°, and the mixt. is refluxed 2 hrs. to give 90% 2-amino-5-(2-chloroethyl)-4-methylthiazole-HCl, m. 170-1° (Me2CO).  Similarly prepd. are the following I (X, R, R1, R2, b.p./mm., nD and % yield given): S, H, Me, CH2CHClMe, 100-4°/2, 1.5330 (21°), 75; S, H, Me, CH2Cl, 62-4°/1.5, -, 36 (m. 32-3°); S, H, H, CH2Cl, -, -, 58; S, H, H, CH2CH2Cl, 99-101°/10, 1.5525 (20°), 58; O, H, Me, CH2Cl, 65-7°/12, 1.4883 (20°), 49; O, Me, Me, CH2CH2Cl, 82-3°/10, 1.4782 (20°), 84; O, Ph, Me, CH2CH2Cl, 140°/0.1, -, 19; S, H, Me, CH2CH2Br, 71-4°/0.07, -, 50: O, H, Me, CH2CH2Br, 87-8°/10, 1.5072 (20°), 60.  I (X = S, R = H, R1 = Me, R2 = CH2CH2Cl) (32.3 g.) is treated with NH3 7 hrs. at 125-50° and 30-40 kg./cm.2 to give 26% 5-(2-aminoethyl)-4-methylthiazole-HCl (IV.HCl), m. 191-2°; IV.2HCl m. 246°.  Similarly prepd. are the following I (X = S) (R, R1, R2, b.p./mm., salt m.p., and % yield given): H, Me, CH2CH2NEt2, -, 2HCl 187-9°, 20; H, Me, CH2CH2NH(CH2)3NEt2, -, 3HCl 135-40°, 17; H, Me, 2-(4-methylpiperazino)ethyl, 135-8°/0.1, 3HCl 250° (decompn.), 60.  2-(3-Chloropropyl)pyridine-HCl, m. 95-60°, and the following II (R, R1, R2, R3, and m.p. HCl salt given): H, H, (CH2)3Cl, H, 129-30°; H, H, H, (CH2)3Cl, 135-6°; H, CH2CH2Cl, H, H, 118-19°; H, H, CH2CH2Cl, H, 156°; Me, CH2CH2Cl, H, H, 86-8°; Me, CH2Cl, H, H, 149-51; are prepd. according to U.H. Lindberg (1966).  The following I ethanedisulfonates are prepd. (X, R, R1, R2, and m.p. given): S, H, Me, CH2CHClMe, 169-70°; S, H, Me, CH2CH2Br, 131-2°; O, H, Me, CH2CH2Br, 125-60°; O, Me, Me, CH2CH2Cl, 137-8°.  Also prepd. are the following I ethanedisulfonates (X, R, R1, R2, and m.p. given): S, H, Me, CH2Cl, 193-4°; S, H, H, CH2CH2Cl, 172-4°; S, H, H, CH2CH2Cl, 148-9°; O, H, Me, CH2Cl, 141-2°; O, Ph, Me, CH2CH2Cl, 154-6°.  Some of the prepd. compds. showed hypnotic and anticonvulsant activity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrREvjnV7e6-7Vg90H21EOLACvtfcHk0liQltUQjLLUVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXhtVGjtLc%253D&md5=9d5997a5185ab37d5aa216487c472c08</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26aulast%3DPedersen%26aufirst%3DJ.%26aulast%3DUlff%26aufirst%3DB.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520II.%2520Haloalkyl%2520and%2520aminoalkyl%2520analogs%2520of%2520clomethiazole%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1967%26volume%3D4%26spage%3D269%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span> </span><span class="NLM_article-title">Hypnotic and anticonvulsant agents related to the thiazole part of thiamine</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5139739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaE38XhsVyksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1971&pages=647-660&author=U.+H.+Lindberg&title=Hypnotic+and+anticonvulsant+agents+related+to+the+thiazole+part+of+thiamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hypnotic and anticonvulsant agents related to the thiazole part of thiamine</span></div><div class="casAuthors">Lindberg, Ulf H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-60</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">The i.v. administration of nontoxic doses of active thiazole and oxazole derivs. into mice induced hypnosis, while pyridine derivs. did not.  In the 5-alkyl-4-methylazole drugs, the anticonvulsant activity decreased with increasing the length of the alkyl chain.  Among the drugs used and prepd. were Hemineurine (clomethiazole ethanedisulfonate) (I) [137-00-8], 5-methyl-4-methyloxazole [20662-83-3], and 3-ethyl-2-methylpyridine [14159-59-2].  The hypnotic potency of these drugs was related to basic strength and soly., and to the position and type of substituents.  5-(2-Chloroethyl)-4-methyloxazole [823-51-8] was active as an oral hypnotic, an i.v. anesthetic, and an agent against spasticity and rigidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkdxexLbi_urVg90H21EOLACvtfcHk0liQltUQjLLUVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XhsVyksb0%253D&md5=f8e231a26fc10796fd4467062bf71258</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26atitle%3DHypnotic%2520and%2520anticonvulsant%2520agents%2520related%2520to%2520the%2520thiazole%2520part%2520of%2520thiamine%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1971%26volume%3D8%26spage%3D647%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. IV. 4-Methylthiazoles and oxazoles with polar side-chains and some other analogs of clomethiazole</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5575873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaE3MXhsVWls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1971&pages=39-48&author=U.+H.+Lindberg&title=Compounds+related+to+clomethiazole.+IV.+4-Methylthiazoles+and+oxazoles+with+polar+side-chains+and+some+other+analogs+of+clomethiazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole.  IV.  4-Methylthiazoles and oxazoles with polar side-chains and some other analogs of clomethiazole</span></div><div class="casAuthors">Lindberg, Ulf H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-48</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">Twenty-four analogs of clomethiazole (5-(2-chloroethyl)-4-methylthiazole) (I) were synthesized and tested for their atoxic and hypnotic effects in mice.  Most of the compds. were prepd. by conventional methods; dehydration of 5-(1-hydroxyethyl)-4-methylthiazole with PCl3 gave 4-methyl-5-vinylthiazole.  Chlorination of II with SOCl2 afforded 4,4'-dimethyl-5,5'-bis(2-chloroethyl)-2,2'-dithiazolyl (III).  5-(2-Hydroxyethyl)-4-methylthiazole trihydrogen phosphate, 5-(2-acetoxyethyl)-4-methylthiazole, 5-(2-benzoyloxyethyl)-4-methylthiazole, 5-(2-hydroxymethyl)-4-methyloxazole, and 5-(2-acetoxyethyl)-4-methyloxazole (IV) were atoxic, whereas 5-methoxymethyl-4-methyloxazole 5-isopropoxymethyl-4-methylthiazole, 5-methoxymethyl-4-methyloxazole, and 5-isoproxymethyl-4-methyloxazole were hypnotic.  Structure-activity correlations showed the importance of the polarity of the side-chain substituents, while an unpolar, lipophilic substituent is necessary for the hypnotic activity, this does not seem to be a strict requirement for the anticonvulsant effect of these types of compds.  Hypnotic potency (HD50) and anticonvulsant effects (AD50) values are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogZP-nwaVKRrVg90H21EOLACvtfcHk0lifiitCUIWjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhsVWls7k%253D&md5=c67dbc47034003d7989efb4615c03de4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520IV.%25204-Methylthiazoles%2520and%2520oxazoles%2520with%2520polar%2520side-chains%2520and%2520some%2520other%2520analogs%2520of%2520clomethiazole%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1971%26volume%3D8%26spage%3D39%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lindberg, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bexell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulff, B.</span><span> </span><span class="NLM_article-title">Compounds related to clomethiazole. V. 4-(Alkyl or aryl) thiazoles and oxazoles with various substituents in the 2- and 5-positions</span> <span class="citation_source-journal">Acta Pharm. Suec.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=5575874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaE3MXhsVWls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1971&pages=49-58&author=U.+H.+Lindbergauthor=G.+Bexellauthor=B.+Ulff&title=Compounds+related+to+clomethiazole.+V.+4-%28Alkyl+or+aryl%29+thiazoles+and+oxazoles+with+various+substituents+in+the+2-+and+5-positions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Compounds related to clomethiazole.  V.  4-(Alkyl or aryl) thiazoles and oxazoles with various substituents in the 2- and 5-positions</span></div><div class="casAuthors">Lindberg, Ulf H.; Bexell, Gunilla; Ulff, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica Suecica</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-58</span>CODEN:
                <span class="NLM_cas:coden">APSXAS</span>;
        ISSN:<span class="NLM_cas:issn">0001-6675</span>.
    </div><div class="casAbstract">Seventeen thiazole and five oxazole derivs. of clomethiazole (5-(2-chloroethyl)-4-methylthiazole) (I) were prepared and tested for their hypnotic and anticonvulsant effects in mice.  Condensation of RC(X)NH2 (R = H or H2N, X = S or O) with α-halo ketones giving, e.g., 2-aminothiazoles, followed by the Sandmeyer reaction gave 2-chlorothiazoles which could be extd. leaving the more basic 2-unsubstituted thiazole protonated in an acid phase; thus the 2 thiazoles could be sepd. by chromatog.  Several of the compds., esp. those with amino substituents in the 2-position such as 2-benzylamino-5-(2-chloroethyl)-4-methylthiazole (Ia), 2-amino-4-methyl-5-propylthiazole, 2-amino-4,5-tetramethylene-thiazole, 2-amino-5-methyl-4-phenylthiazole, and 2-diethylamino-5-ethyl-4-phenyloxazole showed marked hypnotic activity, whereas most of the agents were devoid of anticonvulsant properties.  In contrast to the 2-amino derivs., the 2-methyl, 2-phenyl, and 2-chloro substituted compds. were either inactive or less active as hypnotics than I or 5-(2-chloroethyl)-4-methyloxazole (II).  Hypnotic potency (HD50) and anticonvulsant effect (AD50) values are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkArDTpYgzsrVg90H21EOLACvtfcHk0lifiitCUIWjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhsVWls7Y%253D&md5=87df8c6698fffc80c975e226b289a0f5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DU.%2BH.%26aulast%3DBexell%26aufirst%3DG.%26aulast%3DUlff%26aufirst%3DB.%26atitle%3DCompounds%2520related%2520to%2520clomethiazole.%2520V.%25204-%2528Alkyl%2520or%2520aryl%2529%2520thiazoles%2520and%2520oxazoles%2520with%2520various%2520substituents%2520in%2520the%25202-%2520and%25205-positions%26jtitle%3DActa%2520Pharm.%2520Suec.%26date%3D1971%26volume%3D8%26spage%3D49%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Green, A. R.</span><span> </span><span class="NLM_article-title">Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2FS0163-7258%2898%2900024-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=9839769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1cXmslyrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1998&pages=123-147&author=A.+R.+Green&title=Clomethiazole+%28Zendra%29+in+acute+ischemic+stroke%3A+basic+pharmacology+and+biochemistry+and+clinical+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy</span></div><div class="casAuthors">Green, A. Richard</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-147</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">This review discusses the efficacy of clomethiazole (CMZ) in models of global and focal ischemia.  The fact that neuroprotection is demonstrable by using histol., biochem., and functional measures is emphasized.  The importance of the neuroprotection obsd. when the drug is given after the ischemic insult and at doses that are safely tolerated by humans is discussed, with ref. to requirements necessary for an exptl. neuroprotective agent to be considered as a therapeutic drug for stroke.  The biochem. pharmacol. of CMZ is reviewed and also evaluated with ref. to the possible mechanism(s) by which CMZ exerts its neuroprotective action.  Finally, the clin. evidence that CMZ protects against the neurol. consequences of a major stroke is outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojAvTY7B0m3LVg90H21EOLACvtfcHk0lifiitCUIWjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslyrsrg%253D&md5=f5684337fc341c160c8762cd03e4538b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900024-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900024-2%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BR.%26atitle%3DClomethiazole%2520%2528Zendra%2529%2520in%2520acute%2520ischemic%2520stroke%253A%2520basic%2520pharmacology%2520and%2520biochemistry%2520and%2520clinical%2520efficacy%26jtitle%3DPharmacol.%2520Ther.%26date%3D1998%26volume%3D80%26spage%3D123%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Marshall, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, R. M.</span><span> </span><span class="NLM_article-title">Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1006%2Fexnr.1998.6994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10192783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1MXis1Cjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1999&pages=121-129&author=J.+W.+Marshallauthor=A.+J.+Crossauthor=R.+M.+Ridley&title=Functional+benefit+from+clomethiazole+treatment+after+focal+cerebral+ischemia+in+a+nonhuman+primate+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species</span></div><div class="casAuthors">Marshall, J. W. B.; Cross, A. J.; Ridley, R. M.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Clomethiazole (CMZ) (Zendra) is neuroprotective in rodents following focal and global ischemia.  However, its neuroprotective effects in other species, particularly on functional outcome, have not been reported.  We have therefore examd. the ability of CMZ to ameliorate the functional deficits produced by a focal cerebral ischemic lesion in the marmoset, a New World primate.  Six monkeys received permanent middle cerebral artery occlusion (pMCAO); six further monkeys received pMCAO with administration of CMZ, 5 min after the arterial occlusion, by i.p. bolus injection and by s.c. implantation of an osmotic minipump, which released CMZ for 24 h.  The monkeys were trained and tested preoperatively on a no. of behavioral tasks which were repeated 3 and 9 wk after surgery.  CMZ-treated monkeys were better than non-drug-treated monkeys at using the disabled arm contralateral to the lesion and also showed a redn. in contralateral spatial hemineglect.  Postmortem histopathol. anal. at several stereotaxic levels showed a significant redn. in the area of ischemic damage in CMZ-treated monkeys compared to that in untreated animals.  CMZ treatment reduced the overall vol. of damage by 31.8% (MCA group, 370.8 ± 37.4 mm3 of damage; CMZ group, 253.0 ± 38.0 mm3 of damage).  This study demonstrates that CMZ is neuroprotective in a nonhuman primate species and is able to ameliorate the level of functional disability and reduce the size of infarct produced by focal cerebral ischemia.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqergIwe9iNZ7Vg90H21EOLACvtfcHk0lifiitCUIWjOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXis1Cjtrw%253D&md5=41b00f33b2f2798531cdcc666ea745f8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1006%2Fexnr.1998.6994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexnr.1998.6994%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DJ.%2BW.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26aulast%3DRidley%26aufirst%3DR.%2BM.%26atitle%3DFunctional%2520benefit%2520from%2520clomethiazole%2520treatment%2520after%2520focal%2520cerebral%2520ischemia%2520in%2520a%2520nonhuman%2520primate%2520species%26jtitle%3DExp.%2520Neurol.%26date%3D1999%26volume%3D156%26spage%3D121%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Farooque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaksson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, Y.</span><span> </span><span class="NLM_article-title">Clomethiazole (ZENDRA, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rat</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1007%2Fs004010051047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10412797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1MXjtleksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1999&pages=22-30&author=M.+Farooqueauthor=J.+Isakssonauthor=D.+M.+Jacksonauthor=Y.+Olsson&title=Clomethiazole+%28ZENDRA%2C+CMZ%29+improves+hind+limb+motor+function+and+reduces+neuronal+damage+after+severe+spinal+cord+injury+in+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Clomethiazole (ZENDRA, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rats</span></div><div class="casAuthors">Farooque, M.; Isaksson, J.; Jackson, D. M.; Olsson, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-30</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The effect of pretreatment with CMZ on motor function recovery and nerve cell damage after spinal cord injury (SCI) was studied in rats.  Thirty min before SCI the rats received a single i.p. dose of CMZ (150 mg/kg) or saline.  The spinal cord was injured with a 50-g load, applied over the exposed dura, for 5 min at T8-9.  The animals became paraplegic 1 day after injury.  They were evaluated for recovery of hind limb motor function.  All the animals recovered to some extent over the observation period of 12 wk.  However, hind limb motor function was better in the animals pretreated with CMZ.  After 12 wk the rats were killed and perfused/fixed for morphol. investigations.  Microtubule-assocd. protein 2 (MAP2) immunostaining was used to stain neurons and dendrites and Luxol-fast blue to stain myelinated tracts of the white matter.  The injured segment of the spinal cord showed severe atrophy, distortion, cavitation and necrosis of gray and white matter.  Compared to uninjured controls the transverse sectional area was reduced to 32.7% in untreated animals but only to 38.5% in CMZ-treated animals.  MAP2 staining showed that, compared to uninjured controls, gray matter was reduced to 7.4% in saline-treated injured animals and to 22.7% in CMZ-treated rats.  The results thus show that in this model CMZ improves hind limb motor function and attenuates the morphol. damage to the spinal cord.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE_j1zSf_1-LVg90H21EOLACvtfcHk0ljkTcCHrUU00g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtleksbc%253D&md5=30df21e84e28fc66aa3717a635ff4ef2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs004010051047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004010051047%26sid%3Dliteratum%253Aachs%26aulast%3DFarooque%26aufirst%3DM.%26aulast%3DIsaksson%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DOlsson%26aufirst%3DY.%26atitle%3DClomethiazole%2520%2528ZENDRA%252C%2520CMZ%2529%2520improves%2520hind%2520limb%2520motor%2520function%2520and%2520reduces%2520neuronal%2520damage%2520after%2520severe%2520spinal%2520cord%2520injury%2520in%2520rat%26jtitle%3DActa%2520Neuropathol.%26date%3D1999%26volume%3D98%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wahlgren, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez-Tejedor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arboix, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, E.</span><span> </span><span class="NLM_article-title">Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2000&pages=82-85&author=N.+G.+Wahlgrenauthor=E.+Diez-Tejedorauthor=J.+Teitelbaumauthor=A.+Arboixauthor=D.+Leysauthor=T.+Ashwoodauthor=E.+Grossman&title=Results+in+95+hemorrhagic+stroke+patients+included+in+CLASS%2C+a+controlled+trial+of+clomethiazole+versus+placebo+in+acute+stroke+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWahlgren%26aufirst%3DN.%2BG.%26aulast%3DDiez-Tejedor%26aufirst%3DE.%26aulast%3DTeitelbaum%26aufirst%3DJ.%26aulast%3DArboix%26aufirst%3DA.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DGrossman%26aufirst%3DE.%26atitle%3DResults%2520in%252095%2520hemorrhagic%2520stroke%2520patients%2520included%2520in%2520CLASS%252C%2520a%2520controlled%2520trial%2520of%2520clomethiazole%2520versus%2520placebo%2520in%2520acute%2520stroke%2520patients%26jtitle%3DStroke%26date%3D2000%26volume%3D31%26spage%3D82%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wahlgren, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranasinha, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosolacci, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Erven, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson, L.</span><span> </span><span class="NLM_article-title">Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1999&pages=21-28&author=N.+G.+Wahlgrenauthor=K.+W.+Ranasinhaauthor=T.+Rosolacciauthor=C.+L.+Frankeauthor=P.+M.+van+Ervenauthor=T.+Ashwoodauthor=L.+Claesson&title=Clomethiazole+acute+stroke+study+%28CLASS%29%3A+results+of+a+randomized%2C+controlled+trial+of+clomethiazole+versus+placebo+in+1360+acute+stroke+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWahlgren%26aufirst%3DN.%2BG.%26aulast%3DRanasinha%26aufirst%3DK.%2BW.%26aulast%3DRosolacci%26aufirst%3DT.%26aulast%3DFranke%26aufirst%3DC.%2BL.%26aulast%3Dvan%2BErven%26aufirst%3DP.%2BM.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DClaesson%26aufirst%3DL.%26atitle%3DClomethiazole%2520acute%2520stroke%2520study%2520%2528CLASS%2529%253A%2520results%2520of%2520a%2520randomized%252C%2520controlled%2520trial%2520of%2520clomethiazole%2520versus%2520placebo%2520in%25201360%2520acute%2520stroke%2520patients%26jtitle%3DStroke%26date%3D1999%26volume%3D30%26spage%3D21%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mucke, H.</span><span> </span><span class="NLM_article-title">Clomethiazole (Astra Arcus AB)</span> <span class="citation_source-journal">IDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16160952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlCgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1999&pages=184-193&author=H.+Mucke&title=Clomethiazole+%28Astra+Arcus+AB%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Clomethiazole Astra Arcus AB</span></div><div class="casAuthors">Mucke, Herman</div><div class="citationInfo"><span class="NLM_cas:title">IDrugs</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-193</span>CODEN:
                <span class="NLM_cas:coden">IDRUFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-7056</span>.
    
            (<span class="NLM_cas:orgname">Current Drugs Ltd.</span>)
        </div><div class="casAbstract">Clomethiazole has been marketed for several years as a sedative/antiepileptic.  Astra is now developing it for the potential treatment of stroke.  An NDA is expected to be filed in 1999/2000 [275465].  A North American phase III trial for large stroke has commenced.  This will include 1200 patients.  Two other smaller scale phase III studies with clomethiazole have also commenced in North America for intracerebral hemorrhage (n=200) and safety in combination with TPA (n=100 to 200) (Genentech) [275465].  A large-scale phase III trial has been completed in which clomethiazole was evaluated for its ability to reduce nerve damage in acute cerebrovascular ischemia.  The multicenter, international trial, called CLASS (Clomethiazole Acute Stroke Study), analyzed 1360 patients and found no significant treatment effect.  However, a subgroup of patients who presented with large stroke, experienced a significant benefit.  Of these (n=545), 41% treated patients were functionally independent after 90 days, compared to 30% patients on placebo [275465].  Clomethiazole reduced functional disability and brain damage in the marmoset permanent MCAO model [306981].  Clomethiazole is thought to act through a GABAergic pathway, whereby it augments GABA's depressive effect on the CNS, giving the drug both hypnotic and neuroprotectant properties [216474] [306978].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKiecutOAVCLVg90H21EOLACvtfcHk0ljkTcCHrUU00g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlCgsLc%253D&md5=000e5e93799764a3f3b8f0013b87784b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMucke%26aufirst%3DH.%26atitle%3DClomethiazole%2520%2528Astra%2520Arcus%2520AB%2529%26jtitle%3DIDrugs%26date%3D1999%26volume%3D2%26spage%3D184%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lyden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacoby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzeo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordlund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odergren, T.</span><span> </span><span class="NLM_article-title">The clomethiazole acute stroke study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1205</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=1199-1205&author=P.+Lydenauthor=M.+Jacobyauthor=J.+Schimauthor=G.+Albersauthor=P.+Mazzeoauthor=T.+Ashwoodauthor=A.+Nordlundauthor=T.+Odergren&title=The+clomethiazole+acute+stroke+study+in+tissue-type+plasminogen+activator-treated+stroke+%28CLASS-T%29%3A+final+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DJacoby%26aufirst%3DM.%26aulast%3DSchim%26aufirst%3DJ.%26aulast%3DAlbers%26aufirst%3DG.%26aulast%3DMazzeo%26aufirst%3DP.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DNordlund%26aufirst%3DA.%26aulast%3DOdergren%26aufirst%3DT.%26atitle%3DThe%2520clomethiazole%2520acute%2520stroke%2520study%2520in%2520tissue-type%2520plasminogen%2520activator-treated%2520stroke%2520%2528CLASS-T%2529%253A%2520final%2520results%26jtitle%3DNeurology%26date%3D2001%26volume%3D57%26spage%3D1199%26epage%3D1205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lyden, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuaib, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajput, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wechsler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claesson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odergren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar-Grueso, E.</span><span> </span><span class="NLM_article-title">Clomethiazole acute stroke study in ischemic stroke (CLASS-I): final results</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2002&pages=122-128&author=P.+Lydenauthor=A.+Shuaibauthor=K.+Ngauthor=K.+Levinauthor=R.+P.+Atkinsonauthor=A.+Rajputauthor=L.+Wechslerauthor=T.+Ashwoodauthor=L.+Claessonauthor=T.+Odergrenauthor=E.+Salazar-Grueso&title=Clomethiazole+acute+stroke+study+in+ischemic+stroke+%28CLASS-I%29%3A+final+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLyden%26aufirst%3DP.%26aulast%3DShuaib%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DLevin%26aufirst%3DK.%26aulast%3DAtkinson%26aufirst%3DR.%2BP.%26aulast%3DRajput%26aufirst%3DA.%26aulast%3DWechsler%26aufirst%3DL.%26aulast%3DAshwood%26aufirst%3DT.%26aulast%3DClaesson%26aufirst%3DL.%26aulast%3DOdergren%26aufirst%3DT.%26aulast%3DSalazar-Grueso%26aufirst%3DE.%26atitle%3DClomethiazole%2520acute%2520stroke%2520study%2520in%2520ischemic%2520stroke%2520%2528CLASS-I%2529%253A%2520final%2520results%26jtitle%3DStroke%26date%3D2002%26volume%3D33%26spage%3D122%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wilby, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, P. J.</span><span> </span><span class="NLM_article-title">The pharmacology of chlormethiazole: a potential neuroprotective agent?</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=281-294&author=M.+J.+Wilbyauthor=P.+J.+Hutchinson&title=The+pharmacology+of+chlormethiazole%3A+a+potential+neuroprotective+agent%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilby%26aufirst%3DM.%2BJ.%26aulast%3DHutchinson%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520pharmacology%2520of%2520chlormethiazole%253A%2520a%2520potential%2520neuroprotective%2520agent%253F%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2004%26volume%3D10%26spage%3D281%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Harmon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorten, G.</span><span> </span><span class="NLM_article-title">The effect of clomethiazole on plasma concentrations of interleukin-6, -8, -1beta, tumor necrosis factor-alpha, and neutrophil adhesion molecule expression during experimental extracorporeal circulation</span> <span class="citation_source-journal">Anesth. Analg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1213%2F01.ANE.0000063821.60233.7D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=12818935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVKnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2003&pages=13-18&author=D.+Harmonauthor=E.+Colemanauthor=C.+Marshallauthor=W.+Lanauthor=G.+Shorten&title=The+effect+of+clomethiazole+on+plasma+concentrations+of+interleukin-6%2C+-8%2C+-1beta%2C+tumor+necrosis+factor-alpha%2C+and+neutrophil+adhesion+molecule+expression+during+experimental+extracorporeal+circulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of clomethiazole on plasma concentrations of interleukin-6, -8, -1β, tumor necrosis factor-α, and neutrophil adhesion molecule expression during experimental extracorporeal circulation</span></div><div class="casAuthors">Harmon, D.; Coleman, E.; Marshall, C.; Lan, W.; Shorten, G.</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia & Analgesia (Baltimore, MD, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-18</span>CODEN:
                <span class="NLM_cas:coden">AACRAT</span>;
        ISSN:<span class="NLM_cas:issn">0003-2999</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Clomethiazole (CMZ), a neuroprotective drug, has antiinflammatory actions.  We investigated the effects of CMZ administration on plasma concns. of interleukin (IL)-6, IL-8, IL-1β, tumor necrosis factor-α, and neutrophil adhesion mol. expression during exptl. extracorporeal circulation.  Five healthy volunteers each donated 500 mL of blood, which was subsequently divided into equal portions.  Identical extracorporeal circuits were simultaneously primed with donated blood (250 mL) and circulated for 2 h at 37°C.  CMZ was added to 1 of the circuits of each pair to achieve a total plasma concn. of 40 μmol/L.  Blood samples were withdrawn at (i) donation, (ii) immediately after addn. of CMZ, and at (iii) 30, 60, 90, and 120 min after commencing circulation.  Plasma concns. of IL-6, IL-8, and tumor necrosis factor-α were less in the CMZ group compared with control after 60 min of circulation (2.2 [0.3] vs. 3.2 [0.4], 14.9 [4.8] vs. 21.9 [18.4], 63.3 [43.5] vs. 132.2 [118.9] pg/mL, resp., P < 0.05).  After 120 min of circulation, neutrophils from CMZ-treated circuits showed significantly less CD18 expression compared with control (237.5 [97.4] vs. 280.5 [111.5], P = 0.03).  The addn. of CMZ to exptl. extracorporeal circuits decreases the inflammatory response.  This effect may be of clin. benefit by decreasing inflammatory-mediated neurol. injury during cardiopulmonary bypass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogFOHtqDsbTrVg90H21EOLACvtfcHk0liqtfzBZqdltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVKnsbw%253D&md5=8554c50817e41920b615315914dfe070</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1213%2F01.ANE.0000063821.60233.7D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252F01.ANE.0000063821.60233.7D%26sid%3Dliteratum%253Aachs%26aulast%3DHarmon%26aufirst%3DD.%26aulast%3DColeman%26aufirst%3DE.%26aulast%3DMarshall%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DW.%26aulast%3DShorten%26aufirst%3DG.%26atitle%3DThe%2520effect%2520of%2520clomethiazole%2520on%2520plasma%2520concentrations%2520of%2520interleukin-6%252C%2520-8%252C%2520-1beta%252C%2520tumor%2520necrosis%2520factor-alpha%252C%2520and%2520neutrophil%2520adhesion%2520molecule%2520expression%2520during%2520experimental%2520extracorporeal%2520circulation%26jtitle%3DAnesth.%2520Analg.%26date%3D2003%26volume%3D97%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Clarkson, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, D. S.</span><span> </span><span class="NLM_article-title">Clomethiazole: mechanisms underlying lasting neuroprotection following hypoxia-ischemia</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1036</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1036-1038&author=A.+N.+Clarksonauthor=H.+Liuauthor=R.+Rahmanauthor=D.+M.+Jacksonauthor=I.+Appletonauthor=D.+S.+Kerr&title=Clomethiazole%3A+mechanisms+underlying+lasting+neuroprotection+following+hypoxia-ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarkson%26aufirst%3DA.%2BN.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DRahman%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DAppleton%26aufirst%3DI.%26aulast%3DKerr%26aufirst%3DD.%2BS.%26atitle%3DClomethiazole%253A%2520mechanisms%2520underlying%2520lasting%2520neuroprotection%2520following%2520hypoxia-ischemia%26jtitle%3DFASEB%2520J.%26date%3D2005%26volume%3D19%26spage%3D1036%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Clarkson, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammut, I. A.</span><span> </span><span class="NLM_article-title">Mitochondrial involvement in transhemispheric diaschisis following hypoxia-ischemia: clomethiazole-mediated amelioration</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2007&pages=547-561&author=A.+N.+Clarksonauthor=J.+Clarksonauthor=D.+M.+Jacksonauthor=I.+A.+Sammut&title=Mitochondrial+involvement+in+transhemispheric+diaschisis+following+hypoxia-ischemia%3A+clomethiazole-mediated+amelioration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarkson%26aufirst%3DA.%2BN.%26aulast%3DClarkson%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DSammut%26aufirst%3DI.%2BA.%26atitle%3DMitochondrial%2520involvement%2520in%2520transhemispheric%2520diaschisis%2520following%2520hypoxia-ischemia%253A%2520clomethiazole-mediated%2520amelioration%26jtitle%3DNeuroscience%26date%3D2007%26volume%3D144%26spage%3D547%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Shi, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span> </span><span class="NLM_article-title">Anti-TNF-alpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1368</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.brainres.2010.10.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20971085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1368&publication_year=2011&pages=239-247&author=J.+Q.+Shiauthor=W.+Shenauthor=J.+Chenauthor=B.+R.+Wangauthor=L.+L.+Zhongauthor=Y.+W.+Zhuauthor=H.+Q.+Zhuauthor=Q.+Q.+Zhangauthor=Y.+D.+Zhangauthor=J.+Xu&title=Anti-TNF-alpha+reduces+amyloid+plaques+and+tau+phosphorylation+and+induces+CD11c-positive+dendritic-like+cell+in+the+APP%2FPS1+transgenic+mouse+brains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains</span></div><div class="casAuthors">Shi, Jian-Quan; Shen, Wei; Chen, Jun; Wang, Bian-Rong; Zhong, Ling-Ling; Zhu, Yin-Wei; Zhu, Hai-Qing; Zhang, Qiao-Quan; Zhang, Ying-Dong; Xu, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1368</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239-247</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inflammation plays an important role in the pathogenesis of Alzheimer's disease (AD).  Overexpression of tumor necrosis factor-α (TNF-α) occurs in the AD brain.  Recent clin. studies have shown that the anti-TNF-α therapy improves cognition function of AD patients rapidly.  However, the underlying mechanism remains elusive.  The present study investigates the effects of intracerebroventricular injection of the monoclonal TNF-α antibody, Infliximab, on the pathol. features of AD in the APP/PS1 double transgenic mice.  We found that Infliximab administration reduced the levels of TNF-α, amyloid plaques, and tau phosphorylation as early as three days after daily injection of 150 μg Infliximab for three days.  The no. of CD11c-pos. dendritic-like cells and the expression of CD11c were found to be increased concurrently after Infliximab injection.  These data suggested that the CD11c-pos. dendritic-like cells might contribute to the Infliximab-induced redn. of AD-like pathol.  Furthermore, our results support the use of anti-TNF-α for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj2nCqmPbXQLVg90H21EOLACvtfcHk0liqtfzBZqdltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWktw%253D%253D&md5=88dd0b7905ec4ce6c13b6cc18c22255c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2010.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2010.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%2BQ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%2BR.%26aulast%3DZhong%26aufirst%3DL.%2BL.%26aulast%3DZhu%26aufirst%3DY.%2BW.%26aulast%3DZhu%26aufirst%3DH.%2BQ.%26aulast%3DZhang%26aufirst%3DQ.%2BQ.%26aulast%3DZhang%26aufirst%3DY.%2BD.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DAnti-TNF-alpha%2520reduces%2520amyloid%2520plaques%2520and%2520tau%2520phosphorylation%2520and%2520induces%2520CD11c-positive%2520dendritic-like%2520cell%2520in%2520the%2520APP%252FPS1%2520transgenic%2520mouse%2520brains%26jtitle%3DBrain%2520Res.%26date%3D2011%26volume%3D1368%26spage%3D239%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacabelos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanpedro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Fantini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleixandre, M.</span><span> </span><span class="NLM_article-title">Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.neurobiolaging.2006.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16569464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFyksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=533-536&author=A.+Alvarezauthor=R.+Cacabelosauthor=C.+Sanpedroauthor=M.+Garcia-Fantiniauthor=M.+Aleixandre&title=Serum+TNF-alpha+levels+are+increased+and+correlate+negatively+with+free+IGF-I+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease</span></div><div class="casAuthors">Alvarez, Anton; Cacabelos, Ramon; Sanpedro, Carolina; Garcia-Fantini, Manuel; Aleixandre, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-536</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Tumor necrosis factor-alpha (TNF-alpha) and insulin-like growth factor-I (IGF-I) have been involved in the pathogenesis of Alzheimer's disease (AD) as neurotoxic and survival factors, resp.  Recent exptl. studies suggest that the signalling pathways of TNF-alpha and IGF-I are functionally interrelated.  In order to investigate the possible interaction of TNF-alpha and IGF-I in AD and mild cognitive impairment (MCI), the serum levels of total IGF-I, free IGF-I and TNF-alpha were detd. in 141 AD patients, 56 MCI cases and 30 controls.  As compared with controls, AD patients showed increased TNF-alpha and decreased IGF-I levels in serum, as well as a significant neg. correlation between TNF-alpha and free IGF-I values.  MCI patients also exhibited significantly higher TNF-alpha levels than controls.  The present results suggest that increased TNF-alpha levels are involved in the pathogenesis of AD and MCI, and might antagonize the neurotrophic activity of IGF-I in these medical conditions.  In addn., the combined detn. of TNF-alpha and IGF-I might be useful to monitor anti-inflammatory and/or neurotrophic drug effects in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGRYdwTv6zF7Vg90H21EOLACvtfcHk0liqtfzBZqdltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFyksrc%253D&md5=b5a50a78b96beb6731fc899e20877225</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2006.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2006.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DCacabelos%26aufirst%3DR.%26aulast%3DSanpedro%26aufirst%3DC.%26aulast%3DGarcia-Fantini%26aufirst%3DM.%26aulast%3DAleixandre%26aufirst%3DM.%26atitle%3DSerum%2520TNF-alpha%2520levels%2520are%2520increased%2520and%2520correlate%2520negatively%2520with%2520free%2520IGF-I%2520in%2520Alzheimer%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2007%26volume%3D28%26spage%3D533%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">McAlpine, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhn, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blurton-Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tansey, M. G.</span><span> </span><span class="NLM_article-title">Inhibition of soluble TNF signaling in a mouse model of Alzheimer’s disease prevents pre-plaque amyloid-associated neuropathology</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.nbd.2009.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=19320056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVOgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=163-177&author=F.+E.+McAlpineauthor=J.+K.+Leeauthor=A.+S.+Harmsauthor=K.+A.+Ruhnauthor=M.+Blurton-Jonesauthor=J.+Hongauthor=P.+Dasauthor=T.+E.+Goldeauthor=F.+M.+LaFerlaauthor=S.+Oddoauthor=A.+Bleschauthor=M.+G.+Tansey&title=Inhibition+of+soluble+TNF+signaling+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease+prevents+pre-plaque+amyloid-associated+neuropathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology</span></div><div class="casAuthors">McAlpine, Fiona E.; Lee, Jae-Kyung; Harms, Ashley S.; Ruhn, Kelly A.; Blurton-Jones, Mathew; Hong, John; Das, Pritam; Golde, Todd E.; LaFerla, Frank M.; Oddo, Salvatore; Blesch, Armin; Tansey, Malu G.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">163-177</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Microglial activation and overprodn. of inflammatory mediators in the central nervous system (CNS) have been implicated in Alzheimer's disease (AD).  Elevated levels of the pro-inflammatory cytokine tumor necrosis factor (TNF) have been reported in serum and post-mortem brains of patients with AD, but its role in progression of AD is unclear.  Using novel engineered dominant neg. TNF inhibitors (DN-TNFs) selective for sol. TNF (solTNF), we investigated whether blocking TNF signaling with chronic infusion of the recombinant DN-TNF XENP345 or a single injection of a lentivirus encoding DN-TNF prevented the acceleration of AD-like pathol. induced by chronic systemic inflammation in 3xTgAD mice.  We found that chronic inhibition of solTNF signaling with either approach decreased the LPS-induced accumulation of 6E10-immunoreactive protein in hippocampus, cortex, and amygdala.  Immunohistol. and biochem. approaches using a C-terminal APP antibody indicated that a major fraction of the accumulated protein was likely to be C-terminal APP fragments (β-CTF) while a minor fraction consisted of Aβ40 and 42.  Genetic inactivation of TNFR1-mediated TNF signaling in 3xTgAD mice yielded similar results.  Taken together, our studies indicate that sol. TNF is a crit. mediator of the effects of neuroinflammation on early (pre-plaque) pathol. in 3xTgAD mice.  Targeted inhibition of solTNF in the CNS may slow the appearance of amyloid-assocd. pathol., cognitive deficits, and potentially the progressive loss of neurons in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKWtPLgHkfW7Vg90H21EOLACvtfcHk0lj2_7aKLBDJIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVOgu7o%253D&md5=aeec1eea06c3c035408b37070eb4966b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DMcAlpine%26aufirst%3DF.%2BE.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DHarms%26aufirst%3DA.%2BS.%26aulast%3DRuhn%26aufirst%3DK.%2BA.%26aulast%3DBlurton-Jones%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26aulast%3DOddo%26aufirst%3DS.%26aulast%3DBlesch%26aufirst%3DA.%26aulast%3DTansey%26aufirst%3DM.%2BG.%26atitle%3DInhibition%2520of%2520soluble%2520TNF%2520signaling%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520prevents%2520pre-plaque%2520amyloid-associated%2520neuropathology%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2009%26volume%3D34%26spage%3D163%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Strum, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shehee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roses, A.</span><span> </span><span class="NLM_article-title">Rosiglitazone induces mitochondrial biogenesis in mouse brain</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=17361034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVGju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=45-51&author=J.+C.+Strumauthor=R.+Sheheeauthor=D.+Virleyauthor=J.+Richardsonauthor=M.+Mattieauthor=P.+Selleyauthor=S.+Ghoshauthor=C.+Nockauthor=A.+Saundersauthor=A.+Roses&title=Rosiglitazone+induces+mitochondrial+biogenesis+in+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Rosiglitazone induces mitochondrial biogenesis in mouse brain</span></div><div class="casAuthors">Strum, Jay C.; Shehee, Ron; Virley, David; Richardson, Jill; Mattie, Michael; Selley, Paula; Ghosh, Sujoy; Nock, Christina; Saunders, Ann; Roses, Allen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Rosiglitazone was found to simulate mitochondrial biogenesis in mouse brain in an apolipoprotein (Apo) E isoenzyme-independent manner.  Rosiglitazone induced both mitochondrial DNA (mtDNA) and estrogen-stimulated related receptor alpha (ESRRA) mRNA, a key regulator of mitochondrial biogenesis.  Transcriptomics and proteomics anal. suggested the mitochondria produced in the presence of human ApoE3 and E4 were not as metabolically efficient as those in the wild type or ApoE knockout mice.  Thus, we propose that PPARγ agonism induces neuronal mitochondrial biogenesis and improves glucose utilization leading to improved cellular function and provides mechanistic support for the improvement in cognition obsd. in treatment of Alzheimer's patients with rosiglitazone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_DQHQzEezirVg90H21EOLACvtfcHk0lj2_7aKLBDJIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVGju70%253D&md5=1179690e759268ad73edf039cc1ef11b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrum%26aufirst%3DJ.%2BC.%26aulast%3DShehee%26aufirst%3DR.%26aulast%3DVirley%26aufirst%3DD.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DMattie%26aufirst%3DM.%26aulast%3DSelley%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DNock%26aufirst%3DC.%26aulast%3DSaunders%26aufirst%3DA.%26aulast%3DRoses%26aufirst%3DA.%26atitle%3DRosiglitazone%2520induces%2520mitochondrial%2520biogenesis%2520in%2520mouse%2520brain%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2007%26volume%3D11%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Santos, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreira, P. I.</span><span> </span><span class="NLM_article-title">Mitophagy in neurodegeneration: an opportunity for therapy?</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.2174%2F138945011795528813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=21269269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlOgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=790-799&author=R.+X.+Santosauthor=S.+C.+Correiaauthor=C.+Carvalhoauthor=S.+Cardosoauthor=M.+S.+Santosauthor=P.+I.+Moreira&title=Mitophagy+in+neurodegeneration%3A+an+opportunity+for+therapy%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mitophagy in neurodegeneration: an opportunity for therapy?</span></div><div class="casAuthors">Santos, R. X.; Correia, S. C.; Carvalho, C.; Cardoso, S.; Santos, M. S.; Moreira, P. I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">790-799</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases are characterized by distinct clin. manifestations and neuropathol. hallmarks, but they also share common features like mitochondrial dysfunction.  As strategic organelles in several cellular pathways, including life/death decision, it is crucial to maintain a healthy mitochondrial pool to ensure cellular homeostasis.  Macroautophagy is a pathway of lysosomal-dependent degrdn. of cytosolic portions, such as misfolded proteins or damaged organelles.  In the last decade this process has gained new frontiers and is currently seen as a specific, rather than a random process.  In this regard the term mitophagy came to describe the selective degrdn. of mitochondria by autophagy.  This review is intended to discuss mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.  The recent developments on the mol. basis of mitophagy will be also argued.  Finally, we will discuss mitophagy as a potential therapeutic target for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYKZLdFzkV7Vg90H21EOLACvtfcHk0lj2_7aKLBDJIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlOgtLw%253D&md5=bc44dc68b98c650b170b542df1cd94f9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F138945011795528813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945011795528813%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DR.%2BX.%26aulast%3DCorreia%26aufirst%3DS.%2BC.%26aulast%3DCarvalho%26aufirst%3DC.%26aulast%3DCardoso%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26atitle%3DMitophagy%2520in%2520neurodegeneration%253A%2520an%2520opportunity%2520for%2520therapy%253F%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2011%26volume%3D12%26spage%3D790%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease is a synaptic failure</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=789-91&author=D.+J.+Selkoe&title=Alzheimer%E2%80%99s+disease+is+a+synaptic+failure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520is%2520a%2520synaptic%2520failure%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D789%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, J. N.</span><span> </span><span class="NLM_article-title">NO chimeras as therapeutic agents in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.2174%2F156720506777632925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16842101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFGlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=237-245&author=G.+R.+J.+Thatcherauthor=B.+M.+Bennettauthor=J.+N.+Reynolds&title=NO+chimeras+as+therapeutic+agents+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">NO chimeras as therapeutic agents in Alzheimer's disease</span></div><div class="casAuthors">Thatcher, Gregory R. J.; Bennett, Brian M.; Reynolds, James N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-245</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  NO is an important messenger mol. in the brain, playing an important role in learning and memory, in particular via the ERK/CREB signaling pathway.  NO is also a neuroprotective agent; multiple mechanisms having been demonstrated that can contribute to cell survival as levels of antioxidants and trophic factors are reduced with aging.  Small mols. that mimic the biol. activity of NO, including NO donors, may thus ameliorate cognition and provide neuroprotection.  Several lines of evidence have linked the neurodegeneration and dementia characteristic of Alzheimer's disease with the action of β-amyloid protein at the α7-nicotinic acetylcholine receptor.  The interplay of Aβ with α7-nicotinic ACh receptors operating via the ERK signaling cascade links the amyloid cascade and the cholinergic hypothesis in pathways that impact synaptic plasticity and memory.  This interplay also provides linkages to disruption of NO/cGMP signaling in AD, and in addn., recent direct evidence has been found demonstrating that Aβ downregulates the NO/cGMP/CREB pathway.  Activation of sol. guanylyl cyclase elevating cGMP in the brain represents the central element of a therapeutic approach to the treatment of AD and other neurodegenerative diseases, furthermore, evidence suggests that NO may display cGMP-independent activity and may operate via multiple biochem. signaling pathways to ensure the survival of neurons subjected to stress.  GT 1061 is an NO chimera, an NO mimetic compd. that contains an ancillary, synergistic pharmacophore, currently in clin. trials for Alzheimer's.  NO chimeras and hybrid nitrates hold promise as therapeutics for AD with multiple sites of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0SSQZjqhUKLVg90H21EOLACvtfcHk0li0OmF06PZiCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFGlsbk%253D&md5=e6754a624169c087d960b481e8194bbd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156720506777632925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506777632925%26sid%3Dliteratum%253Aachs%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BN.%26atitle%3DNO%2520chimeras%2520as%2520therapeutic%2520agents%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D237%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusky, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=505-513&author=B.+M.+Bennettauthor=J.+N.+Reynoldsauthor=G.+T.+Pruskyauthor=R.+M.+Douglasauthor=R.+J.+Sutherlandauthor=G.+R.+J.+Thatcher&title=Cognitive+deficits+in+rats+after+forebrain+cholinergic+depletion+are+reversed+by+a+novel+NO+mimetic+nitrate+ester"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BN.%26aulast%3DPrusky%26aufirst%3DG.%2BT.%26aulast%3DDouglas%26aufirst%3DR.%2BM.%26aulast%3DSutherland%26aufirst%3DR.%2BJ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DCognitive%2520deficits%2520in%2520rats%2520after%2520forebrain%2520cholinergic%2520depletion%2520are%2520reversed%2520by%2520a%2520novel%2520NO%2520mimetic%2520nitrate%2520ester%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D505%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniszewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Privitera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leznik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer’s disease mouse model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">8075</span><span class="NLM_x">–</span> <span class="NLM_lpage">8086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.0864-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=19553447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=8075-8086&author=D.+Puzzoauthor=A.+Staniszewskiauthor=S.+X.+Dengauthor=L.+Priviteraauthor=E.+Leznikauthor=S.+Liuauthor=H.+Zhangauthor=Y.+Fengauthor=A.+Palmeriauthor=D.+W.+Landryauthor=O.+Arancio&title=Phosphodiesterase+5+inhibition+improves+synaptic+function%2C+memory%2C+and+amyloid-beta+load+in+an+Alzheimer%E2%80%99s+disease+mouse+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model</span></div><div class="casAuthors">Puzzo, Daniela; Staniszewski, Agnieszka; Deng, Shi Xian; Privitera, Lucia; Leznik, Elena; Liu, Shumin; Zhang, Hong; Feng, Yan; Palmeri, Agostino; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8075-8086</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss, synaptic dysfunction, and accumulation of amyloid β-peptides (Aβ) are major hallmarks of Alzheimer's disease (AD).  Downregulation of the nitric oxide/cGMP/cGMP-dependent protein kinase/c-AMP responsive element-binding protein (CREB) cascade has been linked to the synaptic deficits after Aβ elevation.  Here, we report that the phosphodiesterase 5 inhibitor (PDE5) sildenafil (Viagra), a mol. that enhances phosphorylation of CREB, a mol. involved in memory, through elevation of cGMP levels, is beneficial against the AD phenotype in a mouse model of amyloid deposition.  We demonstrate that the inhibitor produces an immediate and long-lasting amelioration of synaptic function, CREB phosphorylation, and memory.  This effect is also assocd. with a long-lasting redn. of Aβ levels.  Given that side effects of PDE5 inhibitors are widely known and do not preclude their administration to a senile population, these drugs have potential for the treatment of AD and other diseases assocd. with elevated Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69pOrzfjxY7Vg90H21EOLACvtfcHk0li0OmF06PZiCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D&md5=5aead1f7c92b6166b8591c3e7951f78d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0864-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0864-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DLeznik%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPhosphodiesterase%25205%2520inhibition%2520improves%2520synaptic%2520function%252C%2520memory%252C%2520and%2520amyloid-beta%2520load%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D8075%26epage%3D8086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Saura, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, J.</span><span> </span><span class="NLM_article-title">The role of CREB signaling in Alzheimer’s disease and other cognitive disorders</span> <span class="citation_source-journal">Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1515%2Frns.2011.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=21476939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BC3Mvit1CltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=153-169&author=C.+A.+Sauraauthor=J.+Valero&title=The+role+of+CREB+signaling+in+Alzheimer%E2%80%99s+disease+and+other+cognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The role of CREB signaling in Alzheimer's disease and other cognitive disorders</span></div><div class="casAuthors">Saura Carlos A; Valero Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the neurosciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-69</span>
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    </div><div class="casAbstract">Gene expression changes in the brain affect cognition during normal and pathological aging.  Progress in understanding the cellular processes regulating gene expression networks in cognition is relevant to develop therapeutic interventions for age-related cognitive disorders.  Synaptic efficacy mediating memory storage requires the activation of specific gene expression programs regulated, among others, by the transcription factor cAMP-response element binding protein (CREB).  CREB signaling is essential for long-lasting changes in synaptic plasticity that mediates the conversion of short-term memory to long-term memory.  CREB signaling has been recently involved in several brain pathological conditions including cognitive and neurodegenerative disorders.  The β-amyloid (Aβ) peptide, which plays a crucial role in the pathogenesis of Alzheimer's disease, alters hippocampal-dependent synaptic plasticity and memory and mediates synapse loss through the CREB signaling pathway.  The fact that altered CREB signaling has been implicated in other cognitive disorders including Huntington's disease and Rubinstein-Taybi and Coffin-Lowry syndromes suggests a crucial role of CREB signaling in cognitive dysfunction.  In this review paper, we summarize recent findings indicating a role of CREB and its coactivators CREB binding protein and CREB-regulated transcription coactivator in cognition during normal and pathological aging.  We also discuss the development of novel therapeutic strategies based on CREB targeting to ameliorate cognitive decline in aging and cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNqWMEv046oHl8icjszYl0fW6udTcc2eZqBDvydriyX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mvit1CltA%253D%253D&md5=ebba8bee0b273f8deed9602b4d62036d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1515%2Frns.2011.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Frns.2011.018%26sid%3Dliteratum%253Aachs%26aulast%3DSaura%26aufirst%3DC.%2BA.%26aulast%3DValero%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520CREB%2520signaling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520cognitive%2520disorders%26jtitle%3DRev.%2520Neurosci.%26date%3D2011%26volume%3D22%26spage%3D153%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Espana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minano-Molina, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masgrau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Llort, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Alvarez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saura, C. A.</span><span> </span><span class="NLM_article-title">beta-Amyloid disrupts activity-dependent gene transcription required for memory through the CREB coactivator CRTC1</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">9402</span><span class="NLM_x">–</span> <span class="NLM_lpage">9410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.2154-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20631169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslSju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=9402-9410&author=J.+Espanaauthor=J.+Valeroauthor=A.+J.+Minano-Molinaauthor=R.+Masgrauauthor=E.+Martinauthor=C.+Guardia-Laguartaauthor=A.+Lleoauthor=L.+Gimenez-Llortauthor=J.+Rodriguez-Alvarezauthor=C.+A.+Saura&title=beta-Amyloid+disrupts+activity-dependent+gene+transcription+required+for+memory+through+the+CREB+coactivator+CRTC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">β-amyloid disrupts activity-dependent gene transcription required for memory through the CREB coactivator CRTC1</span></div><div class="casAuthors">Espana, Judit; Valero, Jorge; Minano-Molina, Alfredo J.; Masgrau, Roser; Martin, Elsa; Guardia-Laguarta, Cristina; Lleo, Alberto; Gimenez-Llort, Lydia; Rodriguez-Alvarez, Jose; Saura, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9402-9410</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Activity-dependent gene expression mediating changes of synaptic efficacy is important for memory storage, but the mechanisms underlying gene transcriptional changes in age-related memory disorders are poorly understood.  In this study, we report that gene transcription mediated by the cAMP-response element binding protein (CREB)-regulated transcription coactivator CRTC1 is impaired in neurons and brain from an Alzheimer's disease (AD) transgenic mouse expressing the human β-amyloid precursor protein (APPSw,Ind).  Suppression of CRTC1-dependent gene transcription by β-amyloid (Aβ) in response to cAMP and Ca2+ signals is mediated by reduced calcium influx and disruption of PP2B/calcineurin-dependent CRTC1 dephosphorylation at Ser151.  Consistently, expression of CRTC1 or active CRTC1 S151A and calcineurin mutants reverse the deficits on CRTC1 transcriptional activity in APPSw,Ind neurons.  Inhibition of calcium influx by pharmacol. blockade of L-type voltage-gated calcium channels (VGCCs), but not by blocking NMDA or AMPA receptors, mimics the decrease on CRTC1 transcriptional activity obsd. in APPSw,Ind neurons, whereas agonists of L-type VGCCs reverse efficiently these deficits.  Consistent with a role of CRTC1 on Aβ-induced synaptic and memory dysfunction, we demonstrate a selective redn. of CRTC1-dependent genes related to memory (Bdnf, c-fos, and Nr4a2) coinciding with hippocampal-dependent spatial memory deficits in APPSw,Ind mice.  These findings suggest that CRTC1 plays a key role in coupling synaptic activity to gene transcription required for hippocampal-dependent memory, and that Aβ could disrupt cognition by affecting CRTC1 function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRX6uaShWwlbVg90H21EOLACvtfcHk0lhR0p7GTdqBJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslSju7g%253D&md5=837c57a6b8df850a57e34d83112cad50</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2154-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2154-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DEspana%26aufirst%3DJ.%26aulast%3DValero%26aufirst%3DJ.%26aulast%3DMinano-Molina%26aufirst%3DA.%2BJ.%26aulast%3DMasgrau%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DGimenez-Llort%26aufirst%3DL.%26aulast%3DRodriguez-Alvarez%26aufirst%3DJ.%26aulast%3DSaura%26aufirst%3DC.%2BA.%26atitle%3Dbeta-Amyloid%2520disrupts%2520activity-dependent%2520gene%2520transcription%2520required%2520for%2520memory%2520through%2520the%2520CREB%2520coactivator%2520CRTC1%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D9402%26epage%3D9410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibb, J. A.</span><span> </span><span class="NLM_article-title">Is CREB the angry bird that releases memory in alzheimer’s?</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2153</span><span class="NLM_x">–</span> <span class="NLM_lpage">2154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=2153-2154&author=A.+Wangauthor=J.+A.+Bibb&title=Is+CREB+the+angry+bird+that+releases+memory+in+alzheimer%E2%80%99s%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DA.%26aulast%3DBibb%26aufirst%3DJ.%2BA.%26atitle%3DIs%2520CREB%2520the%2520angry%2520bird%2520that%2520releases%2520memory%2520in%2520alzheimer%25E2%2580%2599s%253F%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D2153%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Pugazhenthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sze, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C. B.</span><span> </span><span class="NLM_article-title">Downregulation of CREB expression in Alzheimer’s brain and in Abeta-treated rat hippocampal neurons</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1186%2F1750-1326-6-60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=21854604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1SqtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=60&author=S.+Pugazhenthiauthor=M.+Wangauthor=S.+Phamauthor=C.+I.+Szeauthor=C.+B.+Eckman&title=Downregulation+of+CREB+expression+in+Alzheimer%E2%80%99s+brain+and+in+Abeta-treated+rat+hippocampal+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons</span></div><div class="casAuthors">Pugazhenthi, Subbiah; Wang, Maorong; Pham, Serena; Sze, Chun-I.; Eckman, Christopher B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Oxidative stress plays an important role in neuronal dysfunction and neuron loss in Alzheimer's brain.  Previous studies have reported downregulation of CREB-mediated transcription by oxidative stress and Aβ.  The promoter for CREB itself contains cAMP response elements.  Therefore, we examd. the expression of CREB in the hippocampal neurons of Tg2576 mice, AD post-mortem brain and in cultured rat hippocampal neurons exposed to Aβ aggregates.  Results: Laser Capture Microdissection of hippocampal neurons from Tg2576 mouse brain revealed decreases in the mRNA levels of CREB and its target, BDNF.  Immunohistochem. anal. of Tg2576 mouse brain showed decreases in CREB levels in hippocampus and cortex.  Markers of oxidative stress were detected in transgenic mouse brain and decreased CREB staining was obsd. in regions showing abundance of astrocytes.  There was also an inverse correlation between SDS-extd. Aβ and CREB protein levels in Alzheimer's post-mortem hippocampal samples.  The levels of CREB-regulated BDNF and BIRC3, a caspase inhibitor, decreased and the active cleaved form of caspase-9, a marker for the intrinsic pathway of apoptosis, was elevated in these samples.  Exposure of rat primary hippocampal neurons to Aβ fibrils decreased CREB promoter activity.  Decrease in CREB mRNA levels in Aβ-treated neurons was reversed by the antioxidant, N-acetyl cysteine.  Overexpression of CREB by adenoviral transduction led to significant protection against Aβ-induced neuronal apoptosis.  Conclusions: Our findings suggest that chronic downregulation of CREB-mediated transcription results in decrease of CREB content in the hippocampal neurons of AD brain which may contribute to exacerbation of disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Jy8qMsXYa7Vg90H21EOLACvtfcHk0lhR0p7GTdqBJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1SqtLrM&md5=d844676fb6b7ce36eca53a5438528665</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-6-60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-6-60%26sid%3Dliteratum%253Aachs%26aulast%3DPugazhenthi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPham%26aufirst%3DS.%26aulast%3DSze%26aufirst%3DC.%2BI.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26atitle%3DDownregulation%2520of%2520CREB%2520expression%2520in%2520Alzheimer%25E2%2580%2599s%2520brain%2520and%2520in%2520Abeta-treated%2520rat%2520hippocampal%2520neurons%26jtitle%3DMol.%2520Neurodegener.%26date%3D2011%26volume%3D6%26spage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Yiu, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rashid, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josselyn, S. A.</span><span> </span><span class="NLM_article-title">Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2169</span><span class="NLM_x">–</span> <span class="NLM_lpage">2186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=2169-2186&author=A.+P.+Yiuauthor=A.+J.+Rashidauthor=S.+A.+Josselyn&title=Increasing+CREB+function+in+the+CA1+region+of+dorsal+hippocampus+rescues+the+spatial+memory+deficits+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYiu%26aufirst%3DA.%2BP.%26aulast%3DRashid%26aufirst%3DA.%2BJ.%26aulast%3DJosselyn%26aufirst%3DS.%2BA.%26atitle%3DIncreasing%2520CREB%2520function%2520in%2520the%2520CA1%2520region%2520of%2520dorsal%2520hippocampus%2520rescues%2520the%2520spatial%2520memory%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D2169%26epage%3D2186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Lu, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, R. D.</span><span> </span><span class="NLM_article-title">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">10250</span><span class="NLM_x">–</span> <span class="NLM_lpage">10261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.19-23-10250.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10575022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=10250-10261&author=Y.+F.+Luauthor=E.+R.+Kandelauthor=R.+D.+Hawkins&title=Nitric+oxide+signaling+contributes+to+late-phase+LTP+and+CREB+phosphorylation+in+the+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Kandel, Eric R.; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10250-10261</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term potentiation (LTP) in the hippocampus has an early phase (E-LTP) that can be induced by 1- or 2-train tetanization, lasts ∼1 h, and is cAMP-dependent protein kinase A (PKA)- and protein synthesis-independent and a late phase (L-LTP) that can be induced by 3- or 4-train tetanization, lasts >3 h, and is reduced by inhibitors of PKA and of protein or RNA synthesis.  NO is thought to be involved in E-LTP, but until now there has been no information about the role of the NO-signaling pathway in L-LTP.  Here, the authors examd. this question at the Schaffer collateral-CA1 synapses in slices of mouse hippocampus.  An inhibitor of nitric oxide synthase blocked L-LTP induced by 3-train tetanization and reduced L-LTP induced by 4-train tetanization, whereas an inhibitor of PKA was more effective in blocking 4-train L-LTP than 3-train L-LTP.  Three-train L-LTP was also blocked by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G (PKG).  Conversely, either NO or cGMP analogs paired with 1-train tetanization produced late-phase potentiation, and the cGMP-induced potentiation was blocked by inhibitors of protein or RNA synthesis and an inhibitor of PKG, but not by an inhibitor of PKA.  To test a possible downstream target of PKG, the authors examd. changes in phospho-CRE-binding protein (phospho-CREB) immunofluorescence in the CA1 cell body area and obtained results similar to those of the electrophysiol. expts.  The results suggested that NO contributes to L-LTP by stimulating guanylyl cyclase and PKG, which acts in parallel with PKA to increase phosphorylation of transcription factor CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0i0LYOPf7LVg90H21EOLACvtfcHk0lhR0p7GTdqBJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D&md5=6d09b68560c09b81e38354826f7c21b6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-23-10250.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-23-10250.1999%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%2BF.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DNitric%2520oxide%2520signaling%2520contributes%2520to%2520late-phase%2520LTP%2520and%2520CREB%2520phosphorylation%2520in%2520the%2520hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D10250%26epage%3D10261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Riccio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonze, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginty, D. D.</span><span> </span><span class="NLM_article-title">A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=283-294&author=A.+Riccioauthor=R.+S.+Alvaniaauthor=B.+E.+Lonzeauthor=N.+Ramananauthor=T.+Kimauthor=Y.+Huangauthor=T.+M.+Dawsonauthor=S.+H.+Snyderauthor=D.+D.+Ginty&title=A+nitric+oxide+signaling+pathway+controls+CREB-mediated+gene+expression+in+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiccio%26aufirst%3DA.%26aulast%3DAlvania%26aufirst%3DR.%2BS.%26aulast%3DLonze%26aufirst%3DB.%2BE.%26aulast%3DRamanan%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26aulast%3DGinty%26aufirst%3DD.%2BD.%26atitle%3DA%2520nitric%2520oxide%2520signaling%2520pathway%2520controls%2520CREB-mediated%2520gene%2520expression%2520in%2520neurons%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D21%26spage%3D283%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Zhuo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, R. D.</span><span> </span><span class="NLM_article-title">Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1994&pages=635-639&author=M.+Zhuoauthor=Y.+Huauthor=C.+Schultzauthor=E.+R.+Kandelauthor=R.+D.+Hawkins&title=Role+of+guanylyl+cyclase+and+cGMP-dependent+protein+kinase+in+long-term+potentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSchultz%26aufirst%3DC.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DRole%2520of%2520guanylyl%2520cyclase%2520and%2520cGMP-dependent%2520protein%2520kinase%2520in%2520long-term%2520potentiation%26jtitle%3DNature%26date%3D1994%26volume%3D368%26spage%3D635%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.5291-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16033898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6887-6897&author=D.+Puzzoauthor=O.+Vitoloauthor=F.+Trincheseauthor=J.+P.+Jacobauthor=A.+Palmeriauthor=O.+Arancio&title=Amyloid-beta+peptide+inhibits+activation+of+the+nitric+oxide%2FcGMP%2FcAMP-responsive+element-binding+protein+pathway+during+hippocampal+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span></div><div class="casAuthors">Puzzo, Daniela; Vitolo, Ottavio; Trinchese, Fabrizio; Jacob, Joel P.; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6887-6897</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different 2nd-messenger cascades.  Interestingly, Aβ was found to markedly impair hippocampal long-term potentiation (LTP).  To identify a new pathway that might be responsible for such impairment, the authors analyzed the role of the NO/sol. guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP.  The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Aβ-induced impairment of CA1-LTP through cGK activation.  Furthermore, these compds. reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Aβ.  We also found that Aβ blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Aβ.  These results strongly suggest that, when modulating hippocampal synaptic plasticity, Aβ downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated prodn. of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_M3WUlYelLVg90H21EOLACvtfcHk0lgvSntnqL8A0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D&md5=448717d56147ceb9665d8c1ce8136c98</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5291-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5291-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DVitolo%26aufirst%3DO.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DJacob%26aufirst%3DJ.%2BP.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520peptide%2520inhibits%2520activation%2520of%2520the%2520nitric%2520oxide%252FcGMP%252FcAMP-responsive%2520element-binding%2520protein%2520pathway%2520during%2520hippocampal%2520synaptic%2520plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6887%26epage%3D6897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer’s disease</span> <span class="citation_source-journal">Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1515%2FREVNEURO.2006.17.5.497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=17180876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=497-523&author=D.+Puzzoauthor=A.+Palmeriauthor=O.+Arancio&title=Involvement+of+the+nitric+oxide+pathway+in+synaptic+dysfunction+following+amyloid+elevation+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease</span></div><div class="casAuthors">Puzzo, Daniela; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-523</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Freund & Pettman</span>)
        </div><div class="casAbstract">A review.  Amyloid-beta (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has attracted scientific interest with the aim of characterizing the mechanisms by which it is involved in AD pathogenesis.  Aβ has been found to markedly impair hippocampal long-term potentiation (LTP), a widely studied cellular model of synaptic plasticity that is thought to underlie learning and memory.  The overall purpose of this review is to define the role of the nitric oxide (NO)/cGMP/cAMP-regulatory element binding (CREB) pathway in beta-amyloid-induced changes of basal neurotransmission and synaptic plasticity in the hippocampus, a structure within the temporal lobe of the brain crit. for memory storage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzLKNBiiakNLVg90H21EOLACvtfcHk0lgvSntnqL8A0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ&md5=faa3271286d20c9cd431f9b001476089</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2006.17.5.497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2006.17.5.497%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DInvolvement%2520of%2520the%2520nitric%2520oxide%2520pathway%2520in%2520synaptic%2520dysfunction%2520following%2520amyloid%2520elevation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRev.%2520Neurosci.%26date%3D2006%26volume%3D17%26spage%3D497%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Paul, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleppisch, T.</span><span> </span><span class="NLM_article-title">cGMP-dependent protein kinase type I promotes CREB/CRE-mediated gene expression in neurons of the lateral amygdala</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">473</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2010&pages=82-86&author=C.+Paulauthor=C.+Stratilauthor=F.+Hofmannauthor=T.+Kleppisch&title=cGMP-dependent+protein+kinase+type+I+promotes+CREB%2FCRE-mediated+gene+expression+in+neurons+of+the+lateral+amygdala"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DC.%26aulast%3DStratil%26aufirst%3DC.%26aulast%3DHofmann%26aufirst%3DF.%26aulast%3DKleppisch%26aufirst%3DT.%26atitle%3DcGMP-dependent%2520protein%2520kinase%2520type%2520I%2520promotes%2520CREB%252FCRE-mediated%2520gene%2520expression%2520in%2520neurons%2520of%2520the%2520lateral%2520amygdala%26jtitle%3DNeurosci.%2520Lett.%26date%3D2010%26volume%3D473%26spage%3D82%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, J. N.</span><span> </span><span class="NLM_article-title">Nitric oxide mimetic molecules as therapeutic agents in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.2174%2F1567205053585945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15974915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVantrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=171-182&author=G.+R.+J.+Thatcherauthor=B.+M.+Bennettauthor=J.+N.+Reynolds&title=Nitric+oxide+mimetic+molecules+as+therapeutic+agents+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide mimetic molecules as therapeutic agents in Alzheimer's disease</span></div><div class="casAuthors">Thatcher, Gregory R. J.; Bennett, Brian M.; Reynolds, James N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-182</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nitric oxide is multifunctional messenger mol. in the brain, playing important roles including in learning and memory and in regulating the expression of trophic factors that may be reduced with aging.  Small mols. that mimic the biol. activity of NO, NO mimetics, will bypass cholinergic receptor activation and are anticipated to provide multiple pathways of treating and circumventing dementia in Alzheimer's disease.  Activation of sol. guanylyl cyclase and cGMP formation in the brain represents one element of effective neuroprotective pathways mediated by NO.  Substantial evidence suggests that NO mimetics may display cGMP-dependent and cGMP-independent activity and may operate via multiple biochem. signaling pathways, both to ensure the survival of neurons subjected to stress and also to provide cognition-enabling pathways to circumvent dementia.  GT 1061 is an NO mimetic compd. currently in clin. trials for Alzheimer's disease.  A survey of current research indicates that NO mimetics will provide a combined neuroprotective and cognition-enabling approach to anti-neurodegenerative therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE3z7OoRg7wbVg90H21EOLACvtfcHk0ljHMqLJBBPbNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVantrY%253D&md5=cb19bafe437fac666c7b72e982479743</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2174%2F1567205053585945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205053585945%26sid%3Dliteratum%253Aachs%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DReynolds%26aufirst%3DJ.%2BN.%26atitle%3DNitric%2520oxide%2520mimetic%2520molecules%2520as%2520therapeutic%2520agents%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2005%26volume%3D2%26spage%3D171%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Rostovtsev, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2596</span><span class="NLM_x">–</span> <span class="NLM_lpage">2599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=12203546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Ohsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2596-2599&author=V.+V.+Rostovtsevauthor=L.+G.+Greenauthor=V.+V.+Fokinauthor=K.+B.+Sharpless&title=A+stepwise+Huisgen+cycloaddition+process%3A+copper%28I%29-catalyzed+regioselective+%E2%80%9Cligation%E2%80%9D+of+azides+and+terminal+alkynes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes</span></div><div class="casAuthors">Rostovtsev, Vsevolod V.; Green, Luke G.; Fokin, Valery V.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2596-2599</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">1,4-Disubstituted 1,2,3-triazoles I (R1 = PhCH2, PhCH2OCH2, 1-adamantyl, etc.; R2 = HO2C, Ph, PhOCH2, Et2NCH2, etc.) were readily and cleanly prepd. via highly efficient and regioselective copper(I)-catalyzed cycloaddn. of azides R1N3 with terminal alkynes R2C≡CH in 82-93% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptcW2JUNM1r7Vg90H21EOLACvtfcHk0ljHMqLJBBPbNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Ohsr4%253D&md5=4603664be6639353b5e70f19b9f8d59f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820020715%252941%253A14%253C2596%253A%253AAID-ANIE2596%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DRostovtsev%26aufirst%3DV.%2BV.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520stepwise%2520Huisgen%2520cycloaddition%2520process%253A%2520copper%2528I%2529-catalyzed%2520regioselective%2520%25E2%2580%259Cligation%25E2%2580%259D%2520of%2520azides%2520and%2520terminal%2520alkynes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D2596%26epage%3D2599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Tornoe, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meldal, M.</span><span> </span><span class="NLM_article-title">Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">3057</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo011148j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVeks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=3057-3064&author=C.+W.+Tornoeauthor=C.+Christensenauthor=M.+Meldal&title=Peptidotriazoles+on+solid+phase%3A+%5B1%2C2%2C3%5D-triazoles+by+regiospecific+copper%28I%29-catalyzed+1%2C3-dipolar+cycloadditions+of+terminal+alkynes+to+azides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidotriazoles on Solid Phase: [1,2,3]-Triazoles by Regiospecific Copper(I)-Catalyzed 1,3-Dipolar Cycloadditions of Terminal Alkynes to Azides</span></div><div class="casAuthors">Tornoe, Christian W.; Christensen, Caspar; Meldal, Morten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3057-3064</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cycloaddn. of azides to alkynes is one of the most important synthetic routes to 1H-[1,2,3]-triazoles.  This work reports a novel regiospecific copper(I)-catalyzed 1,3-dipolar cycloaddn. of terminal alkynes to azides on solid-phase.  Primary, secondary, and tertiary alkyl azides, aryl azides, and an azido sugar were used successfully in the copper(I)-catalyzed cycloaddn. producing diversely 1,4-substituted [1,2,3]-triazoles in peptide backbones or side chains.  The reaction conditions were fully compatible with solid-phase peptide synthesis on polar supports.  The copper(I) catalysis is mild and efficient (>95% conversion and purity in most cases) and furthermore, the x-ray structure of 2-azido-2-methylpropanoic acid has been solved, to yield structural information on the 1,3-dipoles entering the reaction.  Novel Fmoc-protected amino azides were prepd. from Fmoc-amino alcs. by Mitsunobu reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJXSF5l0g_lrVg90H21EOLACvtfcHk0ljHMqLJBBPbNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVeks7w%253D&md5=6b3b805572783873952871f1b69f46dd</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo011148j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo011148j%26sid%3Dliteratum%253Aachs%26aulast%3DTornoe%26aufirst%3DC.%2BW.%26aulast%3DChristensen%26aufirst%3DC.%26aulast%3DMeldal%26aufirst%3DM.%26atitle%3DPeptidotriazoles%2520on%2520solid%2520phase%253A%2520%255B1%252C2%252C3%255D-triazoles%2520by%2520regiospecific%2520copper%2528I%2529-catalyzed%25201%252C3-dipolar%2520cycloadditions%2520of%2520terminal%2520alkynes%2520to%2520azides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D3057%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Moorhouse, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, J. E.</span><span> </span><span class="NLM_article-title">Click chemistry and medicinal chemistry: a case of “cyclo-addiction”</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=715-723&author=A.+D.+Moorhouseauthor=J.+E.+Moses&title=Click+chemistry+and+medicinal+chemistry%3A+a+case+of+%E2%80%9Ccyclo-addiction%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoorhouse%26aufirst%3DA.%2BD.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26atitle%3DClick%2520chemistry%2520and%2520medicinal%2520chemistry%253A%2520a%2520case%2520of%2520%25E2%2580%259Ccyclo-addiction%25E2%2580%259D%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D715%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Jones, R. W.</span><span> </span><span class="NLM_article-title">Dimebon disappointment</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1186%2Falzrt49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20836898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BC3cbnsVKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=25&author=R.+W.+Jones&title=Dimebon+disappointment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Dimebon disappointment</span></div><div class="casAuthors">Jones Roy W</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dimebon (latrepirdine) has received widespread publicity as a potential therapy for Alzheimer's disease following a very positive phase 2 study carried out in Russia and published in the Lancet in 2008.  In this study there were improvements over 6 months in all endpoints (cognitive, global, daily function and behaviour), with continuing improvement at 12 months in cognition and daily function.  A more recent multinational phase 3 study, however, showed no improvements whatsoever and no difference between the two drug-treated groups and the placebo group.  Of note, there was little deterioration in any of the groups after 6 months in contrast to the placebo group in the phase 2 study.  The potential reasons for these disappointing results are discussed, as well as the implication for dimebon and drug treatment in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF38Y8DmqCPX6oPH0mYWL1fW6udTcc2eap2D0mYObxrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbnsVKksw%253D%253D&md5=d6b4e50451bbdb83da41e90e4d030a21</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2Falzrt49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt49%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BW.%26atitle%3DDimebon%2520disappointment%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2010%26volume%3D2%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Lizarzaburu, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">1,2,3,4-Tetrahydro-<i>c</i>-carbolinium salts: novel reactions with thiols, mediated by polymer-supported reagents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4781</span><span class="NLM_x">–</span> <span class="NLM_lpage">4783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=4781-4783&author=M.+E.+Lizarzaburuauthor=S.+J.+Shuttleworth&title=1%2C2%2C3%2C4-Tetrahydro-c-carbolinium+salts%3A+novel+reactions+with+thiols%2C+mediated+by+polymer-supported+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLizarzaburu%26aufirst%3DM.%2BE.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3D1%252C2%252C3%252C4-Tetrahydro-c-carbolinium%2520salts%253A%2520novel%2520reactions%2520with%2520thiols%252C%2520mediated%2520by%2520polymer-supported%2520reagents%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D4781%26epage%3D4783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Charonnat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chareton, J.</span><span> </span><span class="NLM_article-title">From a convulsive to an anticonvulsive product in the thiamine series</span> <span class="citation_source-journal">Therapie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1956&pages=261-264&author=R.+Charonnatauthor=P.+Lechatauthor=J.+Chareton&title=From+a+convulsive+to+an+anticonvulsive+product+in+the+thiamine+series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharonnat%26aufirst%3DR.%26aulast%3DLechat%26aufirst%3DP.%26aulast%3DChareton%26aufirst%3DJ.%26atitle%3DFrom%2520a%2520convulsive%2520to%2520an%2520anticonvulsive%2520product%2520in%2520the%2520thiamine%2520series%26jtitle%3DTherapie%26date%3D1956%26volume%3D11%26spage%3D261%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Ogren, S. O.</span><span> </span><span class="NLM_article-title">Chlormethiazole—mode of action</span> <span class="citation_source-journal">Acta Psychiatr. Scand., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1111%2Fj.1600-0447.1986.tb10530.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=2875615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADyaL28zhvFequg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1986&pages=13-27&author=S.+O.+Ogren&title=Chlormethiazole%E2%80%94mode+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Chlormethiazole--mode of action</span></div><div class="casAuthors">Ogren S O</div><div class="citationInfo"><span class="NLM_cas:title">Acta psychiatrica Scandinavica. Supplementum</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-27</span>
        ISSN:<span class="NLM_cas:issn">0065-1591</span>.
    </div><div class="casAbstract">Studies in mice demonstrated that the anticonvulsant profile of chlormethiazole differs from that of diazepam and the barbiturates.  Chlormethiazole protects animals from convulsions induced by a wide variety of chemoconvulsants known to block the action of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), such as bicuculline, picrotoxin, isoniazid and pentetrazol, thus confirming and extending earlier studies on its broad anticonvulsant characteristics.  Chlormethiazole is particularly potent against isoniazid-induced convulsions, which are probably induced by reductions of GABA levels in the brain.  Chlormethiazole was found to have a weak action on benzodiazepine receptor binding, GABA receptor binding and kainic acid receptor binding.  Chlormethiazole inhibited picrotoxin binding at very high concentrations, but lowered the functional effects of picrotoxin at much lower concentrations than those affecting picrotoxin binding.  Moreover, chlormethiazole failed to change GABA or glutamate levels in the brain and did not affect glutamic acid decarboxylase (GAD) activities in the rat brain.  Muscimol (a GABAA agonist) enhanced the anticonvulsant activity of chlormethiazole against picrotoxin but not against bicuculline-induced convulsions.  Muscimol enhanced the anticonvulsant potency of diazepam against both chemoconvulsants.  These data suggest that the anticonvulsant activity of chlormethiazole is not mediated directly through changes in GABA or glutamate levels or by a direct (agonist) action at the GABA or benzodiazepine receptor complex.  These findings suggest that chlormethiazole may enhance GABA transmission beyond the GABA receptors, hypothetically at the level of the GABA receptor coupled ionophore (e.g. the chloride ion channel).  Applied micro-iontophoretically, chlormethiazole was found to potentiate the inhibitory responses to GABA, muscimol and glycine, but not to acetylcholine.  The potentiation of glycine-mediated inhibition is unique for chlormethiazole and does not occur with any other known anticonvulsant (barbiturates, benzodiazepine, phenytoin or sodium valproate).  Studies in primary cultures, derived from spinal cord neurones, showed that chlormethiazole produces hyperpolarization together with an increase in the threshold for action potential generation.  Further in vitro studies indicated that chlormethiazole acts on some types of Ca2+-dependent chloride ion channels.(ABSTRACT TRUNCATED AT 400 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS4x0VSMbsbGUwlCcfExbvbfW6udTcc2eYfQiIXpWWhaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL28zhvFequg%253D%253D&md5=861da22e1915e4a3cb2a810fd71563e6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0447.1986.tb10530.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0447.1986.tb10530.x%26sid%3Dliteratum%253Aachs%26aulast%3DOgren%26aufirst%3DS.%2BO.%26atitle%3DChlormethiazole%25E2%2580%2594mode%2520of%2520action%26jtitle%3DActa%2520Psychiatr.%2520Scand.%252C%2520Suppl.%26date%3D1986%26volume%3D329%26spage%3D13%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Hedlund, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogren, S. O.</span><span> </span><span class="NLM_article-title">Chlormethiazole acts on chloride channels in cultured spinal cord neurons</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1987&pages=217-221&author=B.+Hedlundauthor=S.+O.+Ogren&title=Chlormethiazole+acts+on+chloride+channels+in+cultured+spinal+cord+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHedlund%26aufirst%3DB.%26aulast%3DOgren%26aufirst%3DS.%2BO.%26atitle%3DChlormethiazole%2520acts%2520on%2520chloride%2520channels%2520in%2520cultured%2520spinal%2520cord%2520neurons%26jtitle%3DNeurosci.%2520Lett.%26date%3D1987%26volume%3D78%26spage%3D217%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Nelson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, A. H.</span><span> </span><span class="NLM_article-title">Electrophysiological actions of γ-aminobutyric acid and clomethiazole on recombinant GABAA receptors</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">452</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2FS0014-2999%2802%2902233-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=12359265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVagtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2002&pages=255-262&author=R.+M.+Nelsonauthor=A.+R.+Greenauthor=A.+H.+Hainsworth&title=Electrophysiological+actions+of+%CE%B3-aminobutyric+acid+and+clomethiazole+on+recombinant+GABAA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Electrophysiological actions of γ-aminobutyric acid and clomethiazole on recombinant GABAA receptors</span></div><div class="casAuthors">Nelson, Rachael M.; Green, A. Richard; Hainsworth, Atticus H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-262</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Clomethiazole is a γ-aminobutyric acid (GABA)-mimetic agent with anticonvulsant, sedative and neuroprotective properties.  The pharmacol. actions of clomethiazole that underlie its functional profile have not been fully explored, but are known to result from an interaction with the GABAA receptor.  Here, the authors present a quant. electrophysiol. study of clomethiazole action at human recombinant GABAA receptors.  Whole-cell currents were recorded from murine L(tk-) cells stably transfected with either α1, β1 and γ2 or α1, β2 and γ2 GABAA receptor subunits.  Clomethiazole directly activated GABAA currents in α1/β1/γ2- and α1/β2/γ2-contg. cells, with EC50 values of 0.3 and 1.5 mM, resp.  A low concn. of clomethiazole (30 μM) also potentiated the action of GABA in both cell types, equiv. to a 3-fold increase in potency and up to 1.8-fold increase in maximal current.  Both direct activation and gamma-aminobutyric acid potentiation are likely to contribute to the in vivo profile of clomethiazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6QNADF3WTorVg90H21EOLACvtfcHk0lid89ak_dYyXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVagtrc%253D&md5=ff387c765d1a507b8b1ee27e5bb91547</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2902233-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252902233-1%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DR.%2BM.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DHainsworth%26aufirst%3DA.%2BH.%26atitle%3DElectrophysiological%2520actions%2520of%2520%25CE%25B3-aminobutyric%2520acid%2520and%2520clomethiazole%2520on%2520recombinant%2520GABAA%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D452%26spage%3D255%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Marshall, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, R. M.</span><span> </span><span class="NLM_article-title">Clomethiazole protects against hemineglect in a primate model of stroke</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2FS0361-9230%2899%2900275-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10779698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFGqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2000&pages=21-29&author=J.+W.+Marshallauthor=A.+J.+Crossauthor=D.+M.+Jacksonauthor=A.+R.+Greenauthor=H.+F.+Bakerauthor=R.+M.+Ridley&title=Clomethiazole+protects+against+hemineglect+in+a+primate+model+of+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Clomethiazole protects against hemineglect in a primate model of stroke</span></div><div class="casAuthors">Marshall, J. W. B.; Cross, A. J.; Jackson, D. M.; Green, A. R.; Baker, H. F.; Ridley, R. M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Permanent occlusion of the M1 segment of the middle cerebral artery (pMCAO) in the marmoset, a New World species of monkey, produces unilateral functional deficits, including motor neglect with the contralesional arm and contralesional spatial hemineglect.  This study examd. whether clomethiazole, a drug which modulates the GABAA receptor, would reduce the severity of the hemineglect and other deficits in this primate model of stroke.  Monkeys received pMCAO; 1 h later some were administered clomethiazole by i.p. injection and s.c. implantation of osmotic minipumps, which released clomethiazole for 48 h.  The monkeys had been trained and tested on a no. of behavioral tasks prior to surgery and were retested 3 and 10 wk later.  Three weeks after pMCAO, the monkeys treated with clomethiazole had a reduced degree of spatial neglect compared to untreated controls.  Clomethiazole was not effective against the severe contralesional motor impairment, although it had ameliorated a somewhat less severe motor deficit in a previous study in which the more distal, M2 segment of the middle cerebral artery had been occluded.  Postmortem anal. of the brains showed that clomethiazole treatment had reduced the area of damage in part of the parietal cortex.  Clomethiazole may reduce the neglect that can be a debilitating consequence of right-sided stroke in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJzqnYFto78rVg90H21EOLACvtfcHk0lid89ak_dYyXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFGqsbg%253D&md5=6be6ef6d5328c5f07a0f400ca74de036</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2899%2900275-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252899%252900275-0%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DJ.%2BW.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26aulast%3DJackson%26aufirst%3DD.%2BM.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DBaker%26aufirst%3DH.%2BF.%26aulast%3DRidley%26aufirst%3DR.%2BM.%26atitle%3DClomethiazole%2520protects%2520against%2520hemineglect%2520in%2520a%2520primate%2520model%2520of%2520stroke%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2000%26volume%3D52%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Gilby, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydserff, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, H. A.</span><span> </span><span class="NLM_article-title">Differential neuroprotective effects for three GABA-potentiating compounds in a model of hypoxia-ischemia</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1035</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.brainres.2004.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15722059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslWktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1035&publication_year=2005&pages=196-205&author=K.+L.+Gilbyauthor=S.+G.+Sydserffauthor=H.+A.+Robertson&title=Differential+neuroprotective+effects+for+three+GABA-potentiating+compounds+in+a+model+of+hypoxia-ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Differential neuroprotective effects for three GABA-potentiating compounds in a model of hypoxia-ischemia</span></div><div class="casAuthors">Gilby, K. L.; Sydserff, S. G.; Robertson, H. A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1035</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-205</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Clomethiazole (CMZ) is a GABAA-potentiating compd.; however, it is unclear whether this mode of action is responsible for its neuroprotective effects in animal models of ischemia.  This study compared the neuroprotective efficacies of muscimol and midazolam, two potent GABAA-potentiating compds., to that of CMZ in a model of hypoxia-ischemia (H-I).  To establish a neuroprotective profile for CMZ, CMZ (60, 95, or 125 mg kg-1, i.p.) was administered to post-natal day 25 male rats at numerous post-hypoxic time points and the rats were sacrificed 1 or 4 wk later.  Varying degrees of histol. protection were evident when CMZ was administered 1, 2, or 3 h post-hypoxia with the 125 mg kg-1 dose producing complete histol. protection if administered 3 h post-hypoxia.  To det. whether midazolam or muscimol could match the protection provided by CMZ administered 3 h post-hypoxia, H-I rats received varying doses of these compds. 3 h post-hypoxia and were sacrificed 1 wk later.  Under identical conditions, no dose of muscimol or midazolam provided equiv. neuroprotection to that provided by CMZ.  In fact, muscimol showed no neuroprotective ability whatsoever.  Thus, CMZ, administered as late as 3 h post-hypoxia, was able to completely prevent H-I-induced cell death while a full dose range of other GABA-potentiating agents did not.  Such direct comparison of these compds. in this model suggests the mechanism underlying the protective effects of CMZ may not rely solely on GABAA-potentiating properties.  Elucidation of a novel mechanism of action for CMZ may expose new therapeutic targets in stroke treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb3jTbqIFigbVg90H21EOLACvtfcHk0lhhm2_Wpsf6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslWktb4%253D&md5=b65eca56e9a4f562fc6abf2d98c118df</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2004.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2004.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DGilby%26aufirst%3DK.%2BL.%26aulast%3DSydserff%26aufirst%3DS.%2BG.%26aulast%3DRobertson%26aufirst%3DH.%2BA.%26atitle%3DDifferential%2520neuroprotective%2520effects%2520for%2520three%2520GABA-potentiating%2520compounds%2520in%2520a%2520model%2520of%2520hypoxia-ischemia%26jtitle%3DBrain%2520Res.%26date%3D2005%26volume%3D1035%26spage%3D196%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwyl, R.</span><span> </span><span class="NLM_article-title">Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3370</span><span class="NLM_x">–</span> <span class="NLM_lpage">3378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.1633-03.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15056716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1yhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=3370-3378&author=Q.+Wangauthor=D.+M.+Walshauthor=M.+J.+Rowanauthor=D.+J.+Selkoeauthor=R.+Anwyl&title=Block+of+long-term+potentiation+by+naturally+secreted+and+synthetic+amyloid+beta-peptide+in+hippocampal+slices+is+mediated+via+activation+of+the+kinases+c-Jun+N-terminal+kinase%2C+cyclin-dependent+kinase+5%2C+and+p38+mitogen-activated+protein+kinase+as+well+as+metabotropic+glutamate+receptor+type+5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5</span></div><div class="casAuthors">Wang, Qinwen; Walsh, Dominic M.; Rowan, Michael J.; Selkoe, Dennis J.; Anwyl, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3370-3378</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The mechanisms of action of human synthetic and naturally secreted cell-derived amyloid β-peptide (Aβ)1-42 on the induction of long-term potentiation (LTP) were investigated in the medial perforant path to dentate granule cell synapses in hippocampal slices.  Synthetic and cell-derived Aβ strongly inhibited high-frequency stimulation (HFS)-induced LTP at peak HFS and 1 h after HFS.  Cell-derived Aβ was much more potent than synthetic Aβ at inhibiting LTP induction, with threshold concns. of ∼1 and 100-200 nM, resp.  The involvement of various kinases in Aβ-mediated inhibition of LTP induction was investigated by applying Aβ in the presence of inhibitors of these kinases.  The c-Jun N-terminal kinase (JNK) inhibitor JNKI prevented the block of LTP induction by both synthetic and cell-derived Aβ.  The block of LTP induced by synthetic Aβ was also prevented by the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one, the cyclin-dependent kinase 5 (Cdk5) inhibitors butyrolactone and roscovitine, and the p38 MAP kinase (MAPK) inhibitor 4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1H-imidazole but not by the p42-p44 MAP kinase inhibitor 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene.  The group I-group II metabotropic glutamate receptor (mGluR) antagonist 2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid and the mGluR5 antagonist methyl-6-(phenylethynyl)pyridine prevented the block of LTP induction by Aβ.  However, the α7 nicotinic ACh receptor antagonist methylcaconatine did not prevent the inhibition of LTP induction by Aβ.  These studies provide evidence that the Aβ-mediated inhibition of LTP induction involves stimulation of the kinases JNK, Cdk5, and p38 MAPK after the activation of both the Aβ receptor(s) and mGluR5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM3Y0ZEhug9bVg90H21EOLACvtfcHk0lhhm2_Wpsf6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1yhsL0%253D&md5=59877a2758587038672a2ad3662827e2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1633-03.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1633-03.2004%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DRowan%26aufirst%3DM.%2BJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DAnwyl%26aufirst%3DR.%26atitle%3DBlock%2520of%2520long-term%2520potentiation%2520by%2520naturally%2520secreted%2520and%2520synthetic%2520amyloid%2520beta-peptide%2520in%2520hippocampal%2520slices%2520is%2520mediated%2520via%2520activation%2520of%2520the%2520kinases%2520c-Jun%2520N-terminal%2520kinase%252C%2520cyclin-dependent%2520kinase%25205%252C%2520and%2520p38%2520mitogen-activated%2520protein%2520kinase%2520as%2520well%2520as%2520metabotropic%2520glutamate%2520receptor%2520type%25205%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D3370%26epage%3D3378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Rowan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyubin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwyl, R.</span><span> </span><span class="NLM_article-title">Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity</span> <span class="citation_source-journal">Exp. Gerontol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1661</span><span class="NLM_x">–</span> <span class="NLM_lpage">1667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.exger.2004.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15582282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCltLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2004&pages=1661-1667&author=M.+J.+Rowanauthor=I.+Klyubinauthor=Q.+Wangauthor=R.+Anwyl&title=Mechanisms+of+the+inhibitory+effects+of+amyloid+beta-protein+on+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of the inhibitory effects of amyloid β-protein on synaptic plasticity</span></div><div class="casAuthors">Rowan, Michael J.; Klyubin, Igor; Wang, Qinwen; Anwyl, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1661-1667</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease can be considered a protein misfolding disease.  In particular, inappropriate processing of a proteolytic fragment of amyloid precursor protein, amyloid β-protein (Aβ), in early stages of Alzheimer's disease may lead to stabilization of small oligomers that are highly mobile and have a potential to be extremely toxic assemblies.  Recently, the importance of such sol. species of Aβ in triggering synaptic dysfunction, long before neuronal loss occurs, has become apparent.  Animal models have revealed that plasticity of hippocampal excitatory synaptic transmission is relatively selectively vulnerable to Aβ both in vitro and in vivo.  This review focuses on the mechanisms of Aβ inhibition of long-term potentiation at synapses in the rodent hippocampus from two complementary perspectives.  Firstly, the authors examine evidence that the synaptic activity of this peptide resides primarily in oligomeric rather than monomeric or fibrillar Aβ species.  Secondly, the importance of different oxidative/nitrosative stress-linked cascades including JNK, p38 MAPK and NADPH oxidase/iNOS-generated reactive oxygen/nitrogen free radicals in mediating the inhibition of LTP by Aβ is emphasized.  These mechanistic studies provide a plausible explanation for the sensitivity of hippocampus-dependent memory to impairment in the early preclin. stages of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGHLfBfxTn8bVg90H21EOLACvtfcHk0lhhm2_Wpsf6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCltLbL&md5=b73b5843a0da754004121bf62d2941ac</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2004.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2004.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DM.%2BJ.%26aulast%3DKlyubin%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAnwyl%26aufirst%3DR.%26atitle%3DMechanisms%2520of%2520the%2520inhibitory%2520effects%2520of%2520amyloid%2520beta-protein%2520on%2520synaptic%2520plasticity%26jtitle%3DExp.%2520Gerontol.%26date%3D2004%26volume%3D39%26spage%3D1661%26epage%3D1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snape, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, A. J.</span><span> </span><span class="NLM_article-title">The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolites</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1038%2Fsj.bjp.0703042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10694207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVart7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=95-100&author=A.+R.+Greenauthor=T.+K.+Murrayauthor=A.+Misraauthor=M.+F.+Snapeauthor=J.+A.+Jonesauthor=A.+J.+Cross&title=The+metabolism+of+clomethiazole+in+gerbils+and+the+neuroprotective+and+sedative+activity+of+the+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolites</span></div><div class="casAuthors">Green, A. R.; Murray, T. K.; Misra, A.; Snape, M. F.; Jones, J. A.; Cross, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-100</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A single dose of clomethiazole (600 μmol kg-1 i.p.) has previously been shown to be neuroprotective in the gerbil model of global ischemia.  In gerbils, clomethiazole (600 μmol kg-1) injection produced a rapid appearance (peak within 5 min) of drug in plasma and brain and similar clearance (plasma t1/2: 40 min) from both tissues.  The peak brain concn. (226±56 nmol g-1) was 40% higher than plasma.  One major metabolite, 5-(1-hydroxyethyl-2-chloro)-4-methylthiazole (NLA-715) and 2 minor metabolites 5-(1-hydroxyethyl)-4-methylthiazole (NLA-272) and 5-acetyl-4-methylthiazole (NLA-511) were detected in plasma and brain.  Evidence suggested that clomethiazole is metabolized directly to both NLA-715 and NLA-272.  Injection of NLA-715, NLA-272 or NLA-511 (each at 600 μmol kg-1) produced brain concns. resp. 2.2, 38 and 92 times greater than seen after clomethiazole (600 μmol kg-1).  Clomethiazole (600 μmol kg-1) injected 60 min after a 5 min bilateral carotid artery occlusion in gerbils attenuated the ischemia-induced degeneration of the hippocampus by approx. 70%.  The metabolites were not neuroprotective at this dose.  In mice, clomethiazole (600 μmol kg-1) produced peak plasma and brain concns. approx. 100% higher than in gerbils, drug concns. in several brain regions were similar but 35% higher than plasma.  Clomethiazole (ED50: 180 μmol kg-1) and NLA-715 (ED50: 240 μmol kg-1) inhibited spontaneous locomotor activity.  The other metabolites were not sedative (ED50 >600 μmol kg-1).  Thus, the neuroprotective action of clomethiazole results from an action of the parent compd. and that NLA-715 contributes to the sedative activity of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS1-NIwBMzabVg90H21EOLACvtfcHk0lhPi3WZ-Xc9WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVart7c%253D&md5=7156dc247caefae479ee8669e07af1b5</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703042%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DMurray%26aufirst%3DT.%2BK.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DSnape%26aufirst%3DM.%2BF.%26aulast%3DJones%26aufirst%3DJ.%2BA.%26aulast%3DCross%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520metabolism%2520of%2520clomethiazole%2520in%2520gerbils%2520and%2520the%2520neuroprotective%2520and%2520sedative%2520activity%2520of%2520the%2520metabolites%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D129%26spage%3D95%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Ende, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiteller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heipertz, R.</span><span> </span><span class="NLM_article-title">Urinary metabolites of clomethiazole. Detection and structural analysis by gas chromatography–mass spectrometry</span> <span class="citation_source-journal">Arzneim. Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=543872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaL3cXmvFamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1979&pages=1655-8&author=M.+Endeauthor=G.+Spitellerauthor=G.+Rembergauthor=R.+Heipertz&title=Urinary+metabolites+of+clomethiazole.+Detection+and+structural+analysis+by+gas+chromatography%E2%80%93mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary metabolites of clomethiazole.  Detection and structural analysis by gas chromatography-mass spectrometry</span></div><div class="casAuthors">Ende, M.; Spiteller, G.; Remberg, G.; Heipertz, R.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1655-8</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">Five previously unknown metabolites of clomethiazole (I)  [533-45-9] were isolated from human urine, and their structures were elucidated by gas chromatog.-mass spectrometry.  Metabolic studies of I demonstrated changes only at the Et group, however, the newly isolated metabolites demonstrated changes at the Me group, also.  The newly isolated compds., 5-(1-hydroxy-2-chloroethyl)-4-methylthiazole  [72579-01-2] and 5-(2-hydroxyethyl)-4-thiazole carboxylic acid lactone  [72579-00-1] were more abundant in human urine than 4-methyl-5-thiazole acetic acid  [5255-33-4], previously considered as the main metabolite of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsORu3eG4kcbVg90H21EOLACvtfcHk0lhPi3WZ-Xc9WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXmvFamsQ%253D%253D&md5=2bc31dd1bd54869272aa2845c57aefc2</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEnde%26aufirst%3DM.%26aulast%3DSpiteller%26aufirst%3DG.%26aulast%3DRemberg%26aufirst%3DG.%26aulast%3DHeipertz%26aufirst%3DR.%26atitle%3DUrinary%2520metabolites%2520of%2520clomethiazole.%2520Detection%2520and%2520structural%2520analysis%2520by%2520gas%2520chromatography%25E2%2580%2593mass%2520spectrometry%26jtitle%3DArzneim.%2520Forsch.%26date%3D1979%26volume%3D29%26spage%3D1655%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Simi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingelman-Sundberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tindberg, N.</span><span> </span><span class="NLM_article-title">Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">–</span> <span class="NLM_lpage">1088</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1097%2F00004647-200007000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=10908041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFOmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1077-1088&author=A.+Simiauthor=M.+Ingelman-Sundbergauthor=N.+Tindberg&title=Neuroprotective+agent+chlomethiazole+attenuates+c-fos%2C+c-jun%2C+and+AP-1+activation+through+inhibition+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective agent clomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase</span></div><div class="casAuthors">Simi, Anastasia; Ingelman-Sundberg, Magnus; Tindberg, Niclas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1077-1088</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Recent evidence suggests that stress-activated protein kinases expressed in glial cells have very important roles during cerebral ischemia.  The neuroprotective agent clomethiazole, which is known to enhance the conductance at the GABAA receptor complex, is presently in clin. trials for the treatment of severe stroke.  Here the authors suggested that clomethiazole has anti-inflammatory properties because it potently and selectively inhibited p38 mitogen-activated protein (MAP) kinase in primary cortical glial cultures.  The inhibition of p38 MAP kinase resulted in the attenuation of the induction of c-fos and c-jun mRNA and AP-1 DNA binding by lipopolysaccharide (LPS).  In addn., clomethiazole inhibited the activation of an AP-1-dependent luciferase reporter plasmid in SK-N-MC human neuroblastoma cells in response to glutamate.  Clomethiazole inhibited the p38 MAP kinase activity as revealed by the decrease in the LPS-induced phosphorylation of the substrates ATF-2 and hsp27, whereas the phosphorylation status of the p38 MAP kinase itself was unaffected.  Interestingly, clomethiazole exhibited an IC50 of ∼ 2 μmol/L for inhibition of c-fos mRNA expression, indicating 25 to 75 times higher potency than reported EC50 values for enhancing GABAA chloride currents.  The results indicated a novel mechanism of action of clomethiazole, and provided support for a distinctive role of p38 MAP kinase in cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyPrW4adbmIrVg90H21EOLACvtfcHk0lhPi3WZ-Xc9WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFOmurk%253D&md5=2acd66a47a5058bd2424d06a1af3de08</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1097%2F00004647-200007000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-200007000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DSimi%26aufirst%3DA.%26aulast%3DIngelman-Sundberg%26aufirst%3DM.%26aulast%3DTindberg%26aufirst%3DN.%26atitle%3DNeuroprotective%2520agent%2520chlomethiazole%2520attenuates%2520c-fos%252C%2520c-jun%252C%2520and%2520AP-1%2520activation%2520through%2520inhibition%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab%26date%3D2000%26volume%3D20%26spage%3D1077%26epage%3D1088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Impey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, R. H.</span><span> </span><span class="NLM_article-title">CREB signaling—timing is everything</span> <span class="citation_source-journal">Sci. STKE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">PE1</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2001&publication_year=2001&pages=PE1&author=S.+Impeyauthor=R.+H.+Goodman&title=CREB+signaling%E2%80%94timing+is+everything"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImpey%26aufirst%3DS.%26aulast%3DGoodman%26aufirst%3DR.%2BH.%26atitle%3DCREB%2520signaling%25E2%2580%2594timing%2520is%2520everything%26jtitle%3DSci.%2520STKE%26date%3D2001%26volume%3D2001%26spage%3DPE1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Radley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akram, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, C. L.</span><span> </span><span class="NLM_article-title">Investigation of the mechanisms of progesterone protection following oxygen–glucose deprivation in organotypic hippocampal slice cultures</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">506</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=506&publication_year=2012&pages=131-135&author=E.+Radleyauthor=A.+Akramauthor=B.+D.+Grubbauthor=C.+L.+Gibson&title=Investigation+of+the+mechanisms+of+progesterone+protection+following+oxygen%E2%80%93glucose+deprivation+in+organotypic+hippocampal+slice+cultures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRadley%26aufirst%3DE.%26aulast%3DAkram%26aufirst%3DA.%26aulast%3DGrubb%26aufirst%3DB.%2BD.%26aulast%3DGibson%26aufirst%3DC.%2BL.%26atitle%3DInvestigation%2520of%2520the%2520mechanisms%2520of%2520progesterone%2520protection%2520following%2520oxygen%25E2%2580%2593glucose%2520deprivation%2520in%2520organotypic%2520hippocampal%2520slice%2520cultures%26jtitle%3DNeurosci.%2520Lett.%26date%3D2012%26volume%3D506%26spage%3D131%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Whalley, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constanti, A.</span><span> </span><span class="NLM_article-title">Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1111%2Fj.1476-5381.2008.00110.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=19226287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=994-1008&author=B.+J.+Whalleyauthor=G.+J.+Stephensauthor=A.+Constanti&title=Investigation+of+the+effects+of+the+novel+anticonvulsant+compound+carisbamate+%28RWJ-333369%29+on+rat+piriform+cortical+neurones+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro</span></div><div class="casAuthors">Whalley, B. J.; Stephens, G. J.; Constanti, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">994-1008</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Carisbamate is being developed for adjuvant treatment of partial onset epilepsy.  Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizure models, and exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models.  Phase IIb clin. trials of carisbamate demonstrated efficacy against partial onset seizures; however, its mechanisms of action remain unknown.  Here, we report the effects of carisbamate on membrane properties, evoked and spontaneous synaptic transmission and induced epileptiform discharges in layer II-III neurons in piriform cortical brain slices.  Effects of carisbamate were investigated in rat piriform cortical neurons by using intracellular electrophysiol. recordings.  Carisbamate (50-400 μmol/L-1) reversibly decreased amplitude, duration and rise-time of evoked action potentials and inhibited repetitive firing, consistent with use-dependent Na+ channel block; 150-400 μmol/L-1 carisbamate reduced neuronal input resistance, without altering membrane potential.  After microelectrode intracellular Cl- loading, carisbamate depolarized cells, an effect reversed by picrotoxin.  Carisbamate (100-400 μmol/L-1) also selectively depressed lateral olfactory tract-afferent evoked excitatory synaptic transmission (opposed by picrotoxin), consistent with activation of a presynpatic Cl- conductance.  Lidocaine (40-320 μmol/L-1) mimicked carisbamate, implying similar modes of action.  Carisbamate (300-600 μmol/L-1) had no effect on spontaneous GABAA miniature inhibitory postsynaptic currents and at lower concns. (50-200 μmol/L-1) inhibited Mg2+-free or 4-aminopyridine-induced seizure-like discharges.  Carisbamate blocked evoked action potentials use-dependently, consistent with a primary action on Na+ channels and increased Cl- conductances presynaptically and, under certain conditions, postsynaptically to selectively depress excitatory neurotransmission in piriform cortical layer la-afferent terminals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtZBWJAUuBrVg90H21EOLACvtfcHk0lhoUj2FhrXBnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Oqs7k%253D&md5=81ecb1a4d724b88bf616660055c4de93</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00110.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00110.x%26sid%3Dliteratum%253Aachs%26aulast%3DWhalley%26aufirst%3DB.%2BJ.%26aulast%3DStephens%26aufirst%3DG.%2BJ.%26aulast%3DConstanti%26aufirst%3DA.%26atitle%3DInvestigation%2520of%2520the%2520effects%2520of%2520the%2520novel%2520anticonvulsant%2520compound%2520carisbamate%2520%2528RWJ-333369%2529%2520on%2520rat%2520piriform%2520cortical%2520neurones%2520in%2520vitro%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26spage%3D994%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Pond, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustine, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz-Bloom, R. D.</span><span> </span><span class="NLM_article-title">The chloride transporter Na(+)-K(+)-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1396</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1523%2FJNEUROSCI.1421-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16452663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFait74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=1396-406&author=B.+B.+Pondauthor=K.+Berglundauthor=T.+Kunerauthor=G.+Fengauthor=G.+J.+Augustineauthor=R.+D.+Schwartz-Bloom&title=The+chloride+transporter+Na%28%2B%29-K%28%2B%29-Cl-+cotransporter+isoform-1+contributes+to+intracellular+chloride+increases+after+in+vitro+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">The chloride transporter Na+-K+-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia</span></div><div class="casAuthors">Pond, Brooks B.; Berglund, Ken; Kuner, Thomas; Feng, Guoping; Augustine, George J.; Schwartz-Bloom, Rochelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1396-1406</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Ischemic episodes in the CNS cause significant disturbances in neuronal ionic homeostasis.  To directly measure changes in intracellular Cl- concn. ([Cl-]i) during and after ischemia, we used Clomeleon, a novel ratiometric optical indicator for Cl-.  Hippocampal slices from adult transgenic mice expressing Clomeleon in hippocampal neurons were subjected to 8 min of oxygen-glucose deprivation (OGD) (an in vitro model for ischemia) and reoxygenated in the presence of glucose.  This produced mild neuronal damage 3 h later that was prevented when the extracellular [Cl-] was maintained at 10 mM during reoxygenation.  OGD induced a transient decrease in fluorescence resonance energy transfer within Clomeleon, indicating an increase in [Cl-]i.  During reoxygenation, there was a partial recovery in [Cl-]i, but [Cl-]i rose again 45 min later.  To investigate sources of Cl- accumulation, we examd. the effects of Cl- transport inhibitors on the rises in [Cl-]i during and after OGD.  Bumetanide and furosemide, which inhibit Cl- influx through the Na+-K+-Cl- cotransporter isoform-1 (NKCC-1) and efflux through the K+-Cl- cotransporter isoform-2, were unable to inhibit the first rise in [Cl-]i, yet entirely prevented the secondary rise in [Cl-]i during reoxygenation.  In contrast, picrotoxin, which blocks the GABA-gated Cl- channel, did not inhibit the secondary rise in [Cl-]i after OGD.  [Cl-]i increases during reoxygenation were accompanied by an increase in phosphorylation of NKCC-1, an indication of increased NKCC-1 activity after OGD.  We conclude that NKCC-1 plays an important role in OGD-induced Cl- accumulation and subsequent neuronal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqUf8nabtWD7Vg90H21EOLACvtfcHk0lhoUj2FhrXBnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFait74%253D&md5=ebea2486d8f669b3221fc9cdf404f854</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1421-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1421-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DPond%26aufirst%3DB.%2BB.%26aulast%3DBerglund%26aufirst%3DK.%26aulast%3DKuner%26aufirst%3DT.%26aulast%3DFeng%26aufirst%3DG.%26aulast%3DAugustine%26aufirst%3DG.%2BJ.%26aulast%3DSchwartz-Bloom%26aufirst%3DR.%2BD.%26atitle%3DThe%2520chloride%2520transporter%2520Na%2528%252B%2529-K%2528%252B%2529-Cl-%2520cotransporter%2520isoform-1%2520contributes%2520to%2520intracellular%2520chloride%2520increases%2520after%2520in%2520vitro%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D1396%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Gravielle, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russek, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farb, D. H.</span><span> </span><span class="NLM_article-title">GABA induces activity dependent delayed-onset uncoupling of GABA/benzodiazepine site interactions in neocortical neurons</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">20954</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=20954-60&author=M.+C.+Gravielleauthor=R.+Farisauthor=S.+J.+Russekauthor=D.+H.+Farb&title=GABA+induces+activity+dependent+delayed-onset+uncoupling+of+GABA%2Fbenzodiazepine+site+interactions+in+neocortical+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGravielle%26aufirst%3DM.%2BC.%26aulast%3DFaris%26aufirst%3DR.%26aulast%3DRussek%26aufirst%3DS.%2BJ.%26aulast%3DFarb%26aufirst%3DD.%2BH.%26atitle%3DGABA%2520induces%2520activity%2520dependent%2520delayed-onset%2520uncoupling%2520of%2520GABA%252Fbenzodiazepine%2520site%2520interactions%2520in%2520neocortical%2520neurons%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D20954%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Sedelnikova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erkkila, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakharkin, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, D. S.</span><span> </span><span class="NLM_article-title">Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">577</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1113%2Fjphysiol.2006.120287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16990398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12r" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=577&publication_year=2006&pages=569-577&author=A.+Sedelnikovaauthor=B.+E.+Erkkilaauthor=H.+Harrisauthor=S.+O.+Zakharkinauthor=D.+S.+Weiss&title=Stoichiometry+of+a+pore+mutation+that+abolishes+picrotoxin-mediated+antagonism+of+the+GABAA+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor</span></div><div class="casAuthors">Sedelnikova, Anna; Erkkila, Brian E.; Harris, Holly; Zakharkin, Stanislav O.; Weiss, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">577</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">569-577</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Picrotoxin, a potent antagonist of the inhibitory central nervous system GABAA and glycine receptors, is believed to interact with residues that line the central ion pore.  These pore-lining residues are in the second transmembrane domain (TM2) of each of the five constituent subunits.  One of these amino acids, a threonine at the 6' location, when mutated to phenylalanine, abolishes picrotoxin sensitivity.  It has been suggested that this threonine, via hydrogen bonding, directly interacts with the picrotoxin mol.  We previously demonstrated that this mutation, in the α, β or γ subunit, can impart picrotoxin resistance to the GABA receptor.  Since the functional pentameric GABA receptor contains two α subunits, two β subunits and one γ subunit, it is not clear how many α and β subunits must carry this mutation to impart the resistant phenotype.  In this study, by coexpression of mutant α or β subunits with their wild-type counterparts in various defined ratios, we demonstrate that any single subunit carrying the 6' mutation imparts picrotoxin resistance.  Implications of this finding in terms of the mechanism of antagonism are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXHzn5xmq8O7Vg90H21EOLACvtfcHk0lhoUj2FhrXBnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12r&md5=97a1388bc68aca250186213cd6d0727b</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2006.120287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2006.120287%26sid%3Dliteratum%253Aachs%26aulast%3DSedelnikova%26aufirst%3DA.%26aulast%3DErkkila%26aufirst%3DB.%2BE.%26aulast%3DHarris%26aufirst%3DH.%26aulast%3DZakharkin%26aufirst%3DS.%2BO.%26aulast%3DWeiss%26aufirst%3DD.%2BS.%26atitle%3DStoichiometry%2520of%2520a%2520pore%2520mutation%2520that%2520abolishes%2520picrotoxin-mediated%2520antagonism%2520of%2520the%2520GABAA%2520receptor%26jtitle%3DJ.%2520Physiol.%26date%3D2006%26volume%3D577%26spage%3D569%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Korshoej, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J. D.</span><span> </span><span class="NLM_article-title">Kinetic analysis of evoked IPSCs discloses mechanism of antagonism of synaptic GABAA receptors by picrotoxin</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1111%2Fj.1476-5381.2009.00542.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20105180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlCiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2010&pages=636-649&author=A.+R.+Korshoejauthor=M.+M.+Holmauthor=K.+Jensenauthor=J.+D.+Lambert&title=Kinetic+analysis+of+evoked+IPSCs+discloses+mechanism+of+antagonism+of+synaptic+GABAA+receptors+by+picrotoxin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic analysis of evoked IPSCs discloses mechanism of antagonism of synaptic GABAA receptors by picrotoxin</span></div><div class="casAuthors">Korshoej, A. R.; Holm, M. M.; Jensen, K.; Lambert, J. D. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-649</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: Although picrotoxin is a well-established antagonist of GABAA receptors, detailed studies of its action on inhibitory synaptic transmission have not previously been made.  Exptl. approach: Electrophysiol. techniques were used to study the action of picrotoxin on inhibitory postsynaptic currents (IPSCs) evoked in hippocampal neurons, in culture and slice prepns. prepd. from Wistar rat embryos and juveniles, resp.  Key results: Picrotoxin gradually reduced the amplitude of GABAA receptor-mediated eIPSCs in a concn.-dependent manner.  This was accompanied by a marked acceleration of the eIPSC decay kinetics, which, in contrast to the effect on amplitude, developed immediately and was completely reversed on washing.  The decaying phase of the IPSC could be resolved into two components; 30 μM picrotoxin reduced τfast by 34% and increased its relative amplitude, while τslow was reduced by 38%, and its relative amplitude decreased.  The area under the decaying phase of the normalized eIPSC showed an immediate redn. by 36% in 30 μM picrotoxin.  With increasing concns. of picrotoxin, this normalized area converged towards 55% of the control, indicating that the rate of relaxation and block has a finite max.  This implies that picrotoxin does not act by a pore-occluding mechanism (open-channel blocking), and suggests allosteric stabilization of desensitized receptor states as a more likely alternative.  This was corroborated by modeling, based on two established microscopic GABAA receptor transition schemes.  Conclusions and implications: Although the identity of the stabilized state has not been detd. unequivocally, picrotoxin effectively traps synaptic GABAA receptors in a desensitized state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYbcwdX2gW67Vg90H21EOLACvtfcHk0lhUlIKPOvjZsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlCiu7g%253D&md5=ed734b3f9364ceb42df81091128e0c60</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00542.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00542.x%26sid%3Dliteratum%253Aachs%26aulast%3DKorshoej%26aufirst%3DA.%2BR.%26aulast%3DHolm%26aufirst%3DM.%2BM.%26aulast%3DJensen%26aufirst%3DK.%26aulast%3DLambert%26aufirst%3DJ.%2BD.%26atitle%3DKinetic%2520analysis%2520of%2520evoked%2520IPSCs%2520discloses%2520mechanism%2520of%2520antagonism%2520of%2520synaptic%2520GABAA%2520receptors%2520by%2520picrotoxin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D159%26spage%3D636%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Sceniak, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciver, M. B.</span><span> </span><span class="NLM_article-title">Slow GABA(A) mediated synaptic transmission in rat visual cortex</span> <span class="citation_source-journal">BMC Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1186%2F1471-2202-9-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=18199338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BD1c7itFSjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=8&author=M.+P.+Sceniakauthor=M.+B.+Maciver&title=Slow+GABA%28A%29+mediated+synaptic+transmission+in+rat+visual+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Slow GABA(A) mediated synaptic transmission in rat visual cortex</span></div><div class="casAuthors">Sceniak Michael P; Maciver M Bruce</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Previous reports of inhibition in the neocortex suggest that inhibition is mediated predominantly through GABA(A) receptors exhibiting fast kinetics.  Within the hippocampus, it has been shown that GABA(A) responses can take the form of either fast or slow response kinetics.  Our findings indicate, for the first time, that the neocortex displays synaptic responses with slow GABA(A) receptor mediated inhibitory postsynaptic currents (IPSCs).  These IPSCs are kinetically and pharmacologically similar to responses found in the hippocampus, although the anatomical specificity of evoked responses is unique from hippocampus.  Spontaneous slow GABA(A) IPSCs were recorded from both pyramidal and inhibitory neurons in rat visual cortex.  RESULTS:  GABA(A) slow IPSCs were significantly different from fast responses with respect to rise times and decay time constants, but not amplitudes.  Spontaneously occurring GABA(A) slow IPSCs were nearly 100 times less frequent than fast sIPSCs and both were completely abolished by the chloride channel blocker, picrotoxin.  The GABA(A) subunit-specific antagonist, furosemide, depressed spontaneous and evoked GABA(A) fast IPSCs, but not slow GABA(A)-mediated IPSCs.  Anatomical specificity was evident using minimal stimulation: IPSCs with slow kinetics were evoked predominantly through stimulation of layer 1/2 apical dendritic zones of layer 4 pyramidal neurons and across their basal dendrites, while GABA(A) fast IPSCs were evoked through stimulation throughout the dendritic arborization.  Many evoked IPSCs were also composed of a combination of fast and slow IPSC components.  CONCLUSION:  GABA(A) slow IPSCs displayed durations that were approximately 4 fold longer than typical GABA(A)fast IPSCs, but shorter than GABA(B)-mediated inhibition.  The anatomical and pharmacological specificity of evoked slow IPSCs suggests a unique origin of synaptic input.  Incorporating GABA(A) slow IPSCs into computational models of cortical function will help improve our understanding of cortical information processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnxydL3b1fDSCEBeYuoi7AfW6udTcc2eadJJXpSggK2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7itFSjtw%253D%253D&md5=57679bf2fdfbe69f4215ffaf1b3beadb</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-9-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-9-8%26sid%3Dliteratum%253Aachs%26aulast%3DSceniak%26aufirst%3DM.%2BP.%26aulast%3DMaciver%26aufirst%3DM.%2BB.%26atitle%3DSlow%2520GABA%2528A%2529%2520mediated%2520synaptic%2520transmission%2520in%2520rat%2520visual%2520cortex%26jtitle%3DBMC%2520Neurosci.%26date%3D2008%26volume%3D9%26spage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Han, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youn, D. H.</span><span> </span><span class="NLM_article-title">GABAA receptor-mediated tonic currents in substantia gelatinosa neurons of rat spinal trigeminal nucleus pars caudalis</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2008&pages=296-301&author=S.+M.+Hanauthor=D.+H.+Youn&title=GABAA+receptor-mediated+tonic+currents+in+substantia+gelatinosa+neurons+of+rat+spinal+trigeminal+nucleus+pars+caudalis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%2BM.%26aulast%3DYoun%26aufirst%3DD.%2BH.%26atitle%3DGABAA%2520receptor-mediated%2520tonic%2520currents%2520in%2520substantia%2520gelatinosa%2520neurons%2520of%2520rat%2520spinal%2520trigeminal%2520nucleus%2520pars%2520caudalis%26jtitle%3DNeurosci.%2520Lett.%26date%3D2008%26volume%3D441%26spage%3D296%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Fletcher, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeney, M. E.</span><span> </span><span class="NLM_article-title">Monosubstituted 1,2,3-triazoles from two-step one-pot deprotection/click additions of trimethylsilylacetylene</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7030</span><span class="NLM_x">–</span> <span class="NLM_lpage">7032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=7030-7032&author=J.+T.+Fletcherauthor=S.+E.+Walzauthor=M.+E.+Keeney&title=Monosubstituted+1%2C2%2C3-triazoles+from+two-step+one-pot+deprotection%2Fclick+additions+of+trimethylsilylacetylene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DJ.%2BT.%26aulast%3DWalz%26aufirst%3DS.%2BE.%26aulast%3DKeeney%26aufirst%3DM.%2BE.%26atitle%3DMonosubstituted%25201%252C2%252C3-triazoles%2520from%2520two-step%2520one-pot%2520deprotection%252Fclick%2520additions%2520of%2520trimethylsilylacetylene%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D7030%26epage%3D7032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Bender, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol702892e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=509-511&author=D.+M.+Benderauthor=J.+A.+Petersonauthor=J.+R.+McCarthyauthor=H.+Gunaydinauthor=Y.+Takanoauthor=K.+N.+Houk&title=Cyclopropanecarboxylic+acid+esters+as+potential+prodrugs+with+enhanced+hydrolytic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fol702892e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol702892e%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DD.%2BM.%26aulast%3DPeterson%26aufirst%3DJ.%2BA.%26aulast%3DMcCarthy%26aufirst%3DJ.%2BR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DY.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DCyclopropanecarboxylic%2520acid%2520esters%2520as%2520potential%2520prodrugs%2520with%2520enhanced%2520hydrolytic%2520stability%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D509%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Buckell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartry, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajalingam, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R. J.</span><span> </span><span class="NLM_article-title">Hydrolysis of nitrite esters: putative intermediates in the biotransformation of organic nitrates</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 2</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1039%2Fp29940000401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK2cXisVekt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=401-403&author=F.+Buckellauthor=J.+D.+Hartryauthor=U.+Rajalingamauthor=B.+M.+Bennettauthor=R.+A.+Whitneyauthor=G.+R.+J.+Thatcher&title=Hydrolysis+of+nitrite+esters%3A+putative+intermediates+in+the+biotransformation+of+organic+nitrates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolysis of nitrite esters: putative intermediates in the biotransformation of organic nitrates</span></div><div class="casAuthors">Buckell, Felicity; Hartry, Jeffrey D.; Rajalingam, Umarani; Bennett, Brian M.; Whitney, Ralph A.; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society, Perkin Transactions 2:  Physical Organic Chemistry (1972-1999)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-3</span>CODEN:
                <span class="NLM_cas:coden">JCPKBH</span>;
        ISSN:<span class="NLM_cas:issn">0300-9580</span>.
    </div><div class="casAbstract">Study and comparison of the pH-independent hydrolysis of eight alkyl nitrites shows 3-nitroso-1,2-glyceryl dinitrate, a putative intermediate in the biotransformation of glyceryl trinitrate, to be unexpectedly reactive and too labile to be detected as a biotransformation intermediate in aq. soln., suggesting a role for neighboring group participation by the β-nitrate group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA8x9pPNJUgLVg90H21EOLACvtfcHk0lhUlIKPOvjZsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXisVekt70%253D&md5=526f3f99ad87780c7232c5dfcab11ccc</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1039%2Fp29940000401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp29940000401%26sid%3Dliteratum%253Aachs%26aulast%3DBuckell%26aufirst%3DF.%26aulast%3DHartry%26aufirst%3DJ.%2BD.%26aulast%3DRajalingam%26aufirst%3DU.%26aulast%3DBennett%26aufirst%3DB.%2BM.%26aulast%3DWhitney%26aufirst%3DR.%2BA.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%2BJ.%26atitle%3DHydrolysis%2520of%2520nitrite%2520esters%253A%2520putative%2520intermediates%2520in%2520the%2520biotransformation%2520of%2520organic%2520nitrates%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25202%26date%3D1994%26spage%3D401%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Sant’Angelo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Usefulness of behavioral and electrophysiological studies in transgenic models of Alzheimer’s disease</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1023%2FA%3A1023251005197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=12737525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=1009-1015&author=A.+Sant%E2%80%99Angeloauthor=F.+Trincheseauthor=O.+Arancio&title=Usefulness+of+behavioral+and+electrophysiological+studies+in+transgenic+models+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Usefulness of behavioral and electrophysiological studies in transgenic models of Alzheimer's disease</span></div><div class="casAuthors">Sant'Angelo, Antonino; Trinchese, Fabrizio; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1009-1015</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Over the past several years researchers have engineered many transgenic models of Alzheimer's disease.  Since loss of memory is one of the major hallmarks of the disorder, the phenotypic characterization of these animals has included both behavioral tests which aim to evaluate learning abilities, and electrophysiol. studies to analyze synaptic transmission and long-term potentiation, a widely studied cellular model of learning and memory.  These studies are fundamental for the design of novel therapies for the treatment and/or prevention of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQE0yx9BvJ_LVg90H21EOLACvtfcHk0lhWhHTVNWGAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislyisro%253D&md5=33386492cbaa336643330ec425e8be0e</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1023%2FA%3A1023251005197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1023251005197%26sid%3Dliteratum%253Aachs%26aulast%3DSant%25E2%2580%2599Angelo%26aufirst%3DA.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DUsefulness%2520of%2520behavioral%2520and%2520electrophysiological%2520studies%2520in%2520transgenic%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Res.%26date%3D2003%26volume%3D28%26spage%3D1009%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Bliss, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collingridge, G. L.</span><span> </span><span class="NLM_article-title">A synaptic model of memory: long-term potentiation in the hippocampus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1038%2F361031a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=8421494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADyaK3sXntlOntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=1993&pages=31-39&author=T.+V.+Blissauthor=G.+L.+Collingridge&title=A+synaptic+model+of+memory%3A+long-term+potentiation+in+the+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A synaptic model of memory:  long-term potentiation in the hippocampus</span></div><div class="casAuthors">Bliss, T. V. P.; Collingridge, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">6407</span>),
    <span class="NLM_cas:pages">31-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A review, with 174 refs., of long-term potentiation (LTP) of synaptic transmission in the hippocampus as the primary exptl. model for investigating the synaptic basis of learning and memory in vertebrates.  Topics discussed were: properties of hippocampal LTP; induction of LTP; and expression of LTP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1tHZif2aP7Vg90H21EOLACvtfcHk0lhWhHTVNWGAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXntlOntw%253D%253D&md5=285f5a175da5a77f4f57a3f5236e3e0a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2F361031a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F361031a0%26sid%3Dliteratum%253Aachs%26aulast%3DBliss%26aufirst%3DT.%2BV.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26atitle%3DA%2520synaptic%2520model%2520of%2520memory%253A%2520long-term%2520potentiation%2520in%2520the%2520hippocampus%26jtitle%3DNature%26date%3D1993%26volume%3D361%26spage%3D31%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battaglia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">814</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1002%2Fana.20101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15174014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=801-814&author=F.+Trincheseauthor=S.+Liuauthor=F.+Battagliaauthor=S.+Walterauthor=P.+M.+Mathewsauthor=O.+Arancio&title=Progressive+age-related+development+of+Alzheimer-like+pathology+in+APP%2FPS1+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span></div><div class="casAuthors">Trinchese, Fabrizio; Liu, Shumin; Battaglia, Fortunato; Walter, Sean; Mathews, Paul M.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">801-814</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasing evidence points to synaptic plasticity impairment as one of the first events in Alzheimer's disease (AD).  However, studies on synaptic dysfunction in different transgenic AD models that overexpress familial AD mutant forms of amyloid precursor protein (APP) and/or presenilin (PS) have provided conflicting results.  Both long-term potentiation (LTP) and basal synaptic transmission (BST) have been found to be both unchanged and altered in different models and under differing exptl. conditions.  Because of their more robust amyloid-β (Aβ) deposition, double transgenic mice currently are used by several labs. as an AD model.  Here, we report that mice overexpressing APP (K670N: M671L) together with PS1 (M146L) have abnormal LTP as early as 3 mo of age.  Interestingly, reduced LTP paralleled plaque appearance and increased Aβ levels and abnormal short-term memory (working memory).  BST and long-term memory (ref. memory) are impaired only later (approx. 6 mo) as amyloid burden increases.  Aβ pathol. across different ages did not correlate with synaptic and cognitive deficits, suggesting that Aβ levels are not a marker of memory decline.  In contrast, progression of LTP impairment correlated with the deterioration of working memory, suggesting that percentage of potentiation might be an indicator of the cognitive decline and disease progression in the APP/PS1 mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-0Sep8mnVgLVg90H21EOLACvtfcHk0lhWhHTVNWGAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D&md5=87f7a6dea17b0d35a775712088213641</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1002%2Fana.20101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20101%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBattaglia%26aufirst%3DF.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DProgressive%2520age-related%2520development%2520of%2520Alzheimer-like%2520pathology%2520in%2520APP%252FPS1%2520mice%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D801%26epage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Gong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1624</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1172%2FJCI22831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15578094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2004&pages=1624-1634&author=B.+Gongauthor=O.+V.+Vitoloauthor=F.+Trincheseauthor=S.+Liuauthor=M.+Shelanskiauthor=O.+Arancio&title=Persistent+improvement+in+synaptic+and+cognitive+functions+in+an+Alzheimer+mouse+model+after+rolipram+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span></div><div class="casAuthors">Gong, Bing; Vitolo, Ottavio V.; Trinchese, Fabrizio; Liu, Shumin; Shelanski, Michael; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1624-1634</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Evidence suggests that Alzheimer disease (AD) begins as a disorder of synaptic function, caused in part by increased levels of amyloid β-peptide 1-42 (Aβ42).  Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution K670N,M671L) and presenilin-1 (AA substitution M146V).  Here the authors demonstrate that brief treatment with the phosphodiesterase 4 inhibitor rolipram ameliorates deficits in both long-term potentiation (LTP) and contextual learning in the double-transgenic mice.  Most importantly, this beneficial effect can be extended beyond the duration of the administration.  One course of long-term systemic treatment with rolipram improves LTP and basal synaptic transmission as well as working, ref., and associative memory deficits for at least 2 mo after the end of the treatment.  This protective effect is possibly due to stabilization of synaptic circuitry via alterations in gene expression by activation of the cAMP-dependent protein kinase (PKA)/cAMP regulatory element-binding protein (CREB) signaling pathway that make the synapses more resistant to the insult inflicted by Aβ.  Thus, agents that enhance the cAMP/PKA/CREB pathway have potential for the treatment of AD and other diseases assocd. with elevated Aβ42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI79h3DC1rU7Vg90H21EOLACvtfcHk0lh_dv0X4x0YOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I&md5=72e43d10754678b58a452160fe7142e2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1172%2FJCI22831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI22831%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DVitolo%26aufirst%3DO.%2BV.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DShelanski%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPersistent%2520improvement%2520in%2520synaptic%2520and%2520cognitive%2520functions%2520in%2520an%2520Alzheimer%2520mouse%2520model%2520after%2520rolipram%2520treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D114%26spage%3D1624%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Schindler, U.</span><span> </span><span class="NLM_article-title">Pre-clinical evaluation of cognition enhancing drugs</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S99</span><span class="NLM_x">–</span> <span class="NLM_lpage">S115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1989&pages=S99-S115&issue=Suppl.&author=U.+Schindler&title=Pre-clinical+evaluation+of+cognition+enhancing+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DU.%26atitle%3DPre-clinical%2520evaluation%2520of%2520cognition%2520enhancing%2520drugs%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D1989%26volume%3D13%26issue%3DSuppl%26spage%3DS99%26epage%3DS115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Abdul-Hay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiefer, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasena, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelhamid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavassoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asghodom, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R.</span><span> </span><span class="NLM_article-title">NO-SSRIs: nitric oxide chimera drugs incorporating a selective serotonin reuptake inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=656-661&author=S.+Abdul-Hayauthor=I.+T.+Schieferauthor=R.+E.+Chandrasenaauthor=M.+Liauthor=R.+Abdelhamidauthor=Y.+T.+Wangauthor=E.+Tavassoliauthor=B.+Michalsenauthor=R.+T.+Asghodomauthor=J.+Luoauthor=G.+R.+Thatcher&title=NO-SSRIs%3A+nitric+oxide+chimera+drugs+incorporating+a+selective+serotonin+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fml2000033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000033%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Hay%26aufirst%3DS.%26aulast%3DSchiefer%26aufirst%3DI.%2BT.%26aulast%3DChandrasena%26aufirst%3DR.%2BE.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DAbdelhamid%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DTavassoli%26aufirst%3DE.%26aulast%3DMichalsen%26aufirst%3DB.%26aulast%3DAsghodom%26aufirst%3DR.%2BT.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DNO-SSRIs%253A%2520nitric%2520oxide%2520chimera%2520drugs%2520incorporating%2520a%2520selective%2520serotonin%2520reuptake%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D656%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Satoh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabunoki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arima, K.</span><span> </span><span class="NLM_article-title">Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus</span> <span class="citation_source-journal">Dis. Markers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1155%2F2009%2F618619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=20037212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SmsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=239-252&author=J.+Satohauthor=H.+Tabunokiauthor=K.+Arima&title=Molecular+network+analysis+suggests+aberrant+CREB-mediated+gene+regulation+in+the+Alzheimer+disease+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus</span></div><div class="casAuthors">Satoh, Jun-Ichi; Tabunoki, Hiroko; Arima, Kunimasa</div><div class="citationInfo"><span class="NLM_cas:title">Disease Markers</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">239-252</span>CODEN:
                <span class="NLM_cas:coden">DMARD3</span>;
        ISSN:<span class="NLM_cas:issn">0278-0240</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The pathogenesis of Alzheimer disease (AD) involves the complex interaction between genetic and environmental factors affecting multiple cellular pathways. Recent advances in systems biol. provide a system-level understanding of AD by elucidating the genome-wide mol. interactions.  By using KeyMolnet, a bioinformatics tool for analyzing mol. interactions on the curated knowledgebase, we characterized mol. network of 2,883 all stages of AD-related genes (ADGs) and 559 incipient AD-related genes (IADGs) identified by global gene expression profiling of the hippocampal CA1 region of AD brains in terms of significant clin. and pathol. correlations (Blalock et al., Proc Natl Acad Sci USA 101: 2173-2178, 2004).  By the common upstream search, KeyMolnet identified cAMP-response element-binding protein (CREB) as the principal transcription factor exhibiting the most significant relevance to mol. networks of both ADGs and IADGs.  The CREB-regulated transcriptional network included upregulated and downregulated sets of ADGs and IADGs, suggesting an involvement of generalized deregulation of the CREB signaling pathway in the pathophysiol. of AD, beginning at the early stage of the disease.  To verify the in silico observations in vivo, we conducted immunohistochem. studies of 11 AD and 13 age-matched control brains by using anti-phoshorylated CREB (pCREB) antibody.  An abnormal accumulation of pCREB imunoreactivity was identified in granules of granulovacuolar degeneration (GVD) in the hippocampal neurons of AD brains.  These observations suggest that aberrant CREB-mediated gene regulation serves as a mol. biomarker of AD-related pathol. processes, and support the hypothesis that sequestration of pCREB in GVD granules is in part responsible for deregulation of CREB-mediated gene expression in AD hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrkQ-abEnjnrVg90H21EOLACvtfcHk0lh_dv0X4x0YOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SmsbrI&md5=74a61093c3ca828b41437136046819cd</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1155%2F2009%2F618619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2009%252F618619%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DJ.%26aulast%3DTabunoki%26aufirst%3DH.%26aulast%3DArima%26aufirst%3DK.%26atitle%3DMolecular%2520network%2520analysis%2520suggests%2520aberrant%2520CREB-mediated%2520gene%2520regulation%2520in%2520the%2520Alzheimer%2520disease%2520hippocampus%26jtitle%3DDis.%2520Markers%26date%3D2009%26volume%3D27%26spage%3D239%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Louzada, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paula Lima, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca-Silva, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Mello, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, S. T.</span><span> </span><span class="NLM_article-title">Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer’s disease and other neurological disorders</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=511-518&author=P.+R.+Louzadaauthor=A.+C.+Paula+Limaauthor=D.+L.+Mendonca-Silvaauthor=F.+Noelauthor=F.+G.+De+Melloauthor=S.+T.+Ferreira&title=Taurine+prevents+the+neurotoxicity+of+beta-amyloid+and+glutamate+receptor+agonists%3A+activation+of+GABA+receptors+and+possible+implications+for+Alzheimer%E2%80%99s+disease+and+other+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouzada%26aufirst%3DP.%2BR.%26aulast%3DPaula%2BLima%26aufirst%3DA.%2BC.%26aulast%3DMendonca-Silva%26aufirst%3DD.%2BL.%26aulast%3DNoel%26aufirst%3DF.%26aulast%3DDe%2BMello%26aufirst%3DF.%2BG.%26aulast%3DFerreira%26aufirst%3DS.%2BT.%26atitle%3DTaurine%2520prevents%2520the%2520neurotoxicity%2520of%2520beta-amyloid%2520and%2520glutamate%2520receptor%2520agonists%253A%2520activation%2520of%2520GABA%2520receptors%2520and%2520possible%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520other%2520neurological%2520disorders%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D511%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun-Tian, Z.</span><span> </span><span class="NLM_article-title">Neuroprotection by <span class="smallcaps smallerCapital">d</span>-securinine against neurotoxicity induced by beta-amyloid (25–35)</span> <span class="citation_source-journal">Neurol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1179%2F016164104225014148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15494124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A280%3ADC%252BD2crisVCmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=792-796&author=X.+Linauthor=Z.+Jun-Tian&title=Neuroprotection+by+d-securinine+against+neurotoxicity+induced+by+beta-amyloid+%2825%E2%80%9335%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by D-securinine against neurotoxicity induced by beta-amyloid (25-35)</span></div><div class="casAuthors">Lin Xu; Jun-Tian Zhang</div><div class="citationInfo"><span class="NLM_cas:title">Neurological research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">792-6</span>
        ISSN:<span class="NLM_cas:issn">0161-6412</span>.
    </div><div class="casAbstract">The effects of (+) securinine on behavior and morphological changes after intracerebral ventricle injection of beta-amyloid (25-35) (Abeta(25-35)) in rats were investigated.  A single high dose of Abeta(25-35) could impair the spatial cognitive function.  The latency of locating the platform was longer in the model group than in the sham-operated group.  While chronic administration of D-securinine (40 mg kg(-1)) could significantly shorten the latency.  After Morris water maze, the activity of choline acetyltransferase (ChAT) and acetylcholinesterase (AchE) were detected.  The results showed that D-securinine could decrease the AchE activity significantly and have no effect on ChAT.  Meanwhile, immunohistochemistry analysis revealed that D-securinine could reduce the glial inflammatory responses induced by beta-amyloid protein.  These results suggest that the effect of D-securinine in improving the cognitive deficits and neurodegeneration in betaAP(25-35)-treated rats may involve direct and indirect actions on targets.  The GABA receptor plays a key role in these therapeutic effects and may be helpful in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJMikAQ3UnnYUSrryheKE6fW6udTcc2earn_GLKrsIu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crisVCmtg%253D%253D&md5=9cd653fa6e1526612775cf3cea6186ab</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1179%2F016164104225014148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F016164104225014148%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DX.%26aulast%3DJun-Tian%26aufirst%3DZ.%26atitle%3DNeuroprotection%2520by%2520d-securinine%2520against%2520neurotoxicity%2520induced%2520by%2520beta-amyloid%2520%252825%25E2%2580%259335%2529%26jtitle%3DNeurol.%2520Res.%26date%3D2004%26volume%3D26%26spage%3D792%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Lee, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seong, Y. H.</span><span> </span><span class="NLM_article-title">Chronic stimulation of GABAA receptor with muscimol reduces amyloid beta protein (25–35)-induced neurotoxicity in cultured rat cortical cells</span> <span class="citation_source-journal">Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.neures.2005.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15896866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFanurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=347-356&author=B.+Y.+Leeauthor=J.+Y.+Banauthor=Y.+H.+Seong&title=Chronic+stimulation+of+GABAA+receptor+with+muscimol+reduces+amyloid+beta+protein+%2825%E2%80%9335%29-induced+neurotoxicity+in+cultured+rat+cortical+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic stimulation of GABAA receptor with muscimol reduces amyloid β protein (25-35)-induced neurotoxicity in cultured rat cortical cells</span></div><div class="casAuthors">Lee, Bo Young; Ban, Ju Yeon; Seong, Yeon Hee</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-356</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study was performed to examine how the stimulation of γ-aminobutyric acid (GABA) receptor affects amyloid β protein (25-35) (Aβ (25-35)), a synthetic 25-35 amyloid peptide, -induced neurotoxicity using cultured rat cortical neurons.  Aβ (25-35) produced a concn.-dependent redn. of cell viability, which was significantly reduced by (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (MK-801), an N-methyl-D-aspartate (NMDA) receptor antagonist, verapamil, an L-type Ca2+ channel blocker, and NG-nitro-L-arginine Me ester (L-NAME), a nitric oxide synthase inhibitor.  Pretreatment with muscimol, a GABAA receptor agonist, over a concn. range of 0.1-10 μM 24 h before the treatment with 10 μM Aβ (25-35) showed concn.-dependent inhibition on the Aβ (25-35)-induced neuronal apoptotic death.  However, baclofen (1 and 10 μM), a GABAB receptor agonist, failed to inhibit the Aβ (25-35)-induced neuronal death.  In addn., pretreatment with muscimol (1 μM) for 24 h inhibited the Aβ (25-35) (10 μM)-induced elevation of cytosolic Ca2+ concn. ([Ca2+]c) and glutamate release, generation of reactive oxygen species (ROS), and caspase-3 activity in cultured neurons.  These neuroprotective effects of muscimol (1 μM) were completely blocked by the simultaneous treatment with 10 μM bicuculline, a GABAA receptor antagonist, indicating that the protective effects of muscimol were due to GABAA receptor stimulation.  When, however, treated just 15 min before the treatment with Aβ (25-35), muscimol (1 μM) did not show any protective effect against Aβ (25-35) (10 μM)-induced neurotoxicity in cultured neurons.  These results suggest that the chronic activation of GABAA receptor may ameliorate Aβ-induced neurotoxicity by interfering with the increase of [Ca2+]c, and then by inhibiting glutamate release, generation of ROS and caspase-3 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog0nPnnM_Lf7Vg90H21EOLACvtfcHk0ljVQqYeVZ0DVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFanurk%253D&md5=c180d58b267ec76b7740f7b59089bfd4</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2005.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2005.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BY.%26aulast%3DBan%26aufirst%3DJ.%2BY.%26aulast%3DSeong%26aufirst%3DY.%2BH.%26atitle%3DChronic%2520stimulation%2520of%2520GABAA%2520receptor%2520with%2520muscimol%2520reduces%2520amyloid%2520beta%2520protein%2520%252825%25E2%2580%259335%2529-induced%2520neurotoxicity%2520in%2520cultured%2520rat%2520cortical%2520cells%26jtitle%3DNeurosci.%2520Res.%26date%3D2005%26volume%3D52%26spage%3D347%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Marcade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peillon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rayer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desire, L.</span><span> </span><span class="NLM_article-title">Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1111%2Fj.1471-4159.2008.05396.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=18397369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1Ogtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=392-404&author=M.+Marcadeauthor=J.+Bourdinauthor=N.+Loiseauauthor=H.+Peillonauthor=A.+Rayerauthor=D.+Drouinauthor=F.+Schweighofferauthor=L.+Desire&title=Etazolate%2C+a+neuroprotective+drug+linking+GABA%28A%29+receptor+pharmacology+to+amyloid+precursor+protein+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing</span></div><div class="casAuthors">Marcade, Maryline; Bourdin, Jerome; Loiseau, Nadia; Peillon, Helene; Rayer, Aurelie; Drouin, Dominique; Schweighoffer, Fabien; Desire, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">392-404</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Pharmacol. modulation of the GABAA receptor has gained increasing attention as a potential treatment for central processes affected in Alzheimer disease (AD), including neuronal survival and cognition.  The proteolytic cleavage of the amyloid precursor protein (APP) through the α-secretase pathway decreases in AD, concurrent with cognitive impairment.  This APP cleavage occurs within the β-amyloid peptide (Aβ) sequence, precluding formation of amyloidogenic peptides and leading to the release of the sol. N-terminal APP fragment (sAPPα) which is neurotrophic and procognitive.  In this study, we show that at nanomolar-low micromolar concns., etazolate, a selective GABAA receptor modulator, stimulates sAPPα prodn. in rat cortical neurons and in guinea pig brains.  Etazolate (20 nM-2 μM) dose-dependently protected rat cortical neurons against Aβ-induced toxicity.  The neuroprotective effects of etazolate were fully blocked by GABAA receptor antagonists indicating that this neuroprotection was due to GABAA receptor signaling.  Baclofen, a GABAB receptor agonist failed to inhibit the Aβ-induced neuronal death.  Furthermore, both pharmacol. α-secretase pathway inhibition and sAPPα immunoneutralization approaches prevented etazolate neuroprotection against Aβ, indicating that etazolate exerts its neuroprotective effect via sAPPα induction.  Our findings therefore indicate a relation between GABAA receptor signaling, the α-secretase pathway and neuroprotection, documenting a new therapeutic approach for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrztjL6EyMUk7Vg90H21EOLACvtfcHk0ljVQqYeVZ0DVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1Ogtrc%253D&md5=7cc211782d7167d22844102b4a920603</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05396.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05396.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarcade%26aufirst%3DM.%26aulast%3DBourdin%26aufirst%3DJ.%26aulast%3DLoiseau%26aufirst%3DN.%26aulast%3DPeillon%26aufirst%3DH.%26aulast%3DRayer%26aufirst%3DA.%26aulast%3DDrouin%26aufirst%3DD.%26aulast%3DSchweighoffer%26aufirst%3DF.%26aulast%3DDesire%26aufirst%3DL.%26atitle%3DEtazolate%252C%2520a%2520neuroprotective%2520drug%2520linking%2520GABA%2528A%2529%2520receptor%2520pharmacology%2520to%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D392%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Ziakas, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rekka, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavalas, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleftheriou, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiakitzis, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourounakis, P. N.</span><span> </span><span class="NLM_article-title">Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">6485</span><span class="NLM_x">–</span> <span class="NLM_lpage">6492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.bmc.2005.07.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=16185877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=6485-6492&author=G.+N.+Ziakasauthor=E.+A.+Rekkaauthor=A.+M.+Gavalasauthor=P.+T.+Eleftheriouauthor=K.+C.+Tsiakitzisauthor=P.+N.+Kourounakis&title=Nitric+oxide+releasing+derivatives+of+tolfenamic+acid+with+anti-inflammatory+activity+and+safe+gastrointestinal+profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile</span></div><div class="casAuthors">Ziakas, George N.; Rekka, Eleni A.; Gavalas, Antonios M.; Eleftheriou, Phaedra T.; Tsiakitzis, Karyofillis C.; Kourounakis, Panos N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6485-6492</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tolfenamic acid esters with nitrooxyalcs. are synthesized.  They are anti-inflammatory agents reducing carrageenan rat paw edema, with low gastrointestinal and general toxicity.  In vitro, they are nitric oxide donors, inhibitors of lipoxygenase and cyclooxygenases.  A two to three carbon chain between carboxylic and nitric ester groups seems optimal for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFG3Vrt6Akb7Vg90H21EOLACvtfcHk0ljVQqYeVZ0DVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsLbN&md5=fd4363233e709ce62fb73e94eaebf443</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.07.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.07.049%26sid%3Dliteratum%253Aachs%26aulast%3DZiakas%26aufirst%3DG.%2BN.%26aulast%3DRekka%26aufirst%3DE.%2BA.%26aulast%3DGavalas%26aufirst%3DA.%2BM.%26aulast%3DEleftheriou%26aufirst%3DP.%2BT.%26aulast%3DTsiakitzis%26aufirst%3DK.%2BC.%26aulast%3DKourounakis%26aufirst%3DP.%2BN.%26atitle%3DNitric%2520oxide%2520releasing%2520derivatives%2520of%2520tolfenamic%2520acid%2520with%2520anti-inflammatory%2520activity%2520and%2520safe%2520gastrointestinal%2520profile%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D6485%26epage%3D6492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Madrigal, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dello Russo, C.</span><span> </span><span class="NLM_article-title">Norepinephrine protects cortical neurons against microglial-induced cell death</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1002%2Fjnr.20481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=15948176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnsVeltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2005&pages=390-396&author=J.+L.+Madrigalauthor=D.+L.+Feinsteinauthor=C.+Dello+Russo&title=Norepinephrine+protects+cortical+neurons+against+microglial-induced+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Norepinephrine protects cortical neurons against microglial-induced cell death</span></div><div class="casAuthors">Madrigal, Jose L. M.; Feinstein, Douglas L.; Russo, Cinzia Dello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-396</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Interleukin-1 beta (IL-1β) is one of the main cytokines involved in the inflammatory response; it has multiple effects that can contribute to cell damage, one of which is the upregulation of the inducible form of nitric oxide (NO) synthase (NOS2) in certain cell types.  The authors demonstrated previously that in vivo, cortical microglial inflammatory responses were increased when noradrenaline (NE) levels were depleted, suggesting that NE can reduce microglial activation.  In the present report, the authors examd. the role of IL-1β in neurotoxicity induced by microglial-conditioned media, and possible neuroprotective effects of NE.  Incubation of cortical neurons with conditioned media (CM) obtained from lipopolysaccharide (LPS)-treated microglia induced neuronal NOS2 expression and increased neuronal cell death, and these responses were reduced if the neurons were coincubated with interleukin-1 receptor antagonist.  Cotreatment of microglial cells with LPS plus NE potently blocked IL-1β prodn. and reduced the ability of the CM to induce neuronal NOS2 and cell death.  These results suggest that microglial release of IL-1β is an important activator of neuronal inflammatory responses, and that protective effects of NE upon neurons involve a redn. of microglial-derived IL-1β.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_m4emv_nBLrVg90H21EOLACvtfcHk0lj0KQ7-G3opBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnsVeltLs%253D&md5=891a9e3b4659e918118c0a9e62d57315</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1002%2Fjnr.20481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.20481%26sid%3Dliteratum%253Aachs%26aulast%3DMadrigal%26aufirst%3DJ.%2BL.%26aulast%3DFeinstein%26aufirst%3DD.%2BL.%26aulast%3DDello%2BRusso%26aufirst%3DC.%26atitle%3DNorepinephrine%2520protects%2520cortical%2520neurons%2520against%2520microglial-induced%2520cell%2520death%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2005%26volume%3D81%26spage%3D390%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Canas, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velly, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrande, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillet, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautou-Miranda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masmejean, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieoullon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruder, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, P. S.</span><span> </span><span class="NLM_article-title">Sevoflurane protects rat mixed cerebrocortical neuronal-glial cell cultures against transient oxygen–glucose deprivation: involvement of glutamate uptake and reactive oxygen species</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2006&pages=990-998&author=P.+T.+Canasauthor=L.+J.+Vellyauthor=C.+N.+Labrandeauthor=B.+A.+Guilletauthor=V.+Sautou-Mirandaauthor=F.+M.+Masmejeanauthor=A.+L.+Nieoullonauthor=F.+M.+Gouinauthor=N.+J.+Bruderauthor=P.+S.+Pisano&title=Sevoflurane+protects+rat+mixed+cerebrocortical+neuronal-glial+cell+cultures+against+transient+oxygen%E2%80%93glucose+deprivation%3A+involvement+of+glutamate+uptake+and+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCanas%26aufirst%3DP.%2BT.%26aulast%3DVelly%26aufirst%3DL.%2BJ.%26aulast%3DLabrande%26aufirst%3DC.%2BN.%26aulast%3DGuillet%26aufirst%3DB.%2BA.%26aulast%3DSautou-Miranda%26aufirst%3DV.%26aulast%3DMasmejean%26aufirst%3DF.%2BM.%26aulast%3DNieoullon%26aufirst%3DA.%2BL.%26aulast%3DGouin%26aufirst%3DF.%2BM.%26aulast%3DBruder%26aufirst%3DN.%2BJ.%26aulast%3DPisano%26aufirst%3DP.%2BS.%26atitle%3DSevoflurane%2520protects%2520rat%2520mixed%2520cerebrocortical%2520neuronal-glial%2520cell%2520cultures%2520against%2520transient%2520oxygen%25E2%2580%2593glucose%2520deprivation%253A%2520involvement%2520of%2520glutamate%2520uptake%2520and%2520reactive%2520oxygen%2520species%26jtitle%3DAnesthesiology%26date%3D2006%26volume%3D105%26spage%3D990%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Schubert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piasecki, D.</span><span> </span><span class="NLM_article-title">Oxidative glutamate toxicity can be a component of the excitotoxicity cascade</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7455</span><span class="NLM_x">–</span> <span class="NLM_lpage">7462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=11567035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFCksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=7455-7462&author=D.+Schubertauthor=D.+Piasecki&title=Oxidative+glutamate+toxicity+can+be+a+component+of+the+excitotoxicity+cascade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative glutamate toxicity can be a component of the excitotoxicity cascade</span></div><div class="casAuthors">Schubert, David; Piasecki, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7455-7462</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Along with ionotropic and metabotropic glutamate receptors, the cystine/glutamate antiporter xc- may play a crit. role in CNS pathol.  High levels of extracellular glutamate inhibit the import of cystine, resulting in the depletion of glutathione and a form of cell injury called oxidative glutamate toxicity.  Here the authors show that a portion of the cell death assocd. with NMDA receptor-initiated excitotoxicity can be caused by oxidative glutamate toxicity.  In primary mouse cortical neurons the cell death resulting from the short-term application of 10 μM glutamate can be divided into NMDA and NMDA receptor-independent phases.  The NMDA receptor-independent component is assocd. with high extracellular glutamate and is inhibited by a variety of reagents that block oxidative glutamate toxicity.  These results suggest that oxidative glutamate toxicity toward neurons lacking functional NMDA receptors can be a component of the excitotoxicity-initiated cell death pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7e-C8fPwJ67Vg90H21EOLACvtfcHk0lj0KQ7-G3opBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFCksrY%253D&md5=3085eb710b5808260bad255440a9aa84</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchubert%26aufirst%3DD.%26aulast%3DPiasecki%26aufirst%3DD.%26atitle%3DOxidative%2520glutamate%2520toxicity%2520can%2520be%2520a%2520component%2520of%2520the%2520excitotoxicity%2520cascade%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3D7455%26epage%3D7462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Ha, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeng, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. S.</span><span> </span><span class="NLM_article-title">Chronic glutamate toxicity in mouse cortical neuron culture</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1273</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm300353r&amp;key=10.1016%2Fj.brainres.2009.03.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm300353r&amp;key=19344697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlKisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1273&publication_year=2009&pages=138-143&author=J.+S.+Haauthor=C.+S.+Leeauthor=J.+S.+Maengauthor=K.+S.+Kwonauthor=S.+S.+Park&title=Chronic+glutamate+toxicity+in+mouse+cortical+neuron+culture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic glutamate toxicity in mouse cortical neuron culture</span></div><div class="casAuthors">Ha, Jong Seong; Lee, Chul-Sang; Maeng, Jin-Soo; Kwon, Ki-Sun; Park, Sung Sup</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1273</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-143</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two pathways for glutamate toxicity have been described, receptor-mediated excitotoxicity and non-receptor mediated oxidative glutamate toxicity.  Here, we show that two distinct forms of receptor-mediated primary cortical neuronal death exist, chronic and acute glutamate toxicity, and that these depend on exposure time.  In vitro, neuronal sensitivity to chronic glutamate exposure increased as neurons matured and the initial plating medium contributed as well.  In immature neurons, high concns. of glutamate induced neuronal death.  The chronic glutamate toxicity was independent of neuronal d., whereas increased d. potentiated acute glutamate toxicity.  Activation of ionotropic glutamate receptors (iGluRs) contributed to induction of chronic and acute glutamate toxicity at similar rates at DIV14.  Inactivation of the metabotropic glutamate receptors (mGluRs) by AIDA increased neuronal sensitivity to chronic glutamate exposure but not to acute exposure.  Neuronal death by acute toxicity was much faster than by chronic toxicity in which activation of mGluRs was involved.  These results suggest that acute glutamate toxicity is quite different from chronic toxicity, in which activation of mGluRs is assocd. with resistance to glutamate toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTLWeIYQO1dbVg90H21EOLACvtfcHk0lj0KQ7-G3opBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlKisLw%253D&md5=5d9f68620c43dd811a062f03aa7dd41a</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.03.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.03.050%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DMaeng%26aufirst%3DJ.%2BS.%26aulast%3DKwon%26aufirst%3DK.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BS.%26atitle%3DChronic%2520glutamate%2520toxicity%2520in%2520mouse%2520cortical%2520neuron%2520culture%26jtitle%3DBrain%2520Res.%26date%3D2009%26volume%3D1273%26spage%3D138%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Abdelhamid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandevrede, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litosh, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiefer, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherezghiher, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatcher, G. R.</span><span> </span><span class="NLM_article-title">Benzothiophene selective estrogen receptor modulators provide neuroprotection by a novel GPR30-dependent mechanism</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100106a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm300353r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFektLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=256-268&author=R.+Abdelhamidauthor=J.+Luoauthor=L.+Vandevredeauthor=I.+Kunduauthor=B.+Michalsenauthor=V.+A.+Litoshauthor=I.+T.+Schieferauthor=T.+Gherezghiherauthor=P.+Yaoauthor=Z.+Qinauthor=G.+R.+Thatcher&title=Benzothiophene+selective+estrogen+receptor+modulators+provide+neuroprotection+by+a+novel+GPR30-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a Novel GPR30-Dependent Mechanism</span></div><div class="casAuthors">Abdelhamid, Ramy; Luo, Jia; Vande Vrede, Lawren; Kundu, Indraneel; Michalsen, Bradley; Litosh, Vladislav A.; Schiefer, Isaac T.; Gherezghiher, Teshome; Yao, Ping; Qin, Zhihui; Thatcher, Gregory R. J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">256-268</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The clin. benzothiophene SERM (BT-SERM) raloxifene was compared with estrogens in protection of primary rat neurons against oxygen-glucose deprivation (OGD).  Structure-activity relationships for neuroprotection were detd. for a family of BT-SERMs displaying a spectrum of ERα and ERβ binding affinity and agonist/antagonist activity, leading to discovery of a neuroprotective pharmacophore, present in the clin. relevant SERMS, raloxifene, and desmethylarzoxifene (DMA), for which submicromolar potency was obsd. for neuroprotection.  BT-SERM neuroprotection did not correlate with binding to ER or classical ER activity; however, both the neuroprotective SERMs and estrogens were shown, using pharmacol. probes, to activate the same kinase signaling cascades.  The antiestrogen ICI 182,780 inhibited the actions of estrogens but not those of BT-SERMs, whereas antagonism of the G-protein coupled receptor, GPR30, was effective for both SERMs and estrogens.  Since SERMs have antioxidant activity, ER-independent mechanisms were studied using the classical phenolic antioxidants, BHT and Trolox, and the Nrf2-dependent cytoprotective electrophile, sulforaphane.  However, neuroprotection by these agents was not sensitive to GPR30 antagonism.  Collectively, these data indicate that the activity of neuroprotective BT-SERMs is GPR30-dependent and ER-independent and not mediated by antioxidant effects.  Comparison of novel BT-SERM derivs. and analogs identified a neuroprotective pharmacophore of potential use in design of novel neuroprotective agents with a spectrum of ER activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvBt-wQmRmLrVg90H21EOLACvtfcHk0lhbiu4vMvRhVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFektLg%253D&md5=c1d5a55aee4f2271ec666b42f62b50c1</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fcn100106a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100106a%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelhamid%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DVandevrede%26aufirst%3DL.%26aulast%3DKundu%26aufirst%3DI.%26aulast%3DMichalsen%26aufirst%3DB.%26aulast%3DLitosh%26aufirst%3DV.%2BA.%26aulast%3DSchiefer%26aufirst%3DI.%2BT.%26aulast%3DGherezghiher%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DP.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DThatcher%26aufirst%3DG.%2BR.%26atitle%3DBenzothiophene%2520selective%2520estrogen%2520receptor%2520modulators%2520provide%2520neuroprotection%2520by%2520a%2520novel%2520GPR30-dependent%2520mechanism%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D256%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a href="/doi/suppl/10.1021/jm300353r">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_46120"></div></div></div></div></div><hr /></hr><p class="last">HPLC chromatogram of the incubation of <b>42</b> in phosphate buffer (100 mM, pH 7.4) at room temperature for 48 h and the proposed mechanism of decomposition (Figure S1); inhibition of excitotoxic cell death from treatment with NMDA (100 μM) by CMZ and by a number of MZ derivatives (Table S1). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300353r/suppl_file/jm300353r_si_001.pdf">jm300353r_si_001.pdf (147.3 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300353r&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm300353r%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-15%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300353r" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799137b7e703dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
